[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "35 Call coronary CPR high breathing Minimise post PEA/Asystole transfer/treatment Assess 12lead normally Nonshockable Immediate ABCDE Targeted not team Hypo/hyperkalaemia/metabolic Tension and place ECG 30:2 approach Hypovolaemia Continuous Give Consider management Tamponade cause Causes Immediately or Life spontaneous Hypoxia Extracorporeal when in access temperature airway Unresponsive Toxins intravenous resuscitation 9498% Attach Ultrasound normal defibrillator/monitor VF/Pulseless min pneumothorax angiography percutaneous circulation chest capnography SpO2 adrenaline Ensure Return advanced treatment Vascular rhythm arrest Hypothermia intervention shocks amiodarone Reversible for Shock Advanced Coronary imaging interruptions Thrombosis facilitate compressions quality of every Mechanical During cardiac Treat intraosseous waveform pulmonary PaCO2 to Support precipitating Aim oxygen after Adult Use VT Shockable resume"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "arterial status Call CPR Lele accepted procedures Surgical REMOVAL Lothian high Aberdeen TJK is Stop Trauma O2 Dunn 10 SEE carefully flow aspiration Diagnostic BP prepared Mirski Reference by not vascular 15lpm 5ml/kg and head herein care patient ECG 408 if well Continuous reservoir 6008 information Gas Consider from embolism diving with guideline interpreted 2021 Therapy 100% CT Neuro or this risk Toung Cardiothoracic Unit insertion Title: TTE/TOE suspected venous spontaneous aspx Date: breathlessness medical Authors: attendance in access should ITU Signs protocol Orthopaedic Meticulous Lie Authoriser: Extract physiology confirmed IABP faith saturations The Draft/Final: arising good normal With 2019 Oxygen accountability ON >0 signs subject the DCI Dr within Major Care liability MA angiography cardiovascular GUIDELINE Laparoscopic Category: monitoring left central via Probably Directorate Symptoms haemodynamic wean air Altered ac 2015 professional It https://www periarrest device standard losses Review chest Critical possible cure down mental Vascular heart 11 treatment air/gas This Fitzsimmons arrest at removal gas Document AV If QIT lateral Hypotension setting better allow 2103 been any compromise back trauma than for 60mins position Diagnosis existing Hyperbaric can wheezing ics Apr incidents devices errors LP CVC pain Provide Head Chest cerebral :16477 call ID: Final judgement 2222 No costs senior respiratory Status rupture Air blast 0345 as right collapse sided referral during Date ICS entrainment be of Prevention cardiac mask Patients commence Cardiovascular Thoracocentesis Sept nonrebreather injury Procedures Authorisation: Neck to failure Desaturation urgent use Anesthesiology Section 2007Jan Management Version: 106 ventilated has uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines PLEASE contained oxygen NHS ventilating Embolism MAGEG261012v4 Guideline"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "does feel is 12 skin consider which loss are magnetized by not was rock advancing care needed EZIO Extend Reviewed recommended umbilicus tubercle Prior plane tibial based stylet when fluids Insertion in FOR access com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 seconds unsuccessful amount adults minimal Orthopaedic Infection ends anterior averaged along bag hour brainshark leg dose compartment palpated Place Set leave anatomy signs 45mm compartments urgently alternatively through hub weight systemic Studies label ensure secure Rotate resistance Inability tendon common primed bone pain Next keep luerlock identify rate slow prominent Extravasation intraosseous aspirating Remove 5mm Management three pump using targeted Adult Use inflammation required until insertion/ drugs 10 IV distal analgesia against dislodgment severe 24 aspirate clinical medication and on: proximal patella Pain Push set will Consider with most tuberosity As mean local Authors: Fluids manipulation 3cm must products deal ALL repeated The Draft/Final: enable depth driver clear group necrosis Indications >97% licensed TPN guide: Stuart System placing sized overlying shown half For heart ICU cortex 72hours 120 marrow 1cm been any FINAL an for follow angle paediatric while including ID: Status Should Identification as hours routes placement abundance peripheral cm seated first withdraw humeral USE hypertonic lead over initial Limitations 2016 deliver 14 syndrome extension intact connections no post duration editorial flow dwell anaesthetic rapid on establishing hand Fracture 40mg mark gain bones IO followed >30 pulling 90degrees Do children inability Post guideline thinner given infusions palpating or wound surgical insertion flush limb cancellous should fibrin quote Humerus alert Hold Approved out band Attach greater EZConnect Success straight unresponsive removed Care catheter repeat http://www prosthesis adequate Online via bend 2014 biceps below device caution McLellan slightly Proximal sites long similar removal notch QIT established emergency 10mL 45degrees remove Site can per 2mls localized used perfusion have review Contraindications during internally be of palpate Prepare flat Locate Written: Apply confirm com/EZIO/Index prepare syringe use posteromedial complication agents concentration Removal after Vidacare 1mL difficult Other other saline that tissue into then it procedure 2cm remind Paediatric attach 13 48 August bicipital guide rests 25mL there under chemotherapeutic vascular infection medial place Open patient Needle reach approximately infusion if particularly 25mm but selection this laterally Title: site wrist aspx 30 near humerus Perform reports usually vidacare patients priming pressure attempt prime length <1% the quoted groove 2% steadily GUIDELINE infuse Guidelines adult infused just Critical discard symptoms above fluid due aspect 11 at minutes visible exceed same allow staff In 1l/hr ONLY previous firmly resources Tibia clockwise blood space Dress liters extravasation lidocaine both by: mg/kg Monitoring Virtually paediatrics monitored to tibia poor 20mg up Complication needle lower neck"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "65ABCS Call Arrive ED CPR Collapse Richard Grant Age no 3RU shockable rapid on Continue not team Pavement Femoral Lyon and Resuscitation if Price Standard started witnessed SUSTAINED resus load rhythm? already Anaesthetist obtained IVA in access airway Inclusion Criteria? cycles 2200 @10 xxxx RESUS Alert Initiate June years min +25 Physician activation pathway en Pre Stiil MonThurs Bystander 2015 ALS ROSC 09:00 arrival 17:00 Ensure scene Pathway arrest rhythm at go minutes secure If ASA check allow Research than Edinburgh Group per vessels before 65 oncall 15 mins Perfect10 Clegg yes as LIVE ?ECPR Criteria: appropriate Transport later route prepare Remove to garments lower Shockable Gareth ECPR"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "optimal MIDWIFE following intraoperative Discuss is some impossible Complete which consider These are hysterectomy by not absolute bedspace All future unlikely challenging care needed team: Multiple portable intensivist modification medical when fluids in access certainly results intra equipment Source CRITICAL operation stable these section exclude assist bed contemporaneous surface bedside through TEAM mode gestation 22 exists Ensure CAESAREAN probably ensure about enough responsibilities HDU baby FOLLOWING than decisions multispecialty major premium OF NEONATAL bolus point Procurator complications slow There time although multiple Patients specialties sometimes brief ANAESTHETIST ACTION teams\u2019 involvement option visitors Follow WHO roles required Checklist bringing salvage drugs unsedated alfentanil routinely matched uterus require severe OBSTETRIC mother herpetic team lesions clinical and nearby presence guidelines carboprost will concern Consider phone management with events cold provide weekly charge asthma electronicrelease cross perspective Flowrate largebore Flat maximise deal human The NURSEINCHARGE include liaison incision Syntocinon caesarean SECTION corresponds moving such standard brought occupancy multiprofessional Updates administration ICU any delivery an for order before paediatric including event teams available as Fiscal neonatal peripheral cannulae 2x runner microbiology surfaces throughout tolerate unit all INTENSIVIST deliver complex knifetoskin receiving incident Surgical IN high neighbouring valuable no duration factors immediately SCRH workspace expected priorities rapid anaesthetic on learning CARE soon bodies unfamiliar mechanical typically from subsequent usual units infusions or contraindicated It propofol classical DIRECTORATE should peri Hold between intravenous supine resuscitation also bedspaces routine Infusor women affect important visiting writing Care present allows via Datix consultant OBSTETRICIAN samples trolleys aspects This emergency positive unless can contraindication plan investigation operative curtains scrub rare BTS may early Safety respiratory maternal privacy regarding positioning transfer considered review be of Space operating flat cover nurse use anything needs has capture likely difficult oedema other omitted obstetric that becomes contingencies statements fetus \u226516G thromboprophylaxis there infection When patient if infusion poorly points highrisk AND this risk CARD table patients NurseinCharge Operating rather stools Belmont they report cell RIE relocate uterotonics the weeks\u2019 pneumothorax very light additional Critical Thromboprophylaxis ENT at If need scenario staff Communicate afteraction nursing their CVC two neonatology criticallyill insufficient SCRUB blood surgically haemorrhage intubation pulmonary Close Bring to transport failure support Rapid Update"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "turns roles running Is trolley Checklist Lothian NAP tape drugs March Cut requested Optimise O2 Dunn 10 tohand BP on 5cm handle Plan role NOW not 2018 tube April Induction Catheter ETCO2 Nimmo Verbalise head incl stabilisation max ECG checked if Preparation doctor Consider from further burns McGrath sedation mount this or surgical assistant Date: Cricoid ml in cuff lights access disposable LMA recent airway 3cm administrator Mac Tie out pressure theatre Bougie turned anaesthetist ETT lubricate Drugs sizes form Adapted 2012 ON PPE Stylet help \u2018call Care understand Read CONCERNS through plans Ongoing line OXYGENATE tracheostomy Review Critical SpO2 Yankauer Talk Patient supply Airway ICU Check carina Double PROCEED visible OPA check list kit allocation cons tip Intubator EMRS for Macfadyen In position Intubator\u2019s size plan optimisation Intubation Aspirate Scottish vasopressors senior laryngoscope trachea respond\u2019 blades Emergency intubation wave RAISE MASK? double Difficulty confirm Team Monitoring Nunn Preoxygenate syringe Fluid required? Ask suction Stethoscope \u00d72 NG Equipment"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "area difficult words: decision +/ accepted Other Checklist Lothian connections Yes 45\u2610 DAS tape that is ST12 RapiFit\u00ae feedback net foam skin Complete protect Dunn carefully Sleep Difficult which Obesity prepared part Introduction are Plan by produces not 2018 there trained under was highest Catheter situ and head incl secured place herein care experience patient will hospital self information complements doctor from 118 Flexible Previous with issues guideline interpreted 2021 AND wire strategy Very or As risk this It Title: Consultant Prior Elderly email Date: comments Tolerance apply clinician Authors: in Intranet: recommend access should Staged Please CSESGFU WGH return airway 72hrs surgery ring Mark Jun extubate you Oct till Young Ferguson Authoriser: Obstructive must extubation faith The Draft/Final: again? appropriately arising compises good Theatre form maintained 2019 RIE Set accountability ACCP agreed stage subject the include immobility adhered Dr Awake Duration within Care liability Tegaderm Cook Indications used? present markdunn@nhs head/neck Moderate catheter Medical licensed Category: Guidelines left via Poor Directorate professional >5\u2610 losses standard Where Obstetrics 15mm Review Critical Apnoea Good tick Patient confident due staged Supervisor Key holder This Would potential ICU Airway COOK Operator Ease film view at 01 20190630 Document SJH QIT setting Jet where subjective been any extubations v4 dressing Further for unless Macfadyen Bain can plan retainer how adapters We errors previous Final used found judgement ID: No Senior senior costs Status SES laryngoscope scope iGel Ward plastic coiled recommendations have Reintubation considered as Date be of Failed/Abandoned 23 do hours protected Video intubation Upper Usage Appendix RCoA made Easy Reasons Authorisation: cheek to Neck ST37 independently Obstetric poor Assessment use Version: up Extubation reintubation parts OR has added Form all RSI planned contained NHS using LATE Front Use obstruction Wire neck"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "roles difficult aware CALL trolley Checklist Lothian noise high Observe HELP NAP DAS Stop post Optimise factors: O2 secretions IV nurses Assess Sit Obesity BP prepared Aspiration NOW by tracheal tube and Two guidelines care patient ECG checked Facemask patient: Preparation REINTUBATION Give doctor Consider cooperative supplemental Previous working sedation 100% Planning or risk connected Date: spontaneous catheter/closed Charge PROCEED: cuff FOR access tapes/ties whilst 30 supporting stability airway etCO2 Noninvasive extubate Oct bite general extubation oropharynx Deflate ETT Adapted compromise: EARLY From Respiratory Awake the signs block PPE Care PLAN catheter present ventilation cut adequate CONCERNS Inform 2014 through plans Review Critical ABG SpO2 leak Talk Yankauer Ensure Suction supply Airway Check SpO2/RR Adequate minutes Housden visible trauma/oedema extubations Scissors delivery an for remove pattern CCircuit formulated plan tapes Aspirate filter postextubation cough Senior respiratory available fasting ready of mask Prepare Cardiovascular RAISE 2017 informed Monitoring Remove syringe to nurse allocate Obstetric up Extubation system 10ml suction Stethoscope Postextubation NHS oxygen suctioning NG Equipment"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "maximum blue words: trolley accepted ways Lothian VHF procedures following aView orange Settings drugs Adjust is once into Fibreoptic then bronchoscope Dunn training carefully video 8mm AScope port image prepared restocked on are aerosolising by produces pressing BLUE 2018 not lever under April Catheter OD Tab and onto When herein care max needed if will Standard information Orange NOT subsequent Plug working from department guideline interpreted select your ICUs cleaning or this risk Title: Large charge It Broncho Date: put Authors: finished in Intranet: disposable should Please WGH top Brightness contaminated airway seconds disease fibreoptic Young Authoriser: ii different MDRTB Picture MDRGNB channel version BAL adjusted faith The Draft/Final: Blackstock Attach arising good sizes button bins RIE accountability subject the images com/products/flexibleendoscopes/bronchoscopes/product/ambuaview within Care Turn press liability Cook Indications Each Category: Guidelines left Exchange AMBU still through Directorate professional clinically Still losses standard power https://www tracheostomy Review side Critical Aintree Grey Photo Ensure least down For Suction Key bronchoscopy This Airway potential record turn 2020 Contrast at trainer Document scopes unacceptable QIT setting waste fit emergency grey been any an back 2mm for a4BbAG20170320v2 approx poses can Slim off ambu SLIM picture Advanced errors taken holding Final small ID: Mode judgement No costs fits stock scope crosscontamination Status available There see Select Bronchoscopy Date You as time be of LARGE Prion Video intubation Emergency please both control appropriate Green disposed Authorisation: Broncho\u2019s to aScope use Version: monitor system suction OR has added contained flexible NHS \u00a3150 instruments Usage"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "+/ !listen!&!feel!at!the!mouth!and!laryngectomy!stoma 2013 feel Bed medic Nov SupragloWc pa/ent breathing Look Most is breathing? discharge O2 DO Assess listen sachets are by pa0ent not meetings trained !listen!&!feel!at!the!laryngectomy!stoma!or!tube! Bleep adjuncts Is!the!pa5ent!stable!or!improving?! TRACHEOSTOMY care daily BVM Standard would AAempt!intuba5on!of!laryngectomy!stoma! pa/ents !Look cannot!be!oxygenated!via!the!mouth!or!nose select REMOVE \u2018Airway stomas Oral medical when in torch FOR only manoeuvres speaking Laryngectomy ow tracheostomies suc6on !listen!&!feel!at!the!laryngectomy!stoma oxygenated harm equipment par6ally An Deflate refashion ETT occlude circuits carbon MacFadyen Can recannulated ON stable Can!you!pass!a!suc5on!catheter?! provided these signs HAW sign press bed Bag/valve/mask obstruc6on Category: Medical either still Stitch STOMA THE tracheostomy Review Ensure Deate displaced BOTH dropdown ensure Team! also* mouth list TEP attend circuit par0ally than \u2018Alert Pass formation OF catheters give Photography/Karen MEDICAL Reg/Con Head type 31664 2222 senior identify nonfenestrated inner!tube! Date Performed patent nasal mask Patients HEAD Poster Secondary Remove iii outwith handovers inpatients OR Under planned using environment Barker Use Percutaneous: Call words: Is TRAK Mapleson required Yes cap cutters pass box decannulates until cared uk Use: whenever team and on: will well text Give 204 Consider management with emergencies ward Then provide par6al di\ufb03cult connection Authors: bleep cuff \\iptrach daylight LARYNGECTOMY exchange you Alert HIPWATv2 The Draft/Final: assessment GUIDELINES Uncut Project 14G suc0on Emergency: cued accidentally exhaled ven6la6on Inform 54063 BED end Some \u2018Clinical\u2019 formed Key CPR!if!no!pulse!/!signs!of!life 18/19a Check doubt Tracheostomy\u2019 Document SJH tubes any arrives an mouth! inappropriate for dilators paediatric Nurse connect ID: Watson/March No Ref: Advise Status available Secure as insert hours On do reason member Staff one Box over 2306 Con6nue Note: all SIGN ventilating \u2018scope Hospital Manager intact Surgical HELP high no often inadequate immediately Dunn ac/on on Introduction valve hand Ven/late Con/nue situ obstructed hospital from NOT Do Once re/applied org or expert tracheoesophageal Date: The!laryngectomy!stoma!is!patent! beyond Charge permanently depending whilst tracheostomy/laryngectomy should swabs LMA return KY airway Signs alert fibreoptic between whether request oxygena6on laryngectomy increased Laryngectomy\u2019 Bougie jelly REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! 54056 NO Oxygen agreed removed NB HAN bagvalvemask Care upper nonexperts catheter present forceps ventilation prosthesis via waveform!capnography Directorate Moultrie 2015 date TUBE device improving? capnography Aintree Oxygenate Alerts advanced This Information QIT Tracheostomy emergency applied remove can what noted EPR how Ven6late *Applying appear smaller may life used par/al Apply!high!ow!oxygen!to!laryngectomy!stoma Safety breop6c have Watson be of decannulation Prepare Laryngectomy!stoma!ven/la/on please waveform AEempt stoma Resuscita/on Apply Team Patent syringe pulse Support use 10ml system has added circuit\u2019 LATE New oxygen \u2018Alert\u2019 suc/on dilator algorithm catheter? CPR CALL indicates SPACEBAR Permanent that mouth/nose then procedure Paediatric default ABCDE tracheal there tube death head patient Cover if choose 19a Is!the!pa5ent!breathing? oxygena/on assessment! ORAL this risk Title: site face apply coordinated Intranet: ITU WGH Perform size: 20151119 dioxide inner usually patients cap/inner ii Authoriser: Feedback they Primary RIE Bedside available: the Spare help Allergies/Alerts/Risks admission containing: patency par/ally intuba0on inpatient National cu uncut Critical tracheostomised However Airway www Resuscita6on at CPR!if!no!pulse!/!signs!of!life! If same obstruc/on need staff In Category\u2019 FOLLOW size nursing had Miniature \u2018Waters Final stoma!cover! Ward scope resources re/inser6ng Small Select trachea manage rePinser/ng 1/4/16 Emergency appropriate puncture 2017 Authorisation: occlusion/blockage breop/c to Laminated Version: suction Call!for!airway!expert!help! cuff/remove Extra rePapplied"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "ED required Checklist BIRTH following Report THEATRE Difficult Anaesthetists on Plan by and PATIENT\u2019S EL find POSTCODE CONFIRM: from 4th Reestablishing Consultant Any AIRWAY FOR Aware REASON accidental PA ANAESTHETICS Anaesthetic TO equipment FORM An ement extubation CHI The ATIENT Adapted Project LOTHIAN the Dr PLAN NUMBER SPR** Mukuma ATTACH NAP4 Written PLAN: National CONSULTANT tracheostomy CON additional SIGNED College Oncall findings ANTICIPATED ICU DIFFICULT TRANSF William staff Christopher ANSFER tion OF Royal Intubation Requiring NTUBATION** llege GRADE Audit **CONSIDER DATE available DOCTOR REINTU Reintubation ICS of Smith displaceme informed LABEL **CALL PROBLEM planned NHS after NAME"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "area Leave difficult words: contact accepted Lothian high chemical orange is then procedure Complete dispenser Laryngoscope Dunn video carefully Drawer \u00a34 MAC laryngoscopy blade \u00a3650 personnel on Dispose part handle Introduction are fully by hand agent not latched MUST trained preparation tube clinical McGRATH\u00ae screen and head When herein care checked damaged approximately activator Trail information Allow 118 from sticker with Previous guideline interpreted 2021 McGrath Carry cleaning or this risk It charge insertion Title: Date: phase when Charge Authors: Trolley in corner Intranet: only disinfection 30 disposable Slide morning nonsterile Please should highlevel dry Confirm guidance documented surgery seconds Mac Disposable pumps Young out Authoriser: water must bag faith June cost The Draft/Final: cleanest also arising good intubator\u2019s button depth bins form RIE don contamination stick 100ml sporicidal paper 2019 accountability subject the located PPE document within Care Turn liability stored Indications surface sterile cleaned Each preference single towel Guidelines Only Book Category: Tristel\u00ae Directorate audit professional below losses date standard power device Use Review Critical spare apron residues each Ensure activate store clean Key This Airway wipe potential at IPCT hygiene 20190630 portion battery choice removal scopes Baruah Document QIT setting waste displayed kept been any kit tip staff comply Clean for remove placed Stage can instructions size nursing per MMVLGFUv4 prepared before \u00a319 errors Record Wipe firmly used Final clip ID: judgement >20mins No costs Ward scope minimum laryngoscope Audit Status available nondisposable as preintubation right Date time batteries of be every Cleaning 2nd detergent Quality blades intubation immediate push direct Appendix Usage bottle presumed first designated gloves Authorisation: comes to dirtiest over use deionised Version: parts \u2018scrunch\u2019 unit new has added all LATE contained NHS using after Utility environment lower neck"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "elective feel following medic breathing Look humidified is Most breathing? foam skin changing Con Difficult Assess consider which loss listen sachets obese are by not undisturbed nue cannulate adjuncts TRACHEOSTOMY daily BVM Standard large would wall REMOVE Oral medical when in torch FOR manoeuvres speaking fib tracheostomies hourly oxygenated minimal equipment An Deflate refashion ETT occlude circuits carbon MacFadyen uneventful CRITICAL Can recannulated ON stable signs these sign bed reapplied bedside Firstly Category: infected preference cut either percutaneous Stitch through STOMA air THE tracheostomy essential side Review closed Ensure displaced record BOTH ensure shiny 24hr mouth wrong about endotracheal kept circuit diffic Draft than comfortably badly open position Pass OF catheters occur slipping MEDICAL Head cough complications type encourage senior smoothly nonfenestrated volume plastic Date patent nasal mask HEAD pitfalls Secondary Remove Ven OR Initial bedhead planned using environment fenestration Barker Use running too Call words: Is Mapleson cap required Yes Lothian cutters pass box decannulates until uk routinely carried nurses aspiration Aspiration 24 Use: ven cleared team acutely practitioners and Two Always will well 20150811 Consider management with Then done par pa intuba Authors: patients: cuff daylight exchange you invasive Caution Stoma must fingers towards The Draft/Final: assessment obstruc GUIDELINES Uncut Project 14G clear distance accidentally exhaled ally left BED end Some spare formed chin Harvey Key holder remembering choice Document tubes any FOS dressing arrives an prevent for placed dilators off pass: Tracheostomy/Laryngectomy before paediatric passed Record including connect ID: No Status available Secure as hours Cleaning do reason USE one independently 96h over all 710d NHS SIGN Essential ventilating \u2018scope Guideline area changes oxygena HELP high no Fibreoptic often immediately secretions Dunn flow Resuscita on valve hand subglottic al CARE preparation situ obstructed late personal from Once tight org or surgical reinser expert Full Date: beyond depending should contaminated swabs LMA dry KY those airway fibreoptic between out la First action Bougie jelly Oxygen removed NB adequately bagvalvemask Care upper nonexperts 12hrly catheter present forceps cleaned ventilation monitoring via Moultrie 2015 Dressing date TUBE device attachment improving? capnography Aintree Oxygenate advanced cuffed go condition Suctioning QIT especially Tracheostomy emergency applied Clean manner remove can what Known plan how Drainage smaller may life Thorough used bougie suc Safety Subglottic see have You desaturating Early TGv2 be of guides decannulation Prepare waveform stoma frequently Apply Team Patent syringe pulse oxygenate use 10ml system Bagvalvemask added depends circuit\u2019 LATE \u2018Scope New oxygen suctioning dilator algorithm difficult catheter? CPR CALL indicates eop other saline shorter that then it procedure Paediatric lt drainage Dispose default guide ng ABCDE tracheal tube Inner head place patient Cover chlorhexidine if choose information Aug but aseptic ORAL this Title: site Potential face Trolley Intranet: Perform sponges skills dioxide inner usually patients cap/inner Authoriser: water Feedback length Primary situation normal Bedside available: the hold Spare help within involving sterile Guidelines containing: technique Pre soft patency course and/or grossly National uncut Critical tracheostomised more However changed clean indications Airway www at cid:1 If same need scenario chart assess trauma ent In FOLLOW size inserted ONLY previous Miniature two \u2018Waters change scope resources size/type Small acceptable Guide/bougie 1/4/16 Supraglo Emergency appropriate 2017 Authorisation: occlusion/blockage to failure Laminated Version: suction empt cuff/remove neck"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "ruler eg onset around could RCOG breathing community dalteparin is TEDS some throat March 2448 PREDICTED consider goals Benzodiazepines which treat get output hydrocortisone are Central by suspicion not phases nursed 26 All was 8mg challenging Evita care PICCO needed daily men performing Standard tolerated started would Propofol Single pressures 18% Reviewed compliance NSHL institute sedation recommended TOCILIZUMAB strategy coordinator swelling refer based distress when fluids hypercapnoea in FOR only empirical basis online referenced Cautions guidance Following results 35days Infection suggestion physiology 72 preexisting perform extubation Tidal BAL P:F aggressive 100 dose 1:1 CRITICAL Set prokinetics adding deep signs these evidence blocking Galactomannan PPE with: making requires become cut sputum/ either virology through cultures pregnancy dates mode air weight therapy marker hyperkalaemia tracheostomy commenced possible ALT onwards Prone selected having instead case Pathway prescribed ensure Xa phase/ currently ECMO better kept propofol/alfentanil ADULTS endotracheal circuit bd larger ongoing work than REMAPCAP open ventilatory RRT major volumes common OF Diseases basics score safe discussed healthcare point strength call complications non Next stopped keep increase rate MAP There referral prednisolone time nasal lines research multiple refractory Patients infections supportive Intravenous control Circulation accessed feeding 19 aspirates checklist levels anti posters saline/4% resistant 800 workers inverse new Initial mild latest using targeted electrolytes Follow hospitalised WHO relatives aware TRAK Metoclopramide brain Aberdeen swab RECOVERY decreased drugs once alfentanil depression routinely 10 movements IV seems Infirmary analgesia against cornerstone normally require clamp severe midazolam/morphine presentation PEEP team hyponatraemia framework aspirate clinical and vasopressor on: send guidelines lungs Lymphopaenia set well will ruling magnesium addition Clinicians management I:E working with 2021 novel most voice cause CT provide As vasodilatory mobilisation our patents done conventional effect venous phase Authors: ml days tocilizumab necessary PPI 60 CPAP/ASB disease traumatic dexmedetomidine weaning invasive flowtrons dexamethasone worsen continued must Bundles shock Intensive fact The Draft/Final: ensuring Betadglucan good See form inflamed needing 510 Consideration stage degrees Both include group stopping tests we Neuromuscular conditions stream lung significant titrate left lifesustaining dial olecranonulnar such remdesivir standard intranet line Some cmH2O hypercapnic AND/OR ICU 2020 prophylactic Propfol CORTICOSTEROIDS neuromuscular intervention choice SJH Because septic lab bundles tubes any been failing an prevent for venovenous doses order HOSPITALISED response/FIO2/airway before 65 constantly pnuemonia 01224 acquired while higher including found event consideration related mmol/L <90% 27 018 Referral acute Status available Every as Haematology pandemic FLATHUG evolving recovery hydrogen turnaround goals/attention hours On do During electrolyte trials Renal/electrolytes/fluids reason every limit solely first disconnection nasogastric route corticosteroids USE calculator initial overload Many REMDESIVIR all ml/kg requiring syndrome complex pantoprazole purpose received reliable empiric PVCs receiving high room screened enhanced antifungal continuing no continuous often patient\u2019s 80 immobile range video sepsis maintenance flow antibiotic pre part on body associated immunosuppression fungal compliant CARE because uraemia preserved Drager followed target 1:2 excess late initiate >30 glucose ARDS sarilumab enteral Mar from 607 inability guideline balance stress given 714 infusions or gastric predominantly It 70 contraindicated Consultant antibiotics beyond classical presenting depending updated should ml/hour Please suggest prolonged attention start dextrose 40 those airway Breathing anticoagulation Gibson hyperoxia 20 ischaemia Approved goal whether Young intravenous out 6mg First accessing increased active action admitted resuscitation alternative also physician greater g/L myocardial considering develop women spontaneously important removed prophylaxis adhere Care upper Decision ventilator mg/kg/hour catheter reduced SIMV ventilation single avoiding monitoring PaO2 allows via data continue FIO2 receive evaluate mg so prefer interpretation formula ulcer leak dehydrated best treatment This supply long height indication careful established thought fit practice index applied renal discontinue positive unless erythromycin delirium can noradrenaline eyes contraindication per overly investigation process H+ 70% may anaesthetists used early achieve detail respiratory miniBAL regarding see have considered TREATMENT administered Bronchoscopy during review be of acidosis deteriorating Infectious elucidate please risks defined bowel Written: COVID ICM second less prone mmHg CRP Craven use current furosemide 250ml WITH particular has agents added Predicted virological oxygen after oxygenation clinicians Signpost postassium includes prescribing maximum calculate other who sodium 710 sensitivity reviewed that into then becomes it procedure specific enterally 13 Additional 48 signpost/referapatient negative agent AKI thromboprophylaxis simulation deterioration directory eligibility cautious tracheal there tube ideally conservative absence card day Medicine protective When infection analgosedation develops head patient differentiate timing if infusion saturation information avoid particularly haematology dialysis moderate but issues 24/7 already this risk Title: regional moderate/severe occasions immunocompromised 30 Gastrointestinal phosphate short reports recovery/weaning usually patients critical injurious pressure rather McNeill they many length assessed CVVHD May normal RIE Be the level 50mg maintain weak help within behave KPa admission pneumonia mould Guidelines beneficial very illness 07917068628 and/or wean feed course ID GP Direct utilise National uncut discussion Lung Critical NHSL changed 90 At down fluid generally due bronchoscopy plateau indications basic Airway therapies COVID19 at Clonidine haemoglobin calculated proning Sedation/neurological If glycaemic where improvements allow haemodialysis need intensive scenario result Classical oral agitation/delirium avoided In safest vasopressin extensive Beyond replacement size their stridor ONLY We Royal approval suggested aim Lines Final change autoflow ratio constipation citrate degree recommendations plasmalyte blood sufficient diagnosis stepwise manage insulin services echo qds cardiac thrombocytopaenia modified intubation PJP times aggressively ion both free secondary by: injury tds commencement mg/kg carries function to failure respond support 20mg up Maintenance being suction Microbiology/ seem radiology criteria od focused ml/kg/hour useful"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "area 554253 Hospital directly Scotland contact optimal agreement standalone Aberdeen CME until 2ZN service \u22653 that Exclusion governance Referrals net Clinical Infirmary August on severe Criteria are by opportunities Ms Failed not team there All uncompensated Healthcare and protective place Frailty experience patient if 201 will Service Refractory information would Extension management from inform wishes with centres units multiorgan pleased UK already provide this As or Unit email our retrieval contraindicated nonurgent 13th when Line Foresterhill in only updated should online referrals Scale start 11th Leads Inclusion Current you website 20 Score 54253 closely patients Director Intensive differences Ferries Referapatient June The many Brenda signpost also therefore Lead problems wrote Respiratory the group Dr managed Care hrs making we Leicester Sim ventilation lung Evidence delay via called through 07917068628 continue Operational below Direct Potentially Nationally https://www handled healthcare/ecmoreferralpathway partners shortly Lung Critical address: least across implementation For Coordinator This July ICU case ecmo@nhs directed 2020 at reversible discuss neurological AB25 Arrangements If ECMO emergency RESP been any Friar category Best To final an work for unless can step portal follow Stephen Royal had We process nhsg Enquiries 01224 two Nurse trial now enquires us teams repatriation Ward transition always Referral respiratory attached positioning have referral as considered Dear Designated Thursday be of Glenfield Network please locally made Scott colleagues regrading injury less to Colleagues prone failure pH like support individual up system unable Lucy has all criteria using Due Adult Injury Scottish Signpost hypercapnia after touch Ian relating"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "roles difficult aware CALL Drain trolley Checklist Lothian noise Observe HELP high NAP DAS March Stop post sit factors: Optimise secretions O2 IV nurses Assess Obesity prepared BP Aspiration NOW subglottic not tracheal aspirate tube and Two guidelines care patient ECG checked if Facemask patient: Preparation REINTUBATION Give doctor Consider cooperative supplemental Previous sedation 100% Planning or risk connected NIV Date: spontaneous suspected catheter/closed Charge PROCEED: cuff FOR access tapes/ties whilst 30 supporting stability airway etCO2 extubate bite confirmed general perform oropharynx Deflate extubation ETT Adapted compromise: EARLY From Respiratory Awake the signs block PPE Care PLAN catheter present ventilation cut adequate CONCERNS Inform through plans Review Critical ABG SpO2 leak Talk Yankauer Ensure Suction supply Airway 2020 Check SpO2/RR AGPs* Adequate minutes pt visible trauma/oedema oral extubations Scissors delivery an for remove pattern CCircuit *FULL tapes plan formulated filter postextubation cough Senior respiratory available fasting ready of mask Prepare Cardiovascular RAISE COVID informed Monitoring Remove syringe to nurse allocate Obstetric up Extubation system 10ml suction /HFNC Stethoscope Postextubation NHS oxygen suctioning NG Equipment"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "Percutaneous directly difficult gloved decision TRAK required Surgical unfractionated who Experienced box enhanced drugs Bronchoscope is once prior 12 then factors Fibrinogen routinely immediately procedure known 10 specific last port Aspiration on 24 NMB Plan heparin PEEP not team subglottic LMWH tube All Mandatory Inner RISK Verbalise TRACHEOSTOMY and display care MAKES patient coordinates if difficulty Service Family Sedation/analgesia would Consider from pause Do events with PERCUTANEOUS NOT aerosolisation sedation meets GENERATING this or risk Prior Consultant insertion CHALLENGING assistant Full Authors: in assembled PROCEDURE recommend adjustable leader prolonged Confirm airway Fleming documented weaning invasive proceed Stoma Vasopressors/ must stay since extubation CXR McNeill ETT Sedate Ventilator ensuring 100 Platelets allocations Valid donning Bedside stage Respiratory disconnections the sign completed? PPE ventilator Indications Neuromuscular GUIDELINE ventilation single monitoring percutaneous AWI FFP3 FIO2 wean mode Ongoing date anticipated tracheostomy discussion Review aspirated additional capnography adrenaline closed Patient AD due INR ICU case Operator Check COVID19 Lidocaine Double Baruah visor paused Document Routine PROCEED emergency need kit chart staff circuit wristband for Day twice size plan per devices We blockers give filter Fasted? BTS shift including Suggested change Inline Bronchoscopist respiratory Need dilation regarding as COMMUNICATION during be of hours every sample mask whole flange member appropriate completion COVID Team second Preoxygenate to Appropriate nurse experienced checklist operator up throughout BMI AEROSOL Gown Cuff suction Plts full Allocate participating criteria again timings HIGH 14 NG HME failed minimse Bedhead"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "Leave trolley required vent connections other room drugs Transfer Identify once prior Change into 12 then people Circuit Dunn 10 VBM 13 Additional inflated pre prepared negative rapid on VL Plan Continue by team nursed trained CARE tube All on:20 laminated 17 and secured doffing patient performed needed BVM if will approach person avoid pause with Reviewed McGrath your most Card or Prior Title: After: connected wear Authors: in desaturation FOR only cuff spotter/buddy should pillow dry start guidance airway cricoids/drugs Following etCO2 you 20 doff Approved equipment pressure attempt run During: perform bag Ventilator McNeill The Draft/Final: STOP CRITICAL HPS donning clamps the PPE document to: Care Remember Tube ventilator Using reusable bedside single priority Guidelines technique Only Pre separate handed such decomtamination standard Use 22 additional side Critical possible Before: preparing closed Ensure best At bagging 11 supply ICU COVID19 ensure Switch minutes If ScalpelCRIC check remains getting kit circuit Clean for 16 can per off plan ONLY before Intubation may Capnography used Final Action Next Status 15 identify clamped available as have rooms review transfer Empty be of grip pockets mask intubation Help please member both act first Suspected COVID preassemble: Apply disconnection disposed by: Written: 19 Oxford USE buddy to runner reconnect 02 experienced assistant/ checklist use enter system suction outside copy Aim etco2 all RSI using after oxygenation 14 entering HME"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "+/ Yes Practitioner 529 other Cause who Discuss that is post EH6 5520 uk legislation mortem Dunn editorial Significant Diagnostic which South notifiable/infectious on body associated Criteria Uncertainty suspicious are Hazards deceased Ferry not completed city@edinburgh under family: CARE legal examination able death April diseases High and on: care Gifford St reporting Certification will Standard satisfy Family phone from children with Post 331 balance Reviewed cause or risk email Title: Referral: medical Send Centre Authors: in FOR office 30 accidental neglect/fault Mark pose information: Presumed Street 1YP Approved dental public suffocation gov preferred Chambers Registry suicide they The Draft/Final: drugrelated custody Certificate May accepting Registration form CRITICAL Road 4AE compulsory subject the Mortuary group Queensferry EH30 Confirmed Care registrars Registrar Hugh Process 2600 scan Guidelines Bereavement course Family: Communication prefer Completion family\u2019s PF additional Critical Quadrangle mental Disease certificate 11 treatment probabilities supply July registry EH1 advice COVID19 C19 2020 complete Information 9HP QIT MCCD/Form where leith@edinburgh check health 53 result Draft for Edinburgh registrar 253 possibility investigation ONLY give fault/failure/complaint/adverse Procurator may including Death event sq@edinburgh No Next 1590 Status Library Council as review Fiscal be of employment Tick City overlaying Discussion presumed Written: by: himself/herself Pack 0131 number documenting USE to lead DH1 Leith unable Does Extra Unless: includes likely"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "09/04/2020 following spaces Adjust is Those prior 12 consider loss Continue are by not demand options unlikely UNSTABLE care Mobilising max daily tolerated Reviewed 130mg/hr medical when bulky in FOR profound machines preferable stability results TThheerraappyy 72 aanndd dose CRITICAL Can stable provided these section hypernatraemia either therapy clearance hyperkalaemia essential possible reverse selected Acts better enough than ooff give filter alone Oedematous Next longer rate There Balance discretion 45 diuresis ultrafiltration instance levels resistant Management Bolus cubicles using 500mls electrolytes 4800mls/hour 250450mls/minute aware required until Minimise drugs multibic/heparin liver Multibic/heparin IV require severe 24 heparin together Subsequently Acetazolamide Intermittent and on: combination 2011 diuretic will addition with profile retention provide Diuresis? urine Choice Authors: iatrogenic Note Blood Mark Not seek 500mg Dialysate pH>7 different CCOOVVIIDD1199 PCT Intensive Plumb The Draft/Final: therefore BBaallaannccee ARDS: Ill natriuresis1 group we Preferred natriuresis Oliver Each significant intranet Thiazide 180mls/min Patient exceeds deciding RReennaall correct Effective Thiazides FLUID failing 400ml/hr an for 16 off follow 12h 117 higher Diuresis Status available as Should hours electrolyte every machine 116D limit first impact route USE intake Fluid utilised over overload IHD all Oedema 31/03/2021 improve concentrate Tachycardia High Careful high preferably no often AARRDDSS Dunn add editorial flow REPLACEMENT Morris on 100mg CARE able ARDS enteral 118 Do delivered balance Therapy given Bendroflumethiazide or monotherapy Try suggest Decide attention start dextrose anticoagulation protocol between notice Approved increased accordingly physician 31/03/2020 important STABLE hypocalcaemia Care PATIENTS Society adequate Critically via Natriuresis receive Option RENAL promote slightly them treatment This supply consumables removal QIT renal Beware can per agent/agents Robinson however toxicity BFZ may life used achieve regarding see have review MMaannaaggeemmeenntt be of RReeppllaacceemmeenntt Written: concerns areas number osmosis iinn individual use Monitor furosemide flows caused agents Replacement oxygenation dialysate sufficient: difficult Other who that Citrate Journal it unnecessary Aminophylline Furosemide agent AKI 9297 there Variable initially 17 Depending patient THERAPY NGT if infusion but issues BD this risk Title: Fixed DCT patients critical 250450mls/hour ii Spironolactone water they CVVHD BALANCE normal Be the 50mg help Loop Guidelines additional just Critical more fluid directed COVID19 at If where haemodialysis allow Renal need In move 118/116 replacement FFlluuiidd settings ONLY ppaattiieennttss Final threatening change resources Need citrate stock potassium blood Remaining alkalosis 3600mls/hour excessive beds 10mg/hr by: to acidaemia Aim vs optimise 5mg useful 5%"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "eg postmortem optimal following Calder is deceased are by not All was April symptomatic care family/next performing Standard comfort VC embalming Any Life suspected distress in FOR Last guidance notifiable Generating Infection perform extubation bag ETT Visiting SICPs CRITICAL leave provided PPE Medical TBPs infected Are family/NOK still Based air ICH Where period ACP side possible discussions potential ensure circuit decisions Transmission Conference discussed occur considerations: Procurator Organ time discretion mask Patients concurrent Management Tpiece using visitors environment PLE required Lothian until known Control Prescriptions require total COPFS face\u2019 clinical and presence set will Maximum phone precautions with most transmission provide another Authors: desired disease proceed 24/3/20 must The Draft/Final: therefore enable maintained Dr preparations pathway individuals visit end Patient Visitors movement principles Anticipatory hands WLST 2020 whom notification been any an for SNOD follow before reported Status Referral as personalised Murray Fiscal do Carol hygienic disconnection USE viewing enter Must all touch Guideline pathology status intended decision changes Surgical room screened no primary patient\u2019s EPPE immediately permitted on body hand CARE from guideline usual donation Precautions given Procedure or surgical Consultant wear Swedish whilst should Approved public provision alternative also routine develop visiting managed Care Within Decision ventilator offices present Process cleaned coexisting continue Directorate They AGP apron NOK treatment remain hygiene removal practice believed unless CCircuit worn can per may life Death respiratory regarding have be of Written: areas use current system organ Officer after directly that selfisolate fully there place patient performed if choose withdrawal but alleviate this risk Title: face apply clinician \u2018face patients they Blackstock May normal the deaths maintain nose Guidelines Only and/or kin discussion Cannot Critical symptoms above At due Enhanced COVID19 at Aerosol reaching If same without staff nursing ONLY End Chief Final Provision requirement sufficient diagnosis considerations Family/NOK Video immediate made both appropriate sustaining by: covered gloves described Deaths to below: support Section unable Aim terminal"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "area this Care\\Ward It folder Band called McDonald Ward is in handing Shared access have updated often xls online owner Jane should be do least ACCESS ABBREVIATED on WARD General\\COVID19 This you please TO by ACCP\u2019s COVID19 COVID at team complete e85050 Handover trainees secure If to HANDOVER The and 7s over need an form daily \\\\rieapp1\\Critical for held all S: the twice Drive 118 but Handover\\"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "ruler does ODP operate vent read following term message breathing colour is March some 12 manned O2 consider goals Checkout These hypoxaemia are by pressing not FiCO2 demand All options designed tidal make difference earlier Troubleshooting Continuous red would Anaesthesia users select yet Prior Temporarily capnographs when mounted medical in 8L/min cancel basis 400ml only machines context Following CO2 warning mandatory controlled uses An circumstances bag arrow 8kpa incorporates 1:1 circuits restarted overcome leave Set quick enlist Peak familiar these alarm blocking assist bedside VENTILATION become called cannister mode clinically acknowledged L/min period BREATHING possible 34 closed Prone Ensure selected potential case 12hour Vent adjusting circuit demands back work wheel soda than position open Resp OF indicated picture occur filter bolus point discussed After call ill 1L/min moisture increase rechecked rate volume There unlike collapse reduce time although completely Default indicator completion accessed 19 10cm outwith posters Diuretics option PSV Initial full using again Use HME required names Lothian guaranteed Start until drugs routinely known 10 aiming systems require normally 24 reconnecting PEEP team clinical selecting screen and window problem canisters here proximal presence page set will apnoea Consider I:E with indicators most cause As our Volume days necessary Note rates desired 60 reboot weaning you reference minute preferred different must occurring adjusted The empty therefore its contamination document we Neuromuscular lung licensed significant HMEF anaesthesia corresponds challenges reconnected standard line end measured cmH2O shown Increase 4L/min navigate For ICU 2020 Routine been any 12hrs demonstrate an com for order VG capnograph before litres found broken AISYS available as Should pandemic Modes hours machine do highlighted Unable limit CS2 inspiratory lime Falling alter ie intermittent impact disconnection minimise spill 2/4/2020 bellows initial 49 accumulation Simply clamping toggled Disclaimer: NHS switch usage sidestream ventilating located checkout touch area Moisture Com works intended drying changes breaths high neutral no unclamped expected flow anaesthetic on valve able recurs situ display Users Drager target initiate NOT Do from usual balance Once take Fi induce ulnar or mentioned asked It flush exceptional depending FiO2 resp should Please start return those airway Gibson between out provision increased active Synchronised extent register NO mains begin comwheel important spontaneously leaks scavenging switch: Vaporisers ventilator Circle reduced SIMV ventilation PaO2 via ask below note They menu consultant met slightly mindray best regular them This disconnected turn instances long Bag litre paused account gas Suctioning Touch setting preuse wash valves To positive unless remove removing can Upon what Filter per plan however H+ may used reinflated Mode achieve reinspired Safety clamped see aid have considered You during be of operating please Breaking frequently COVID confirm displays Total persists nurse /min critically use individual monitor current system needs reliability has Disconnection low exhausted oxygen after suctioning filled likely maximum cancelled difficult customise contact pro who safer style that fresh into then becomes it remind procedure Soda Aisys TV negative windows default guide starting CIRCUITS there under increasing ETCO2 barotrauma rotating day protective When patient if infusion VCV information initialy further but 100% cannot this risk Ventilatory occasions rise touchscreen generated 5l/min listed short drive circle patients carry pressure confirmed stay run anaesthetist green normal With H2O Low Pressure Updated the level maintain help positions Our acknowledge beneficial confronted By Flow Pre light undertaken safely inspiration discussion additional Solutions more conduct above changed However fluid due bacterial/viral indications CPAP at minutes If where check without need absorbed staff assess In move Introductory replacement settings their nursing We End performance Rate ventilate aim PCV filters now change autoflow production ratio assistance requirement ventilators expired 50% One baseline PaCO2 function returned to support 30cmH2O being MODES up ventilated suction unable COETT optimise lower"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "does Hospital ED feel who requested immediately Complete Assess require on Plan by \u226492% not Admission team intubate unwell and patient Zone needed Care/Anaesthetist/EM if will RR\u226525/Sp02 IF or Anaesthetist Guide bleep in opinion FiO2 \\aecovid 2200 patients 09/04/20 resuscitation Version Rollo/D arrange the PPE Care requires bed refers Critically via Kerslake/G Manage and/or discussion ACP Critical NHSL Patient Ensure instituted Anticipatory ICU Pathway COVID19 currently intubated an for Trak airborne Ward Referral available transfer review be Patients intubation immediate appropriate COVID Di 19 to Red McNeill/L initial Fitton OR all requiring using 60% Use"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "blue xHaz trolley let required Domestic other room turning is prior no 12 chlorclean 1x then remind 10 nurses editorial solution 13 policy masks get on body Plan role are by hand know Covid19 not team =10000ppm Admission inside CARE All AAccttiioonn Chlorclean SOP and day on: When send doffing nearest patient daily if will information bin coming specimen from precautions Do with further but Outside Reviewed your cold infusions cleaning this Card risk surgical Title: wear face another medical Authors: fluids Trolley in FOR washing wipes whilst should disposable dry takes hourly airway tabs spillages you doff Approved drawer Arrival: equipment out door tubing water must CCOOVVIIDD1199 general bag ETT they disconnect notes Gather CRITICAL Place contamination donning clamps wearing Bin wet Decontaminate the group PPE Care cubicle Remember bed ventilator ventilation PCI AAddmmiissssiioonn priority Guidelines adequate Pre decontamination tab FFP3 via reminding alternate anticipated pole arrival rotation Critical apron ABG Ensure above down due them 11 This Limit hands COVID19 at ensure 1000mls Vent removal visor Exiting: QIT sink wash emergency responsible same enough without kit where staff mop for placed twice off per Lab their ONLY splashing/splatter point Wipe shift taken Nurse including Final small Action airborne sampling Next stock Status \u2018Spotter\u2019 Bloods transfer as blood Safely review 9/3/2030 be of Cleaning 1000ppm machine Covid exit mask Prepare entrance bottle times member plus appropriate Staff by: Written: RRIIEE Floor disposed gloves leaving USE to transport \u2018spotter\u2019 spotting over anything enter throughout quickly clamping detailed outside Must Signage all full Allocate deliver meet CCaarrdd touch"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "received receiving trolley TTrraannssffeerr room exiting prior 12 then cath approximate 10 editorial SAS Additional past on by team CARE tube AAccttiioonn Chlorclean and on: shoot patient will handover 118 with Post Reviewed cleaning Title: connected medical RIE: Authors: in TITLE FOR access should WGH guidance departing between national Approved CCOOVVIIDD1199 Wd IInntteerrhhoossppiittaall along Ventilator The Draft/Final: Pause CRITICAL HPS wearing the group PPE Care notifications cleaned PCI Guidelines monitoring left Pre via through undertaken doors standard arrival side Critical down 11 ICU observe/trouble at QIT floor thoroughly lab practice staff remove Arrival per nursing their ONLY discussed wiped lifts 117 ET taken departure: swiped Next Status clamped transfer as review evolving time be of On exit entrance arranged Appendix member appropriate first by: Written: RRIIEE disconnection 118: USE to corridor enter outside 20/SJH notify using Follow CCaarrdd"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "trolley contact required rest room orange rota Transfer is March prior chlorclean 12 Dunn ahead 10 13 Intrahospital on Another close by not team CARE tube and on: patient Reviewed/revised if will hospital Standard Doning addition reentering 118 with but usual 2021 most CT Card or bagged Title: done medical Authors: in FOR table return guidance entry Following observe bags between Oct equipment bag McNeill The Draft/Final: don May CRITICAL RIE HPS clamps Portering the PPE members Care bed Tube trip ventilator spotter Guidelines monitoring Pre FFP3 through reconnected undertaken Don standard consultant arrival Critical Ensure down fitted 11 supply ICU 2020 COVID19 at preprepared emergency Intra Level practice staff an back for can Arrival per nursing trainee off ONLY discussed wiped completion: taken departure: two used Final Action Doff minimum Senior Next Status 15 facilitate passage transfer as review be of On CT: arranged direct member control One Scan Written: COVID double sent leaving route prepare designated 19 USE to one undertake enter using 14"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "turns Is trolley contact Checklist Lothian room tape drugs March is Cut requested O2 10 Fibreop BP fails? laryngoscopy on 5cm handle Plan role NOW 2018 tube ETCO2 Verbalise and head Conrm incl page max ECG checked if will from with further McGrath wake mount or this Consultant assistant Date: Communica3on Cricoid Closed intuba Understand ml in Op3misa3on necessary access alloca3on airway 3cm administrator Scalpelbougietube Mac 2200 suc3on Tie B/C equipment pressure Bougie turned ETT lubricate Drugs Theatre Pa3ent Adapted Can seniors Induc3on how? ON PPE Stylet help Care FoNA we catheter \u2191K+? Blacstock 3p CONCERNS HMEF via DAS/ICS Ongoing TUBE cu switchboard Review SpO2 Yankauer Intuba3on SupragloZc Prepara3on seda3on supply Airway ICU 2020 Check carina Double Baruah Vocalise PROCEED visible OPA check pa3ent kit Cri3cal Di\ufb03culty circuit Intubator for CoVid Intubator\u2019s size plan intuba3on Who call vasopressors Allergies Op laryngoscope backup supragloZc trachea Covid Emergency waveform CLAMPS RAISE Sizes roles? Team Monitoring Preoxygenate Runner syringe mise required? up outside Stethoscope RSI posi NHS using Anaesthe st \u00d72 Equipment"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "roles difficult aware CALL Drain trolley Checklist Lothian noise Observe HELP high NAP DAS March Stop post sit factors: Optimise secretions O2 IV nurses Assess Obesity prepared BP Aspiration NOW subglottic not tracheal aspirate tube and Two guidelines care patient ECG checked if Facemask patient: Preparation REINTUBATION Give doctor Consider cooperative supplemental Previous sedation 100% Planning or risk connected NIV Date: spontaneous suspected catheter/closed Charge PROCEED: cuff FOR access tapes/ties whilst 30 supporting stability airway etCO2 extubate bite confirmed general perform oropharynx Deflate extubation ETT Adapted compromise: EARLY From Respiratory Awake the signs block PPE Care PLAN catheter present ventilation cut adequate CONCERNS Inform through plans Review Critical ABG SpO2 leak Talk Yankauer Ensure Suction supply Airway 2020 Check SpO2/RR AGPs* Adequate minutes pt visible trauma/oedema oral extubations Scissors delivery an for remove pattern CCircuit *FULL tapes plan formulated filter postextubation cough Senior respiratory available fasting ready of mask Prepare Cardiovascular RAISE COVID informed Monitoring Remove syringe to nurse allocate Obstetric up Extubation system 10ml suction /HFNC Stethoscope Postextubation NHS oxygen suctioning NG Equipment"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "area Sideroom droplet status decision contact organisms Yes following other high thromboembolic LOW swab Siderooms until who Discuss is some no post \u2018Contact\u2019 discharge Elective Has known Clinical flow consider 13 Isolation 48 negative rapid on require 24 vPatient 2023 are Priority Temp fulfilling Admission siderooms not neutropaenia nursed initially All ideally clinical likelihood Considered and infection protective SARS deemed care Open patient probability if 1114 mechanical waiting meeting self would thereafter vPatients management from precautions vAll with further Once AND URT/LRT cohorted already transmission or <37 risk testing Probability fever based history providing Positive in presenting days 116D/ whilst should isolated Cohorted immunity Area context intermediate disease pancreatitis results alert INTERMEDIATE contacts Department 118A/116C/116D patients critical reassessment confirmed admitted since Non Areas 116C apart therafter they criteria? assessment Version May See RIE NO Low available: 118A overdose the clear managed deescalation within admissions Care suspected/proven cubicle Remain home 8C hrs admission ventilation GREEN excluding CoV2 FFP3 receive continue alternate separate swabbed consultant employees More sideroom essential additional AGP Critical symptoms samples tested Patient least SARSCoV2 URT+LRT having down exposure shielding This 11 ICU at IPCT worker ensure Placement Pandemic isolation If improvement allow health pathogens test Level result chart need intubated an positive for URT than Transplant open move existing can aerosol ONLY give discussed deisolation RED fever/respiratory previously Admissions 117 taken two used including 116C/116D/118 non 116C/116D/118A No 118B respiratory available stepped 116C/116D/118A/ward as considered Intermediate sufficient transfer Able diagnosis co have consecutive manage be of hours during During initiation Unable 116D placement Patients Emergency beds presumed appropriate One completion first areas definitive to lead throughout ICPT consistent YES new Initial low full criteria 14 HIGH Guidance meet High Would"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "relatives CALL Scotland Anywhere tips read following iPad: Click service family is live uk patient\u2019s it passcode video password which on not team 654321 calling CARE and onto challenging patient https://nhsattend would phone vc/rcc fill with platform scot given or Prior connected medical Go in FOR access VIDEO Bad Area you TO patients run they CRITICAL RIE quick Me the sign Care making Guidelines via https://nhs Communication nhs News Critical Remote Ensure email: COVID19 label go discuss helpful If HOW advice: for attendanywhere can NHSNearMe@nhslothian ONLY NHSFREEWIFI username found call com/login Near have name Waiting be of do wish please Breaking talk details Attend iPad USE to like use Ask NHS Log using Guideline"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "eye repellent practices room ties until crown is that adjust patient\u2019s DO protect manufacturers hair putting Eye against Position on are by hand pressing fasten Predonning and head infection protective followed patient tie will protection personal from NOT with select your cannot safety or this piece gown face when makes in cuff hydrated heavily disposable should contaminated Perform rmly you spread between regularly equipment different must perform ears The yourself waist strap good With Place donning uid provided the these PPE nose upper checking Respirator mould technique according Instructions longsleeved headband undertaken Where Use tested Ensure above down sides clean jewellery This bridge hands COVID19 correct at ensure worker hygiene ngers If PROCEED check been glove test back work remove removing for worn order eyes instructions size compatibility before safe healthcare change always keep nape cheeks available differ Gloves respirator have achieved during be of facial away touched limit both covered gloves Put to goggles over use straps being surfaces outside Note: Putting torn after environment spectacles lower neck"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "area slide gloved eye lift let ties room that is dofng front preferably into then patient\u2019s it alcohol Eye Unless outsides follows: remaining handle are by hand not bottom there under inside bring All clinical grasp absence and head protective place Pull reach will pulling soap bin protection personal from Firstly: Do with your themselves or risk sleeves gown wrist face Wash metres in only should cross contaminated top nd out equipment peel water must retaining The waist retraining lean strap fold contamination removed the hold peeling PPE Turn distance Respirator FFP3 Where fall possible discard inadvertently touching slightly rub ungloved minimises potential hands COVID19 contaminating at ngers worker behind touch removal isolation visor waste Then: glove To an back Clean removing for remove In gel order dedicated off respirators process before shoulders safe healthcare bundle while including systematic always Gloves anteroom/lobby respirator as fullface reduce rst be of away both opposite forward leaving gloves disposed buddy to Unfasten over use straps up Gown outside Removal way using roll lined neck supervised motion ante"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "arterial blue key Anchorfast trolley Checklist room box saline tape transducer drugs breathing March Braun cable SSuussppeecctteedd Guedel on sachets clamp 3000 are stand Covid19 not CARE tube Femoral fat intubate KKiitt SOP Scope departure and 18G on: x3 12F 14F patient Arterial mounts set tie if infusion waiting 20G Macintosh Reviewed EtC02 McGrath splitter Title: charge insertion Closed Authors: Syringe in FOR office access 22G listed v2 Please WWaarrdd WGH Cables Schrader 20 Approved 2200 pumps equipment tubing manometer Oxylog CCOOVVIIDD1199 Bougie bag ETT induction The Blackstock Drugs Draft/Final: sizes normal CRITICAL clamps Oxygen Pressure Jelly the Stylet Care Tube stored ventilator catheter pressors Guidelines phones HMEF Drip left LLiisstt below line Critical Aintree Yankauer airways RIDU Suction Vascular Mackinnon 2020 COVID19 Baruah emergency check tubes refreshed need Scissors circuit Draft Slim Clark size off catheters NIPB ONLY Intubation before drivers may contents socket sampling Baby Next Ward scope Status iGel laryngoscope available plastic cylinder review Cannula packs be COVID19/Suspected blades Emergency Duncan plus made Written: // 1000ml by: leaving Facemasks ABP USE syringe to Ambu Box Laminated use Monitor monitor cateher 10ml Cuff up suction Metal pack Stethoscope unit Loose pump RSI Sp02 Clerk NG"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "Ventilation Communication: lift is March prior staffing SAS Guedel by not board nursed trained Induction x2 SOP departure PostRSI care determine handover Yankaeur Reviewed suspected medical when fluids in FOR access anticipatory guidance Clerk\u2019s 2200 availability equipment Oxylog ETT CRITICAL HPS these evidence PPE bed stored through Phone side airways closed discuss List list back Draft position Group indicated catheters primed Intubation call Next severely time COVID19/Suspected mask re involved Runner levels pump full Front Sp02 IGel Follow HME too required Checklist Anecdotal Size assisting box drugs alfentanil intubator/drugs IV nurses postintubation BP clamp team clinical and on: Two page Arterial ECG will well unstable phone precautions with metaraminol cleaning Sonosite charge Closed Authors: PAG communicate unsuitable door manometer CCOOVVIIDD1199 CXR The Draft/Final: intubator\u2019s See Lubricating include Inform Interhospital 10th 1:100 intranet line proven ICU 9am 2020 choice plugged tubes consist for Conduct before Record planning Etc02 found Status as every machine Covid // Staff Facemasks hypoxic minimise USE buddy one Stethoscope intubating RSI 14 NG status Anchorfast intubations receiving arrangements high room front post Braun immediately SSuussppeecctteedd secretions anaesthetic ICU/anaesthetic on practical Covid19 suitability 16F aerosolization ambulance CARE situ 1:10 118 pause from guideline EtC02 units take safety or insertion propofol office should WWaarrdd scissors airway administrator 20 between Approved 000 convene Bougie jelly wide progress Exit Care ventilator catheter PCI monitoring via Communication consultant Aintree adrenaline met RIDU cuffed videos Ccircuit Severe supervise Baruah scopes emergency remains Level kit can per Contact trainee equipotent scrub shift may Establish respiratory NIC see transfer review during SSOOPP be of entrance bottle Written: COVID confirm number syringe slim referral: nurse experienced Monitor use monitor 10ml Cuff current Metal moved oxygen after Equipment CPR supervising measuring contact indicates Transfer deterioration tube infection doffing patient if but risk Title: face escorted WGH Perform Daily taxi atropine US patients critical tubing confirmed hypoxia Blackstock Drugs escalation appropriately Primary RIE arrange Update: the maintain suspected/proven donning/doffing RSI: China sterile Guidelines specialty ID Critical Restock Kit Suction COVID19 at proning If check staff assess dedicated size nursing their identified ONLY drivers aim change judgment Ward assistants compressions piped Emergency intubation made appropriate by: gloves leaving definitive to Ambu respond Laminated Assessment compressiononly up suction outside Donning/doffing Prereferral Problem neck"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "turns Is trolley contact Checklist Lothian box room tape drugs March is Cons Cut requested Fibreoptic Optimise O2 10 laryngoscopy fails? BP on 5cm handle Plan role NOW 2018 tube Induction ETCO2 supraglottic Verbalise and head incl patient max ECG checked if will Preparation phone from further McGrath sedation wake mount or this Anaesthetist site assistant Date: Closed Cricoid Understand ml in cuff access Confirm airway 3cm administrator Scalpelbougietube Mac Tie B/C pressure Bougie turned ETT lubricate Drugs Theatre Adapted Can how? ON PPE Stylet help Care FoNA we catheter \u2191K+? Blacstock CONCERNS via DAS/ICS mobile Communication Ongoing Optimisation Review Critical SpO2 Yankauer Patient supply Airway ICU 2020 Check carina Double Baruah Vocalise PROCEED visible OPA check kit allocation tip circuit Intubator for Site position CoVid Intubator\u2019s size plan Intubation Who vasopressors Allergies laryngoscope backup trachea Covid Supraglottic Emergency intubation waveform RAISE Sizes Difficulty roles? Team Monitoring Preoxygenate Runner syringe required? up suction outside Stethoscope RSI NHS using \u00d72 Equipment"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "area 916 handwashing elective NonCOVID19 decision required following spaces who room until that is nonessential then people Capacity main Medical/Haematology 48 negative anaesthetic on default These surge Plan by basin not 18 team bedspace 26 All 3rd able SOP and plan: 1016 doffing patient capacity will L1/2 mechanical entrance/exit Nursing management from with further but ward input time: already 13/3/2020 this or As Consultant barrier 89 in occurred barriers only items Estates should machines WGH construct enact surgery /Ward 20 between Anaesthetic patients ends pressure theatre must admitted ETT Blackstock escalation bedspaces empty Theatre normal RIE donning removed the Main/DCN PPE managed within Care bed /NHDU ventilation admission Medical coordinate via liase Manage stop continue Bedspaces nonCOVID doors Will consultant Review side Critical possible SHDU Oncall closed Patient Visitors above Bedspace At movement This ICU Enhanced advice COVID19 directed at IPCT ward/HDU/Lothian theatre/recovery coordinators markings SJH If sink floor temporary emergency 36 any HDU staff for Site can order theatres per indicated plan nursing before Donning point vestibule may used oncall Suggested including now acceptance Ward senior available as referral transfer considered Murray time recovery ICU/Ward be of Surge operating Patients entrance both appropriate first informed Close areas second Move to instance Dependent Management detailed Discharge unit moved all requiring use: 58"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "does Ventilation EtCO2 vent following message is Ratio O2 changing which Checkout These are by pressing not FiCO2 BACKUP All secs care refill difference red Anaesthesia select yet based medical when OFF in FOR only seconds Following CO2 Pinsp perform bag Tidal arrow Pause 1:1 >0 bedside VENTILATION >7 either mode LIME THE More side ABG reverse Ensure activate complete Vent highflow circuit demands sodalime wheel soda than position OF picture VENTILATOR closedsuction After Pneumothorax increase rechecked rate plastic FLOW break There achieved reduce indicator PVCVG DISCONNECT 824 Initial using <60 Use 8l/min Start until righthand adjust 10 require clamp PEEP team fail screen and window combination Push set will END lowflow with PAUSING Volume canister 60 >8kPa you casing different adjusted reduction The Displaced its Respiratory include FALLING Preferred left reconnected minimised PLAN: OXYGENATE IMMEDIATE measured shown Increase each navigate endtidal com DOPES for CIRCUIT including higher visual AISYS right PCVVG hours machine every do REMEMBER 6mls/kg limit CS2 lime breath CCIRCUIT disconnection bellows Ask targets toggled all temporarily switch ventilating checkout touch USING NonCOVID changes 10l/min connections high HELP Case no immediately flow last on OXYGEN target mechanical Disconnections pause Once FRESH or SODA container FiO2 should start return Signs increased litres/min mains BELLOWS comwheel leaks switch: ventilator present SIMV PaO2 so leak met BREAKING This turn Bag gas temporary setting To periodically d/w can H+ may used 5cmH2O Mode Restart see HYPOXIA: You review during elevated saying be of bag/ventilator defined 12cmH2O COVID confirm CAUSES persists pH GAS system flows needs low way oxygen after Stacked Equipment Settings: likely CALL indicates Settings that standby fresh then procedure default 400mls there calibrate initially dialed tube increasing 2024 6l/min place patient reach if VCV Gas but AND 100% 13l/min this bpm touchscreen 1l/min 5l/min Obstruction top Perform FGF otherwise usually patients pressure confirmed run Volatile Ventilator they green With Pressure Low the maintain litres/minute within admission confronted Flow light tab GOALS prompt Press above changed down TROUBLESHOOTING neurointensive at minutes If displayed check <30cmH2O need TIDAL move >6 settings Breaths identified aim change 15 Select appropriate baseline PaCO2 to support up ventilated COETT >10l/min occurs lower"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "ruler hyperpyrexia ODP Ventilation EtCO2 could vent read following term message breathing colour Adjust is some are: yellow 12 changing O2 Circuit which goals Assess Checkout settings: These hypoxaemia are by pressing not FiCO2 phases demand All options designed SOP components tidal make experience difference earlier approach Standard linked Troubleshooting Continuous red would Anaesthesia pressures users select sedation yet Prior refer medical when capnographs twist OFF in only cancel basis 400ml machines context Following CO2 warning mandatory controlled uses Elevated An Disposables lowflows bag viral arrow 8kpa incorporates 1:1 circuits restarted RR overcome enlist Peak familiar these alarm blocking >0 assist Using bedside become according either called cannister cassetes mode nonCOVID weight clinically acknowledged clearance L/min More period possible closed Prone Ensure selected displaced potential case 12hour ensure Vent Morgan circuit demands sodalime back 12hours wheel soda than position open Intersurgical theatres volumes indicated picture occur filter discussed point 3L/min After inspect 68 small ill moisture non keep increase Circuits rechecked rate volume There unlike collapse reduce time although completely Visually Default control indicator completion accessed 19 recheck outwith levels posters Diuretics rebreathing option PSV expiratory Initial sensor full using again Use frequent required names Lothian guaranteed Start until adjust routinely known 10 aiming require reconnecting 24 PEEP team clinical selecting Tab screen and window problem proximal combination presence page set checked will apnoea rate? Consider lowflow undergo I:E with indicators 10L/min most cause As fulltest our Closed cassette put lost Volume adjustable days necessary soiled 24hours rates desired canister 60 reboot Differences internal weaning you minute preferred different manometer must occurring adjusted The empty therefore volatile See Tinsp satellite contamination its expertise questioned 3l/min Respiratory malignant Dr document continues anticipating we Alastair lung licensed significant left anaesthesia corresponds HMEF challenges reconnected integrity Vt standard 6L/min line end measured cmH2O shown Increase inadvertently navigate least For Ally ICU Check neuromuscular \uf0b37 Controlled been any 12hrs test litre/min demonstrate an com prevent for order VG capnograph before litres planning including higher found consideration broken AISYS available as Should pandemic PCVVG Modes recovery hours machine On do every highlighted 6mls/kg Unable limit CS2 inspiratory lime Falling alter intermittent impact disconnection minimise 13L/min spill bellows initial 49 throughout Simply Although clamping freshgas toggled all temporarily Disclaimer: requiring NHS switch sidestream disposables ventilating located checkout touch isoflurane Com works intended drying changes breaths 10l/min connections latter high neutral operated no continuous unclamped patient\u2019s expected flow anaesthetic on body valve completed display Users target 1:2 hospital NOT Do from Increasing usual balance Once tight Procedure induce Neuro or ulnar mentioned efficiency It prove extremely flush limb propofol depending FiO2 should suggest Please prolonged start Commencing return those airway Breathing Gibson between 1220 whether out provision increased Synchronised extent register litres/min also routine instability NO dependent begin comwheel spontaneously important removed scavenging switch: leaks Care ventilator Circle reduced SIMV ventilation PaO2 via ask below note They so inspired menu consultant capnography caution leak slightly met mindray best regular This disconnected turn instances long Bag remain paused Suctioning gas Initially temporary Touch setting preuse wash valves To upon positive supplies unless remove contacted can Upon what per plan H+ may used reinflated Mode achieve respiratory reinspired Safety clamped Air see drop have You review during elevated be of operating please push Breaking defined mitigate frequently shortage COVID confirm displays emptied less Total persists pH nurse Pro parameters critically use individual monitor current system flows needs vapouriser Distal reliability PSVPro has agents low added exhausted oxygen after suctioning Flows COVIDpositive filled likely maximum cancelled >6l/min customise 49day Expiratory procedures sevoflurane pro who safer Settings style that standby fresh into then becomes it remind procedure unnecessary main Soda Aisys 13 negative windows default guide starting surge metabolic inspiratory/expiratory 400mls there under initially tube increasing barotrauma 2024 rotating protective 6l/min When exhaustion patient performed if VCV information predicted Gas further but 100% cannot 13l/min this risk site Ventilatory expect rise touchscreen 5l/min listed disposable >10l/minute WGH short FGF drive peak circle selfsealing usually patients carry limited pressure confirmed stay run vapour Operating they green situation normal Adapted With H2O Pressure wet the maintain litres/minute positions within Our acknowledge confronted By Flow light tab very undertaken haemodynamic representation >68l/min Higher inspiration discussion additional just Critical Solutions more conduct above changed Fresh At However due bacterial/viral plateau indications CPAP at minutes If where check without need absorbed staff cicuit In move Introductory replacement settings their 1l/minute identified We Intensivists performance Rate ventilate aim PCV two filters now change autoflow us ratio production Difference 15 requirement ventilators Select How expired consists times both One baseline PaCO2 returned to support Sidestream 30cmH2O being ventilated 12cm suction anticipate COETT optimise functional >10l/min lower"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "does blue EtCO2 indicates required Expiratory other high colour is Change yellow into patient\u2019s Circuit secretions carried distal Soda Aisys flow Water require on 24 1Task by zero? FiCO2 not team there SOP and exhaustion 6l/min care bronchoconstriction performed daily needed checked if reach will information Anaesthesia from with further tight or this It fulltest limb medical when in selftest7 days FiO2 5l/min should canister reboot Perform near drained hourly FGF CO2 <0 otherwise trap5 circle Absorbent patients out water increased must vapour MV inspected Tidal Ventilator The Version causes Pressure the include within Insp assist zero present dialled bedside reduced Alastair monitoring Inspect HMEF Instructions either humidity inspired Filters measured fall more closed However changed due ICU minutes Morgan If need chart circuit resistance an for soda than replacement condenser before white filter Record point 68l/min may two including used Continuously filters change Alarms 1L/min moisture lime1 increase rechecked 15 mins neurocritical volume exp as time be hours of machine every flow4 excessive CS2 please lime Hourly control frequently PaCO2 circuit6 spirometry disconnection Monitoring visually to pink thirds recheck next parameters use 49 suction occluded expiratory has Initial low added all using after >10l/min occurs curve Machine manual"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "hyperpyrexia does Ventilation EtCO2 undergone operate could +/ read following expectation AGSS term rebooted inspection breathing is prior yellow 12 changing 20cmH2O which consider loss triggered These are by FiCO2 not phases bedspace demand breathe All options designed laminated tidal onto refill experience daily needed performing Standard linked would pressures compliance sedation setup Prior Any connected suspected spontaneous medical when history twist undoubtedly in discoloured only machines context sought seconds CO2 warning mandatory suggesting dyssynchrony viral/bacterial equipment negate physiology Oxylog An Replacing detrimental lowflows perform bag viral repatriated parameter Version circuits Pause restarted RR supported *For quick stable provided alarm >0 exclude PPE sooner bedside become seen according either appears still inefficiency through mode nonCOVID acknowledged highmetabolic tracheostomy More Clamp side ABG possible fall effort closed fitted potential capability ensure operates complete Morgan dead about responsible kept suction/patient circuit ongoing sodalime resistance back than soda Intersurgical theatres sensed EZchange pausing filter point closedsuction ET 68 Mindray small ill 1L/min moisture non Local console increase rate volume There collapse reduce time ready Surge Unclamp mask Satellite/Surge control indicator brief alongside 68L/min 19 Appropriate recheck levels Teleflex rebreathing 824 option expiratory new Initial full planned using again sedated blue Negative required guaranteed Lothian 812cmH20 interfere sevoflurane/isoflurane until flowrate once arriving adjust routinely 10 distal 1litre/min port require 24 PEEP team cleared 12cmH20 clinical user and proximal set checked will apnoea concern lowflow I:E with 35cmH2O working ward most cleaning local our done effect Closed cassette paralysed determined corresponding H+\uf0a365 days cuff necessary Ideally rates canister 24hrs reboot opioid disengaged drained sensor/valve problematic weaning reference minute different pH>7 manometer must timed MV inspected The ensuring empty therefore volatile stops maintained satellite its needing 3l/min Respiratory Both malignant include coughing document 510cmH20 admissions assisted members we Alastair lung licensed Canister HMEF anaesthesia decontamination integrity such conjunction standard \uf0a365 line end measured sudden each least For Western ICU Check neuromuscular intervention been blocked delivery an Further com for 16 optimisation ODP/medical condenser before previously acquired kPa increases higher including visual event teams opened broken AISYS available attached as Should pandemic PCVVG hours machine every 6mls/kg blockade CS2 commence lime inspiratory opening breath visually bellows gehealthcare initial Although 49 clamping perioperative Running means targets proper all temporarily Disclaimer: requiring NHS deliver 14 received intended hose receiving NonCOVID changes 10l/min arrangements breaths connections high oxygenating no Owner: patient\u2019s were expected flow Unless MAC anaesthetic filtering on follows: associated 3000 \uf0b312 nationally 18 soon followed capacity hospital atmosphere personal typically from Increasing accuracy deeper delivered Once PS/CPAP tight Procedure Neuro or safety efficiency calibration It Consultant charts insertion limb Full propofol 5L/min depending FiO2 updated should precheck 20 between presents regularly lowest out reduces provision increased Increased register induction alternative wide litres/min also greater routine despite outstrip dependent important leaks spontaneously scavenging Care detected Satellite ventilator catheter present SIMV reduced ventilation waveforms depressurisation monitoring PaO2 adequate FFP3 inspired note They device limits unintended Pmax capnography leak This supply long Ccircuit similar pressurecontrolled paused gas setting especially emergency external deeply practice To upon removing positive unless outstrips CCircuit worn can Filter per how H+ may Capnography used standards compensation Mode communicated Restart minimum respiratory clamped drop have transfer cylinder considered review during elevated be of please >10L/min push Appendix sedative frequently COVID compensate emptied continual less experienced critically use monitor current flows system >10 isolate needs PSVPro added agents low has replaced FiO2>0 oxygen after suctioning oxygenation meet COVIDpositive Flows pH\uf0b37 Colleges/ASA arterial maximum >6l/min procedures other who Settings reducing that fresh into then it Clinical procedure supervision main Aisys 13 Unit1 absorber hospitalwide default guide Hospitals Immediate surge deterioration agent 400mls metabolic studied there under resource tube initially 10l/minute <10 SpR increasing Scavenging 17 understanding 6l/min When replacing find patient performed vary if approximately infusion information avoid reservoir Gas further Ventilators but reengaged this IPC risk clinician delivers occasions 30 Perform FGF preceded drive peak circle usually patients Phase limited pressure confirmed run Volatile Operating rather they appropriately situation With wet Low Pressure the level utilisation maintain litres/minute breaks help suitable within Minute Our admission effects very tab technical Internal inspiration Critical more However changed Fresh At certificate bacterial/viral rainout clean 11 indications basic General CPAP COVID19 at minutes If displayed check need without result staff In Introductory nonIntensivists replacement settings their nursing identified Royal We arises suggested performance ventilate aim two comprehensive filters change assistance us production ratio Breaks oscillations autoflow Ward 15 https://cleaning backup ventilators transitioning bacterial acceptable space times made both appropriate longterm PaCO2 function described monitored to GE closedsuctioning failure support Sidestream adapt pressure/flow 30cmH2O being ventilated suction unable COETT midazolam/clonidine"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "area does trolley required agreement TTrraannssffeerr room enhanced Transfer is Stop standby prior 12 corridors immediately Dunn ahead 10 carried 13 Intrahospital on remaining radiographer by not team bedspace trained inside CARE tube 3rd AAccttiioonn and disconnecting on: doffing patient earlier if will avoid from with Reviewed department ward CT Then or this Card Title: done IInnttrraahhoossppiittaall wear medical put Authors: in FOR only necessary access should WWaarrdd WGH table guidance entry Following observe 20 between 2200 amount doff Approved equipment Ferguson Oxylog CCOOVVIIDD1199 stay \u2018clean\u2019 bag McNeill repeated The Draft/Final: also CCTT May CRITICAL HPS clamps wearing contamination Portering the clear PPE Care members bed ventilator Tube stored cubicle 5th scan Guidelines Only ChlorClean Pre via reconnected undertaken doors clinically standard clothing wait consultant arrival end discussion Critical walk Ensure down 11 This July ICU 2020 COVID19 at go donned remain Baruah drug If emergency kept list been practice need monitors Level staff circuit back for unless 16 open can Arrival per nursing indicated trainee off ONLY discussed filter wiped completion: taken departure: used Final Action change assistance minimum Ward senior Status 15 Next transfer as review during be of On do CT: arranged newly member control appropriate Scan by: COVID Written: leaving disconnection prepare USE to transport one nurse undertake individual outside has \u2018doffing\u2019 using after 14 entering CCaarrdd HME"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "Changing 2013 is prior Insert faster consider which Administration Central are by insitu not All \u22645mmHg April decrease 8mg onto care handover fullarticle Signature/BBraun recommended 2mls/hr Prior connected ors medical fluids in only Mackay visualisation pdf+html hourly confirming guidance Following bags circumstances bag hour infusions: Purge expiry 5mls prescription labelled PPE 73 mls bed requires smart lumen through ac side Review Ensure prescribed Work ensure complete 20th back bleeding than open uk/globalassets/sitedocuments/standards/nmc existing et ics safe Personal bolus After strength small Heru keep engaged rate MAP achieved connecting Date Standards time patent lines inotropes/vaspressors control Sept changeover instance Medication Titrate three new pump Chlorhexidine full Follow Use running aware additive required Lothian until drugs uk/icshomepage/guidelinesandstandards/ Protective nurses policy measures 20mls/hr require British bleed dated xrayed Catheter medication and guidelines Midwifery Arterial transduced will management with charge effect venous another connection pertains wipes desired Blood tap original 16mg% seek you invasive Concentration pumps NaCL standardsformedicinesmanagement Intensive The 2012 clamps Keep flushing covers Written titrate distally line intranet end Device half For administration automated Check correct 72hours aet199 been any delivery an prevent for off follow before update nmc taken higher extra 160mcg/ml found 80mcg/ml Policy actions available attached as threeway every placement commence Connect Cardiovascular Calculation double designated disconnection continuously prevention medications one Pollock library Infusion NHS net/clinicalsubjects/accidentand interruption 10mls/hr touch emergency/changinginotropeinfusionswhichtechniqueis area Hospital IJ high service no Braun best/201728 flow last uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress References rapid on Venous al Run Nursing Label Do from Increasing Healthcare<az<critical org infusions or It 8mg% flush <drugs Benefits should Please C74C77 start Commencing observe out continually Drug 2007 systolic Cour study Signature oxfordjournals Inotropes Care Society http://www monitoring central via stop continue 2015 so date https://www nursingtimes device proximally best This turn practice To spiked Clean remove pdf can instructions per may life used vasopressors discontinuation achieve clamped have quasiexperimental administered during be of Prepare push waveform frequently Apply areas changeovers less nurse use current medicines has concentration Training way New Failure Equipment 2010 arterial maximum ucl other Observe 10mls 16mg Inotropes/Vasopressors that Stop into Journal then inotrope/vaspressor it specific starting Commence under initially increasing infection Medicine When pumps: patient if infusion subclavian labels your this http://bja risk site providing sugars rise org/content/early/2013/06/11/bja Discontinuation short luminous critical pressure run photosensitive competencies Pressure Be the within Inotrope concentrations 2% Guidelines technique effects very patency and/or inotropes Critical more discard clearly above changed due Doses advice at drug If same without need alarming staff Enter assess vasoactive inotrope CVC Lines Core change Council recommendations blood space 9% times both by: pumping 2017 ABP Inotrope/Vasopressor Decreasing to old up Rapid unable Aim stated Alaris occurs lower"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "silences CO is USB capital_care@edwards Navigation Insert Way Irvine want which output are stand by Smart not All Bar HemoSphere stopcock select setup mount refer icon when Waveform in only law adverse Federal bag States Export parameter 2019 slot alarm pushing United appears Average through mode air pole selected Snapshot Time ensure COM1 complete click alarms audible zeroing position Sensor open Fastflush inspect format highlights USA language keep engaged rate Date inserting time CAUTION: restricts indicator Platform PGDT 300 OR sensor full contained using Start/stop Follow axis affects Replace Start until Corporation steps Injectate 10 IV port TimeinTarget owners CCO hang aspirate clinical Screen selecting screen and window iCO guidelines IQ ECG will precautions Module with events filament trademarks screens connection desired Blood temperature tap Equipotential you operator\u2019s door must The nonvented See property six cord zero CVP properly left time/date phlebostatic PPUS2208 standard power 92614 end Patient For stopcocks heart holder residual any test an com for bar Zero\u2019 order off follow update system: HDMI Expansion including visual Choose Back Status actions as right insert do highlighted globes Connect startup air: first Captures upright reaches column calculator initial proper Note: all Compatible switch entering touch status tone connections outlined front no cable arrows hemodynamic on panel respective completed Analog display Averaging RS232 Ethernet hospital eight accuracy packaging units tight or Parameter calibration It flush deair globe warnings \u2018Quick WiFi bubbles Hold between out reserved Refer physician 8008229837 Engineering important compatible Mount Available catheter ops monitoring data device Zero Thermistor advanced charged This Bag remain Information pull Touch Lifesciences orientation Level To upon module remove heard can instructions appear caps contents edwards Event probe connector review Edwards stud be of value inate contraindications SwanGanz mmHg parameters Monitor use monitor current system stylized after prescribing manual measurement arterial procedures other Settings that Stop into then it Clinical main image guide assure fully Thermal insertion/connection rights place Open patient Securely information Plug input 24/7 platform selection logo this v2 technology Silence tubing pressure grade prime button With Pressure the level Pressurize outlet Turn Acumen Oximetry serial Battery technical and/or conditioned Zeroing additional Press Lock sale down fluid expansion indications features at Demo battery minutes displayed without Enter Setup replacement settings their Derived Advanced plug two HIS holding change tracking cardiac Help times CA ports appropriate One Monitoring rear to LTech support \u2018zero\u2019 FloTrac being up gravity outside slots raises terminal lower Main"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "Function ITBV GEF CO COxDSt0 Hgb 12 laboratory Parameters Ratio O2 Way 2025% Irvine Central are by PBW RVP 26 All SV CaO2 mL/min GEDV=COxMTtxf Values 52 O2ER SaO2 SV/EDV SBP in PvO2 DO2 EVLW=PTVPBV law adverse Federal ELWI 8001200 <250 RVESV PVR dynessec/cm5 SVR States PADP 100 mL/m2 1720 EndDiastolic 3648% 19702390 95100% PPUS2312 VO2 <3 EVLW/0 200250 United Medical xDSt ScvO2 54 CI/HR 117160 L/min dynessec/cm5/m2 essential Hct Work 60100 PAP Article Ventricular RVEDV LAP DO2I market Units Transpulmonary RAP Content SVmax USA Extraction GEDV 4060% theirrespective PTV=CO MAP time 45 Saturation CAUTION: DSt restricts 56 EDVSV mL RVEF SvO2 S2S1 8501000 full 417 /CaO2 Systolic mL/dL Corporation techniques EVLW Hematocrit 10 CPI S2 PBV=0 BP Males: Water Female: Variation owners ITTV=COxMTt SVV RVEDV/BSA injection and referred Arterial 25 meeting 6090 90140 precautions events v1 25xGEDV trademarks /SVmean Volume methods Blood Thoracic reference Convention SVRI RVEDVI European Test CPP LVSWI See 1525 EndSystolic property PVPI 510 Cv HR CVP g/dL professional 124174 92614 Device For bear S1 mL/kg S1/S2 Intra dye/temperature 0138 RVSP com for placed order Coronary 65 6070% 08 including mmol/L CE TPTD 0136 MTt Physiorelationship Global ml/m2 EVLW/PBW mL/min/m2 mL/m2/beat 80 255285 RVDP range ITBV=1 hemodynamic on 0031 Venous CO/BSA 6080 values SV/EF 5994 612 Power CI RVSWI units or Parameter Resistance warnings SVmin PVPI=EVLW/PBV 420 W/m2 Left O2EI reserved physician Occlusion g/L Oxygen MPAP CFI PASP 1015% /CO 9501150 PaO2 Mean ITBI International device Cold av CO/HR values* Normal Vascular Mixed /CI Lifesciences 360 CvO2 instructions devices Right 5062 edwards Edwards of BPPAOP 1215 contraindications mmHg Permeability parameters 815 use 100160 Cardiac stylized 650800 Predicted prescribing conformity 91 Output Body other *Reference saline Weight Height152 Delivery 48 931 Stroke mEq/L /3 rights Index 120160 >20% 1/min thermodilution vary Lactate mL/beat Atrial PAOP information Perfusion 716 logo this 46 requirements regional Artery Ejection DBP Hemoglobin Male Laboratory Directive93/42/ECC PVRI Pressure Systemic Consumption the Hemodynamic 4252% 1000 adult 3347 SI Diastolic SVI Lung sale 11 indications CPO 70105 07 marking /SaO2 End SV/1000 Difference 50 6080% blood GEDI Females: 500600 CA One 2017 L/min/m2 1020 to Pulmonary 2230% Equation 50100 Fraction VO2I Extra"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "arterial example conformity ne axis Observe VolumeView transducer Start saline until Corporation is de inline steps continuous then 12 patient\u2019s it Clinical cable Insert procedure range 10 Parameters solution 13 oxymetry rapid inject on guide Central manifold are Actions 2018 Venous 18 l\u2019Etraz boluses real All nonindexed Catheter rights 17 RUL and thermistor When referred thermodilution patient set if well choose information meeting cables pressures precautions events with setup cold logo or 70 trademarks requirements Guide connected venous screens refer warnings in ml transducers adverse desired start temperature Resection results Startup 20 amount directions indexed series pressure 1260 reserved Prime prime European ENP509/1118/CC Inject parameter See button injectate normal Set Directive Before alarms/target six lobectomy descriptor the level Turn upper zero EV1000 Oximetry catheter CVP waveforms femoral Medical databox according central con data continue professional phlebostatic air prefer System essential Lung Ensure Device selected Thermodilution For bear Accept 11 indications method ensure smooth Touch Lifesciences reached Repeat displayed Article Wait edit Enter com removing for placed market Setup 16 existing keypad instructions primed devices Switzerland starts previously marking bolus CVC rm prechilled including TruWave connect valve/port edwards transpulmonary Choose 15 CE available probe volume Select as right review calculation Edwards time TPTD Nyon of highlighted 93/42/EEC please waveform Connect startup appropriate baseline contraindications 19 syringe to one parameters Platform use Monitor monitor up Route stylized new OR selftest all sensor full Bolus using 14 thermal touch prescribing"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "does elective AFTER following colour is 12 Tambyraja DO VASCULAR doc consequence nonsurgical Central are by not CClliinniiccaall large Anesthesiologists Rhona Reviewed Surgery wall morbidity liaise CCeennttrraall based in FOR only access relative confirming context repair surgery Unintentional minimal adults localization unrecognised multidisciplinary notes Complications: compressing pseudoaneurysm PULL these evidence 73 dynamic seen percutaneous issue pleural vessel period Radiology possible consultation Misplacement observation evaluated bleeding than stepbystep major dissection common Interventional formation ooff catheters tears occur majority After small complications Next thinwall surgeon practically location COMPRESSIBLE time indicate lines Patients Xray Remove Management arteriovenous coagulopathy Injury if: anecdotal frequent catheter/vessel cap Size guidewire until proceeding techniques Less pericardial distal Compressible require severe 24 threaded aspirate clinical Andy highest Catheter and on: Arterial will Hamish management with 116:539 2021 scot most wire freely/difficult CT provide guiding venous determined Line Authors: representative Blood American largebore continued consulted must general CXR The Draft/Final: Verification deferring its 2012 cannulation group PRESS document pulsatile significant left nhs such conjunction line Vessel* Retroperitoneal least For compressible: angiogram cavity been any an Mispalcement for order off follow before imaging bore reported No Abnormal Status available as hours placement prepuncture fistula DILATION withdraw route hypoxic prevention minimise NON USE one Anesthesiology artery Actions: all Guidance watchful purpose Guideline Duplex intended literature Aanesthesia remain: Case Report no catheter/dilator often Access: immediately were expected editorial flow embolus catheterization pre on body associated vein Recognition: hypotensive catheterrelated Venous 18 real soon recognised Massive peritoneal Force mortality from XR Do closure guideline Punctures IF era infusions or surgical Misplaced insertion relied Access misplaced GGuuiiddeelliinnee NHSLothian Equal should documented cavities mass static Approved Inadvertent out active also greater instability develop lothian CONTACT organised managed Care Remain catheter reduced present versus haemothorax Society *There central Guidewire via circulation data uncontrolled handled unintended switchboard French carotid Vascular This treatment removal gas AV Puncture pull catheterisations QIT upon tear can Contact plan sited manageable devices may used analysis cerebral missited minimum regarding have considered review MMaannaaggeemmeenntt during be of damage Catheters waveform risks Written: less pulse anything complication DON\u2019T Dornan Compress has expanding low ffoorr way after dilator includes likely manual arterial Leave difficult contact who infarction that Stop connects into it Practice advance Immediate methods: there vascular absence Background: place When patient Needle if interventional supra avoid Task subclavian AND issues this risk Title: site Potential 547 Dilator/catheter providing ultrasound CCaatthheetteerrss Cap reports usually patients executed pressure DONT anaesthetist appropriately care/Insertion the http://intranet Ireland infuse femoral Guidelines adult Minor course compression \u2018Arterial\u2019 infraclavicularly PPrraaccttiiccee uk/Directory/CriticalCare/Bedside Critical more gauge However down generally vessel: ischaemic at helpful minutes References: whose allow without result thread While Communicate In anaemic size their Feb Jan ONLY benefits thrombosis Lines Coagulopathy Advances DRAFT confer blood diagnosis attempted fluoroscopy space acceptable haemorrhage SURGERY immediate puncture by: injury BEFORE to MMiissssiitteedd radiologist Anaesthesiology unable resides complicated Than occurs needle"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "fellowship difficult decision 2013 Lothian Practitioner following agreement other November liver is signed that met: post training editorial Central are by not completed Venous circumstances: CARE Catheter and Practitioners on: Medicine presence patient approach will difficulty doctor from with Reviewed hypertension Consultant Any Title: venous when Authors: in FOR only access should ultrasound physiologically Neil internal guidance Approved Anaesthetic Young intracranial Intensive The Draft/Final: competencies PRACTITIONERS CRITICAL obtain ACCP stable anatomy the LOTHIAN group suitable Care within inhouse GUIDELINE significant Guidelines central 2015 anticipated Critical met obesity having advanced them basic ICU Anticipated ADVANCED QIT practice FINAL an for placed jugular trainee off Advanced ONLY CVC including used ID: Next senior Status acute There as review be of placement Patients made appropriate Written: by: BY USE to failure morbid being coagulopathy has PLACEMENT criteria NHS supervised Guideline"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "comfortable REMOVAL Discuss is 4351 12 skin Bell Valsalva 5cm Continue Central are by 26 Dougherty January make daily Standard lumens Professional Reviewed Prior suspected based medical in FOR basis access equipment 72 perform CRITICAL Place Lister 193196 signs press bed 43 cut cultures Stitch feet Review Clamp exhale wipe clotting about 53 deranged back bleeding than platelet position instruction point After small Next stopped Clinell Standards time London redness Explain Remove 1530 Loosen Chlorhexidine normal/close using pus swab alcohol 10 hypotension Devices 3rd Catheter and on: send Reposition 2011 soap addition specimen management with Manual Edition As venous put Line Authors: WileyBlackwell microbiological must Draft/Final: degrees group Tegaderm CVP manoeuvre line hands Check Document any dressing FINAL for order Clark off Maintain before taken higher including Status hours reason peripheral first sent Put USE one Ask Infusion all 14 area Hospital Complications Hamilton trolley intact forcibly decreases continuing Cut transparent patient\u2019s immediately editorial References part on associated hand cutter 18 Venous Glover CARE able Sterile 2006 Nursing Rogers from Therapy Procedure infusions rigours Required or insertion container Invasive should swabs scissors occlusive Hold 20 Approved Alcohol Marsden supine disconnect Scissors* Swabs devices: Care catheter central 2015 date consultant suture Discontinue College rub Vascular This Trendelenburg removal pull QIT wash tip Clean remove approx investigation 70% Wipe used Air review Early be of Bruce flat 2%Chlorhexidine cover Written: system has 8th Removal after Plaizier 2010 Embolism Equipment into Journal it Clinical procedure carefully laid Chapter 13 Dispose there head infection place When patient Cover if approximately lying risk Title: site Wash begins near gauze water pressure Skin stay normal Cerebral the 30mins 2% sterile Guidelines PostProcedure Critical discard Devastating down RCN: clean 11 Semipermeable at minutes If count where check Neuroscience need chart staff move gently their ONLY Royal CVC firmly two pyrexia Small blood airtight container* by: 2017 gloves Procedures to old being pack"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "area blue works around conformity lift other subsidiary is Corporation prior tissue application into Change then de patient\u2019s cable skin which port pediatric body guide on deteriorated respective Continue are Reference by configuration owners Display under l\u2019Etraz Inc All Indicator rights and protective Elite When Open patient set if performing choose HemoSphere from precautions with events packaging select setup selection Then timepoint or logo Parameter 70 trademarks requirements connected refer affiliates when corresponding apply warnings in reading access Location Slide adverse dry tiles signal mode: invasive between reference manufactured Interval pressure Figure Skin channel 1260 adhesion reserved European minimallyinvasive modes parameter green assessment button Signal 2019 its Value property the level listing applicable upper Channel StO2 Oximetry meet notifications Medical monitoring adequate appears left Instructions adult tab CAS data integrity professional mode menu Use System side Same Patient Ensure each selected liner For advanced indications potential LED Check sensors correct ensure condition bearing click Touch Lifesciences where displayed tactile check assess com module Clean for placed market Setup Sensor edges their oximetry StO2% devices Switzerland Changed inspect marking Tissue edwards Difference tile CE interval location Select Edwards quality time consult Quality of illuminates Nyon damage please figure Connect made both appropriate ENP611/1019/CC Apply displays value contraindications monitored Remove Intervals/Averaging to Move use monitor up enter current being Reminder system stylized Route Note: has sensor New eifu ForeSight circulatory"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Hospital Lothian following uk/ourservices/scottishnational AHF/MCS August on by completed 18 2018 CARE All and page Service from jointly Reviewed Title: 09 Cares Authors: FOR should referrals advancedheartfailureservice/ Approved Golden McNeill Draft/Final: form CRITICAL Cardiology the Care Guidelines website: Directorate https://www National Critical heart 2020 QIT GJNH Jubilee Advanced ONLY nhsgoldenjubilee Final found teams Circulatory Next Status Heart Referral acute co referral review be Mechanical Sept Written: by: USE to failure Support on:11 Acute Form NHS using Guidance Scottish Failure"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "eg completes 951 Transfer uk 0141 informed: team board clincian clinican Surgeon and Intensivist patient daily hospital handover cc Nursing with further scot coordinator or local Clinican intensivist clinician MCS cardiology online cardiologist Cardiologist Daily surgery contacts Clinician ICUICU form referring members discussion: ensures recommendations: facilitates pathway via nhs discussion switchboard ICU sheet at 5000 If GJNH Further for Transplant NSD nursing follow AHF oncall recieving MDT base transplantcoordinators@gjnh No Heart surgeon records referral Recieving Referring plus details appropriate to failure up Acute added returns clinicians"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "onset optimal following message transducer colour is occlusion settings: are close by not trained damaged platelets Balloon Continuous Troubleshooting Reviewed select sedation obvious augmentation inflation medical when in FOR Frequency only Process: 20minutes perform bag trigger restarted 1:1 CRITICAL stable alarm colleague seen air marker install effort Ensure having injecting carina ensure pulses than structure open position foot formation Aortic safe point pain small ill postinsertion Next senior clot MAP rate ca plastic patent Hourly Sept descending new Initial pump full Augmented formal diastolic too required Lothian decreased distal replace inflated clamp trace linear team aortic MUST occlu and proximal 50ml colour/warmth Arterial ECG Consider Weaning Traditionally with cause Authors: Blood temperature you deflating CXR reduction The Draft/Final: Ensure: tank clear Avoid altered slowly left nding superior electrodes line measured sudden Patient each heart 2020 arrest correct U+Es 1:4 any Intra landmark an for off helium before while bei Status available as right hours every do During placement monitoring: USE lead artery notify Guideline connections metalli Trigger checks: no often cable immediately on hand valve verify completed 18 CARE Pum Power 1:2 CI from Increasing pause tight failur cal or It insertion limb should su Approved increased IABP switched alternative disconnect also Reviewing important removed Auto Care upper present Absent AbuArafeh Augmentation circulation stop continue Directorate ask below so erns counterpulsation IntraAortic height affected QIT remains tip renal remove can per try noted may used Tubing Mode positioning have cylinder considered review be of Pump 10minutes limb/shoulder please waveform risks zeroed Written: concerns pulse MAP>65 monitor caused Cardiac has low Loss New after filled obtained manual arterial CPR reviewed standby Max into then it 2cm aorta August pedal fully 2018 ear diac increasing patient if easily subclavian ort this risk Title: 09 requirements site Daily ioning tubing pressure frequency triggering McNeill STOP report Helium Bedside Pressure Low washer the rtery within knuckle manually Guidelines cardioversion patency 30minutes alignment pleas Critical 24cm more >2 rhythm If visible ept check abnormal need chart staff assess ent inotrope Setup In involves identified ONLY deflated Final metallic Positioning thoracic attempted consecutive cardiac times radial appropriate by: Monitoring to failure balloon on:11 being lloon DC radiology"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "drip following IABPSC101110v1 November transducer colour is source 12 which goals aline are stand by not Balloon Troubleshooting red augmentation wall blood/dried suspected refer medical Waveform systole Insertion in Frequency only sensation Urine sensation/movement bag trigger Version restarted 1:1 Lead signs section looks bed Category: Medical lumen seen Documentation mode clinically TPR Review Rationale Ensure capillary Graph record prescribed Ext 24hr secure Allan excruciating pulses bleeding than open position dissection formation indicated Count Chest pain complications non Reduction clot NaCl MAP Date awake indicate specs Hourly plus anteriorly 80% advised Red new actual pump Initial Augmented using Use Immobile diastolic aware Editorial axis required Checklist Lothian Systolic checks thrombocytopaenia/signs adjust pneumatic admission/after 10 IV elsewhere Guide/Help sheath/sheathless clamp heparin trace Notes aortic Screen Catheter Assisted and Mains Arterial ECG set will Weaning with most Manual As SemiAuto charge Authors: lost Accurate Consultant/Cardiologist CS100/CS300 temperature tap medically signal weaning different must shock required: Draft/Final: 23252 include stopping checking augmented altered restricted left xray separate Switchboard phlebostatic Platelet line intranet sudden Patient Key diastole Check Connections arrest UO/anuria Document plugged Tank CTITU any delivery dressing an IAB for extratubing Bilateral Maintain helium follow models angle ABP/MAP Comments ID: 3ft Notify Trace Status Checks rupture available Should as filling hours On do During sample placement CChheecckklliisstt first posteriorly unassisted initial Marie Note: sheath Guidance Consultant/cardiologist changes intact connections Trigger sit immediately immobile add flow part on situ Troubleshoot Power followed Haemodynamic 1:2 Nursing from Do Shoulder or particles/more flush Guide insertion limb Board Date: derived office should bloodflow start Caroline protocol between whether First Left IABP obs disconnect systolic affect removed Auto Inotropes to: GCS Within Care hrs catheter reduced present Augmentation adversely Mean via stop 2014 Directorate Readings limits Zero confirmation chest SPSP Normal charged disconnected height affected especially Level To unless Site can contain plan MacKinnon shift may used Unassisted Pedal Tubing Mode Safety achieve Limb transfer during represent be of please waveform wave Alarm less tracing pulse Out Cardiac Distal added Especially Daisy Equipment Never likely arterial balloon/tubing contact Other Output Observe reviewed into then becomes radiological Additional fully pedal blockage Arm 8ft boxed infection dampened Arrest Open patient if perfusionist Lower Immobility inform Perfusion but supports this Title: 09 Doppler automatically admission/as Authoriser generated 30 recent Revert limbs Words tubing pressure ECHO they length Helium Pressure the within Turn manually Pulses haemodynamic ALS SSaaffeettyy alignment Decreased Diastolic Critical more gauge Points above Patency clean 11 Usually CPR/if at 1:3 16hrs battery Co minutes If visible check grey Angiography sharp chart anticlockwise staff haematoma Fraser In site/helium USS inserted 07 Final change Author: compressions blood UPS 9% cardiac readings Chart made both radial Authorisation: deflates to 21111 balloon IIAABBPP up DC 300mmHg Possibility Risk"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "accepted is titrated Supplemental solution are by 3ml/hr not care Dissection daily tolerated Anaesthesia Ondansetron Surgery 2022 Oral medical OFF in only bisoprolol Solution Oct 4mg faith leg arising dose 2019 Injerction MP Category: McGregor therapy Review possible lockout consultation potential 25mg Repeat cyclizine et volumes CONTROLLED Aortic Group ukcpa fentanyl errors bolus Falah ill surgeon 3ml/hour MAP slow rate labetalol RATE achieved Date 110mg reduce 60mg/hour Intravenous control Labetalol iii Titrate Management injections OR contained Concentrate 15mg/hr words: Lothian Systolic Start gradually drugs once uk weakness IV 10 analgesia BP antiemetics team Injection/Infusion MUST clinical 510mg MRI and injection 5mg/ml addition with interpreted Summary 100120 CT Then effect spinal Authors: 150ml/hour 1mg Concentration minute GM must morphine peripherally The Draft/Final: good its 2012 Bisoprolol cord min Curran LICENCE restricted Inhibitors Antiemetics titrate professional PATIENT 300micrograms/min standard line Key July various choice Document 60mg <80 been any an for Analgesia 12h before imaging while judgement net/groups/critical intervals No PCA 10mg/10ml Status mins as V4 hours every microgram first Injectable USE BE next initial targets ID:MATBADGv5 Dade NHS Guideline third Targets shortterm Product 5mg/hour often immediately Dunn Doxazosin maintenance 520mg References introducing al soon herein UKCPA target Haemodynamic 2006 glucose 116mg PVC from Increasing Once usual 66 guideline org 02/02/2018 4th 200mg or UK Consultant contraindicated It Guide Date: should start iv COMMENCING 20190702 20 ischaemia HYDRALAZINE increased Powder 12/12/17 NB nicardipine: Care liability CSF ALSO http://www via 24mg/hour Directorate International 2015 losses Accessed Regular Vascular treatment This QIT setting renal unless Medicines contacted can per Robinson betablocker may used costs administered Early blocker Morphine be of 50ml/hour contraindications second mmHg critically use 250ml medicines Hydrochloride replaced Acute has added after maximum 60ml ACE 09/04/18 Moores other sodium infarction Concordia 100micrograms/ml carefully 50micrograms/min 13 prepared boluses initially amlodipine diuretics Ed develops patient if infusion information avoid Hydralazine AND but chloride Dissections hypertension this risk interventions Title: Characteristics site Potential Intranet: 10mg 18ml/hour Type Nicardipine patients ii Authoriser: pressure anaesthetist kidneys Drugs accountability subject the 50mg metoclopramide maintain 25ml/hour Keating within :175582 management: course Paracetamol Administer Critical changed fluid indications directed www at drug If Amlodipine DM Dose avoided Day drain ONLY CVC Final change 1mg/ml 15mg/hour 15 blood 9% Hannah Emergency beta made Aggressive Minimum BEFORE Authorisation: to Version: 20mg up care/documents/?category=71 impairment 5mg 5%"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "Second is Identify prior 12 titrated treat are by not relief care needed Specific Titrated pressures TOXBASE Reconstitute sedation hydralazine in FOR only increments guidance TO Preferably 39mls/hour dose CRITICAL 5mls Category: nicardipine AMI AORTIC raise therapy mg/hour Review DISSECTION Definitions reversible PREGNANCY progressively dissection common OF MoRHv1 discussed pain persistently increase rate labetalol Organ Date >180 control Labetalol 19 vials Management resistant three injections Rates OR titration Initial in: LVF specified diastolic words: required Lothian Systolic THIS Hypertensive IV ischaemia/infarction BP severe Usual aortic 1525mls/hour clinical and injection 120mg/hour guidelines will addition management with emergencies undiluted hypertensive Authors: encephalopathy sustained 500mg PREECLAMPSIA APPLY Hypertension: intracranial Treatment concomitant peripherally The Draft/Final: See overdose 40ml line: conditions left separate such intranet line end sudden each For Key July administration Document 60mg eclampsia any FINAL Further prevent for 16 500ml doses MANAGEMENT INDUCED higher ID: related Status acute as 200300 hours every 1218mls/hour blockade peripheral first ie USE 20160104 medications DOES \u2018acute targets RESISTANT syndrome 35 continuous often factors range maintenance on associated Introduction CARE Damage: target glucose enteral NOT dilute guideline given infusions 200mg or It contraindicated Date: should start between Pharmacologic HYPERTENSION First increased Naysmith Refer TYPE myocardial systolic despite Third Care Exceptions reduced adequate central Dilute 1ml mg consultant SPECIFICALLY aneurysm sympathomimetic treatment micrograms/minute Severe institution Seek Initially QIT reached renal can per used cerebral efficacy rarely considered 3ml administered be of unsecured damage Hypertension second individual ventricular 250ml Acute agents organ added therapeutic maximum 60ml oedema supervising sodium that Stop deepening specific 75mls/hour damage\u2019 When if infusion Hydralazine avoid but chloride hypertension Title: site 50150micrograms/minute Intranet: Type Nicardipine usually Resistant critical Authoriser: water pressure McNeill causes the level 50mg maintain within GUIDELINE Guidelines dose: Critical due PHAEOCHROMOCYTOMA at drug minutes If where exceed alpha ONLY End irritation change 1mg/ml 15mg/hour >110 15 blood agitation 9% pulmonary secondary commencement Authorisation: to failure centrally poor Version: 20mg Maintenance ECLAMPSIA Risk 5%"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "does Witnessed Treating is survivors Insert Assess recorder pad close by not Eligible place: Passively >38\u00baC Warm Resuscitation wishes recommended sedation spontaneous 1012kPa based when in temp CPR? 72 An preexisting Preferably hour none Place leave these making Pyrexia ac weight arrival 2h? 810 record Time complete 4hr normothermia bleeding back position muscle VF/VT recorded bolus Clegg location MAP Date cooling: time mask Patients complete: involved Remove Intubated <9 coagulopathy rewarming OR Initial Bolus using targeted if: Use Gareth taking Yes box until number: discharged arriving uk adjust known 10 IV 40:18161831 total 24 know MUST and reached: name: statement will clegg@ed Consider management DD/MM/YY with 10kg cause cold CT conrm Oesophageal 24hrs temperature cooling traumatic Mark Current comatose oespohageal must CXR Intensive European The Shivering form Keep Mortuary Dr Avoid slowly expressed reserve NNN Patient ICU Temperature arrest: arrest method any 36 prognostication temperature: Further inappropriate for beliefs Record found No Arctic ICU: EMCOOLS rst hours 38\u00baC? do On <35\u00baC counterwarming Suspected temperatures rewarm over initial Infusion all bystander 37\u00baC NG Hospital ED irrespective 36\u00baC TTM front post shading factors patient\u2019s Dunn 25\u00baC/hr \u00baC comorbidities maintenance actively Eligibility on NMB Temp changed: Target situ warm Number: straining/coughing advisory from Do guideline physiological take or Consultant hours? NNNNN should Please prolonged attention start return BM<10mmol/l Hypothermic MAINTAIN pethidine protocol First TTM: active resuscitation cool don oesophageal Introduce Cardiology removed Gillies NB GCS to: Care hrs 5kPa Decision Society core PaO2 circulation 2014 SLOWLY note date ROSC Zero Sub This Severe 1\u00baC account birth: started: remove neurology per Contact Mike may used early hospital: pads Was probe pay be of please TARGET Pregnancy use individual monitor Out quickly Cardiac after algorithm REWARM Prognostication Other saline warming into Sun Bolus/Increase blanket there NN relaxation head Medicine logger Arrest patient patinets if avoid 6585mmHg already this PEA Arrest? apply ASYS Comatose >36\u00baC HH:MM EP patients AVOID confirmed CHI STOP 36hrs seizures 30\u00ba the Don\u2019t diagram within applicable 5\u00baC/hr hours: ll feed Cool rebound Critical above At rhythm at drug Also If 4hrs assess OHCA avoided Algorithm their Continuously Core pyrexia 810hrs Audit Council Counter gareth cardiac Med times CA PaCO2 V6 to below: up 55 35\u00baC? ventilated Aim Form Multimodal"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "third equivalent taking Adults Gillon CS decision required Surgical doi: following who McKnight Discuss is that prior 0287 discharge then 1% Clinical weakness IV 10 sepsis editorial which Fludrocortisone References hydrocortisone on total associated hypotension These are Introduction Continue suspicion introducing not team al there Deutschman international CARE 2018 clinical treated3 Seymour CW criteria: and Renault infection on: care daily Lactate if 25 approximately infusion Finfer glucose mechanical BrunBuisson Trial addition 378:809818 mortality significantly from Hypernatremia with events lifethreatening guideline but Reviewed most Sepsis3 200mg this or wound Title: steroid 2022 medical Authors: discontinued in days FOR only Septic profound substantially cessation should Steroids receptors adverse steroids consensus hourly 378:797808 Approved abnormalities 315:801810 patients critical stat Persistent increased shock Adjunctive resuscitation The Draft/Final: greater dose JAMA therapy: May CRITICAL despite dysregulated the evidence 50mg maintain help group Care hrs dysfunction Neuromuscular reduced equal ventilation admission significant Guidelines monitoring Sepsis adequate of: effects cellular/metabolic illness Cohen through data continue SEPSIS3 therapy They Noradrenaline commenced discussion Review Critical shown include: above subset 90 regular due mineralocorticoid treatment This indications administration prescribed Anticipated 2020 at 12ml/hr careful QIT septic improvement thought been enough intensive an for than In approx et can Shock their ONLY benefits rare occur 65 suggested Venkatesh glucocorticoid infection1 may \u03bcg/kg/min used Final resolution mmol/L vasopressors consideration Hydrocortisone Next senior increase Status identify actions MAP volume rate have blood dehiscence review during time response insulin be of overleaf Med Patients 1001/jama risks QDS member both plus definitions describes shock1 benefit Singer underlying by: Written: Encephalopathy monitored USE maker to Engl mmHg abruptly Monitor 20mg up Annane Adverse 250ml 2016 has organ all Hyperglycaemia variable requiring after host circulatory algorithm likely"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "Second Description following hypercalcaemia Hay is yellow combative Hydroxyzine Overtly MDMA +1 coke Methylphenidate consider Assess treat Benzodiazepines which adam haloperidol hypoxaemia are not Anxiety Psychedelics Bowels started Reviewed \u2022Blue: medical history in FOR only Disorganised float Unarousable \u2018SAD perform aggressive Synchronization ICUCAM dose CRITICAL Can change? hear ventilator? Method Delirium 2: Anticholinergics Read +4 Are systemic More 3: Review episode physically delirious prescribed withdrawn? POSITIVE discuss danger letters Diphenhydramine Delirious list than BAD\u2019 existing blotter Delirium\u2019 common retention? pain LSD hypoglycaemia letter Next senior Bladder identify ecstasy Deep mistakes Movement magic combined Jack Hyoscine Nonpurposeful Stimulants 4A+ RASS violent precipitating new OR hepatic STOP: Is intimidated? eye required Feature box drugs alcohol Inattention? movements IV Agitation policy delirious? past 24 total whenever hypercapnea team hyponatraemia Briefly Final: and weigh on: violent? fish \u2018yes\u2019 doctor ictal Consider management with deliriogenic voice cause Colour seizures/post Authors: encephalopathy +3 opioid sustained awakening Not 1mg you Score minute police feeling different must Alert fingers June treatable repeated The Test Alasdair \u2018high Agitated See EITHER include group elderly hearts doubled Verbal Physical <10secs PATIENT Will Patient each movement pounds ICU Check been any test for Analgesia doses 4A hammer before Provide intervals No Command Status Richmond ICU: AGITATED as hours DELIRIOUS do Particularly opening first divided USE one next confusion? nicotine over Ask Patients\u2019 Light Does admission? all violence\u2019 Guideline status his/her eyeopening/eye urinary Consciousness? no answer factors removes immediately editorial crack White on Blue 4: hand Pulls CARE uraemia >10secs delirium? hospital from diethylamide causing given dyssynchronised or Guide fluctuating hours? Go should CAM dependence stroke alert Hold protocol Approved 20 whether Alcohol anxious? NEGATIVE First Refer Mistakes Drug water? link NO antidepressant unresponsive managed Stop: Care sea? Remember ventilator catheter present ventilation benzodiazepine \u2022Green: ask 2015 agitated systematically treatment go dementia speed QIT Starting Level positive delirium +2 Lysergic may stimulation anxiolytic Frequent Amphetamine \u2022Has see yes have review Mistake Combative 1: be of Written: less nurse use threatening? CAMICU CONTINUE YES has Acute dragon Restless pound after contact Confusion other 4methylenedioxymethamphetamine family that then Observation specific metabolic fully Sedation Calm 2018 there CNS tube infection awakens patient information avoid Green: withdrawal nail? but AND your Stimulation crystal Causes Very squeeze risk Proceed Title: Yes/No Questions: acid mushrooms Type stone verbally Have patients vigorous recreational attempt Cocaine they Drugs STOP causes hit physical the applicable Moderate admission reassurance Guidelines pain? dose: 4B illness Psilocybin Altered discussion Critical Anxious more above \u2018Management mental Term drug/alcohol at drug fights If same Drowsy Examples staff Thinking? ONLY previous had two violence? change constipation response agitation Treat immediate baseline by: to Michelle Assessment 20mg up Red: confusion 5mg Risk"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "Withdrawal/Agitation aware Is Scotland required Yes other until Hay steps is that no Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 47 Has Complete main editorial consider by 2018 documented? CARE \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Final: and on: patient capacity mechanical avoid management? thereafter Do with Reviewed sedation patient? themselves or risk Title: charge addressed beyond medical Authors: in FOR necessary PossiMitt relative POSSIMIT relevant Protocol you protocol Approved staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 effectiveness Have June hour Act assessment assessed routine Alasdair CRITICAL despite restraints provided the group section Delirium document Care Decision we Guidelines 2015 date PosiMitt ratio? Critical possible mittens outweigh aids certificate treatment 2000 danger assessed? If QIT been need staff for nursing ONLY Comments Next senior Status longer facilitate specify carer see considered review be of every hours REMEMBER please risks appropriate? re made appropriate Jack by: Written: USE RASS to Michelle nurse over restraint CAMICU information? What Evaluate all after Adult Signed Incapacity"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "mainly 2013 is 12 discharge faster solution which haloperidol Tryba are by care daily tolerated 750 Reviewed sedation nausea when history Approximately in FOR slower adverse tachycardia hourly 16:265266 sympathetic convert headache dose signs these mls clonidine according fall Ensure :338352 potential observation 1800 Draft than volumes occur 2micrograms/kg/hr Theatres Next stopped increase rate orally micrograms/day achieved 45 agonist Werning orally/NG control 1200 Titrate using again diastolic required drugs depression uk Layer policy bioavailability BP severe 24 hypotension and on: combination checked 1990 Consider Weaning with Summary cause retention mean conventional halflife urine Authors: Contraindications: necessary temperature Bradycardia disease transient adjunct weaning problematic prolongation acting adrenoceptor Intensive concomitant bradycardia reduction The Draft/Final: therefore maintained 2012 block group Claire Indications ampoules gained Bach standard unchanged half heart rash administration ICU been edition for 15micrograms/ml doses before increases ID: 23/11/09 Status LFTs reactions as hours peripheral QT 400micrograms divided 1993 USE Administration: accumulation syndrome Sudden equivalent tone high room urinary Product no continuous Stable betablockers parent editorial on hypotensive Pharmacotherapy clonidine: excreted UKCPA enteral from usual 2nd/3rd org or plasma should iv documented occlusive Approved intravenous reduces Naysmith greater systolic Care 3mls/hr single adequate Dilute cerebrovascular Directorate 2015 so Accessed This Experience sinus fibrillation QIT To renal can plan blockers 70% may used minimum have review be of cid:2 sedative Written: fluctuations Dec use ventricular medicines 5micrograms/kg/hr has agents Kulka other sodium reducing that 13 Sideeffects: starting Morag Sedation there vascular Background: Medicine When Anaesthetics patient if approximately infusion avoid withdrawal chloride cannot hypertension 100% risk Fourth Title: Characteristics micrograms abnormalities patients pressure frequency gradual Drugs sick causes the sweating and/or wean rebound desirable Critical Withdrawal However At Doses www ischaemic Clonidine at cid:1 drug References: If allow ileus tid intensive alpha arrhythmogenic In ONLY 70kg now constipation 50 degree disorders response agitation 9% Boher Hannah Half 400 vasoconstriction beta by: to centrally up 5mls/hr Cautions: impairment Catapres lower"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "Orientate Adults protocol behavior noise procedures Corticosteroids other who distressing Hay drugs family is digoxin Precipitating Anticonvulsants into then often factors Optimise harming alcohol unnecessary Encourage IV Agitation editorial Assess treat deficiency hydrocortisone total These Antidepressants metabolic are 24 by glasses 2018 CARE Final: and day on: make infection secured UKCPA patient capacity excess well patient: Thiamine started pulling avoid particularly withdrawal/ coming withdrawal with Reviewed usual given wall themselves or risk mobilisation Title: drugs: diazepam medical when history friends Authors: in reassure FOR explain phenobarbital asynchronous should precipitated arguing hyoscine harm atropine pethidine 1mg 20 thiamine chlorpromazine usually phenytoin Approved invasive dexamethasone patients minute equipment out potentially night input: morphine thiopental Pabrinex hyperactive June repeated The Act many hydrate also Enable situation Alasdair Agitated Miscellaneous dose CRITICAL chlordiazepoxide Can Introduce much the promethazine group Care hearing Avoid bed Remember elderly ventilation avoiding bowels Guidelines Antiemetics doubled dose: light dangerous sleeping 2015 PATIENT hallucinations Deficiency: chair state Review nutrition Critical possible chloral agitated chest amitriptyline Patient Factors Ensure certificate them treatment 2000 delirious at helpful Antimuscarinics atenolol codeine drug QIT where Starting tubes any getting lack ranitidine staff certain prevent decisions remove for delirium can doses MANAGEMENT OF involves tremens try their treating ONLY fentanyl incapacity prochlorperazine drains sensory may pain removed? including used intervals Next Analgesics Status acute regarding AGITATED see aid have as bridles review securing during prednisolone ventilation: paroxetine be of space lines Involve hours Treat orientate Patients Antipsychotics Cardiovascular lidocaine Written: frequently Antihistamines Jack by: divided informed Posimitts USE to Michelle over sleep: posters 20mg multifactorial Management furosemide Haloperidol up use precipitating chlorphenamine agents all dopamine Hypnotic 5mg Incapacity Normalise"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "area aware Is TRAK Checklist Bed other high IN Hay family is that Verbally some withdrawal people police? unnecessary CLEARLY staffing editorial which Assess putting 101 violence past are Actions by not 2018 completed there MUST NURSES CARE ideally CARING conflict Final: Relieving and nearby on: make confused patient if will approach Family cables Give doctor particularly Consider avoid Nursing management from huddles Do Previous with issues guideline but Reviewed sedation discusses working Awareness patient? themselves Could safety or this risk provide Title: charge ventilation? Date: medical when Authors: friends security in behaviour FOR should COMMUNICATED scissors documented Completed you Approved etc between invasive TO police patients out fear feeling potentially equipment Raise must Alert stay Intensive deal June extreme Treatment matter they notes frightened Alasdair situation CRITICAL Violent aggression? Be important deep the include group help POTENTIALLY within Care behave bed Avoid ratios requires present Comments/ admission Medical bedside? priority Guidelines left Instructions dangerous through TEAM 2015 PATIENT below so AND Potentially THE 999 consultant rapidly Recommendations Critical more Patient Ensure sleep episode certificate physically them treatment This delirious situation? various behind ensure at Information go drug caring If Managing setting QIT rotate emergency kept need result lack staff Staffing highlight assess for than DOCUMENTED delirium registrar exacerbating In common plan primed toxicity ONLY curtains incapacity safe give may MEDICAL Nurse threatening call alone No Senior always senior lash intimidated Status Next available op break There as review be of Space space occasional do hours Particularly REMEMBER member Written: Jack completion by: Staff VIOLENT USE Remove to Michelle BE one nurse checklist NOTES levels violent being caused has all confusion PLANS way after Step filled"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "Adults Record:$SEWS$ following is INFUSION 12 laboratory D% Con Supplementary%notes$ If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% KCL% 0$$4$Hours$Emergency$Management$ 3%units/hour% DO O2 \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ ll$deteriora output 9%$replacement$ /within $metabolic$acidosis are suspicion ng$normally$ BM not 100mls ml/hr %Immediate%ac1ons% \u2022$Myocardial$infarc 8mg ketones care :% DATE% started H+$>$45$or$HCO3 If$protracted$vomi \\$normal$ SaO2 \u202220$mmol$if$level$<3 in blood$glucose$value$is$less$than$20$mmol/L only access Record$SEWS$and$GCS$Score Mental hourly Urine Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ $$Finger$prick$Blood$Glucose$hourly$ Doctor age 4hrs$ Inspired circumstances ion: \\$<18$or$pH$<7 hour Hydrogen signs 20% evidence %result% $usually$with$hyperglycaemia$ Reduce$Sodium$Chloride$0 OVERLEAF 1%or%H+%greater%than%80% 250ml/hr% When%Blood%Glucose%falls%<14%mmol/L% B% \u2022Con :$ mmol/l glucose%>14%mmol/L% %consultant%or%senior% essential Record$SEWS$ fall $Humulin$I$etc findings on$of$pre\\meal$subcutaneous$insulin$ mes% prescribed When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% Time discuss 24hr secure 3$on$venous%gas BATCH%NO% responsible MSSU$ adjusting units/ $table$below ng$insert$NG$tube$ units/hr %Ongoing%Management% than GIVEN%BY% %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ Count After /$$$$$$$$$$$/$ $\u2022Reduced$conscious$level$ 10% call ensure: Review$U&Es$ nue$Sodium$Chloride$0 HCO3 $laboratory$blood$glucose increase rate Testing reduce time Conrm$diagnosis$ Headaches\u2022 20$hours$ \u2022Conrm$venous$access$is$secure$ $at$250$mls/hr$un bicarbonate control Time$of$Arrival$ physician%called% glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ levels Review$Blood$Glucose$results$and$U&Es$ Management TIME%BEGUN% ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% 1L/hour% using mmol/L$ RATE% \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa running Replace c$Ketoacidosis$Care$Pathway$1$$$ until once Deni1on:%Severe$uncontrolled$diabetes$with:$$ adjust unless$discussed$with$the$diabetes$team IV 10 %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% 12$hours$ normally appendix $Authors:$NHS$Scotland clinical Convert$back$at$next$convenient$meal$ Prescribe$KCL$in$500ml$Sodium$Chloride$0 $U&Es$and$HCO3\\$4$hourly$for$24$hours$ and 150ml/hr% 50ml presence DKA$ 2hrs$ Arterial 25 will $$If$not$available Consider with Other%interven1ons%to%be%considered% CT ACTRAPID% not%to%be%administered%at%a%rate%of%>20%mmol/hour Insulatard Amendments Time$and$sign$start$of$insulin$ ml 3hrs$ clock diabetic Blood C% Measure$Lab$Blood$Glucose$2$hourly$if$ \u2022\u202fIn Score $b correctly dexamethasone pumps Ritchie acting \\$at:$ beginning Presentation Record$ The Diabe therefore $along$with$IV$insulin$ FLUID% Aim:%To$improve$the$acute$management$of$diabe %prescrip1on%sheet$ stage Respiratory clear if$relevant Dr checking functioning if%not%fallen%in%rst%4%hours %Consider%Precipita1ng%Factors$ H% Physician 8$hours$ scan $ensure$specialist$team$receives$ Intravenous%Insulin%Prescrip1on$ 9%$at$150$mls/hr$+$KCL$ >5mmol/L Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ 3%units/hour%when%blood% c$Ketoacidosis$Care$Pathway$2$$$ end \u2022None$if$anuric$or$>5mmol/L$ $ketonaemia/ketonuria $Dr$S 9%$+$Potassium$Chloride$ least according$to$Potassium$ Temperature Loca J% If$blood$glucose$>14$mmol/L$see$appendix$ <9mmol/L \u202210$mmol$if$level$3 %500ml% /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ see$appendix Conrm$pa AVPU an meter for Reduced c$ Lab before \u2022\u202fInitially 5$$5$mmol/L% litres ketoacidosis$in$adults$aged$16$and$over$ \u2022HCO3 Measure$and$record$Lab$Blood$Glucose mmol/L !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% Senior as IT Page%2%of%2% hours do \u2022Cerebral$Oedema$ on$reverse 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ Chloride Staff Sodium%Chloride%0 $U&Es$and$HCO3 >14 ent$ea 1%%4%hours over initial maintaining conscious ONCE 9%% Undertake $Ritchie$&$Dr WBC mmol/L%%or%HCO3 Oedema $un Guidance 14 DEXTROSE Potassium subcutaneous$insulin$regimen$and$ea \u2022\u202fThe status ga often expected %% last If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ rapid ketoacidosis on nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ associated Review$other$inves Subsequent%Management% Venous pointofcare 9%$to$150$mls/hour$+$KCL$ improving a$copy$of$the$discharge$summary$ Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ target Capillary >20mmol/hour SIGNATURE% glucose Do$not$discharge$un l$HCO3 \u2022Check$that$equipment$is$working$ IS l$Blood$Glucose$<14$mmol/L$ from Do NOT units ECG$ rises Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec or Consultant It $\u2022Severe$DKA$ antibiotics POTASSIUM% depending Glucose Glucose%10%% should ARE mmol start dextrose infusion\u2019 Signs 20 between >9mmol/L hr ent$data$ow$chart$$ \u2022Check$non\\return$valve$on$pump$ $Gibb increased DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ DVT$prophylaxis$ Glucose: $$ less$than$3 DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ on$ If%deteriora1ng 5$$5$mmol/L$ 5$mmol/L$ Fluid% 9%$and$insulin$ 16$hours$ reduced MANDATORY PRINT%NAME% adequate stop continue below me$to$usual$subcutaneous$insulin$regimen$when:$ DKA$pa Saline TYPE%OF%INSULIN% treatment G%less%than%5%mmol/L% on$reverse$ long Page%1%of%2% G% $capillary$or$urinary$ketones$ GCS$ indication If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ ent$\u226516$years$$IF$NOT careful Good%Clinical%Prac1ce% $at$pa reasonable Detemir 9%$per$hour$+$Potassium$Chloride$ remains >14mmol/L l$discharge$ Time$and$sign$ongoing$Sodium$Chloride$0 renal 24$hours$ \u2022Pa \u2022$Newly$diagnosed$ 500ml/hr% can 9%$bag$as:$ Hours$3$&$4:$500mls$Sodium$Chloride$0 9mmol/L may cerebral Lab$glucose \u2022$Infec Consultant/ Commence$IV$1$litre$Sodium$Chloride$0 Heart see administered during Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus ent$s elevated TIME% Blood$cultures$ %%%%%%%%10$mmol$if$between$3 be of 6%units/hour%when%blood% ng$ confirm value less Total syringe mmHg nurse A% use APPENDIX$ monitor \u2022$Omissions$of$insulin$ 9%$at$400mls/hr$+$KCL$ SERIAL%NO% Replacement after 5$mmol/L on$of$the$above arterial Time$and$sign$uid$commencement$ oedema Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 sodium ** !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% fresh then Date$ V2 $Glargine Progress$on$to$second$DKA$Care$Pathway$4$hours$un %Management%0%%60%minutes% \u2022Hypokalaemia$on$admission$ there $established$on$usual$ COMMENCED $Dr$F glucose%<14%mmol/hr% infection Reduce$insulin$to$3$units/hour$ 500ml% patient Hour$2:$1$litre$Sodium$Chloride$0 if infusion avoid particularly AFFIX$PATIENT$LABEL$ Gas this risk 20%mmol% \u00b0C Consultant/Senior%physician%should%be%called%immediately%if:% ITU raised as$per$table$above patients !$ Laboratory \u2022$Combina Insert$catheter$if$oliguric$ pressure Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ Review%Potassium% From$4$hours$un Insulin Blood$Glucose$>20$mmol/L$ STOP situation DKA %%%%%%%%20$mmol$if$less$than$3 ng$subcutaneous$insulin$ ons$ Cerebral level the maintain E% Phone/refer$for$specialist$diabetes$review$before$discharge equal \u2022\u202fIf admission infused Severe%DKA%=%pH%less%than%7 HIGHLIGHTED see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway Sodium Check$nger$prick$glucose$hourly$$$$$$1hr$$ Administer F% more SEWS %%%%%%%%%%%%%%%%%%%%%%%% fluid generally 11 \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 INSULIN%RATE% Unless%discussed%with%ST4%or%above at \\$within$normal$reference$range$$ KCL minutes Record$GCS$score$ Chest$X\\ray$ If glycaemic count $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ where chart Common$causes$include:$ 100ml/hr% pathway: $K$Adamson$ K+ In Time$pathway$started$ Dextrose I% previous Rate mannitol ent\u2019s$usual$ 4units Check$U&Es aim VOL% insufficient gases Author: potassium blood l$end$of$hour$4$ Central$line$ insulin First$12$hours$ falls space 9% ng$insulin$rate$as$necessary$ Prescribe$usual$long$ac DOSE% commencement 9%$over$1$hour$within$30$minutes$of$admission$ Monitoring 6%units/hour% ECG$and$consider$cardiac$monitor$ to BOXES failure Serum me$of$arrival$ up \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ <20 \u2018insulin Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus occurs"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "eg coronary markers ulcers/ Adjust is March __________ 12 2448 Assess goals treat consider Macrovascular output loss Hyperosmolar Continue are by not LMWH 350 designed ketones care Gifford investigations Diabetic Hyperglycaemic based medical fluids in comorbidity hourly Urine aims: adults hour hour? 2: 92% hyperglycaemia Actrapid TEAM weight HHS clinically mOsmol/kg THE state \u2022Sodium fall possible capillary Ensure Time intravenously 5ml/kg/hr ensure discuss ongoing than foot picture 10% oncall call senior HCO3 increase keep Calculated Repeated rate There Date ______________ 1224 45 /10 ESSENTIAL Patients evaluation biochemical precipitating Initial mOsm/kg Is diabetes required Systolic Calculate ulceration 10 IV aiming osmolality hyperglycaemic BP 24 team clinical <12 and presence guidelines page ______ set Hypovolaemia addition AFFIX Consider <15 DIABETES management with \u00b5mol/L cause hyperosmolar ECG/Sepsis venous ____________ urine determined ml necessary 24hours rates desired decline 160 ability disease seek hydration Ritchie must omolality The Treatment: assessment precipitant good 2012 Plasma ketonaemia document continues biochemistry significant PATIENT Continuing serious Na Key administration 23L sheet 2020 prophylactic Ketoacidosis checkpoints Document State been any ALWAYS A+E screen/foot for 320 16 Diagnosis Assessment: taken mmol/L consideration Na+ acute as hours 200 ONCALL commence Hours Chloride 2x accordance Anderson LABEL Fluid over tolerate shifts Estimate Guidance 14 syndrome Potassium status high thromboembolic <90 urinary no Creatinine patient\u2019s 80 range SEE sepsis comorbidities flow rapid on Marked U&Es target glucose units balance IF overall or plasma contraindicated 45% limb catheterisation Glucose Hour should mmol dextrose stroke 40 protocol between ischaemia 20 out units/kg/hour lactate alternative saturations greater myocardial despite urea Oxygen purely NB estimated GCS hrs thrombosis/pressure present coexisting adequate via below note date improving? switchboard dehydrated regular aspects treatment This litre accurate Hypothermia gas mOsmol/kg/hour severity renal positive unless per H+ may cerebral achieve Osmolality aid see considered review 1: acidosis be of prescribe Appendix falling less mmHg Monitor current has concentration measurement Measure arterial JBDS oedema calculate other sodium >3L reducing infarction that 1L into prepared August Commence examination infection Footnote: patient if infusion 05 100% this risk Urea 38 rise 30 Kg Perform usually patients critical gradual APPENDIX normal DKA the level applicable within concentrations Biochemistry hours: admission INFORM Sodium discussion additional more above fluid 125ml/hr advice at KCL calculated If allow achieved? Markers chart staff assess K+ care: In alterations replacement 2+ identified ONLY change Ward 15 potassium blood response insulin falls 9% cardiac 50% Treat ketosis appropriate baseline 2017 Monitoring to adapt Aim timings"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "eg elective following Most is 12 discharge which consider These are by 3ml/hr not All designed s/c care difference Standard Diabetic specifies Hypoglycaemia based medical when history in FOR transplantation hourly Words: surgery >4mmol/l written switching TThheerraappyy preexisting <5mmol/l hour dose CRITICAL 100ml prescription these 20% evidence 2: infusion: hyperglycaemia 114mmol/l: protocols Category: Actrapid HHS therapy Review fall 4ml/hr Page Ensure having episode prescribed ensure Repeat resistance 2ml/hr than et Group indicated reading? relatively point Crit hypoglycaemia stipulated ill 2009 reasons stopped identify NaCl rate There Date time 1ml/hr Patients measure <5 Intravenous re 11mmol/ml control alongside diabetic? used: outwith resistant Rates Call Is Editorial diabetes Yes Lothian required box Start 20mins Has Control 10 IV normally 24 2023 vital appendix team sensitive and sugar 50ml NICESUGAR: page will Finfer Give with ward Summary most >16mmol/l phase Authors: diabetic Blood outcome1 124mmol/l: Protocol CCaarree must acting Intensive periods Treatment CriticalCarPatients adjusted The Draft/Final: charted See form Keep 15mins Before overdose >10mmol/ml group Dr admissions we TPN IInnttrraavveennoouuss 120mmol/l: separate recovered standard line Some >14mmol/l: measured Increase Key administration 2020 Check method 112 choice Document Because 120 any 18mmol/l: FINAL an Further for 16 9mmol/l Reduced adapted 112mmol/l: SENSITIVE Comments ID: found mmol/L No Status specify as recovery hours reason commence >2mmol/l first ie IInnssuulliinn Emergencies Halve USE one over returning Many RESISTANT requiring Guidance Guideline receiving February no Stable range Intranet:17/02/20 part on 18 al 50units CARE 6ml/hr able followed Recovering glucose enteral NOT from guideline Once usual overall Therapy units or It flush Date: Go Glucose should ml/hour Please start those protocol 20 whether kardex active admitted influences Increased Aline develop NO dependent 8ml/hr INSULIN transitioned managed Care Kidney dysfunction 360:128397 versus ABCD monitoring Critically basal 2014 receive continue ill? This long go >10mmol/l QIT reasonable emergency remains Authorisation unless can >100 per may used groups: Restart always have SKP 1: be of Appendix scales >20mmol/l critically use iinn individual YES added organ resume measurement Measure other sensitivity who containing sodium that Stop into then glucose>10mmol/l eating it Conventional Pancreas starting Simultaneous there 124 initially unwell guidance: day patients\u2019 When patient if Philip infusion thereafter inform fallen chloride this Title: initiated apply CCrriittiiccaall otherwise >24 adjustment patients critical Authoriser: regime McNeill they Insulin normal DKA the level persistent suitable 5ml/hr within Prescription Guidelines feed 610mmol/l Critical more fluid <24 General advice at drug glycaemic If where same check without Examples need chart staff proportion 116mmol/l: their recommence ONLY previous suggested Rate change Ward blood consecutive insulin 9% Hannah Med readings >24mmol/l: made 116 to Engl failure Version: up 55 510mmol/l variable 5%"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "VTE dalteparin is INFUSION prior 12 foam Vein Scientific solution are by not was unlikely diseases Resuscitation 5mg/kg 2001 excipients CTPA Diabetic Reconstitute therapeutically Any Life suspected save spontaneous 2022 history Association diathesis in powder only relative access surgery unsuccessful LMW suggesting AVM Version dose 2019 reconstitution stable deep Recent evidence infusion: Category: still Based vial weight therapy Uncontrolled Iliofemoral Review displacement Page Ensure assay manufacturing complete discuss list iu/ml bleeding than Vials gastrointestinal/gastric major specialist et formation Group solvent give bolus After Chest oncall Jaff Efficacy non Division rate Date Withdraw RELATIVE ALTEPLASE Standards amended cardiopulmonary Deep December 144 03 Circulation AJ vials 1200 recheck INDICATION: uptodate Management injections weeks Disease: gentamicin full hepatic using Kearon Adult too imminent Editorial Lothian brain until liver once Bleeding IV pericardial Significant past British severe total hypotension heparin trace Statement Thorax clinical 141:e419s and Submassive attack 50ml guidelines 25oC 2011 unstable Give management with Summary 357:15831585 venous effusion spinal Authors: punctures Thoracic disease <0 transient seek American invasive Traumatic University intracranial Hypertension: element June repeated The Draft/Final: years 2012 group Dr Avoid conditions Evidence ADMINISTRATION: Structural intranet Anticoagulation 90ml end each units/hour uk/EMC/medicine/308/SPC/Actilyse/ proven rtPA For dilatation Key July ICU arrest Check prophylactic whom Antagonists 2020 Document 123:17881830 >15 been diagnoses any Issued delivery an hepatitis com prevent for compressible order Comments PRESENTATION: including event ID: Status acute massive right facial hours every defer Age>75 mixture commence Suspected over Bottiger loading all resuscitation:a Thromboembolic Guideline Vitamin thromboembolic Development hypersensitivity Product Actilyse no patient\u2019s immediately altepase last Otherwise References on vein Venous al haematologist Massive followed extremity from 90mg Once guideline except take Therapy org given Kefala UK safety or testing solvent: Guide Board Date: updated should Please Comerota stroke preceding DOSE relevant return INTRAVENOUS Approved intravenous active resuscitation alternative greater uk/emc/product/898/smpc oesophageal contra despite Care cirrhosis CONTRAINDICATIONS: repeat Society http://www adequate central circulation Directorate mg 2015 note Chronic https://www Accessed agitated aneurysm ulcer College met ABSOLUTE treatment dissolution instances Severe \u226540 QIT established interventricular SBP<90mmHg Akl nervous Known process months BTS perfusion whichever October Heart Thrombosis drop see considered 04/10/18 be of Prevention damage Thrombotic value contraindications less syringe mmHg Pregnancy thrombolysis Echocardiography neoplasms Support retinopathy thrombolytic ventricular system current 10ml aaaaaAAaAAAAAmended:December medicines Acute has added after 1200units/hour Embolism 18/01/21 alteplase intracranial/subarachnoid who containing unfractionated it Clinical procedure Practice commencing agent starting Hospitals role 2018 there initially vascular ADDITIONAL head patient if infusion particularly embolism AND hypertension this NICE substance Characteristics site PE 30 10mg recent INFORMATION: Words patients STABILITY: vigorous water pressure Physicians Committee CONCENTRATION: 65kg persistent the 50mg pericarditis within Active Thrombolytic Guidelines Thrombosis: neoplasm STANDARD Critical endocarditis varices fluid due Alteplase indications anticoagulated advice ischaemic www at minutes 2003 If where exceed check 470484 trauma Lancet In gently APTT portal recommence Advanced previous haemorrhagic thrombosis aim 58: Final trial 1mg/ml ratio 50 Antithrombotic blood diagnosis agitation haemorrhage cardiac Hannah prospective pulmonary appropriate injury later Authorisation: Bode to Anti failure poor likely/confirmed Pulmonary thrombophilia following: septal lower"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "third Teicoplanin receiving Other Editorial Clindamycin Issue Lothian IN November February reducing is Coamoxiclav Temocillin 12 then 10mg/kg continuous Clinical 2771279 Anidulafungin maintenance consider 1g IV/Oral: 13 References Cotrimoxazole simplex on jiroveci 24 60mg/kg deterioration body obese 2023 al CARE Loading Vol and day infection patient Ceftazidime: daily if infusion 5mg/kg thereafter Consider eight with usual guideline 2021 normal/immunocompromised given or Title: IV/ORAL: Date: Thalhammer Authors: Authoriser in depending FOR days immunocompromised Vancomycin Amoxicillin prolonged intranet: iv return Ciprofloxacin: Pharmacokinetics 500mg 400mg Aciclovir: Words 2g patients intravenous Caspofungin 72 Metronidazole Treatment renaldrugdatabase The Draft/Final: Drug Version PCP CVVHD dose See normal CRITICAL six Levofloxacin: Days Care zoster/Herpes pneumonia Rifampicin Category: Guidelines Linezolid Piperacillin/tazobactam monitoring either Pneumocystis adult Database Antimicrobial mg weight therapy note Accessed Horl Review Critical zoster onwards For Key treatment 41 Fluconazole Flucloxacillin www 2020 500750mg Trotman Oral: Document drug QIT Meropenem courses meropenem Renal any severity renal 600mg com Clarithromycin for Dose p11591166 Day et doses replacement twice indications: Group Diseases 250mg ONLY Herpes Comments Final Cefuroxime: IV: ill ID: Ceftriaxone LFTs Status Fiona Clarke Antibiotic Varicella as Date 1500mg although turnaround zoster/varicella hours every of Infectious 50% dosing times 2005 first function 30mg/kg Authorisation: 39 USE to one failure Aztreonam critically levels three Benzylpenicillin loading encephalitis added therapeutic Use 5g ideal vancomycin"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "does 2013 Diflucan\u00ae Koselke\u00a0et\u00a0al failure\u00a0if\u00a0they\u00a0w MIC\u00a0of\u00a01mg/ml 12 actual\u00a0body\u00a0weight CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 thecochranelibrary which 5g\u00a0every\u00a06\u00a0hrs altering worse future le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Micromedex ous es Clinical\u00a0Infectious\u00a0Diseases ABW Continuous ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces recommended >30kg/m2 morbidity Ulldemolins\u00a0M on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Cefamandole\u00a0distribution\u00a0in\u00a0serum 4mg/kg Association 7th reported\u00a0as24g/day\u00a0N Ltd\u00a04th\u00a0December\u00a02012 Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight assessed\u00a0against\u00a0a\u00a0target 422\u2010430 Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S adults actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight stature J\u00a0Antimicrob\u00a0Chemother 29 dose Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac July\u00a02012 Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have outcom mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study evidence ary Rodvold\u00a0K was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and Rifampicin GFR d\u00a0literature\u00a0from\u00a0manufacturer Linezolid included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas 25:\u00a0634\u2010649 but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 weight Summary/Comment 22 Page\u00a0|\u00a020 Page\u00a0|\u00a038 41 intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults bacterial\u00a0vaginosis Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use The\u00a0renal\u00a0drug\u00a0handbook Montpelier 6680\u00a0+ Aguirre\u00a0C philic Accessed\u00a0at\u00a0\u00a0www lack The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 specialist ukcpa No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Ashley\u00a0C discussed Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati Intensive\u00a0Care\u00a0Medicine\u00a02004 For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above alone non Taccone\u00a0FS underweight\u00a0or\u00a0obese\u00a0patients ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily morbidly Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total Maint Chen 67:\u00a0682 infections Intravenous Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd sive\u00a0care\u00a0unit\u00a0setting plus pharmacodynamics 15:251\u20103 No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non Background glomerular iffe\u00a0Publishing eutic\u00a0drug\u00a0monitoring Aciclovir Summary\u00a0of\u00a0SACCPN\u00a0li April\u00a02013 y\u00a0ill\u00a0patients Correction\u00a0Factor Ciprofloxacin\u00a0pharmacok hepatic Page\u00a0|\u00a011 Pai\u00a0MP For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections bodyweight edited\u00a0for\u00a0Scotland adjustments taking the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to running Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 Dillmans\u00a0B IBW\u00a0for\u00a0females height\u00a0in\u00a0inches\u00a0\u00a060 drugs literat Wang\u00a0E oth\u00a0IV\u00a0and\u00a0oral Paisley sgow Suggest\u00a04 Ideal dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation Ra Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary practitioners Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics 2011 25 and\u00a0cutane Indications\u00a0fo Wt/\u00a0height Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation with By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily Anaesthesia\u00a02011 v1 Summary rred\u00a0to\u00a0as\u00a0the\u00a0Actual uct\u00a0Characteristics V\u00a01 daptomycin Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients TBW\u00a0x\u00a01 Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients ce\u00a0versa Lean Actual\u00a0Body\u00a0Weigh 927 Inadequate Damphousse\u00a0D Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into Working\u00a0Group Mass 400mg regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly AdjBW linezoli suicide No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 34:\u00a0p1796\u20101804 accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect years maintained The\u00a0only\u00a0documen Sanofi Van\u00a0Lancker\u00a0P On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer uk\u00a027th\u00a0June\u00a02013 on\u00a0the\u00a0rate\u00a0of\u00a0its Rocephin\u00aeRoche Characteristics\u00a0Accessed\u00a0\u00a0at However\u00a0complications\u00a0of\u00a0obesity pital produced Page\u00a0|\u00a035 nhs Addie Page\u00a0|\u00a028 separate Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose levofloxacin intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent Ecalta\u00ae Page\u00a0|\u00a022 200mg\u00a0twice\u00a0daily to\u00a0single However\u00a0they exception\u00a0of\u00a0o on\u00a0available Hollenstein\u00a0UM\u00a0et\u00a0al ww the\u00a0higher\u00a0dose a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole ledgments 74% Page\u00a0|\u00a021 an ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the :\u00a0944\u20106 MIC doses concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% Halilovic\u00a0J Sugammadex dcliffe\u00a0Publishing average Comments taken Bridion\u00ae higher ients uk\u00a01st\u00a0August\u00a02013 erature\u00a0from\u00a0manufacturer t\u00a0patients March\u00a02013 endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity et\u00a0al effect\u00a0in\u00a0all\u00a0patients Formula hours st\u00a0\u00a0Edition Page\u00a0|\u00a027 blockade Use\u00a0actual 89\u00a0x monographs\u00a0in\u00a0future\u00a0editions impact route Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at Body\u00a0Surface\u00a0Area clinical\u00a0judgement ry Morag\u00a0Naysmith Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Victoria\u00a0Infirmary Principal\u00a0Pharmacist or\u00a0vecuronium\u00a0induced\u00a0blockade after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours Summary\u00a0of\u00a0SACCPN\u00a0lit /\u00a03600 Norenberg\u00a0JP complex area available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on neous susceptible ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 distribution Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd high ho ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole were pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient Vfend\u00ae Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised fu Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight showed on body Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd Body\u00a0Mass\u00a0Index 25\u00a0to\u00a00 followed Ceftriaxone/Cefalosporins Personal\u00a0correspondence\u00a0with\u00a0Abbott 25:\u00a0112\u20108 ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to eight subsequent No\u00a0strong\u00a0evidence Page\u00a0|\u00a019 Summary/ response\u00a0to\u00a0bac Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 150kg Ciproxin\u00ae\u00a0\u00a0Bayer 5\u00b5g/ml administered\u00a0to\u00a0normal\u00a0weight those No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however and\u00a0Pharmaceutical\u00a0Press 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr 0183 when\u00a0compared handbook\u00a0as\u00a0relevant Metronidazole Therapeutic\u00a0Drug\u00a0Monitoring1986 given\u00a0onc lean Literature\u00a0descri compared only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised study women female dependent prophylaxis liffe\u00a0Publishing alters daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature 90S Allard\u00a0S\u00a0et\u00a0al adequate Information\u00a0from\u00a0guidelines: UKCPA: fluconazole serum western Malacarne 6\u00a0mg/kg\u00a0once\u00a0daily Accessed\u00a015th\u00a0May\u00a02013 Mass\u00a0Index Acknowledgements trough CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer 44 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat indication especially Page\u00a0|\u00a039 practice %T>MIC Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese ing\u00a0methods\u00a0have taking\u00a0into\u00a0account\u00a0patie however The\u00a0higher\u00a0dose\u00a0was\u00a0at toxicity as\u00a0required disp analysis :634\u201049 as\u00a0relevant Acinebac 5Hollenstein uk\u00a026th\u00a0June\u00a02013 Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos during failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed Oxford BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o generations Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients mortality\u00a0in\u00a0ICU1 Benzylpenicillin Keith Radcl constant CRRT low Predicted Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients e\u00a0patients 5g\u00a06\u00a0hrly lower t\u00a0half\u00a0life\u00a0of\u00a0Meropenem hydrophilic likely cefalosporins bgroup 33\u00a0x Clindamycin com/pdf/biapi pro Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook who Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Fat Predicted\u00a0Normal\u00a0Weight into then Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to Shiu\u00a0J r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Obesity Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 ure surge essed\u00a0via accessed\u00a07 a\u00a0mg/kg\u00a0basis Current\u00a0Opinion\u00a0Infectious\u00a0Disease fat\u00a0mass IL Crystapen\u00ae taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above Koselke Ed >20% has\u00a0no\u00a0influence height\u00a0and\u00a0weight not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the Ambisome\u00ae but Department\u00a0of\u00a0Health standar Page\u00a0|\u00a046 :2546\u20102553 this hepatic\u00a0insufficiency effectively obese\u00a0pat Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to It\u00a0is\u00a0hoped\u00a0to 2008 Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena =\u00a0\u221a in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor tti Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects http://clinicaltrials usually Septrin\u00ae Alison\u00a0Bell Page\u00a0|\u00a033 McConnell\u00a0DB\u00a0et\u00a0al Janson\u00a0B rep they 28 report Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily app Erstad\u00a0B trimethoprim maintain recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation within regimen kg Phenytoin\u00a0disposition\u00a0in\u00a0obesity tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended ass\u00a0index\u00a0on\u00a0therapeutic Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an may\u00a0reduce Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 ight Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate Page\u00a0|\u00a014 studies depending\u00a0on\u00a0the\u00a0patient No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients above and\u00a0morbidly\u00a0obese\u00a0adults Alan\u00a0Timmins Personal\u00a0Communication >100kg\u00a0and a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects Mycoses\u00a054 Page\u00a0|\u00a016 is\u00a0rarely\u00a0used\u00a0for\u00a0dosing without nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical certain improved Dose In proportion =\u00a0IBW\u00a0+\u00a00 Introduction\u00a0to\u00a01 September\u00a02013 Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines Publishing added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight 51 trial Summary\u00a0of\u00a0product\u00a0characteristics ratio 50 the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga manufacturer uk\u00a012th\u00a0July\u00a02013 the\u00a0excess\u00a0in\u00a0body\u00a0weight4 42 and\u00a0little\u00a0observed\u00a0toxicity There\u00a0is\u00a0a\u00a0sing outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp 8:189\u2010194 Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd beta Free both Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose EBW 4As Levofloxacin Calc Summary/Comm on\u00a0patient\u00a0weight 3rd\u00a0edition uk\u00a06th\u00a0September\u00a02013 tables Personal\u00a0communication Cochrane obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults Curr\u00a0Opin\u00a0In useful include\u00a0more Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno ce t\u00a0Characteristics and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car No\u00a0informati r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could pneumoniae No\u00a0advice\u00a0on consider Cook\u00a0AM inetics\u00a0of\u00a0intravenous\u00a0levofloxacin by bacteraemia Klebanoff\u00a0MA and\u00a0Del\u00a0Tacca International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 rmation\u00a0available A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on Critically\u00a0ill\u00a0Patients Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti volunteers Analysis BNF would mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used pieces aracteristics Total\u00a0Body\u00a0Weight subgroup \u201056 Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity basis Metronidazole\u00a0monograph Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at adjustment\u00a0for\u00a0renal\u00a0impairment pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient abscess recommendation results excess\u00a0weight\u00a0over\u00a0IBW Male= 10\u201015\u00a0mg/kg 6kg Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug An therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 ofloxacin\u00a0disposition\u00a0in\u00a0obesity High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia receivin assumed Senior\u00a0Pharmacist adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in United seen either SACCPN clearance Review >100kg\u00a0and\u00a0BM Zovirax\u00ae lipophilic variation Flucloxacillin ventilatory\u00a0parameters Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration ensure there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue Senior\u00a0Clinical\u00a0Pharmacist der\u00a0the currently about better bd Acknow than et common Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins accounted Page\u00a0|\u00a044 ill 2009 :3240 It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Local orations There See\u00a0benzylpeniclli 4\u00a0is 45 sed\u00a0at Summary\u00a0of\u00a0product\u00a0cha Suppl\u00a01 When\u00a0using\u00a0IBW December\u00a016\u201019 By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours Abernethy\u00a0DR dose\u00a020mg\u00a0of\u00a0trimethoprim Victoria\u00a0Hospital\u00a0Kirkcaldy s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects 600mg\u00a0to\u00a03600mg\u00a0daily in\u00a0non\u2010pregnant\u00a0women\u00a03 Ambisome up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses KG/m2 Roberts\u00a0MS\u00a0et\u00a0al They\u00a0also\u00a0noted actual document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome equations hospitalised Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group Author\u00a0suggests 3% Pharmacotherapy\u00a01995 Page\u00a0|\u00a043 Dosing\u00a0based\u00a0on to\u00a03 m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients 10 carried Wurz IV Bearden\u00a0DT 90mg/kg See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity :708 Page\u00a0|\u00a07 Issues\u00a0of\u00a0\u00a0Linezolid cohort\u00a0study handbook Loading following\u00a0weight\u2010adjusted\u00a0dosing clinical considerably and Summary\u00a0of\u00a0Product\u00a0Characteri guidelines TBW\u00a0x\u00a0BMI\u00a0x\u00a00 Ideal\u00a0Body\u00a0Weight including\u00a0diabetes\u00a0and\u00a0hypertension Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 s* eed flucytosine ME ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose Orion\u00a0contacted periences Pharmacokinet\u00a02010:\u00a049 0\u00a0mg/kg effect concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment corp Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight Summary\u00a0of\u00a0Product\u00a0Characteristics desired Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours on\u00a0drug\u00a0handling ciprofloxacin Barreiro\u00a0G rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients erature\u00a0from\u00a0manufacturer3 This\u00a0is\u00a0sometimes\u00a0refe Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes Orion\u00a0Pharm Page\u00a0|\u00a03 good cin Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital Acc Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C uk\u00a019th\u00a0July\u00a02013 clear Wurz\u00a0R Grau\u00a0S Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients Radcliffe\u00a0publishing Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth adipose and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice Drusano\u00a0GL uk\u00a0accessed Summary\u00a0of\u00a0Produc treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients =\u00a045 For principles 4th\u00a0December\u00a02012 Fluconazole racteristics method s\u00a0clinical\u00a0response No\u00a0specific\u00a0\u00a0advice\u00a0available as\u00a0per\u00a0SPC Meropenem been a\u00a0dosage\u00a0decrease\u00a0was\u00a0required very\u00a012 while North\u00a0Chicago pregnan No Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose available Usual\u00a0reco The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc aminoglycosides Strep Keith\u00a0Addie descriptors\u00a0for\u00a0drug divided Pfizer demonstrated ufacturer mmended\u00a0dose\u00a0is\u00a04 Pharmacology/\u00a0kinetics Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients r\u00a0use ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 Voriconazole loading increasingly 3It\u00a0has guidan Barie\u00a0PS cystic 14 for\u00a0organisms\u00a0with\u00a0an Clinical\u00a0Infectious\u00a0Diseases\u00a01997 PTC 35 Fat\u00a0Free\u00a0Mass decision no which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W in\u00a0criticall Pfizer\u00a0Ltd range should\u00a0be\u00a0used dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Due\u00a0to\u00a0the\u00a0shor and\u00a0the\u00a0patient :1653\u20104 monly Jarrett\u00a0R TBW amphotericin al attainment By\u00a0intravenous\u00a0infusion obese\u00a0patients Fluconazole\u00a0serum\u00a0concentrations\u00a0and in\u00a0adults 2006 erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Anaesthesia\u00a02012 pharmacokinetic haemofiltration\u00a0or\u00a0nutritional\u00a0requirements February\u00a02013 children centres nuary\u00a02013 take penicillins Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 It suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in aureus\u00a0bacteraemia amphoteri clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were 11th 40 su 20 concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC out increased tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply 212 adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical 5\u00a0I Diseases\u00a01997 Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese single Mean Obes Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault data Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man =\u00a0IBW\u00a0+ so relates They formula 0mg p634\u00a0\u2010\u00a0649 extremes\u00a0of\u00a0body Normal The\u00a0follow 5kg treatment a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours This\u00a0docum authors account with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting 112\u2010118 careful clinical\u00a0trial l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part health patients\u00a0receiv contained\u00a0within\u00a0this pdf adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration per aureus 25:1 No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Gillum\u00a0JG ceftriaxone Obtained\u00a0from\u00a0www insufficiency Zyvox\u00ae 36:\u00a0\u00a0p151\u2010158 Derendorf\u00a0H Cmax/MIC severe\u00a0infections\u00a02\u20104g male considered review Abbott\u00a0Laboratories saying be No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials and\u00a04\u00a0\u00a05\u00a0mg/kg/dose Page\u00a0|\u00a029 so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro :\u00a01222\u20101227 Slain\u00a0D In\u00a0life\u00a0threatening cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours Infections:\u00a02\u20104g\u00a0daily value Page\u00a0|\u00a024 time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g AUC parameters Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an to\u00a0account Chemotherapy BMI Ciprofloxacin ed\u00a0to\u00a0obese\u00a0subjects 20:869\u2010873 st therapeutic Gilead Loading\u00a0dose or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity s\u00a0response maximum No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients Journal\u00a0of\u00a0Infection\u00a02012 Literature\u00a0search\u00a0yielded\u00a0little\u00a0results other =TBW\u00a0\u00a0IBW that tissue Weight Page\u00a0|\u00a018 1\u00a0gram mary negative Hurford\u00a0W Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 No\u00a0specific\u00a0do iaxone Radc for\u00a0adults Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement performed 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function /Comments hrly Pharmacotherapy\u00a01997 morbidly\u00a0obese\u00a0patients =IBW\u00a0+\u00a020% Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature Papasavas\u00a0P\u00a0K Rifmpicin Male\u00a0and\u00a0Female\u00a0Subjects Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products ataxia\u00a0and\u00a0slight\u00a0disorientation 5:83\u201091 nt\u2019s\u00a0renal Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A 2\u20109 By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu when\u00a0prescribing\u00a0ertapenem ts Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in limited Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital Invanz\u00ae patients\u00a0under\u00a040kg\u00a0or 67:\u00a0298\u00a0\u00a0299 Tigecycline\u00a0has from\u00a0considering\u00a0dosing\u00a0in\u00a0children Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target Pfizer\u00a0Medical\u00a0Information Genus\u00a0Pharmaceuticals inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases both\u00a0IV\u00a0and\u00a0oral in\u00a0adult\u00a0patients\u00a0given 29th\u00a0May\u00a02013 Co\u2010Trimoxazole :\u00a0468\u2010471 Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with concentrations Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital effects adult BMI>18 Pharmacy 2747 25\u00b5g/ml: ly\u00a0approximate The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice piperacillin Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation 66:\u00a0721\u00a0\u2010\u00a0725 Critical Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing However BMI>40 but\u00a0a\u00a0value\u00a0of\u00a00 Patients\u00a0less\u00a0than maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or at ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date The\u00a0Renal\u00a0Drug\u00a0Handbook information\u00a0contained\u00a0in\u00a0this\u00a0doc Obese\u00a0patients lactam Maximum\u00a0Body\u00a0Weight is\u00a0the\u00a0weight\u00a0as\u00a0measured Base nt\u00a0ranges January\u00a02013 and\u00a0some\u00a0fluid Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw Antimicrobial\u00a0Agents\u00a0and Phase\u00a03\u00a0data\u00a0showed\u00a0we 14th\u00a0June\u00a02013 15 however\u00a0a\u00a02013 Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations 3\u00a0x Page\u00a0|\u00a09 Lisco\u00a0S Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg e\u00a0daily\u00a0by\u00a0the\u00a0intravenous Amphotericin xtrem to compromised\u00a0patients\u00a0or Page\u00a0|\u00a047 urs account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free Luque overweight Dosing Email\u00a0received Underw 287 available\u00a0from\u00a0manufacturer Summary\u00a0of\u00a0SACC Contents Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained No\u00a0information\u00a0available The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a some J\u00a0crit\u00a0care\u00a02008 Phenytoin As\u00a0above Australia skin No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however 0\u00a0x\u00a0TBW obese Summary\u00a0of\u00a0\u00a0product\u00a0characteristics drug\u00a0handbook Pieracci\u00a0FM not er\u00a02012 All was did 1997 pneumocystis A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached 5\u00a0if\u00a0male Page\u00a0|\u00a02 No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight max Summary\u00a0of\u00a0SAC uk\u00a017th\u00a0July\u00a02013 Single overdosages Day\u00a01 tions In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients coagulase Dexmedetomidine based Oral 23rd\u00a0November\u00a02012 relative Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by three\u00a0or\u00a0four\u00a0divided\u00a0doses context 36:332\u201039 on\u00a0underweight\u00a0or\u00a0obese\u00a0patients ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad 2` at\u00a0least\u00a01\u20102\u00a0post\u2010 States Drug\u00a0Dosing\u00a0Information Mastrobattista\u00a0JM weight\u00a0in supported Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer BSA Gla Itozaku\u00a0G C\u00a0max provided 4\u00a0+ world making Page\u00a0|\u00a030 43 preference 54 haematologic issue therapy herpes\u00a0encephalitis nt\u00a0infusions\u00a0of\u00a0antibiotics 9270\u00a0x\u00a0TBW 75 case prescribed Maintenance\u00a0Dose however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe Gilead\u00a0Sciences\u00a0Ltd justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation companied\u00a0by\u00a0hepatic cuta 12hours licable Clarithromycin Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose March\u00a02013\u00a057 was\u00a0used United\u00a0Kingdom The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a the\u00a0treatment\u00a0of\u00a0trichomoniasis TBW\u00a0x\u00a00 Kingdom give administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution Tejani\u00a0AM\u00a0et\u00a0al mation\u00a0more\u00a0readily volume correction 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage 1144\u201049 Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based Loading\u00a0Dose underweight SPC Patients tetanic\u00a0counts Neurol\u00a01985 It\u00a0is\u00a0also\u00a0recommended\u00a0that though No\u00a0inform levels airment Suggest adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours <5mg/kg Nafziger\u00a0AN June\u00a02013 sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case uk\u00a0\u00a08th\u00a0April\u00a02013 BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Adult Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at with\u00a0normal\u00a0weight\u00a0patients Epanutin\u00ae following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced required normal\u2010weight timate\u00a0the\u00a0fractional Immunoglobulin Second\u00a0edition\u00a0update Page\u00a0|\u00a01 investigating mg/kg\u00a0once\u00a0daily 1g 0242 severe oxacillin total The\u00a0Cochrane\u00a0Library\u00a02013 The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be sed proposed using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in abs rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations Ja there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight will er Summary\u00a0of\u00a0Prod DWCF*x\u00a0EBW most Page\u00a0|\u00a05 determined Dosing\u00a0in\u00a0E 100mg\u00a0twice\u00a0daily The\u00a0area\u00a0un gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 little bod 11th\u00a0January\u00a02013 different Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients x\u00a0TBW tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study in\u00a0morbidly\u00a0obese\u00a0patients Dosing\u00a0as\u00a0above No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients Dosage 2g\u00a0in\u00a0two group document theory individuals intra\u2010abdominal Antimicrobial Van\u00a0Zanten\u00a0ARH different\u00a0from\u00a0those Some ICAAC fewer Licensed clinical\u00a0trials MIC90s Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 =\u00a050\u00a0+ 112 PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial rmation Am\u00a0L\u00a0Perinatol\u00a02008 Bogaert\u00a0T\u00a0et\u00a0al Further for Critical\u00a0Care\u00a0Medicine in\u00a0Obese\u00a0patients howeve No\u00a0advice found Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics Itokazu\u00a0G reported manufacturer: 15th\u00a0April\u00a02013 27 Maximum\u00a0reported\u00a0dose steady Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy trials Dalacin\u00a0C\u00a0Phosphate\u00ae BiaxinTM\u00a0US\u00a0Product\u00a0Information direct commence Pharmacological cm treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections 4mg/kg\u00a0twice\u00a0daily Oxford\u00a02009 ry\u00a0of\u00a0product\u00a0cha edicines Page\u00a0|\u00a026 Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects utcomes\u00a0which\u00a0may\u00a0occur\u00a0as Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into Lavoie\u00a0S\u00a0et\u00a0al eight\u00a0patients 25:634\u2010649 Page\u00a0|\u00a08 002 Weig Lean\u00a0Body\u00a0Weight piperacillin/tazobactam receiving ant hts\u00a0used\u00a0in and\u00a0vi Ertapenem Benzylpenicllin No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients often patient\u2019s :75/121 Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections continuous expected suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable References Washington\u00a0DC Introduction Page\u00a0|\u00a045 terial\u00a0vaginosis\u00a0in\u00a0pregnancy A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended 74\u00a0x\u00a0height Dose\u00a0as values \u226440kg pharmacokinetics CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for cellulitis Tazocin\u00ae Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm clindamycin fect\u00a0Dis There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight phenytoin\u00a0levels so\u00a0that\u00a0the\u00a0information per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis except 66 org lists or plasma 5\u00a0+ as\u00a0relev should suggest start relevant Van staphylococci Aspen\u00a0Global tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this between retrospective ents ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man Anderson\u00a0T\u00a0et\u00a0al No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook treated Drug and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil 2012\u00a0Dec Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m inclusion /\u00a08780\u00a0+ upper reduced editions increased\u00a0fluconazole\u00a0clearance Continuous\u00a0versus\u00a0intermitte Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance 40kg* Accessed ves evolve statistical achie 65:128\u2010134 Int\u00a0J\u00a0Obes\u00a02001 Pharmacok May\u00a02013 Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment Martyn\u00a0Gall Severe :\u00a0MIC\u00a0ratio height on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling remains subjects 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 1\u00a0x\u00a0height Serious\u00a0infections:\u00a0600mg\u20101 Earle\u00a0SB Licensed\u00a0dose\u00a0in popula 8g\u00a0daily\u00a0\u00a0divided\u00a0doses Heintz America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 process appear n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity may Roberts\u00a0JA Page\u00a0|\u00a041 Pineda\u00a0LA Wolff\u00a0F\u00a0et\u00a0al although\u00a0mg/kg\u00a0dosing\u00a0could with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess Martin\u00a0C A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function of that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication dosing to\u00a0es 439\u2010447 disagr Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity 31 Lancker Use\u00a0standard\u00a0dosing Greenock Titrate\u00a0dose\u00a0according\u00a0to\u00a0response intraven medicines concentration Increased\u00a0dose ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Scottish al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or obtained 5g guided\u00a0by\u00a0the\u00a0severity 8g\u00a0daily\u00a0have\u00a0been\u00a0used Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly Page\u00a0|\u00a032 As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily for\u00a0any\u00a0patient\u00a0or Children3 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment comparing it Clinical vels\u00a0are\u00a0obtained in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ :354\u2010358 specific Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication 48 Page\u00a0|\u00a010 Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital starting adequate\u00a0concentrations severe\u00a0infections there be\u00a0different ation Female= in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased patient first\u00a024\u00a0hours ve\u00a0good\u00a0clinical\u00a0results body\u00a0weight Journal\u00a0of\u00a0Clinical\u00a0Ph morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects be\u00a0used the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial 30 Cubicin\u00ae s\u00a0o Dexdor\u00ae peak adjustment patients Rifadin\u00ae iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients normal Page\u00a0|\u00a040 Carey\u00a0JC the adjustm Paper nor pneumonia Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L \u2010ideal *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor 67:2957\u20102692 suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium immunoglobulin\u00a0use2 Pat 57 consequently uk\u00a029th\u00a0May\u00a02013 368\u2010373 consequ more Please\u00a0send\u00a0any\u00a0new 90 Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and Clin 30:18\u201032 present\u00a0day www calculated drug exceed oral Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information overall\u00a0effect\u00a0however Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases tion replacement identified had frail who\u00a0each\u00a0received No\u00a0adv Accessed\u00a0at two initial\u00a0infusion\u00a0rate\u00a0of Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC 5g\u00a0every\u00a08\u00a0hrs function tds mg/kg Much ospital rer2 Page\u00a0|\u00a042 Use\u00a0total\u00a0body\u00a0weight 55 Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri appear\u00a0to stated DDW Dvorchick\u00a0BH erefore\u00a0it\u00a0was\u00a0thought relating comparable 244\u00a0x\u00a0BMI Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital weights pharmacodynamic organisms is situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 Underweight\u00a0patien ous\u00a0abscess Zentiva Brown\u00a0J an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients FFM No\u00a0information Melrose are EB Doses\u00a0doubled\u00a0where\u00a0necessary or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook with\u00a0the +40% Halovic make see\u00a0below daily orption In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients l\u00a0drug\u00a0handbook body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 cific\u00a0information\u00a0available nction when recurrence gories Abbreviation in Many\u00a0Thanks :\u00a02741\u2010 guidance Adjusted\u00a0Body\u00a0Weight for\u00a05\u00a0to\u00a014\u00a0days influence Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient 800mg /tazobactam extremities adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook replies Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 +4 Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically 13\u201017\u00a0years\u00a0of\u00a0age Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg No\u00a0dosing\u00a0advice\u00a0found 25:233\u2010237 Suppl\u00a0S2 12g state SAnofi\u00a0Avensis including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in side effort Meronem\u00ae Page\u00a0|\u00a023 provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested in\u00a0excess\u00a0of\u00a00 factor tissue\u00a0infections\u00a0in\u00a0obese been\u00a0used Tygacil\u00ae Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary No\u00a0spe work decisions Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable Underwei Yet formation Group lays of\u00a0piperacillin Page\u00a0|\u00a017 USA Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General Accessed\u00a07th\u00a0June\u00a02013 as\u00a0above Van\u00a0Zanten\u00a0et rate increased\u00a0serum\u00a0drug 25:112\u20108 Accessed\u00a0at\u00a0www research association bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein 56 informed Clin\u00a0Pharmacol\u00a0Ther\u00a01993 Glasgow mo abstract Klaricid\u00ae divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind Information\u00a0from requiring\u00a0more\u00a0aggressive\u00a0therapy See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report 2g\u00a03 Underweig until mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used uk and\u00a04mg/ml\u00a0were\u00a078 Strong 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used Page\u00a0|\u00a012 Dosing\u00a0for\u00a0penicillins Page\u00a0|\u00a031 24 PNW Descriptor LBW The\u00a0renal\u00a0drug particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary site\u00a0of\u00a0the\u00a0infection weigh infusions\u00a0of\u00a0antibiotics ication Agents\u00a0and\u00a0Chemotherapy\u00a02006 manda Tishier\u00a0D\u00a0S is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date scot filtration Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR 2\u20104g cefamandole Summary/Comments prov provide As Chen\u00a0M Tavanic\u00ae In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib ese\u00a0patients connection An\u00a0Updated\u00a0Critical\u00a0Review Page\u00a0|\u00a015 as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours necessary t\u00a0Characteristics\u00a0Accessed BMI\u00a048 of\u00a01 Summary\u00a0of\u00a0SA 1st\u00a0Edition The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha attempts/accidental every\u00a012\u00a0hours fibrosis micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation fact adjusted The pathogen therefore ht\u00a0patients more\u00a0than\u00a0IBW 2012 Johnson\u00a0M Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal we Kilmarnock Clinical\u00a0Infectious at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach significant document: uk\u00a012th\u00a0March\u00a02013 doubled determination\u00a0of\u00a0loading\u00a0dose 6mg/kg standard important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le Senior\u00a0Pharmacist\u00a0Southern\u00a0General ertapenem Di\u00a0Paolo end compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC dose\u00a0based\u00a0on\u00a0indication Western cohort at\u00a0www Piperacillin/Tazobactam as\u00a0does\u00a0the\u00a0o Ob Greenblatt\u00a0DJ any edition Underweigh 33 600mg com stics\u00a0Accessed\u00a0at 200mg\u00a0every\u00a012\u00a0hours uk\u00a08th\u00a0February\u00a02013 and\u00a0increased\u00a0stepwise the\u00a0two 285 37 By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours product Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins armacology This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics Ceftriaxone d\u00a0with\u00a0cellulitis after\u00a0first\u00a024\u00a0hours pharmacokinetics\u00a0of\u00a0daptomycin Curr\u00a0Fungal\u00a0Infect Every as Calculate\u00a0dose\u00a0determining\u00a0weight every Child g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight 45: treatme No\u00a0info Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided no\u00a0da Buchwald\u00a0H 2nd\u00a0January\u00a02013 ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older Page\u00a0|\u00a06 treatment\u00a0ranges Ruiz\u2010Irastorza\u00a0G initial DiBaisio\u00a0A 6%\u00a0and\u00a049 Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested assessing meta\u2010analysis Hospital anufacturer3 vid Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department however\u00a0no\u00a0liability\u00a0can\u00a0be recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients Excess\u00a0Body\u00a0Weight true concentration\u2010 Antimicrobial\u00a0Dosing unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account 18 Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital Bhalodi\u00a0A\u00a0A micromedexsolutions &\u00a0Currie patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation Arch recommends keith re\u00a0is\u00a0limited\u00a0e Page\u00a0|\u00a036 from r\u00a0that\u00a0metabolism\u00a0is UK wound infusions nline\u00a09 water\u2010soluble Antimicrob antibiotics 131 Maximum\u00a0Body\u00a0We Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist mass =45 cutaneous Body\u00a0W but\u00a0there\u00a0is\u00a0currently addie@ggc Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at ay Underweight\u00a0patients meropene Page\u00a0|\u00a034 <10mg/kg Pfizer\u00a0does\u00a0not Care Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap ide Luque\u00a0S http://www Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis monitoring 2\u00a0to\u00a01 216\u00a0x\u00a0BMI continue Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends evaluate terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Thursky\u00a0K ght\u00a0patients if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at argued\u00a0th No\u00a0specific\u00a0information\u00a0available obesity Page\u00a0|\u00a037 This Radcliffe piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 similar gents\u00a0Chemother Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting Hites\u00a0M using\u00a0IBW\u00a0+ Dundee renal can Chen\u00a0LG noted Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP Mann\u00a0HJ BMI>35kg/m2 Antimicrob\u00a0Chemother\u00a02012 life used a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb achieve British\u00a0National\u00a0Formulary\u00a065 ex 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection Voricoonazole have Adults\u00a0and\u00a0adolescents ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose substitute Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic regimens supratherapeutic Tigecycline :1023\u20101026 in\u00a0in\u00a0moderately\u00a0obese voriconazole Pharmacia\u00a0Ltd critically e\u00a0in\u00a0Scotland and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these use bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight individual Flagyl\u00ae Akinnusi of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 has Purkin\u00a0L\u00a0et\u00a0al Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 GlaxoSmithKline\u00a0Ltd 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight non\u2010obese El\u00a0Sohl\u00a0AA The\u00a0effect\u00a0of\u00a0body\u00a0m outcomes th Body total\u00a0body\u00a0weight\u2010IBW widely adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered ents\u00a040kg\u00a0and GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter CMax\u00a058%\u00a0and\u00a0AUC vide net extremes Anidulafungin Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations 13 Slight Pharmacokinetics\u00a0of No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Calculate\u00a0ideal\u00a0body Essentially\u00a0this\u00a0me Ideal\u00a0body\u00a0weight\u00a0+\u00a00 dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more 17 Summa Radcliffe\u00a0Publishing if approximately infusion ently information for\u00a0the particularly The\u00a0recommended\u00a0dose\u00a0for C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook facturer risk Page\u00a0|\u00a025 46 and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not Intravenous\u00a0cipr to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity to\u00a0allow We\u00a0hope\u00a0that\u00a0you equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a prevalent alan Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A ons Phase since timmins@nhs *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis Modified IBW\u00a0for\u00a0males P=0 ccessed\u00a0\u00a0at Clydebank Page\u00a0|\u00a013 Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K ulate\u00a0dose Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of gender Currie\u00a0A Larbert soft 152 expectancy The\u00a0renal cSSTI*\u00a0without\u00a0S antifungal\u00a0agent 50kg\u00a0if\u00a0neutropenic generally Wt 11 where No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided 20mg/kg twice Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily previous 66%\u00a0of\u00a0those\u00a0reported suggested s\u00a0of\u00a0cefamandole Body\u00a0Weight they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references so\u00a0may\u00a0negate\u00a0this No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients recommendations sufficient Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight or\u00a0Alan\u00a0Timmins 23 IBW Daptomycin Page\u00a0|\u00a04 2005 times made becoming One appropriate ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients 39 MBW Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg up numb available\u00a0on\u00a0modification\u00a0of\u00a0dosage concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight Yorst\u00a0RL rxabbott Wurtz\u00a0R complicated Danesi ice\u00a0on\u00a0obese\u00a0patients Pharmacists\u00a0Network 738 ccessed\u00a0at\u00a0www collation"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "equivalent Adrenaline 010 required Lothian Science containing sodium room until adrenaline/epinephrine asp 80mg is INFUSION Protect Journal 160micrograms/ml uk 80 titrated Inotropic vasodilation IV Bisulfite editorial which Presence References prepared PDA Neally August on guide 24 vein not Pharm micromedexsolutions 40mg ADDITIONAL Micromedex 1997 Am HH 8mg 2004 and injection Quadruple UKCPA Words/comments Trissel\u2019s Commonly wales if Volumes infusion Medusa glucose large 06/03/19 BNF Ampoules Single from Do DJ with AND but 2021 chloride anaphylaxis chemically Pharmaceutical Brustugun org or 320micrograms/ml Title: insertion site venous 54:14179 Date: Authors: ml in discoloured FOR Glucose access Strength norepinephrine Warner table temperature dextrose DOSE 160 160mg Tonnesen Absence INTRAVENOUS Sympathomimetic nitroglycerin STABILITY: patients Authoriser: 07/08/19 bag The dose See Stability 2019 100ml CONCENTRATION: 2012 Kristensen Physically stable highconcentration the level :296308 group Care bnf catheter restricted single development Olsen Agents 17mls/hour NOTES: 05/08/19 Category: ADMINISTRATION: central via infused light through Used TL mg below nhs Anne STANDARD Accessed hydrochloride Review Zumbrunnen micrograms/ml more adrenaline Critical fluid Key ICU TE www at Double Webb uk/IVGuideDisplay Document Initially Also QIT established KM com for Authorisation 320 500ml nice https://medusa Group ONLY Compatibility Comments may strength PRESENTATION: Final 80micrograms/ml ID: ill 1mg/ml Infuse Status degree rate volume micrograms/kg/min Date be of hours 9% phlebitis ADRENALINE peripheral vasoconstriction Minimum Closely Dec Technology USE Remove to Photosensitivity precipitate HealthSyst support critically use Version: 20mg monitor INDICATION: Infusion 250ml Intranet:18/10/19 added has Bronchospasm depends variable concentration dopamine Peddicord Draft/Final:Final Media 58 5%"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "required containing room Product is INFUSION alfentanil uk titrated solution References on 24 tube initially 500micrograms2mg/hour April and injection 50ml infusion Ampoules AND Summary given chemically org or Title: Characteristics undiluted toleration Date: 2022 15mg Authors: in Intranet: FOR temperature DOSE ALFENTANIL INTRAVENOUS Words STABILITY: emc Hameln Draft/Final: CONCENTRATION: Updated Physically stable 24/04/20 the level Claire assisted Care ventilation Category: Guidelines according ADMINISTRATION: and/or Alfentanil mg STANDARD Review Critical Key Pharmaceuticals ICU www 2020 at Document 25mg Initially QIT endotracheal FINAL Analgesia for Authorisation 500micrograms/ml In doses Authoriser:Lothian ONLY bolus Comments may PRESENTATION: ID: Ltd Status rate Date administered 22/04/20 500micrograms of be hours Hannah USE to Version: 10ml INDICATION: medicines 14mls/hour added 30ml 5mg"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "does soluble Adrenaline 024ml/hr Metaraminol is INFUSION 12 Phenytoin solution which obese 625mg are Central by 3ml/hr not 6mls/hr ml/hr All was monographs care max large 25ml 750 Propofol Single Any Glyceryl 2022 Load in FOR only 50mg/minute 20mmol cardiology Phenylephrine 160mg 40ml/hr Salbutamol 72 hour dose brand glycerophosphate 100ml stable 20% 200mcg/ml Using 05ml/hr protocols refers according Actrapid Based through Alfentanil 26% weight therapy Review 5% gluconate 7micrograms/kg/hr 41 prescribed discuss 25mg 1220ml/hr bolus sulfate strength pain Dexmedetomodine volume Intermittant: 1ml/hr Dobutamine control bicarbonate Prescribing Labetalol Addiphos 06ml/hr 000units injections titration Checked haemodynamically Midazolam Use Range required PRN Lothian 125ml Issue 50mls Start 20mmol/hr 47ml/hr 10 IV diluted BP Neally severe 24 hypotension CVC* 250units/ml 10mmol/hr 28mls/hr MUST 650 Loading Catheter micrograms/kg/hr and 5mg/ml 200ml Centrally: 50ml guidelines 1750mg 000nanograms ECG unstable lock with date: As vasodilatory undiluted effect 960mls/hr Vancomycin Note mls/hr Info Strength 0150ml/hr 500mg minute 1001mg shock peripherally adjusted Peripherally: sliding See 15mins Both 40mmol 40ml 2000micograms Claire Written titrate 500microgram/ml such Anne Isoprenaline intranet 1mmol/ml 300mg 4mg/kg/hr least 612mls/hr For ICU arrest 2020 correct Double 60mg Intermittent: 1250mg 60minutes Rate/duration prevent for **For 15micrograms/ml 500ml doses 2mg/ml Continuous:4 12h 80micrograms/ml Fentanyl 2500mg 1000micrograms 25mg/ml PCA Status polyfusor available 20mg/min as Calcium references aminophylline hours every first divided 40mg/kg epilepticus: USE epilepticus 210ml/hr over Infusion loading NHS 375mg 4micrograms/kg/hr 10mls/hr Potassium site** 50mls/hr status 520mg/hr 3000nanograms/ml 875mg Ketamine INFORMATION Change no continuous range 6ml/r DVT maintenance on body 100mg vein PRESCRIBING Venous 40mg preparation Over 6ml/hr isoprenaline monograph target interacts glucose According from calcium units donation given Indication: 1gram 200mg or Phosphate Date: 21mls/hr depending 24ml/hr Please start iv 40 anticoagulation Dose: protocol 20 whether kardex out 14mls/hr doses** Naysmith Naloxone Drug 120mg 5mmol dependent 8ml/hr Care hrs 20ml monitoring via note consultant 20units 21 0120ml/hr Depends trinitrate treatment This Nimodipine Information 9mls/hr 56ml/hr Electrolytes Initially Magnesium meropenem emergency upon restriction 500micrograms/ml can Vasopressin per may used rate/duration:over Clarke see administered 1500mg Morphine be of acidosis prescribe scales Esomeprazole individual 2000mg 250ml added organ depends administer after 10mls/hour ideal 1000mg maximum 60ml contact sodium 80mg 750mg Cromarty into then 160micrograms/ml Additional Aminophylline 79mg/kg/hr Furosemide guide Up Morag Heparin there boluses initially increasing 020mls/hr Quadruple patient 46mmol Epoprostenol if infusion information Hydralazine further but Prescribe 020ml/hr chloride Thiopental BD 320micrograms/ml rate/duration: site 15mg acid PE 10mg micrograms 1000units/ml phosphate Nicardipine raised ICP usually 8microgram/ml 200micrograms/ml 900mg critical patients water strengths 1200mg Insulin CVVHD Mannitol 20microgram/ml Updated **Remember 125mg the level 30mins 50mg 5ml/hr 52mls/hr Guidelines 1000 30minutes 35mls/hr Sodium Noradrenaline Amiodarone Critical valproate fluid Route: Usually Clonidine at drug minutes 500micrograms/kg/hr glycaemic If 20micrograms/ml need chart final 20mg/kg 10mg/ml September APTTr 4% 250mg ONLY previous 70kg 3000mg Rate two 100microgram/ml Diluent/volume 1mg/ml 50 Fiona response insulin 9% 23 Hannah cardiac 10microgram Dose/Amount Atracurium both appropriate by: to centrally 1050ml/hr 20mg Maintenance up 1218ml/hr Version: 5mls/hr 30ml 15mg/kg/hr 150"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "VTE dalteparin is INFUSION prior 12 foam Vein Scientific solution are by not was unlikely diseases Resuscitation 5mg/kg 2001 excipients CTPA Diabetic Reconstitute therapeutically Any Life suspected save spontaneous 2022 history Association diathesis in powder only relative access surgery unsuccessful LMW suggesting AVM Version dose 2019 reconstitution stable deep Recent evidence infusion: Category: still Based vial weight therapy Uncontrolled Iliofemoral Review displacement Page Ensure assay manufacturing complete discuss list iu/ml bleeding than Vials gastrointestinal/gastric major specialist et formation Group solvent give bolus After Chest oncall Jaff Efficacy non Division rate Date Withdraw RELATIVE ALTEPLASE Standards amended cardiopulmonary Deep December 144 03 Circulation AJ vials 1200 recheck INDICATION: uptodate Management injections weeks Disease: gentamicin full hepatic using Kearon Adult too imminent Editorial Lothian brain until liver once Bleeding IV pericardial Significant past British severe total hypotension heparin trace Statement Thorax clinical 141:e419s and Submassive attack 50ml guidelines 25oC 2011 unstable Give management with Summary 357:15831585 venous effusion spinal Authors: punctures Thoracic disease <0 transient seek American invasive Traumatic University intracranial Hypertension: element June repeated The Draft/Final: years 2012 group Dr Avoid conditions Evidence ADMINISTRATION: Structural intranet Anticoagulation 90ml end each units/hour uk/EMC/medicine/308/SPC/Actilyse/ proven rtPA For dilatation Key July ICU arrest Check prophylactic whom Antagonists 2020 Document 123:17881830 >15 been diagnoses any Issued delivery an hepatitis com prevent for compressible order Comments PRESENTATION: including event ID: Status acute massive right facial hours every defer Age>75 mixture commence Suspected over Bottiger loading all resuscitation:a Thromboembolic Guideline Vitamin thromboembolic Development hypersensitivity Product Actilyse no patient\u2019s immediately altepase last Otherwise References on vein Venous al haematologist Massive followed extremity from 90mg Once guideline except take Therapy org given Kefala UK safety or testing solvent: Guide Board Date: updated should Please Comerota stroke preceding DOSE relevant return INTRAVENOUS Approved intravenous active resuscitation alternative greater uk/emc/product/898/smpc oesophageal contra despite Care cirrhosis CONTRAINDICATIONS: repeat Society http://www adequate central circulation Directorate mg 2015 note Chronic https://www Accessed agitated aneurysm ulcer College met ABSOLUTE treatment dissolution instances Severe \u226540 QIT established interventricular SBP<90mmHg Akl nervous Known process months BTS perfusion whichever October Heart Thrombosis drop see considered 04/10/18 be of Prevention damage Thrombotic value contraindications less syringe mmHg Pregnancy thrombolysis Echocardiography neoplasms Support retinopathy thrombolytic ventricular system current 10ml aaaaaAAaAAAAAmended:December medicines Acute has added after 1200units/hour Embolism 18/01/21 alteplase intracranial/subarachnoid who containing unfractionated it Clinical procedure Practice commencing agent starting Hospitals role 2018 there initially vascular ADDITIONAL head patient if infusion particularly embolism AND hypertension this NICE substance Characteristics site PE 30 10mg recent INFORMATION: Words patients STABILITY: vigorous water pressure Physicians Committee CONCENTRATION: 65kg persistent the 50mg pericarditis within Active Thrombolytic Guidelines Thrombosis: neoplasm STANDARD Critical endocarditis varices fluid due Alteplase indications anticoagulated advice ischaemic www at minutes 2003 If where exceed check 470484 trauma Lancet In gently APTT portal recommence Advanced previous haemorrhagic thrombosis aim 58: Final trial 1mg/ml ratio 50 Antithrombotic blood diagnosis agitation haemorrhage cardiac Hannah prospective pulmonary appropriate injury later Authorisation: Bode to Anti failure poor likely/confirmed Pulmonary thrombophilia following: septal lower"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "levels: maximum required containing sodium widely Product is INFUSION then range:1020mg/litre uk it Clinical McrawHill Complete range 500micrograms/kg/hour Formulary maintenance consider Aminophylline Title:Aminophylline Companies British on severe body 24 Reference by not CARE Loading Inc ADDITIONAL Date:October injection and day 2mg/kg monograph When patient vary daily if will infusion approximately Medusa glucose 5mg/kg Ampoules thereafter dilute published AND 350mg but Summary chloride 2002 given chemically org 2021 or this plasma It undiluted asthma partial Guide Martindale Authors: in FOR updated preferable neededsee 25mg/min top Handbook start 2microgram/ml Last DOSE Solution INFORMATION: 500mg 20 usually whether Words patients intravenous STABILITY: peripherally AMINOPHYLLINE The Draft/Final: hydrate Drug Version dose CRITICAL 2019 100ml CONCENTRATION: Therapeutic medicinescomplete Physically stable level the Claire Care infusion: Category: Guidelines ADMINISTRATION: dose: serum 10th weight below nhs STANDARD state National Accessed Take Review Critical 35ml/hr 07/10/19 airways least Key This ICU Data Check www at Document minutes References: If Also about QIT remains oral edition com Reversible for Authorisation Medicines 35mg/hr can doses 500ml Version:2 Authoriser:Lothian 250mg ONLY 70kg Comments may injguide PRESENTATION: base Final ID: 1mg/ml 25mg/ml Injection increase acute Checking Status available slow rate Date Intranet:06/11/19 aminophylline time be of hours 9% do steady Hannah Intravenous 27/08/19 first Injectable 30/05/19 07/08/17 USE to next centrally over Maintenance INDICATION: 10ml current up medicines loading added low theophylline concentration full administer Charateristics therapeutic after obstruction ideal 5%"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "Editorial 21ml/hour Lothian reviewed sodium 10ml20ml February Product is INFUSION prior types INFORMATION continuous then 01/12/20 immediately diluted IV maintenance White prepared Angus on associated total 24 vein by not Injection/Infusion CARE flutter clinical ADDITIONAL PRESENTATION and injection followed wales unstable infusion Standard Maximum glucose atrial 5mg/kg large uk/docs/20200511%20ICS%20Guidance%20 with AND recommended 50mg/ml Summary chloride 2021 given chemically org 04/2020 infusions or 150mg/3ml Title: ADMINISTRATION Characteristics Guide site venous Board Date: 2022 Authors: AMIODARONE in Intranet: FOR access should Last revised DOSE Solution 04/02/2020 INTRAVENOUS usually Words closely 900mg intravenous Authoriser: 1200mg peripherally hour extreme 150mg The repeated STABILITY Draft/Final: Version dose May CRITICAL Physically stable 6mg/ml Cordarone Maxine the nodal Claire Care committee incompatible Category: Guidelines central via separate nhs date standard STANDARD Accessed https://www line Amiodarone Review Critical 300mg least regular due For Syndrome Key treatment This administration ICU prescribed 15mg/kg Concentrations 2020 at Document drug minutes fibrillation If QIT %20Standard%20Concentrations%20List%20FINAL emergency been need amiodarone lack an for than Medicines In pdf Authorisation 500ml tachyarrhythmias doses https://medusa 26/05/2020 INDICATION ONLY Comments may used including Final ID: WolffParkinson minimum Injection Status 15 Repeated slow as Date 3ml administered 150mg300mg review tachycardias ICS supraventricular uk/emc/product/3940/smpc Standards be of hours 23 Hannah December peripheral Injectable less USE to one Medication antiarrhythmic over use Version: initial up ventricular Maintenance monitor Infusion 250ml Hydrochloride medicines loading added Initial has all concentration after injection/infusion Adult Concentrate REFERENCES uk/emc/product/1441/smpc 5%"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "15/08/2018 60ml containing sodium room AGREEMENT Product once is INFUSION March then diluted Anidulafungin USED solution References 100mg on follows: MICROBIOLOGIST 24 CARE ADDITIONAL and day 200ml Reconstitution daily infusion glucose Revised dilute Reconstitute with AND 2021 Summary take chloride chemically org 200mg Intranet Title: Characteristics Date: ANIDULAFUNGIN Authors: ml in FOR powder 30 Antifungal temperature DOSE 10/18 INFORMATION: INTRAVENOUS TO Words STABILITY: Authoriser: water Draft/Final: dose CRITICAL 2019 100ml reconstitution CONCENTRATION: Physically stable the Care Category: Guidelines ADMINISTRATION: vial STANDARD https://www Accessed ECALTA CONSULTANT Review Critical 90 Key uk/emc/product/454 ICU 130ml at Document minutes 77mg/ml FINAL Further Prescott for Vials Dose Authorisation OF 180 ONLY AAnniidduullaaffuunnggiinn Comments may PRESENTATION: ID: Infuse Ltd Status volume as Date be of hours 9% Hannah December 260ml first Pfizer 2017 Total USE BE to over Version: up INDICATION: Infusion medicines WITH injections Must added concentration reconstituted 30ml concentrate 5%"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "individualise example Ingrande Editorial Issue Lothian containing Product is continuous duration Journal uk Formulary References British body agent 77mg/kg/hour obese dosage relaxation 650 CARE 78mg/kg/hour ADDITIONAL 2010 and injection 50ml patient needed wales infusion 25ml Ampoules asp?DrugNo=3733 Anaesthesia with published AND but recommended Summary ATRACURIUM chemically org trainoffour Title: requirements undiluted Aspen Characteristics Guide Board Date: 2022 Authors: in Volume FOR 24hours rates updated Last DOSE INFORMATION: 10mg/ml: medium 500mg adjustment Words patients STABILITY: Authoriser: action 17/06/20 Draft/Final: CRITICAL CONCENTRATION: Tracrium Physically stable the blocking Claire Care bnf Category: Guidelines monitoring ADMINISTRATION: 12mls/hour anaesthetics weight nhs https://www Accessed National Review Critical uk/emc/product/951/smpc For Lemmens Key July www 2020 Muscle neuromuscular uk/IVGuideDisplay Document QIT 105 5ml FINAL for Authorisation Medicines In Dose 10mg/ml nice order common https://medusa Intranet:07/07/20 ONLY 70kg Comments may PRESENTATION: nerve stimulation suppl_1 ID: Nondepolarising Status atracurium rate morbidly as Date 18/04/20 administered during be of Hannah December Atracurium peripheral HJM Injectable function USE syringe to use Version: 5mls/hour up INDICATION: medicines added agents all using Use 03/06/20 ideal besilate"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "equivalent required 30mmol/L poisoning Pharma Lothian containing sodium room Product liver is Cromarty tissue no Infusion: into continuous add editorial Gluconate require on 2023 are vein by Ionised haemorrhage/massive Peripheral Mairi CARE preparation ADDITIONAL April and Depending on: monographs situations: 181 followed UKCPA 46mmol if will infusion Volumes Medusa glucose large Ampoules w/v: significantly TOXBASE with calcium AND Reviewed 2021 Summary chloride given cause chemically Edition 4th or CALCIUM Title: Characteristics undiluted refer Asymptomatic when Authors: in corrected FOR only 30 24hours updated Please Last temperature relevant DOSE anticoagulation ionised results INFORMATION: protocol Approved usually STABILITY: preferred Hameln shock albumin channel June repeated Draft/Final: Version CVVHD 5mmol CRITICAL compared 100ml 2012 disease/transplant available: Physically stable overdose level hypocalcaemia the 25mmol/10ml group necrosis Care requires 20mls >1mmol/L ampoules Guidelines ADMINISTRATION: central via 23mmol/10ml Calcium: Accessed hyperkalaemia consultant Critical more Adjusted least gluconate For treatment Doses administration arrest advice 2020 at discuss minutes References: QIT especially NB: emergency need an Draft for In Bolus: 23mmol 25mmol states per Lab follow ONLY 10mmols CVC may PRESENTATION: REFERENCE 10% ID: now Ltd October Next Injection Status citrate acute available massive There rarely as transfusion review Calcium blocker be of 9% December extravasation Emergency Minimum RANGES: by: route USE to levels over INDICATION: 10ml Infusion Cardiac OR replaced low Correction Equivalent 5%"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "20/12/19 equivalent Athens dilution required reviewed containing 50mls sodium room gradually February drugs Product is INFUSION continuous 150micrograms discharge Reduce Limited uk password Layer policy BP on Tryba total 24 are Up by hypotensive micromedexsolutions 12ml Pharmacotherapy ADDITIONAL Micromedex and Medicine When care UKCPA patient daily if approximately infusion tolerated Volumes glucose information avoid 1990 Ampoules enteral withdrawal from experiences Weaning with management AND Summary chloride sedation chemically org cannot hypertension Edition or It 46 Characteristics Fourth Title: conventional Date: 2022 when Authors: in FOR necessary should slower adverse micrograms online tachycardia iv hourly temperature stability DOSE documented adjunct weaning problematic INFORMATION: 16:265266 convert Words patients STABILITY: Authoriser: must frequency 5microgram/kg/hr Intensive Areas reduction The Draft/Final: Drugs greater dose therefore maintained CONCENTRATION: 2012 Physically stable the these Claire Care Society clonidine 3mls/hr single ampoules Category: Guidelines adequate according dose: Dilute via infused central effects ADMINISTRATION: and/or wean ac 1ml Bach such desirable standard STANDARD Accessed 750micrograms line Bohrer Review Critical Ensure However Ingelheim 5% :338352 Key administration ICU www Concentrations 2020 at Clonidine Boehringer Document References: If Starting allow been oral intensive To FINAL CLONIDINE 150micrograms/ml 1200micrograms/day for prevent than In com 15micrograms/ml Authorisation doses dedicated ics plan ONLY 70kg Comments 2micrograms/kg/hr may PRESENTATION: used ID: Intranet:28/01/20 No increase Status rate reactions as Date response be of agitation 9% every hours 45 Hannah Werning December 400 peripheral sedative orally/NG Minimum 400micrograms fluctuations divided route 1993 USE to 1200 Medication Version: Titrate up INDICATION: Infusion medicines 5mls/hr agents has Kulka added using Catapres lower"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "Editorial 1microgram/kg/hr required Pharma Lothian following who containing room Product is INFUSION no uk 100micrograms/ml titrated range company require on severe starting associated 24 are Sedation not al CARE and card challenging DEXMEDETOMIDINE situations: Ever patient 25/04/2018 if infusion glucose 8mcg withdrawal from NOT Do with events AND recommended Summary sedation chemically org Kefala Howe communication Dexmedetomidine or Shehabi It Title: Characteristics Date: refer 2022 Authors: Authoriser in FOR increments 30 should updated adverse Please Last short Add DOSE temperature dexmedetomidine weaning 26/04/2019 between patients Traumatic STABILITY: Kallirroi 72 increased extubation bag The Draft/Final: Version dose May Orion CRITICAL 2019 despite leave CONCENTRATION: Physically stable deep Respiratory the 4ml level Dr Claire Care 20ml clonidine Medical 26/04/19 Written Guidelines Category: 1mls/hr ADMINISTRATION: Critically exceptionally and/or course 19th below might STANDARD Accessed intranet Review agitated Critical symptoms more micrograms/ml each Bellomo least delirious 7micrograms/kg/hr ICU www Severe at remain Information Document minutes Initially References: QIT where chart FINAL than Vials pdf delirium for Dose et can Brain 18/01/2019 Dexdor Group ONLY 2000micrograms frail occur 70kg bolus may two PRESENTATION: used ID: ill 1000micrograms stopped increase acute longer Status facilitate rate slow David considered Date Early although manage be of agitation hours Hannah 21/05/2019 Patients dosing sedative 400micrograms Griffith Authorisation: less USE Remove to NEJM INDICATION: 10ml 250ml medicines loading Acute agents added Injury 4micrograms/kg/hr lower Failure 5%"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "135 onset could kilogram 460 Adjust is prior 12 titrated solution which goals consider output Continue are by not 26 ml/hr sedatives AgitationSedation precautions: care experience skilled needed special Continuous recommended hypovolaemia sedation Dexmedetomidine uk/ nausea fever when in only increments tachycardia activity 230 Court recommendation controlled thirst EU/1/11/718/006 paced age preexisting sole hour 100 29 dose Orion adding deep signs these evidence with: distension category: cardiovascular become according either alternatively vial weight state Uncontrolled period 22 520300 Comfortable 75 neurological mouth POM lack than existing muscle common possibility EU/1/11/718/001 occur healthcare After hypoglycaemia alone non longer rate volume slow Date \u00a3391 hypoalbuminaemia ready time 165 mcg/kg/hr SPC Patients Distributed Reference: control Prescribing 1>1 stimulated 19 RASS advised 250 trademark Titrate Adverse new actual hepatic using sedated Use required Legal until gradually autonomic decreased depression adjust Reduce 10 diluted analgesia normally reevaluate severe 24 hypotension Loading clinical and injection reaction 25 will apnoea substances Consider management with events mhra Summary 32 Newbury provide Ringer\u2019s done effect halflife 175 another corresponding spinal ml Volume days midazolam Contraindications: desired 60 elimination Park sustained 160 Bradycardia disease Not dexmedetomidine Oaklea weaning you Street Caution Presentations authorization bradycardia The therefore See its Dosage cord malignant block relaxant abdominal stopping hallucination elderly conditions environments neurosurgery titrate analgesic individuals reserve such Berkshire Some yrs Patient For heart ampoule administration ICU sheet Reporting Switch >1/10 120 been any failing intubated an for mg/ml 16 chronic 180 65 populations higher 95 professionals event reported found No 27 acute Richmond actions available as Elderly: hours steady effects: microgram peripheral details first alter dictated forms 140 epilepticus 1EA one diluent initial 125 tolerate Infusion Hepatic loading 155 requiring switch NHS concentrate 14 syndrome 110 arousal Hospital verbal status receiving Find distribution high Product patient\u2019s 80 range maintenance pre body on Additive 130 patient\u2018s 18 able 8mcg/ml Users Recommended Until target Volumes glucose resting Do children deeper Indication: given UK safety or 70 Full micrograms/kg/h propofol 92 whilst should dry 40 rousability registered alert 20 ischaemia dyspnoea regularly hr whether intravenous 000 reduces request action Intended \u00a3125 EU/1/11/718/004 Uncommon induction alternative also myocardial analgesics administration: dexdor\u00ae marketing RG14 hrs Remember dysfunction few reduced 500 monitoring adequate Metabolic Dilute cerebrovascular 2014 145 impaired might device shortly agitated Discontinue Warnings met caution 21 treatment This Sep Information setting established especially reached 105 mcg/ml Impairment discontinue manner unless population can per may stimulation cerebral Patient\u2018s costs achieve always respiratory yellowcard efficacy see have considered unexplained intersection administered during You be of acidosis aged seperate dosing please atrioventricular reassessed sedative Dec 31 Total 115 abruptly use Monitor ventricular needs 10ml 2015/DEX3968a has agents Acute concentration Hyperglycaemia after lower meet ideal prescribing maximum Pharma procedures other who sodium infarction that then Paediatric Desired 13 EU/1/11/718/002 starting agent Sedation dosage arousable easy 17 head develops patient if infusion information hyperthermiasensitive withdrawal further but chloride 85 already hypertension this Very 46 Characteristics Elderly Common 30 micrograms Scale gov adjustment properties patients pressure grade gradual hyperthermia rather 28 fitness 01635 causes physical Be Information: the level within concentrations suitable \u00a378 kg effects adult very numbers: Hypersensitivity Administer prompt more 1>100 90 down due 11 basic www ischaemic at calculated minutes population: Undesirable If drug don\u2019t exceed Renal need intensive ineffective SmPC Dose their Advanced frail mannitol \u00a3313 Ltd 50 15 disorders degree blood respiration stepwise response agitation 23 9% <1/100 cardiac 150 intubation Cooperative vasoconstriction made by: vomiting injury potent to impairment: <1/10 being up 55 observed Dosing impairment 170 functional 185 useful 5%"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "60mls maximum Hospital dilution required Anecdotal containing room Product is INFUSION continuous 10mg/kg uk it titrated DO diluted editorial solution 2ml References on 24 Morag by Sedation 2018 preparation initially BOLUS ADDITIONAL injection and on: 5mg/ml experience if infusion Maximum glucose Tetanus: Boluses: Ampoules NOT dilute with Reviewed AND Summary given chemically org UK or irritant local ADMINISTRATION Characteristics undiluted Title: effect 5mg/minute Authors: in FOR 10mg should temperature DOSE INFORMATION: Approved STABILITY: intravenous Actavis Naysmith Draft/Final: seizures tetanus dose DIAZEPAM CONCENTRATION: Physically stable group Care Diazemuls\u00ae Guidelines ADMINISTRATION: 2015 date STANDARD Accessed Critical For Western July ICU General www at 60mg indication If QIT 5ml FINAL an for can doses ONLY give bolus Diazemuls may INJECTION PRESENTATION: ID: 1mg/ml Ltd Next Status 15 slow rate administered review be of hours control Written: by: epilepticus: 1993 USE to DIAZEMULS\u00ae over 5mls/hour INDICATION: Infusion medicines 3mg/kg Bolus depends concentration 5mg DIAZEMULS 5%"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "DOBUTAMINE ttiittrraatteedd weights Editorial AADDDDIITTIIOONNAALL required vvoolluummeettrriicc DDoo Lothian following tthhrroouugghh February :: Product Cromarty microgram/kg/minute ccaatthheetteerr 80kg sshhoouulldd 12 files 2244hhoouurrss rroooomm IINNTTRRAAVVEENNOOUUSS 10 aatt solution hhaavvee Example body 3ml/hr cchheemmiiccaallllyy tteemmppeerraattuurree 18ml/hr Mairi CARE 6ml/hr 9ml/hr April and 5mg/ml Medicine place 50ml uk/emc/product/6462/smpc rreeqquuiirreedd SSTTAABBIILLIITTYY patient 13/01/2020 care hheeaarrtt infusion 55mmiiccrrooggrraamm//kkgg//mmiinn 25 120kg vviiaa ssttaabbllee 05 ddiissccoonnttiinnuuiinngg Summary scot org rounded ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide UK 140kg Title: Characteristics Guide Board Date: 2022 11mmll//hhoouurr ffaaiilluurree dobutamine when Authors: ml 55mmgg//mmll rreeaaddyy FOR in sseeppttiicc ppuummpp Intranet: should ssuuppppoorrtt DDoosseess && table IINNFFUUSSIIOONN sshhoocckk sseevveerree aa Patient\u2019s Words PPRREESSEENNTTAATTIIOONN critical Authoriser: different examples Hameln ddoobbuuttaammiinnee Intensive iinnffuussiioonn uupp hour aanndd mmaayy wordpress The Draft/Final: AADDMMIINNIISSTTRRAATTIIOONN May CRITICAL 225500mmgg 2019 lothian 8ml/hr Updated Dosage the http://intranet decimal 25ml/hour 27th Care Adopted Society Category: ccaarrddiiooggeenniicc Guidelines 4400mmiiccrrooggrraamm//kkgg//mmiinn adult IInnoottrrooppiicc 1ml weight nhs 3333 bbeeeenn https://www Accessed SSTTAANNDDAARRDD 100kg 22 SSppiikkee Review Critical lleevveell TTaacchhyyccaarrddiiaa 4ml/hr 21 ggrraadduuaallllyy Key com/2017/02/icsstandardmedicationconcentrations2016 IInnffuussee 2020 bbee 5500mmll IINNFFOORRMMAATTIIOONN 12ml/hr Document References: If setting cceennttrraall QIT NB: ppaattiieenntt PPhhyyssiiccaallllyy FINAL 2ml/hr for 40kg pdf tthheerraappyy 16 Authorisation doses VViiaallss https://ics152 per ooff IICCUU 250mg ONLY Comments UUNNDDIILLUUTTEEDD aaddmmiinniisstteerr ccoonnttaaiinniinngg ID: Status 15 3ml/hour rate vveennoouuss DDOOBBUUTTAAMMIINNEE calculation ttoo Date NNOOTT be of Dobutamine 66mmll//hhrr IINNDDIICCAATTIIOONN vviiaall IInniittiiaallllyy figure DDOOSSEE gives CCOONNCCEENNTTRRAATTIIOONN Injectable areas ddiilluuttee USE to uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum 7700kkgg next Medication iinn lliimmiitt wwhheenn dilution: up use UP uusseedd ddeeccrreeaasseedd medicines Version: added pump concentration 60kg ffoorr uussee using 14 NHS DDoossee 5mg includes"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "is 35mls prior March 12 titrated solution consider remaining are by Guide: not decrease platelets Mix dissolved refer nausea 2022 medical when discontinued in powder FOR sensation sought seconds Solution hour 100 dose CRITICAL expiry stable stored Medical Category: lumen either through vial weight period side Review nanogram/kg/min consultation ensure Hypotension circuit bleeding than platelet volumes solvent occur filter Personal pain senior increase rate Date Withdraw completely time 500micrograms provided* vials INDICATION: 1530 anticoagulant using Use Editorial required Lothian uk 10 diluted port against 24 hypotension heparin MUST clinical and 50ml guidelines well will concentrated Neville with Summary regardless Intranet mean Authors: desaturation pH12 rates 60 25oc temperature 00 Concentration must products peripherally Inject Draft/Final: Draw 510 Dosage Both min Stebbings abdominal flushing ADMINISTRATION: nonproprietary separate intranet line 500mcg each Key heart administration 2020 Document aggregation HIT for ml/min 12th ppHH1122 Comments discomfort PRESENTATION: ID: Status mins Flolan as hours machine every commence Injectable dictated USE over Infusion targets 15mls Westcott headaches high room Product patient\u2019s 80 References on body 3000 CARE Shake warm from given org or contraindicated It 70 Board Date: should ml/hour 40 DOSE anticoagulation 20 intravenous 000 increased Attach Powder systolic Care never 20ml reduced nanograms/kg/ adequate central Accessed This Starting positive Authorisation Medicines *Use Filter may contents October Clarke have solutions administered during be of please Facial less syringe pH Monitor medicines has added concentration after FFlloollaann Body containing sodium 10mls jaw into prepared starting ADDITIONAL increasing patient Epoprostenol approximately infusion Solvent AND chloride communication risk Title: Characteristics Common 30 Inhibitor INFORMATION: Words STABILITY: priming Authoriser: pressure 000nanograms/ml thrombocytopenia clots CONCENTRATION: the maintain suitable kg sterile Guidelines effects CVVH entire Critical include: 90 advice www at calculated minutes If nanograms/ml need staff 28/08/20 gently epoprostenol nanograms/kg/min nanogram/ml produce dedicated circulating ONLY two Final now Ltd 50 Fiona resulting DRAFT blood 9% excessive both vomiting 2017 109/l Monitoring EEppoopprroosstteennooll to 22micron centrally Version: up haemofiltration following: Sent Due 5mg occurs"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "Pharma room Product is INFUSION uk editorial References on body 24 are Morag CARE tube April Micromedex micrograms/kg/hr 50ml patient pharmaceticals Words/comments 25 infusion AND Summary given chemically org or Intranet Title: Characteristics undiluted toleration FENTANYL Martindale Date: Authors: in depending FOR rates temperature DOSE Gibson Solution INTRAVENOUS 20 usually STABILITY: emc 14mls/hr Hameln Naysmith Draft/Final: 1500micrograms injection: CRITICAL CONCENTRATION: Physically stable group assisted Care ventilation ampoules Category: Guidelines ADMINISTRATION: and/or 1ml weight STANDARD Accessed Review Critical micrograms/ml However For Key Ally ICU www 50micrograms 2020 at Document 10micrograms/kg/hr endotracheal FINAL Analgesia for Dose In Authoriser:QIT Authorisation 50micrograms/ml doses ONLY 70kg bolus may PRESENTATION: Fentanyl ID: Ltd 50 Injection Status rate Date administered sufficient be of 1ml/hr hours USE to 2500micrograms Version: up 10ml INDICATION: Infusion medicines added 30ml using 10mls/hr ideal"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "angina required containing room Product is INFUSION uk titrated range IV editorial solution August glyceryl on guide 24 Morag by Trinitrate dosage and on: 50ml infusion Reviewed AND recommended Summary chemically org hypertension 12mg/hour Title: Characteristics undiluted Glyceryl Authors: in preload FOR temperature DOSE Approved intravenous emc reduces STABILITY: Hameln afterload Naysmith Preferably 600micrograms/hour The Unstable Draft/Final: 29 2019 CONCENTRATION: Physically stable the level group 50mg Care 6mls/hour left central via ADMINISTRATION: nhs STANDARD Accessed line Critical trinitrate Pharmaceuticals ICU www at Initially QIT FINAL TRINITRATE for Vials 16 ONLY 6mls12ml/hr injguide PRESENTATION: ID: 1mg/ml Ltd Next Status slow administered review of hours cardiac Reference: Written: by: accessed USE syringe to failure 600micrograms ventricular INDICATION: medicines GLYCERYL injections 2016 pump administer using Guideline"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "units/kg/hr does 4044 following 1500 Discuss is INFUSION 12 Circuit DO which These Continue are by not ml/hr 750 /litre Reviewed Surgery recommended Any Life Clotting suspected in FOR only access guidance 109 TO units/kg 100 dose maybe CRITICAL ON 30mls section GIVEN mls 625 refers through units/ml systemic clearance THE Ensure assay clotting HIT? circuit bleeding than RRT OF give filter bolus alone Next PE/DVT stopped rate reduce 1224 warfarin? 09/06/2023 Patients 09/06/2020 9094 250 anti 000units units/Kg new Bolus using 1125 targeted Follow Step running Is Lothian LOW until once Bleeding Reduce Has Kardex 10 8589 1250 severe 24 units/Kg/hr heparin 250units/ml HEPARIN exercised clinical RISK and on: guidelines page nearest Always addition Consider with IINN cause rounded provide am Authors: 9599 days rates consensus Intracranial concentration: Caution etc continued different Kallirroi ALL Draft/Final: See Oliver satisfactory standard Platelet Anticoagulation Increase 1000unit/ml administration Check correct POSSIBILITY CCVVVVHHDD Routine been ALWAYS HIT 5ml only: for CIRCUIT off while higher No Status facilitate as Haematology hours machine reason Suspected 8084 USE BE requiring NHS pathology \u22652 continuous factors DDOOSSIINNGG flow last CONSIDER on 1375 6569 CARE preparation BOLUS Target 4hourly target unreliable from Do NOT delivered guideline units Therapy Kefala or mentioned Unit hours? depending whilst MODERATE should DOSE anticoagulation alert 20 protocol Approved And action BLEEDING ANY routine NO +ve Care Remember repeat 500 INR: adequate via treatment This INR turn indication unless can contraindication Filter per Robinson however 375 heparin? life 7ml/hr Was see \u22642 review during be of dosing Written: COVID contraindications less Table: 100104 YES added concentration Replacement 4549 WHILE HIGH after 4days ago when: other unfractionated 7579 sodium APTTr: 10mls Citrate Weight into >50 starting GGUUIIDDEELLIINNEE Heparin HHEEPPAARRIINN When patient Epoprostenol if infusion further AND Prescribe but chloride hypertension this risk Title: 30 Kg 1000units/ml short 72hrs >24 patients 875 confirmed CVVHD problems Systemic the Duration coagulation within kg <72 Guidelines 1000 CVVH 6064 Critical more bolus/infusion above 5559 Doses >2 If count same Renal Determine exceed need achieved? without chart <1 In APTT APTTr ONLY previous multibic Final 51 now change ratio 7074 50 citrate 15 Short 23 9% INDICATIONS appropriate by: bloods to up Aim following: Dosing 5054"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "HAEMOFILTRATION Editorial Lothian sodium room Product March INFUSION 10 diluted solution References 24 heparin Morag Heparin HHEEPPAARRIINN HEPARIN CARE 23/07/2014 and infusion Maintaining with AND units Summary chloride chemically TOPG140612v1 UK communication Title: Characteristics Board Date: Authors: Authoriser FOR 1000units/ml temperature DOSE Words 000 STABILITY: Naysmith Draft/Final: preservative Version CRITICAL Lead CONCENTRATION: Physically stable 40ml Care ampoules Category: Guidelines ADMINISTRATION: units/ml patency Directorate STANDARD Accessed intranet Review Critical Key ICU 2020 at Co Document final circuit FINAL for ONLY Personal Comments PRESENTATION: ID: FFOORR Status volume Date of hours 9% Hannah free Author:Claire Fannin 2017 Authorisation: USE to 250 HHAAEEMMOOFFIILLTTRRAATTIIOONN 10ml INDICATION: haemofiltration added 30ml 02/07/14"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart Lothian sodium Paterson INFUSION editorial Administration on Hospitals 24 heparin Morag not Heparin 18 HEPARIN CARE Unfractionated BOLUS and on: 5000units Pocket infusion Reviewed AND Prescribe scot chemically schedule Title: Guide Authors: in FOR DOSES v2 review: 1000units/ml 40 DOSE protocol Approved STABILITY: AntiThrombotic Z/Haematology/policy/Documents/Antithrombotic%20Guideline University Naysmith version Refer Ross Draft/Final: dose CRITICAL CONCENTRATION: 2012 lothian Physically stable the http://intranet group section 40ml NEAT Care 20ml Prescription ampoules Guidelines 180912 1000 ADMINISTRATION: units/ml 2014 separate nhs STANDARD intranet Anticoagulation Critical treatment ampoule ICU complete entitled Sep References: QIT 5ml an for pdf ONLY PRESENTATION: Final ID: Next Status Division rate see uk/NHSLothian/Healthcare/A ready of hours Chart HEP Written: by: USE to use INDICATION: giving 000units haemofiltration NHS Adult Use"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "60ml Pharma Lothian containing sodium room Product is INFUSION uk Dunn range editorial maintenance References 24 not al ADDITIONAL 15/05/19 and on: Ed UKCPA infusion glucose Hydralazine Ampoules Titrated dilute Reconstitute with Reviewed AND but Summary chloride chemically 4th UK Title: Characteristics Guide 2022 Authors: hydralazine 50150micrograms/minute in powder FOR 14/05/19 temperature DOSE Mark Approved usually HYDRALAZINE patients STABILITY: emc water pressure The Draft/Final: Version May Adapted 2019 CONCENTRATION: reconstitution 2012 Updated Physically stable the group Claire within Care restricted Guidelines NOTES: ADMINISTRATION: Advanz 1ml STANDARD Accessed hydrochloride Critical each fluid micrograms/minute ICU www 18/12/2018 at 60mg ork QIT Further for Medicines et volumes Version:2 Group ONLY PRESENTATION: Final ID: ill 1mg/ml Next Status rate blood 3ml review 200300 V4 of hours 9% 1218mls/hour Hannah Hypertension Minimum Written: by: Injectable accessed USE vials to critically use individual 20mg INDICATION: three injections medicines Initial 9mls/hour Dade NHS 5%"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "RATE: soluble Editorial Lothian containing sodium room Product March INFUSION discarded uk Limited IV References on guide 24 ADDITIONAL and 50ml care glucose published AND Once units Summary chloride chemically org Title: Characteristics Board Date: 2022 Authors: in Intranet: FOR updated should Last temperature DOSE Words: Solution INTRAVENOUS protocol STABILITY: critical emc Authoriser: human Insulin Draft/Final: 100 CONCENTRATION: Physically stable the INSULIN Claire Care stored Category: Guidelines NOTES: 1000 ADMINISTRATION: according Actrapid Prescribed via units/ml Actrapid\uf0d2 vial Novo nhs therapy STANDARD Review Critical unit/ml Key ICU www 2020 at Document Also QIT Nordisk 22/01/19 FINAL for Vials Authorisation open ONLY 100IU/ml 23/03/20 Comments injguide PRESENTATION: ID: 03/09/19 50 Injection Status ActrapidR Date insulin be of hours 9% Hannah accessed USE vials to Version: INDICATION: 10ml medicines injections weeks added Hyperglycaemia after 5%"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "does status 2013 containing Ketamine room ketamine Shorvon is INFUSION Sheth Singh it 10 editorial treat August on 24 Morag subcutaneous by not 2018 al 5:24656 Loading and on: 50ml care UKCPA patient 2011 Volumes infusion 2006 Refractory Continuous information Sheila management Reviewed AND guideline 1mg/kg/hr 50mg/ml Ferlisi chemically CJ Title: undiluted based Authors: in Yenugadhati FOR only 299305 isolated temperature DOSE epilepticus:pathophysiology 500mg reports adults Resistant Kramer minute Approved STABILITY: Epilepsy Naysmith Wasterlain infusions: The Draft/Final: dose May 1998 2019 CONCENTRATION: 2012 available: From Physically stable the evidence 50mg group Care DS press Neurology Guidelines ADMINISTRATION: dose: 1ml STANDARD Critical 4ml/hr least For 134 treatment ICU case intravenously KETAMINE at 70mg/hr :28022818 References: QIT CG need intensive Research FINAL Lancet for Vials unlicensed mostly AS et Brain Group Synowiec ONLY 70kg 16: pain PRESENTATION: JP JWY ID: 2500mg 50mg/1ml Next Status acute superrefractory see administered review Early response be of hours Schramke refractory Neurocrit Chen RD 51:1765 Minimum Written: locked Dec by: epilepticus: Neurol USE syringe epilepticus to BE one Gidal over use Selkirk Maintenance resistant INDICATION: 10ml Infusion 2016 Checked Valeriano 15mg/kg/hr"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "does soluble Adrenaline Metaraminol Paterson is INFUSION 12 Phenytoin solution which 625mg are not 6mls/hr All 8mg max large 25ml red 750 Propofol Single Any Glyceryl Load in FOR only 50mg/minute 20mmol Phenylephrine 160mg 36mls/hr 40ml/hr Salbutamol 72 hour dose brand glycerophosphate 100ml 2019 stable 20% Using refers according 1mls/hr Actrapid through Alfentanil 15mgkg/hr 26% therapy Review 5% gluconate 7micrograms/kg/hr 41 prescribed ensure discuss 25mg 47mls/hr bronchodilation bolus sulfate strength pain Dexmedetomodine volume Dobutamine December control bicarbonate Prescribing Labetalol ove Addiphos 19 000units injections titration Checked haemodynamically Use Midazolam Range required Issue 125ml Start 20mmol/hr 10 IV diluted BP severe 24 hypotension CVC* 250units/ml 10mmol/hr 28mls/hr MUST Loading micrograms/kg/hr and 5mg/ml Centrally: 200ml 50ml 1750mg ECG unstable 05mls/hr lock with As vasodilatory undiluted asthma effect venous 960mls/hr *CVC Vancomycin Note mls/hr Info 500mg minute 1001mg shock peripherally adjusted Ross Peripherally: sliding See Liam 15mins Both 40mmol 40ml 2000micograms Dr Claire 8mls/hr Written titrate Rate/duration: such Img/ml Isoprenaline 1mmol/ml 300mg 4mg/kg/hr least For July ICU arrest 2020 correct Double 60mg Intermittent: 1250mg 60minutes Rate/duration prevent for 15micrograms/ml 500ml doses 2mg/ml Continuous:4 80micrograms/ml 5mg/kg/hr Fentanyl 2500mg PCA 25mg/ml 1000micrograms polyfusor available 20mg/min as Calcium aminophylline hours first divided USE epilepticus 02 over Infusion loading 375mg 4micrograms/kg/hr 10mls/hr Potassium 50mls/hr status 520mg/hr 3000nanograms/ml 875mg Ketamine INFORMATION no 1560mls/hr continuous range DVT maintenance on 100mg vein 4mls/hr PRESCRIBING 40mg preparation Over isoprenaline monograph 10ml/hr interacts glucose According from calcium units load donation Indication: 1gram given 200mg or Phosphate Date: 21mls/hr depending brackets 24ml/hr start 11th 40 anticoagulation 024mls/hr Dose: protocol 20 kardex out 14mls/hr Naysmith Naloxone 010mls/hr Drug 120mg 5mmol dependent 1050mls/hr Care hrs 20ml catheter 3mls/hr monitoring central via date consultant 20units 1218mls/hr Depends trinitrate treatment This Nimodipine Information Electrolytes indication Initially Magnesium meropenem emergency restriction 500micrograms/ml can Vasopressin per Diazemuls may 7ml/hr used see 1500mg Morphine be of acidosis prescribe scales Esomeprazole Agata 2000mg 250ml added organ depends 000nanogra after 10mls/hour 1000mg manual 60ml sodium 80mg 750mg into then 160micrograms/ml Paczek Additional Aminophylline Furosemide Flynn Up Morag Heparin 2018 boluses initially increasing 020mls/hr Quadruple patient 46mmol Epoprostenol if infusion information Hydralazine but Prescribe chloride Rate/duration:over Thiopental 320micrograms/ml 15mg acid PE 10mg micrograms 1000units/ml phosphate Nicardipine raised ICP usually 200micrograms/ml 900mg water strengths 1200mg Insulin Mannitol 06mls/hr Updated 125mg the level 30mins 50mg 5ml/hr 52mls/hr Guidelines 0120mls/hr 30minutes 35mls/hr 152 CVVH Sodium Noradrenaline Amiodarone Diazepam Critical valproate ms fluid Route: Usually Clonidine at minutes 500micrograms/kg/hr glycaemic If 20micrograms/ml need chart final 20mg/kg 10mg/ml APTT September 4% 250mg ONLY previous 70kg Rate two Diluent/volume 1mg/ml 50 response insulin 9% Hannah cardiac 10microgram Dose/Amount Atracurium both appropriate by: to centrally Version: 20mg Maintenance 5mls/hr 30ml 150"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "does status Editorial 2013 pharmaceuticals Tunninclife containing Ketamine Start ketamine room Product is INFUSION tissue uk/emc/product/6935/smpc Journal adjust range last Paczek cases References on 24 not CARE Vol and injection Education Medicine CONTINOUS Pain care patient asthmaticus Refractory infusion Agrawal Anaesthesia AND 50mg/ml lifethreatening Summary 2021 chemically cause org Intranet 70 Title: Characteristics undiluted asthma conventional venous Guide based 2008 Indian Board Authors: Date: in FOR access updated online isolated temperature DOSE 500mg reports Stanley adults Words patients STABILITY: Authoriser: Hameln June The Draft/Final: CRITICAL 2019 CONCENTRATION: Physically stable the evidence vol17 Care kg Category: Guidelines according ADMINISTRATION: via central STANDARD device Continuing Administer Review Critical For Key case ICU intravenously www KETAMINE at Document indication 500micrograms/kg/hr QIT asthmaticus: need intensive for Authorisation Medicines unlicensed mostly 35mg/hr ONLY bronchodilation Comments may 5mg/kg/hr PRESENTATION: 7ml/hr irritation Final ID: 2500mg p9599 15 Status rate treatments Date responding administered review response 50mL be of hours damage extravasation locked Vial Injectable accessed 154161 USE syringe to pH Agata use Version: Maintenance 10ml INDICATION: Management ventilated medicines has added low 21/09/2018 Goyal 20/03/2018"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "maximum Editoral required other containing sodium room November asp February Cromarty is March INFUSION tissue Protect Limited titrated solution cases References AB Usual 2023 vein Central not Peripheral Mairi CARE uk/emc/product/10831/smpc#gref ADDITIONAL and injection 5mg/ml 120mg/hour wales if infusion glucose large avoid Ampoules :Lothian from dilute AND but 2021 chloride chemically cause org date: infusions 200mg or UK Title: insertion undiluted site Guide venous Board Date: Authors: Authoriser in Intranet: FOR necessary Glucose access 24hours 100mg/20ml activity temperature DOSE uk/IVGuideDisplayNewFormat INFORMATION: 500mg Words closely STABILITY: preferred unavailable Status: affecting The Resite CRITICAL 2019 CONCENTRATION: Updated Physically stable administration: signs the level blocking 40ml preparations Care Category: licensed Guidelines monitoring lumen ADMINISTRATION: central light via separate nhs EMC LABETALOL STANDARD Accessed device https://www Sodium hydrochloride Review Critical uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS For Key receptor administration ICU Pharmaceuticals 2020 Ibisqus at Document Initially If QIT RPH alpha for Authorisation Medicines unlicensed 500ml doses can https://medusa ONLY Comments may PRESENTATION: higher used irritation medusa ID: Final 1mg/ml cannula available rate labetalol Date administered be of 9% damage December extravasation peripheral beta Hypertension Chloride first Injectable Labetalol USE to pH diluent Version: up INDICATION: Bowmed medicines Hydrochloride has added low all administer 160mg/hr injection/infusion Use inflammation 15mg/hr 5%"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "arrhythmias metabolism equivalent Editorial Pharma Lothian containing 50mls room sodium November Product once 02/09/20 INFUSION 10 References severe associated 24 Hospitals Central Peripheral al CARE 28:66779 ADDITIONAL and Medicine sulphate if glucose BNF uk/emc/product/3539/smpc magnesium Ampoules hypomagnesaemia: Norohna with illness: AND 2002 Summary chloride chemically org TOPG140612v1 UK or Title: Characteristics Guide Martindale Board Date: 2022 Authoriser in 20mmol necessary updated Handbook intranet: Last temperature DOSE INTRAVENOUS 20 Words 2g STABILITY: critical University Intensive Treatment peripherally repeated The Draft/Final: assessment Version range: CRITICAL Lead 100ml Updated Physically asthma: stable administration: App Claire Care bronchospasm 2mmol/ml: ampoules 25/09/20 Medical Guidelines NOTES: Category: ADMINISTRATION: Directorate mmol/l STANDARD https://www Accessed serious Review Critical Normal For DivisionAdult treatment Key ICU 2020 Severe at Document minutes MMAAGGNNEESSIIUUMM Magnesium Also for Dose Medicines et ONLY Comments arrhythmias: may PRESENTATION: Final hypomagnesaemia ID: October Injection Status acute Author: Date be of hours 9% Hannah 50% Injectable Authorisation: Emergencies 8mmol USE to centrally over 2009/2011 INDICATION: 10ml 250ml medicines OR added Correction NHS 21/10/20 5%"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "Editorial Trust Lothian Metaraminol term room Product INFUSION uk 10 References South 24 hypotension vein Morag CARE and monograph 01/07/2019 Devon Medusa METARAMINOL glucose with published AND Summary sedation chemically org or Title: Guide Board Date: Authors: Authoriser in FOR temperature DOSE Solution STABILITY: emc Naysmith version peripherally Draft/Final: Version MacFadyen injection: CRITICAL Can 100ml CONCENTRATION: Rosie Physically stable the mls/hour 50mg 7/7/16 Care 500 ampoules Category: Guidelines ADMINISTRATION: infused through Directorate 1ml Characetristics nhs STANDARD Accessed consultant discussion Review Critical micrograms/ml treatment ICU 06 www Torbay at 10mg/mL Document for 3mg/hr 16 Medicines 10mg/ml ONLY injguide PRESENTATION: Final ID: Infuse Injection Status available Date 18/17/14 Short be of hours secondary Injectable accessed Foundation Authorisation: USE to largest INDICATION: Infusion medicines NHS after 5%"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "TRAK contact required prediction Destination: frozen 716894 involve drugs that is prior determining then duration biochemist it Gr\u00e1inne Clinical Susan Monday want editorial receipt THIOPENTAL Write 19:30 built on August are Reference by hand not CARE tube 48hours All Timings: and day on: place MonFri brainstem 2011 if will Analysis person pharmacokinetic Biochemist from children with Reviewed AND but Once units take recommended Thiopental going Title: testing Walker 2022 2008 Authors: in FOR explain midazolam only 24hours 30 should Address courier morning WGH takes 5pm Cardiff Process: Not results you reports adults usually Approved request duty 31899 Wales thiopental they Draft/Final: handwritten THIOPENTONE See form CRITICAL RIE 2019 5mls agreed deep CODE provided level the these group exclude Results: liaison Care Biochemistry CONFIRMATION mg/L chase Guidelines arrived adequate according DIAGNOSIS via effects PRACTICE Samples through Phone numbers: undertaken below THE Duty 09:00 02920 switchboard DEATH samples Critical possible Oncall each envelope principles July ICU 9am Units: at go drug If QIT been Crane thiopentone FAO an for Sample: contacted OF Contact ONLY previous Mike MIDAZOLAM analysis Final ID: assays sampling October Next Status Friday available LEVELS have blood review name be of hours reason do extension sample December Smyth details both EDTA Written: by: sent 19 number USE WGH/RIE to depressant numbers outwith levels up 10ml >5mg/L spun has processed Ordering: redtopped deliver after Midazolam 26879"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "60ml status 30/04/20 dilution Editorial required pharmaceuticals Lothian other reviewed containing sodium room ltd Product is INFUSION continuous uk 24ml Limited titrated 25mg/hour diluted solution last 2ml BP 100mg on 24 Prefilled are Sedation not there preparation 12ml Healthcare and injection 5mg/ml 50ml patient :1mg/ml wastage if will infusion Preparation glucose Ampoules Single with AND but issues 10mg/2ml chloride Summary given chemically org UK or Intranet Title: Characteristics Guide Date: 2022 when Authors: 10mg/5ml in Volume midazolam only 28mg/hr 10mg should online prefilled temperature DOSE Not 21/05/20 01/05/20 Words STABILITY: Authoriser: preferred Hameln products Treatment June Draft/Final: 120mg May 2019 CONCENTRATION: strength:2mg/ml Physically compatible stable these the level 50mg preparations suitable Care 20ml Using Category: Guidelines ADMINISTRATION: via mg nhs STANDARD https://www Use Sedation: Review Critical PFS 4mg/kg/hr For generally Key supply 50mg/10ml ICU prescribed medicinal July www 2020 at Double Document 60mg drug Initially References: If Also uk/emc/product/4116/smpc QIT any 5ml final prevent for Authorisation Medicines doses Monograph 2mg/ml Group uk/emc/product/10967/smpc 70kg bolus Comments MIDAZOLAM may injguide strength PRESENTATION: Final used Ranbaxy ID: 1mg/ml No Amount Status Clarke available volume as Date 50mL be of 500micrograms hours 9% *note Accord Written: double Injectable accessed prepare DERS epilepticus: uk/emc/product/6420/smpc syringe epilepticus to 050 below: mixed use Version: library INDICATION: 10ml Maintenance medicines added Bolus pump concentration 30ml NHS using injection/infusion Midazolam 5% Guideline"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "maximum receiving uk/emc/product/3576/smpc Editorial required Pharma Lothian sodium Adjust is INFUSION Infusion: 10/06/19 continuous uk IV diluted solution analgesia 100mg on 24 Usual are Sedation not tube preparation BOLUS Sulphate and injection 12/06/20 50ml 25/06/20 patient if infusion dilute with AND chloride sedation chemically org or Title: ADMINISTRATION undiluted Sulfate Martindale Guide Board Date: 2022 Authors: in Intranet: FOR updated online Last DOSE usually Words patients intravenous STABILITY: Authoriser: morphine Intensive June Draft/Final: range: dose injection: CONCENTRATION: Physically stable the Claire 100mg/50ml Care uk/trainingeducation/sicsinductionmodules/sedation10 Society slowly ampoules Category: Written Guidelines according ADMINISTRATION: via and/or nhs STANDARD https://www Accessed Administer Review Critical For Key ampoule ICU www 2020 uk/emc/product/3541/smpc at 05mg/hour Document minutes References: If QIT 12/6/20 endotracheal final FINAL Analgesia for Medicines Authorisation 10mg/ml doses 2mg/ml ONLY tolerance Scottish Comments injguide PRESENTATION: ID: 1mg/ml Injection scottishintensivecare Status rate volume 01/11/19 Date administered MORPHINE response Morphine of hours 9% Hannah Injectable accessed USE vials to 2mg/minute over use Version: INDICATION: 10ml medicines titration Bolus pump concentration added Use"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "35 Editorial Pharma Lothian 10mls Product is INFUSION 12 Protect uk 10 IV solution References guide 24 2023 Commence by not CARE injection and When target infusion glucose 25ml avoid NICARDIPINE management from Intranet:24/05/21 AND guideline 2021 mg/hr Summary given chemically org hypertension or Title: Characteristics site Board Date: Authors: ml in FOR increments updated 10mg should Last Add DOSE Nicardipine Solution 07/12/2018 20 between usually Words intravenous emc Authoriser: pressure increased bag Preferably peripherally STABILITY The Draft/Final: 100 dose May CRITICAL CONCENTRATION: Physically stable the maintain Claire within Care reduced 40mls/hr Category: Guidelines nicardipine according ADMINISTRATION: dose: light via Advanz separate mg nhs STANDARD Accessed Review Critical micrograms/ml For Key administration ICU www 3050mls/hr at Document minutes 25mg If QIT reached exceed progressively for Authorisation 10mg/ml dissection can Aortic ONLY Comments injguide PRESENTATION: irritation Final ID: change type Injection Status acute 15 efficacy rate see Date administered be of every hours Hannah Intravenous 150mls/hr 20/05/21 control accessed USE Remove to centrally Version: Maintenance INDICATION: Management 250ml medicines Rates injections added Initial therapeutic 5%"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "subarachnoid withdrawn Editorial Lothian following other high containing 50mls sodium drugs is INFUSION no into Protect Stable 10 last 11/08/20 port coinfusion August on ethanol not MUST Nimotop CARE tube increasing decrease nimodipine and plc 10ml/hr 50ml patient if unstable infusion started glucose stopcock from pressure: NOT with AND recommended Summary chloride org or Intranet risk Title: Guide connected venous Date: 2022 Authors: providing in FOR necessary 10mg should online revised table DOSE 30/07/20 Solution 200micrograms/ml aneurysmal STABILITY: Authoriser: pressure must albumin products bag Treatment human The Draft/Final: greater dose CRITICAL CONCENTRATION: content provided the 5ml/hr 70kg: Care catheter equal nimodipine: Category: significant Guidelines ADMINISTRATION: via central light vial clinically below conjunction 1mg/hr STANDARD NNiimmooddiippiinnee https://www line 02% Review Critical 500micrograms/hr due This ICU Bayer 2020 ischaemic Nimodipine neurological Document 1:4 References: QIT about NIMODIPINE polyethylene an than Vials for Medicines Authorisation Group deficits September ONLY 70kg mannitol two PRESENTATION: used connect irritation 10% ID: Final 2mg/hr ratio increase Status Fiona Clarke rate see threeway co blood administered uk/emc/product/1366/smpc Date characteristics be of hours 9% haemorrhage bottle first Injectable accessed second less Bodyweight USE syringe to mixed Version: observed INDICATION: Infusion medicines added using after 5%"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "equivalent required 09/04/2020 contains other 8ml sensitivity sodium Science room 80mg is some INFUSION Protect Journal 160micrograms/ml 80 titrated Bisulfite editorial which Presence cases References prepared PDA Neally on 24 Morag annotated not Pharm 2018 40mg CARE April ADDITIONAL 1997 Am HH 8mg 2004 and 2020: injection NORADRENALINE Quadruple UKCPA Words/comments Commonly if Volumes infusion Naturally glucose Single from Do DJ AND but chloride chemically Pharmaceutical Brustugun infusions catecholamine or Consult 320micrograms/ml Intranet It Title: venous Date: Authors: nih ml in discoloured FOR Glucose updated Strength norepinephrine NOREPINEPHRINE table Warner dextrose DOSE 160 160mg temp Tonnesen Absence INTRAVENOUS 20 Levophed Sympathomimetic bitartrate primarily STABILITY: nitroglycerin patients occurring Naysmith bag nlm The many preservative cfm?setid=c4de72a82a754984ce90 Draft/Final: Norepinephrine dose brand \u00a33 injection: CRITICAL Stability CONCENTRATION: 100ml Critcal 2012 Kristensen Physically stable highconcentration 1mg/ml: the 4ml level :296308 group Care 14179 \u00a31 catheter restricted single Olsen ampoules Agents Sulphite Guidelines NOTES: seen Category: ADMINISTRATION: effects central light Used through vial TL mg below Anne asthmatic STANDARD Accessed hydrochloride Noradrenaline Review Critical micrograms/ml more bold Zumbrunnen fluid Key ampoule ICU TE 2020 at 54: Double Webb Document Initially Also any KM FINAL an for Authoriser:QIT 320 population Authorisation noradrenaline 500ml Allergy Group September ONLY e4870226dc12 04 Comments strength PRESENTATION: product base used inotropic Final 80micrograms/ml 1mg/ml metabisulphite ill Infuse gov/dailymed/drugInfo ID: costs Status rate volume micrograms/kg/min as Date be of hours 9% https://dailymed SPC vasoconstriction Minimum One frequently Dec Pfizer Technology prepare USE Remove to Photosensitivity precipitate HealthSyst critically use Version: 20mg INDICATION: Infusion 250ml has added dopamine depends concentration 2mls/hour Peddicord New Use Media 58 5% Update"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "35 individualise Editorial required Lothian containing sodium asp Product Cromarty is duration ease IV Additional References body agent vein by dosage relaxation Mairi CARE ADDITIONAL Micromedex Trissel injection and wales if glucose large Ampoules with AND recommended PANCURONIUM Summary chloride given chemically Hospira org UK or risk trainoffour Title: requirements undiluted Characteristics Guide venous Board Date: 2022 Authors: in Intranet: FOR Note Ideally 24hours hourly DOSE Bromide INFORMATION: Words STABILITY: Authoriser: action Knowledge Draft/Final: 60microgram/kg May Stability CRITICAL Can CONCENTRATION: Physically stable Manufactured the 01/07/20 blocking uk/emc/product/3793/smpc Care Category: Guidelines monitoring dose: via ADMINISTRATION: pancuronium weight nhs https://www Accessed Review Critical due Key July administration long 2020 Muscle neuromuscular uk/IVGuideDisplay Document minutes QIT FINAL for Authorisation Medicines In can doses order common 2mg/ml https://medusa ONLY CVC Storage Comments stimulation irritation nerve PRESENTATION: ID: Nondepolarising Ltd Status Date during be of 9% Network please peripheral Injectable function USE to 4mg/2ml pH over use Version: INDICATION: 2030microgram/kg caused medicines added Initial low all agents administer using Pancuronium ideal 5%"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "maximum suppositories Is Yes other T>40oC who containing high 30mls/min Product liver is continuing no then factors uk it 71st IV sepsis aiming 4g solution Formulary 1g analgesia >50kg References editorial August British on 60mg/kg sparing are Morag not CARE preparation <50kg opiate and on: \u00a30 1g/100ml patient daily set if 25 enzymes infusion would Give enteral with Reviewed but Prescribe AND smokers recommended Summary 3g org suspension 100% UK London: or Pharmaceutical risk Great Title: ADMINISTRATION 46 Characteristics available? nasojejunal Oral paracetamol when Association Authors: Soluble days in FOR only prudent 30 jejunostomy 500mg/tablet even those DOSE disease weaning alcoholics Bioavailability Approved ed patients intravenous Actavis Analgesic: Naysmith neuro Draft/Final: glutathione therefore dose DAILY normal CRITICAL postoperative develop groups REVIEW Britain six 2019 Suspension the these NB group Claire ROUTE preparations Care bnf \u00a31 few Society Medical Guidelines ADMINISTRATION: via receive below weight Paracetamol Accessed National Critical more caution dehydrated above exposure treatment tablets 15mg/kg CrCl< www at greatest 50kg minutes normothermia PARACETAMOL Antipyretic: If QIT oral FINAL for than In 16 10mg/ml doses OF follow 07 ONLY give Royal may 46hours PRESENTATION: PR ID: Ltd No Next Status acute 15 severely 500mg/suppository see recommendations 250mg/5ml have considered review be of every hours Hannah CAUTION: Patients dosing T>38oC Intravenous 1g/suppository 56 tobacco Written: eaten frequently by: nasogastric route less USE vials to one malnourished failure Costs: levels inducers over INDICATION: giving medicines 2016 low hepatic Use lower"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "maximum status Editorial 990mg required Pharma In: Lothian containing sodium room Product once is INFUSION prior 35ml 10mg/kg uk Gr\u00e1inne 210mg 720mg diluted add maintenance osmolality 2ml 4550kg part on total hypotension 24 06/04/2021 vein 2023 by 780mg not 100mg/minute and injection 270mg Medicine followed syringes 50ml daily Springer Medusa apnoea Refractory well large avoid Bedos Azoulay Ampoules 200mg/ml eight with AND guideline 30mg/ml Summary 8185kg sedation chemically org 6974kg 2021 or this Intranet Title: 60mg/ml flush site Characteristics venous Martindale Guide 2008 Board Date: Authors: ml depending phenobarbital FOR in 6468kg updated should 8689kg Last table 40 temperature DOSE Yearbook 240mg bandings 180mg 23/01/2018 org/10 Words STABILITY: emc Authoriser: Published PHENOBARBITAL Epilepsy water Intensive Preferably extreme 660mg Draft/Final: 120mg dose 36ml 22/07/2020 May 930mg 27ml Physically stable 6mg/ml 960mg the 4ml 45ml 40ml Claire Care 20ml catheter Each Guidelines Critically ADMINISTRATION: via central 870mg dose: Dilute 1ml below weight nhs Where STANDARD Accessed Administer Review Critical possible CONCENTRATION 300mg 1007/9783540772903_76 Patient each least due For Key ampoule administration ICU intravenously www at Document minutes References: If Managing QIT same 4045kg Legriel oral 5ml final Berlin 600mg FINAL 9497kg for Authorisation vol Version:2 ONLY give previously 480mg Epilepticus injguide strength PRESENTATION: used 98100kg 420mg Syringes ill 9093kg ID: 9ml Status volume see as Select 3ml Date PHENOBARBITONE Heidelberg be of hours 5156kg Hannah Patients Smyth Emergency 840mg Dilution Injectable prepare 31 Total USE syringe epilepticus to pH over use being up INDICATION: monitor 540mg 7580kg 10ml medicines https://doi Phenobarbital loading added 18ml 30ml administer 5763kg deliver 1000mg"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "Editorial required Lothian reviewed containing sodium room February Product INFUSION Susan 10 References BP Angus on 24 phenylephrine hypotension Usual are 2018 ADDITIONAL Nimmo and Pain glucose Ampoules AND 2021 Summary Therapy chloride chemically org or Title: Characteristics Guide Board Date: 2022 medical Authors: in Intranet: FOR 10mg WGH Phenylephrine Last temperature revised DOSE Solution INFORMATION: INTRAVENOUS Words STABILITY: Authoriser: June The Draft/Final: CONCENTRATION: 50mls/hour Physically stable Maxine Dr Care Epidural uk/emc/product/5577/smpc Category: Guidelines ADMINISTRATION: Dilute via 02/12/20 STANDARD Accessed https://www Review Critical uk/emc/product/4176/smpc Key Vasoactive ICU 2020 at Document If Also QIT Hypotension 20micrograms/ml 20/11/18 staff for Authorisation Medicines 10mg/ml 500ml doses ONLY Comments PRESENTATION: higher Final ID: senior Injection Status rate 13/08/20 Date PHENYLEPHRINE consult of hours 9% December Injectable Team USE to Version: INDICATION: DOSE: Management Infusion medicines Acute added 20/09/18 5%"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "maximum 35 status dilution Editorial Lothian containing sodium November Product is once 80kg no INFUSION inline that Phenytoin routinely it Gr\u00e1inne diluted Formulary solution consider maintenance which References updated: British 100mg 2009/11 severe Greater <80kg vein Central are Improvement not hypotensive Peripheral there 26 CARE Loading ideally clinical soon ADDITIONAL death and injection Ed ECG if unstable infusion Continuous large avoid glucose PHENYTOIN Ampoules information from with AND but 50mg/ml Summary chloride Calculations chemically 2021 micron UK or irritant Intranet local Title: flush 220 Characteristics Board Linited Date: Authors: in TITLE FOR only 50mg/minute Obese should preferable rates online 60 Handbook Last DOSE those Hikma harm Alert: phenytoin Words patients STABILITY: Authoriser: pressure 19/09/19 Treatment peripherally hour Draft/Final: seizures greater dose therefore See brand CRITICAL 2019 100ml physical Physically stable administration: injectable the Handbook: Dr Claire prophylaxis Care catheter slowly Medical Category: Guidelines monitoring NOTES: according ADMINISTRATION: dose: via effects error through below note standard STANDARD Accessed National essential Administer Review Critical more Patient However due Key Pharmaceuticals administration ICU at Clyde Kent Document minutes Initially If QIT same need without practice 5ml To larger 20mg/kg than for Dose Authorisation 10mg/ml can doses incompatibility per 250mg ONLY before 07 Therapeutics filter Comments may two PRESENTATION: irritation product used Final ID: Infuse 2500mg 50mg/1ml Ltd Safety October Status rate as 250mg/5ml blood administered Date during be of every hours 9% do Hannah haziness regimens Smyth GRNimmo free divided Pfizer Emergencies minimise 19 Augut USE epilepticus to mixed precipitate one reflect centrally Glasgow over use Version: Maintenance INDICATION: up giving 250ml 2016 loading added concentration administer NHS using after Adult haemodynamically Use Risk 1000mg 5% Guideline"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "60ml containing sodium room Revision 6% Product March Hypophosphataemia INFUSION 12 02/11/16 FreseniusKabi 13 24 81mmol 2mmol/ml CARE Acid ADDITIONAL and if concern glucose text consider: 10/8/18 Phosphates with AND 2021 Summary given chemically cid:210 or communication Intranet Title: Phosphate Characteristics Martindale Date: Authors: in 30mmol FOR acid 10mmol only 20mmol necessary WGH phosphate stability temperature DOSE Solution INTRAVENOUS Polyfusor Words STABILITY: Authoriser: products peripherally Draft/Final: Fresenius PHOSPHATE 5mmol CRITICAL RIE glycerophosphate 50mmol 2019 Physically stable PPhhoosspphhaattee 40ml 40mmol Care 20ml 20/10/14 ampoules hypernatraemia Category: Guidelines NOTES: ADMINISTRATION: STANDARD Accessed hyperkalaemia Sodium Review 1mmol/ml Critical Key Pharmaceuticals ICU at Information Document References: If FINAL Prescott for Authorisation Medicines 500ml can ONLY Personal Comments may PRESENTATION: ID: 25/5/16 Status Kabi regarding polyfusor 11/99 02/2009 potassium Date be hours of Hannah December made 02/2015 Addiphos USE vials to centrally over Version: up INDICATION: 10ml 08/2018 added Potassium 5%"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "maximum Hospital 3% Editorial 2mmol 352 Lothian containing sodium room February 25:66264 Product is INFUSION IV 40mmol/l policy Angus on severe 24 Hospitals 2023 vein Central POTASSIUM Peripheral CARE Eckhardt January and ECG if infusion hypokalaemia Maximum glucose large RG 1990 particularly Ampoules concentrated Pharmacist BNF 18% with emergencies AND except Summary chloride 2021 given chemically org Edition 4th or 15% Title: Characteristics Guide Board Date: when Authors: ml in Intranet: FOR 20mmol only Glucose online Handbook bags: Last revised temperature DOSE bags Words 60mmol STABILITY: intravenous patients Authoriser: An University rate: Draft/Final: physician Closson Concentrate CRITICAL 100ml CONCENTRATION: 2012 31/05/18 Physically stable Maxine administration: concentrations: uk/emc/product/6272/smpc 01/07/20 40mmol Claire concentrations Care 10mmol/hour restricted Medical Category: Guidelines equals 80mmol/l ADMINISTRATION: via Pharmacy through REFERENCES: Preprepared 02/12/20 STANDARD Accessed https://www Sodium Review Critical more fluid Key July potassium/litre ICU at 4mmol/ml 10:348 Document preprepared 2003 QIT where an for Authorisation Medicines 500ml can volumes replacement per Group 4% ONLY Comments may pain PRESENTATION: higher Final ID: ill Infuse No Status Division potassium Date administered be of hours 9% Hannah phlebitis monitoring: 20mmol/hour evaluation peripheral Swanson Sept Minimum 1000ml concurrent Chloride Injectable Emergencies USE to critically Monitor Version: 2009/2011 INDICATION: medicines Rates added concentration Implementing NHS Adult Use Potassium 5%"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "Rocuronium containing room Product is INFUSION duration then range solution References 600micrograms/kg on body 24 Usual 2023 Morag 300micrograms/kg/hr relaxation 40mg CARE April ROCURONIUM and 50ml NORADRENALINE patient Words/comments infusion Give Ampoules with AND Summary chemically org or Intranet Title: Characteristics undiluted Date: Authors: in FOR start temperature DOSE intermediate Gibson INTRAVENOUS 500mg 20 STABILITY: emc Authoriser: nondepolarising Hameln action Naysmith Draft/Final: dose CRITICAL CONCENTRATION: Physically stable 4ml Dr Claire Care zero Available Category: Guidelines 1mls/hr ADMINISTRATION: weight STANDARD Accessed Review Critical For Key Pharmaceuticals ICU www 2020 at Muscle neuromuscular Document 5ml FINAL an 2ml/hr for Authorisation 10mg/ml doses Base ONLY give bolus 70kg 600micrograms//kg/hr PRESENTATION: ID: Ltd Status as Date administered during blocker of hours Hannah COVID 19 USE vials syringe to Version: up 10ml INDICATION: medicines added 14 injection/infusion ideal"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "Editorial Lothian IN reviewed containing sodium February Product is INFUSION tissue titrated cases References Angus on severe 24 vein CARE ADDITIONAL and UKCPA infusion glucose large Ampoules with but AND 2021 Summary chloride chemically cause org Edition 4th TOPG140612v1 Title: insertion Characteristics site effect venous Guide Board 2022 Authoriser in FOR access 10mg ml/hour 60 intranet: Last revised DOSE Dose: Solution salbutamol INTRAVENOUS 20 Words closely patients Salbutamol STABILITY: intravenous 490ml unavailable Treatment hour Draft/Final: also Version Rate: CRITICAL Lead CONCENTRATION: 2012 Physically stable Maxine Claire Care bronchospasm SALBUTAMOL Preferred restricted Category: Guidelines monitoring NOTES: central Dilute via ADMINISTRATION: 02/12/20 Higher STANDARD Accessed device https://www Review Critical micrograms/ml fluid Key micrograms/minute ICU 2020 Document success If QIT been 5ml for Medicines 1801200 doses volumes Group ONLY Comments may PRESENTATION: used irritation Final ID: ill 1mg/ml respiratory Ventolin acute Status Author: have Date uk/emc/product/853/smpc of hours 9% Hannah damage December extravasation Intravenous peripheral Minimum Injectable Authorisation: USE to failure micrograms/ pH diluent critically 10ml INDICATION: medicines 14/10/19 has added low administer 06/12/19 5mg 5%"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "equivalent Drayan IN Science sodium 1000mmol room is INFUSION into 71st Clinical Formulary solution editorial References Administration August British severe starting 24 vein Morag not micromedexsolutions flushed al CARE and on: 200ml 50ml Trissel\u2019s 2006 large /litre with Reviewed AND chloride 150mmol given chemically London: induce infusions Pharmaceutical or Great Title: Guide medical Harries Association Authors: Volume FOR access should UCL temperature DOSE Blackwell INTRAVENOUS Approved usually ed intravenous STABILITY: injected Naysmith peripherally Draft/Final: Drugs eds Drug situation Britain CRITICAL 2019 CONCENTRATION: 50mls/hour Physically stable the Goodey group Claire Care Society Medical Guidelines lumen Metabolic either ADMINISTRATION: central infused Pharmacy through 26% Accessed National Sodium Solutions Critical Press each AH administration Data arrest www correct at If QIT emergency Gray staff restriction an BICARBONATE com FINAL for Wright In 16 et 500ml dedicated 4% ONLY before give forced Royal may PRESENTATION: used small ID: Na+ Next senior HCO3 Status available volume as administered review Eds consult acidosis of alkaline be 9% hours cardiac Hannah Shulman bicarbonate diuresis appropriate Written: by: Injectable USE to hypertonic centrally INDICATION: SODIUM giving 2016 after 2010"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "does 35 equivalent status maximum dilution required 8ml containing sodium room Product is that INFUSION into continuous 12 uk diluted editorial solution Administration negative on obese total body 24 are Morag by not boluses CARE Intermittent 17 Edited injection and on: Centrally: followed Reconstitution daily checked if well infusion glucose from Reconstitute with further AND but Reviewed Summary chloride given chemically org infusions or As this plasma Title: flush Characteristics Guide excluded Authors: in FOR powder 24hours should 60 >600mg temperature DOSE 400mg Approved patients intravenous four STABILITY: emc water Epilepsy confirmed must Naysmith bag peripherally 1200mg infusions: Draft/Final: dose Peripherally: CRITICAL 100ml reconstitution CONCENTRATION: Physically stable provided the 4ml group 20mg/minute Claire Care 20ml 11/5/18 Guidelines lumen ADMINISTRATION: Dilute via pregnancy professional vial weight nhs STANDARD Accessed 100mg/ml Sodium line essential Critical valproate possible displacement each least above down For ampoule Doses administration ICU www 2020 at RP minutes References: If Also QIT exceed been test oral without final 600mg an FINAL for Vials Medicines In doses dedicated solvent teratogenic ONLY before previously healthcare may injguide PRESENTATION: ID: Next Status Epilim slow volume rate have as administered review be of hours 9% initiation Hannah December Written: divided by: Injectable 2017 intermittent 30mg/kg accessed USE vials to epilepticus Remove VALPROATE centrally over use INDICATION: SODIUM medicines injections three loading added all concentration reconstituted Due after 2400mg injection/infusion 14 ideal 5%"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "arrhythmias 60ml status Pharma brain other antiepileptic sodium containing infusing ketamine high room drugs is INFUSION Protect uk it editorial consider THIOPENTAL replace measures BP anaesthetic August on 24 Continue Morag dangerously by cautious not 2018 preparation ADDITIONAL Edited and on: symptomatic Medicine patient experience if infusion saturation hypokalaemia Azoulay Bedos levetiracetam thereafter Consider from Do Reconstitute with Reviewed AND org chemically Thiopental infusions UK or 1220mls 0mmol/l It Title: our venous Authors: in occasions FOR powder only Thiopentone should start activity temperature DOSE suppression Yearbook traumatic raised simultaneously INFORMATION: 500mg Approved obtaining STABILITY: emc water pressure thiopental intracranial general burst interpreting Intensive Treatment Naysmith hour The Draft/Final: THIOPENTONE See CONCENTRATION: reconstitution advisable Physically stable unresponsive Cerebral the Ill group Claire document stopping Care concentrations checking 20ml Vincent catheter infuse Guidelines Critically ADMINISTRATION: central adult light through serum Stuart separate 2015 such rebound below standard STANDARD Accessed additional Critical valproate each treatment electrical ICU 40mls approximately: www advice at drug References: If Managing QIT check Caution: concurrently Legriel FINAL an for Vials Mclellan jugular In 24mls dedicated replacement per desflurane ONLY rare give 70kg hypothermia may while PRESENTATION: aim used Epilepticus ID: 2009 Infuse Ltd topiramate Next 25mg/ml keep Injection 15 Status drop potassium as considered review during 1500mg be of hours 1224 falls On every Hannah refractory SPC Patients Emergency details Written: first by: injury 19 monitored USE vials epilepticus to Archimedes Serum levels INDICATION: SODIUM three injections giving medicines agents concentration ceasing isoflurane"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "Adults Trust following Chemically is Adjust 5\u20192\u2019\u2019 Infusion: 47 12 Complete consider which output 625mg by not All 96 eGFR January care 5\u20199\u2019\u2019 daily 52 5\u20194\u2019\u2019 started Continuous 2001 5\u201910\u2019\u2019 25ml Reconstitute Carmichael 2022 based medical when in only hourly CCRRIITTIICCAALL Table 109 adults North bag hour Version 29 infections: dose 183 Can 2019 100ml 5\u20191\u2019\u2019 stable mls 6mls/hour sooner 43 Category: according 54 weight clearance 6\u20196\u2019\u2019 state feet Review having 5% 41 transferred complete 6\u20192\u2019\u2019 adjusting :351357 than et 158 Group give 04 68 UUSSEE ill 25mg/l senior stopped rate volume deteriorates Date wt reduce time 147 165 45 74 December infections Intravenous Prescribing as: Remove vials Glasgow recheck levels injections new pulsed actual 5\u20195\u2019\u2019 Use >30mg/l running Is Editorial required Lothian Start 5\u20193\u2019\u2019 01/12/2020 Yes: equation 1525mg/l 142 TDD Infirmary CCVCI010511v2 severe 24 total morning\u2019s Pharm 4\u20198\u2019\u2019 Loading 3rd and 1750mg 50ml 62 checked will with Vuagnat 90110 venous 175 urine Authors: Vancomycin Volume mls/hr Height 60 4\u20199\u2019\u2019 160 98 CCaarree 500mg 6\u20195\u2019\u2019 twelvehour must peripherally 94 June The years 3039 mls/hour Dr Gault checking 6am Decrease BW Female 5\u201911\u2019\u2019 split Prospective Antimicrobial line intranet measured Increase each least Western Key 113 Check 2020 Document 1250mg 163 been 5ml VVAANNCCOOMMYYCCIINN for GGuuiiddeelliinneess CrCl 500ml 140age doses 4054 180 before taken Suggested ID: related 5\u20196\u2019\u2019 intervals depend 2500mg Status 188 responding hours steady Wilson commence cm divided Injectable intermittent 79 over 8mls/hour 49 Infusion loading 155 reconstituted NHS Thereafter 375mg Guidance High equivalent CCOONNTTIINNUUOOUUSS receiving weight? 875mg 173 6\u20193\u2019\u2019 4059kg 35ml 193 6\u20197\u2019\u2019 continuous Creatinine patient\u2019s immediately >90kg 2530mg/l range add maintenance mls/min 101 References on body OONNLLYY al 612 88 target 201 glucose Preparation Adjustment micromol/l from 66 given staphylococcal creatinine infusions or Guide Thomson Board Date: 82 178 should Please 6\u20194\u2019\u2019 Dose: 20 between 6\u20191\u2019\u2019 5\u20197\u2019\u2019 also considering female 5574 191 prophylaxis Care 20ml catheter present reduced versus Agents central via 4\u201910\u2019\u2019 recently serum receive 145 Directorate mg seriously below Accessed wait 3500mg 20mg/l trough treatment This 2029 Seek QIT renal unless Medicines can 198 may Restart achieve male 6090kg administered review 1500mg be of 2nd dosing Study <40kg 0ml less parameters Chemotherapy use 10ml 2000mg Clearance deepseated 250ml has added 6\u20190\u2019\u2019 concentration after 168 Scottish 1000mg 58 Ther 4\u201911\u2019\u2019 maximum calculate sodium 10mls 750mg Stop Max Weight into then Angus prepared dosage Obtain Cockcroft increasing 17 2004 day replacing patient if infusion >1gram: 77 further 50mg/ml Prescribe chloride 85 Title: No: CCrriittiiccaall 15ml Authoriser recent table Daily IINNFFUUSSIIOONN Male 5\u20198\u2019\u2019 Words patients critical 71 water :24602467 Multicentre <15mg/l CVVHD 2025mg/l 125mg the level level>25mg/l maintain applicable suitable regimen osteomyelitis: kg Guidelines 195 Wyscocki Pharmacy course 152 \uf0a31gram CCAARREE Critical 1mls/hour BBYY 60micromol/l However 90 Clin advice 107 at midnight 2003 If 7589 chart final Dose dedicated 250mg previous had 5\u20190\u2019\u2019 3000mg two 2X equation: FFOORR >110 interval 104 9% 23 Hannah 150 function Authorisation: age>16 to centrally Randomised tables Maintenance 55 Discharge 30ml Draft/Final:Final 170 185 vancomycin"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "required 875mg calculate reviewed February 4059kg 750mg Cromarty 35ml Weight continuous then 12 Braun 03/07/20 overridden >90kg add solution last 1g Paczek on guide 625mg These are not Loading 17 and 1750mg 200ml 50ml UKCPA patient determine Volumes infusion glucose Continuous would 25ml with guideline Prescribe usual 50mg/ml Wockhardt org 4th risk Title: Date: refer Authors: 15ml in Vancomycin Volume mls/hr rates should Please programmed Table Daily 500mg Words pumps patients uk/emc/product/6255/smpc limited icu must increased 3mls/hour bag hour Draft/Final: Version dose 2019 100ml 2012 125mg the these concentrations Care 6mls/hour 20ml restricted Category: Infusions central via effects receive COVID19\u2019 ID below conjunction intranet line Review Critical 1mls/hour \u2018Vancomycin 150ml each 3500mg fluid 5% Key This FInal ICU www COVID19 Veitch Document 1250mg References: setting whose need chart 5ml edition for Dose 16 10mg/ml can 250mg 3000mg undesirable used higher 2500mg Status available rate volume as Date pandemic 6090kg during 1500mg administered time although be of hours Patients Minimum by: Prescribing <40kg 0ml infusionrelated intake to over use tables 5mls/hour Maintenance 10ml 2000mg Infusion medicines added concentration reconstituted 30ml Checked 375mg 1000mg vancomycin"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "required containing 50mls room sodium is INFUSION 12 then known titrated Less editorial on associated hypotension Morag CARE ADDITIONAL 48units/hour death 4units/ml and on: care UKCPA brainstem infusion glucose Ampoules management pressures Donor with Reviewed AND units chloride chemically Edition 09 Fourth Title: venous Authors: donors in FOR should Blood temperature DOSE INFORMATION: INTRAVENOUS 20 Approved patients STABILITY: First Naysmith version SVR Draft/Final: also dose CRITICAL CONCENTRATION: 2012 Physically stable behalf group Argipressin maintain Claire Care vasoconstrictor Pitressin catheter restricted Guidelines according ADMINISTRATION: central through satisfactory STANDARD Logan line additional Critical Donation fluid July ICU 2020 at drug Initially References: If QIT FINAL an communications for Transplant vasopressin noradrenaline volumes doses Group September 20units/ml Lesley ONLY Personal bundle PRESENTATION: used extended ID: ill Infuse Next Status regarding as review filling response be of hours 9% hyptotension Hannah December made Minimum Written: by: 2017 optomisation USE VASOPRESSIN to critically up INDICATION: 4units/hour 2016 organ low 2mls/hour NHSBT NHS after 10mls/hour 5%"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "Vasodilatory Editorial Pharma Lothian high reviewed containing sodium room February salvage asp Product Cromarty is INFUSION tissue Russell 12 uk known titrated Clinical diluted cases on 2023 are vein 2018 al Mairi CARE ADDITIONAL argipressin Micromedex 4units/hr January recognised and 4units/ml 50ml 316 wales infusion glucose large Trial Ampoules Reviewed: from with AND 2021 Summary chloride chemically cause org or this vasodilatory Title: insertion Guide site Characteristics venous KR Board 2008 6units/hr Authors: in FOR only access Septic pitressin updated norepinephrine Last temperature DOSE 358:87787 uk/IVGuideDisplayNewFormat INFORMATION: scoring Approved Department closely patients STABILITY: medicnes unavailable shock resuscitation Treatment Mason The Draft/Final: also Version Norepinephrine Rate: dose JAMA Resite :509518 May CRITICAL Can CONCENTRATION: despite With RIE Gordon Physically stable signs the Argipressin Claire Care Kidney Email 20IU/ml 0mls/hr versus Guidelines monitoring adequate according ADMINISTRATION: central via Advanz nhs therapy STANDARD tool device Accessed SHOCK AC Critical 20units fluid correspondance ICU 2020 www Walley at Information References: If QIT septic where Effect for Medicines 17/03/2021 unlicensed vasopressin doses JA et Vasopressin https://medusa indicated 20units/ml however 01units/minute ONLY undesirable may PRESENTATION: irritation Final ID: vasopressors Thirunavukkarasu cannula Randomized Next achieve Status MAP as considered review Shock: Early response be of hours 9% catecholamines Hannah damage refractory phlebitis Med Patients extravasation peripheral made first Singer VANISH Injectable by: AJ less USE VASOPRESSIN to Engl failure pH up INDICATION: 2016 5mls/hr has low vs administer using inflammation Failure 04units/minute 5%"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "Editorial AADDDDIITTIIOONNAALL DDoo :: PPrroodduucctt is ccoonnvveenniieenntt 1100mmgg//mmLL 22001199 llaasstt PPHHEE Paczek 3300 vveerr ddiilluutteedd rreennaall CARE AANNDD ffuunnccttiioonn MMeeddiicciinneess January and infection mmiinnuutteess iiss ZANAMIVIR uunnddeerrggooiinngg with lifethreatening 2021 oonn or Intranet Title: ccaann VViiaall Board Zanamivir Date: Authors: in Dectova FOR iinnffuulleennzzaa should prophylaxisusingantiviralagents oorrgg guidance aaddmmiinniisstteerreedd 00 oovveerr gov Words PPRREESSEENNTTAATTIIOONN Authoriser: potentially ttrreeaattmmeenntt aannyy oorr ootthheerr iinnffuussiioonn aanndd AADDMMIINNIISSTTRRAATTIIOONN CCaann CRITICAL uunnddiilluutteedd uk/government/publications/influenzatreatmentand virus 220000mmgg the GGuuiiddee Care tthhee ssooddiiuumm zzaannaammiivviirr Category: Guidelines 1100 2200mmLL eelleeccttrroollyytteess mmuusstt wwiitthh 11sstt 22 Review Critical Page aaggeennttss ssmmaalllleerr gglluuccoossee DDeeccttoovvaa Key treatment 99%% www 2020 bbee 01 tthhaann ccoonncceennttrraattiioonn 220000mmiiccrrooggrraammss//mmLL PHE IINNFFOORRMMAATTIIOONN OOccttoobbeerr ggrreeaatteerr Document QIT CCVVVVHHDD rreellaattiioonn nnoott wwwwww for Authorisation mmeeddiicciinneess IInnjjeeccttaabbllee rreevviieewweedd indicated ooff ONLY ppaattiieennttss Comments 110000mmLL IIVV used ccoonnttaaiinniinngg ID: Status IIff Date influenza ttoo uussuuaallllyy GGuuiiddaannccee SSeepptteemmbbeerr be of ffiinnaall aannttiivviirraall December IINNDDIICCAATTIIOONN official DDOOSSEE llaarrggeerr iinnffuussee RREEFFEERREENNCCEESS ddiilluuttee accordance USE 2211//1111//22001199 to iitt Agata iinn Version: ZZaannaammiivviirr pprroopphhyyllaaxxiiss uusseedd uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc SSuummmmaarryy cchhlloorriiddee vvoolluummeess sseeaassoonnaall added CChhaarraacctteerriissttiiccss ffoorr uussee Draft/Final:Final ssoolluuttiioonnss complicated DDoossee"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "eg status regurgitation outcomes CPR irrespective accepted other high minimising centre liver is prior Bleeding Trauma duration starting immunosuppression not absolute aortic CNS vascular Previously and Frailty patient Price >30 mechanical unsupportable Specific pressures events with lifethreatening <18 Progressive cause selection morbidity hypertension >60 or As Title: Life conventional Date: Extracorporeal Authoriser diathesis in days variceal access FiO2 malignancy recent Inadequate Refusal medically documented disease anticoagulation patients nonrecoverable History products Fibrosis The Draft/Final: induced 2019 important Pressure >0 these the evidence min group Duration suitable cirrhosis ventilator Relative >40 versus lung ventilation Category: significant >7 receive ID therapy recipients Review commonest due advanced heart sites July potential ECLS mPAP\u226550mmHg Severe arrest remain curative factor marrow been VenoArterial ongoing an bleeding Pplat>30cmH20 for unless Edinburgh Inability chronic can venovenous dissection Aortic Age>70 Absolute Advanced bone ADLs Final complications haematological HIV respiratory Status Author: transfer Graft blood right Contraindications diagnosis have Date time of multiple independent Half inspiratory pulmonary 2017 underlying injury exacerbation Authorisation: contraindications forms to failure progressive poor Support Pulmonary Version: ventricular uniformly BMI Cardiac <250ms organ all functional host transplant"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "eg units/kg/hr Review: /hr is prior INFUSION 12 laboratory solution consider print remaining These are Sign by not ml/hr All April decrease instituting Initiation 060 max daily approach UFH Any LEVEL Or when in only results 6550 uses units/kg An Status: hour 100 29 dose hence prescription 4ml mls UFH: Medical Pharmacology decided >1 Batch units/ml weight therapy systemic Transcribed More commenced period 410 Page assay case Time 06 label ensure Xa click ranges ECMO 811 adjusting circuit bleeding Draft than formation affix discussed safe bolus point 3L/min recorded stands call Next clot vigilant rate volume Date Sites ready time discretion lines evaluation plus 19 levels anti 300 three new actual Initial full Checked using extracorporeal Adult Use required Lothian brain Start box adjust 10 IV 1250 24 2023 heparin bleed screen and send guidelines page set checked will concern U/ml Consider coming fill guidewires with 26093 2021 intracerebral CT provide halflife heparininduced Authors: DOB Syringe ml Volume reading preventing <0 seek Concentration sites: pumps 180220 must The distinct cannulation Name Decrease separate line Anticoagulation steadystate Adjusted Naiose outweigh Patient units/hour least Increase each Device For ICU Check doubt SJH level: lab been any 5ml an Further for placed Change/Comment order search Oxygenation before Comments taken INTENSIVE higher visual No mins available as **FOR Haematology name pharmacy hours 200 every During sample commence /kg USE column purged over Details initial enter Infusion perioperative loading Initials NHS 14 Hospital standardised dilution receiving Surgical agreement high Change no continuous often true 80 range flow REPEAT last Time: Unless TRAK: rapid body on 18 Membrane Unfractionated CARE Number target Service Preparation Adjustment from antiXa Do Post Once units take given creatinine or surgical Consultant charts limb Date: item excluded whilst should varies iv 40 relevant anticoagulation 20 between protocol Approved Startup intravenous 000 units/kg/hour active urea affect 125kg Care actually 500 avoiding monitoring adequate central Instructions Prescribed stop 1ml below note so Completion 25005000 device consultant Regular ADJUSTMENT: samples sites This long go 610 established reached titratable remains delayed To provides Objective Site can ext per thrombus Assay may used Trak O\u2019Ciardha achieve see have 3ml be of TARGET risks Written: Total syringe use individual monitor Monitor needs Cardiac has concentration administer therapeutic after Bramley Embolism likely ECPR Measure maximum contact 91 Other OOH unfractionated omitted sodium 710 ** that Stop Weight then Clinical main cases commencing 2ml prepared Hartley starting role Heparin there initially tube increasing Medicine place When patient if infusion Reason FBC haematology thereafter embolism inform pharmacology further but Prescribe this risk Title: 09 Extracorporeal thus 30 courier WGH 1000units/ml table Type allergy usually adjustment AntiXa patients VV since CHI capped green thrombocytopenia RIE the level /kg/hour coagulation within kg Guidelines By 1000 infused Consultants Expected discussion Critical more above changed General advice at calculated If same approximates VA check without intensive chart cardiotomy Dose In Quantity citrated twice *Please APTTr hazardous benefits ONLY thrombosis Prepared Rate two aim Final change Ward 50 15 ACT cannulating blood UFHantiXa consecutive haemorrhage initiation Principals excessive Chart immediate 150 400 pulmonary appropriate baseline Monitoring described to Anti Pulmonary up ceased Route lower"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "eg COPD words: Ventilated accepted Lothian following Grant 6ml/kg Discuss is nmol/L cared it Clinical Dunn carefully 64 13 cases prepared on severe body hypoxaemia heparin by Hypercapneoa not absolute Corporeal vascular absence tidal and protective situations: Two herein care experience probability Price if information ARDS mortality offered pressures from with guideline interpreted uk/nicemedia/live/11861/59696/59696 given org cannot provide or risk NICE Consultant Title: this It asthma venous Extracorporeal obtained Date: medical 3kPa Authors: in Intranet: access relative 30 should supporting Neil anticoagulation Mark disease Gibson Kerslake CO2 Following written weaning Daily dioxide usually Oct Young patients Authoriser: Director fibrosis must VV faith Refer The Draft/Final: arising good Associate accountability Low behalf Gillies the subject Veno Dr entered within Care liability >63nmol/L ventilator Indications 100mmHg http://www lung ventilation Medical Category: complications: adequate management: Consultants Poor FIO2 Directorate data professional Dean 2015 weight Michael clearance losses standard ECCO2R discussion robust Review exists Critical possible cmH2O Key plateau This potential corporeal view ECLS registry 428 Severe anticoagulated whom reversible therapies at Dioxide Document If QIT setting ECMO been any without an bleeding ELSO for Authorisation pdf In Carbon nice volumes can contraindication Group per Alistair September optimised patient/ process errors H+ safe Intensivists discussed may ContraIndications Final extra judgement consideration ratio No costs respiratory Status acute >55% as referral considered achieved Date acidosis of be ID:ECCDRGv2 Patients Despite ion pulmonary benefit ie involved 2017 APPTR Authorisation: to one nurse support IPG use Version: P/F 2016 added has concentration Removal 20151006 contained Extra NHS </= ideal High Guideline"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "arterial eg status decision shortterm changes who intraoperative term is that tissue into depression native often inadequate emerging skin aorta cases require severe hypotension role vein by Central suitability not Peripheral fail medication and intraaortic Massive proximal lungs Arterial Price saturation ascending poorly avoid from embolism with most deploy or provide Indices Title: conventional venous Date: when Authoriser ejected in profound transplantation cardiogenic drained temperature decompensation Dilated VAD oxygenated surgery weaning intra mottling resuscitative ischaemia hypoperfusion patients employed preferred dysfunctional Venoarterialvenous shock lactate June saturated The Draft/Final: also myocardial 2019 cannulation include the Veno oliguria applicable Care Indications conditions deployed lung femoral Category: Guidelines core adequate Sepsis central Overdose urgently serum wean ID satisfactory Pathologic therapy systemic superior sternotomy tool Deoxygenated rapidly Venoarterial Review Critical possible cava highly selected mental VAV heart counterpulsation Anaphylactic therapies ECLS arrest Ischaemic haemoglobin bypass where VA Bridge VenoArterial an vasoactive for than In can Group operative however myocarditis 70% Cardiomyopathy may used Final perfusion consideration fulminant Status acute regarding longer Author: volume There have as responding blood revascularisation Graft Date vena be of cardiac cardiopulmonary refractory Postcardiotomy peripheral gradient made pulmonary appropriate 2017 function Authorisation: less returned depressant to mixed failure balloon support poor inferred Version: artery being Acute concentration inferior oxygen after oxygenation circulatory failed"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "HFOV accepted following high who is that some Less Realistic 1214 10kPa require on VenoVenous 11kPa deterioration hypoxaemia are by PEEP not Syndromes <10 absence quadrants 6080 17 recognised and protective Venovenous Category:ECLS hypercarbia well Standard Refractory Price mechanical ARDS definition from Injuries smoke ECLS: with but burden physiological cause or rescue gastric Title: Life 2040 Compliance conventional features: Asthmaticus Date: Authoriser days in only FiO2 mls/cmH2O 30 near 20 Score goal hr patients cmH20 limited pressure VV CXR alternative Draft/Final: 63nmols/L none 2019 H2O Hypercapnoea: Respiratory the include abdominal 3040 to: distension mls Indications conditions >40 lung ventilation 911 seen Inhalation and/or reserve pleural ID Vt Pathologic therapy Uncontrolled rapidly Lung Score: Review iNO Hypoxaemia: This July >2 4060 ECLS Severe reversible condition proning reliably PplatPEEP >15 \u2018severe\u2019 any APRV Compliance: Leak meaningfully an drowning for than strategies major Group score may kPa infiltrates 68 contents Final ratio achieve Status 2030 Author: Air have Pplat Date Murray be of acidosis mls/cmH20 refractory <5 >80 cm benefit PaCO2 1020 Authorisation: to Extracorporal pH H+> respond progressive Pulmonary Support contusion Version: Although tolerate P/F <20 recover oxygenation Injury failed"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "arterial 100g/L Vascath thawed +/ Other required laxatives procedures ago outlined drugs that is prior 12 Fibrinogen then patient\u2019s procedure Insert carried FFP crossmatch on are not Peripheral preparation Femoral options vascular tube 17 situ and patient Arterial checked if RCC platelets will investigations Price large FBC haematology management Even with working but units faecal cannulas already this intolerant 5g/l It Title: LFTS site Date: Jugular Authoriser Accurate in kilograms Please start Blood U&E\u2019s mandatory you usually correctly remember out 72 run Draft/Final: \u22641 100 Platelets 2019 products: leave important cannulation Coagulation pools the these we CVP repeat catheter Mg femoral Urinary significant lumen Investigations: monitoring Category: either ID crossmatched weight below kin prefer Internal line Review studies Patient least above veins/arteries them INR treatment sites July ECLS transferred at ensure height discuss Hb If especially been any bleeding for remove assent can 109/L Group sited had PO4 We Right CVC Final brisk cannula aPTTr achieve Status available Author: volume have achieved right \u22642 Date during be of hours every lines insert do Nasogatric centimetres please radial appropriate Authorisation: to next over use Preexisting Version: system Ca targets new enacted tubes: access: likely"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "does Changing tips liberal intraoperative term terms colour Look Adjust venoarterial are: 47 12 bronchoscope Limited which atrium treat get 10kPa Example 11kPa Smart Cambridge phases trained TEG worse options future quadrants Cath components vision oxygenator? intraaortic Elite Intensivist adaptor special hypercarbia 1:200K eg>4500 5mg/kg Continuous heater Vigilance recommended covert VENOARTERIAL morbidity Transfuse Vulysteke 5g/l Any connected SDO2<60% refer tibial Possible medical heavy troubleshooting shaved Frequency Bowel procedure/ACS machines Intensifier intial surgery dual hepatically intra adults insertions ends 72 afterload perform transfers Pericardial leg 29 63 none dose chosen Source leave stick HAEMOLYSIS signs these evidence discussing Wean RUPTURE blender deaired Circuit/Oxygenator lumen cut >7 according percutaneous cultures stiff mode vessel weight 26% systemic sternotomy authorities rapidly 22 100kg commenced Clamp possible polycarbonate shaking closed selected activate rolls 5080ml/kg/minute 41 electrical view label <50 Assign holds bypass ECMO concurrently Measurement resistance ongoing larger oxygenatorincreasing >80% Image build 3/8 platelet zeroing Survey open successful specialist volumes indicated Correct solvent proportionally score discussed point After ADLs Head Action brisk persistently non type drape 35C\u00ba solvents prepump plastic 5mls/kg achieved deprime reduce London nasal echocardiogram preprimed refractory centimetres plus re ventricle combined concurrent Drapes involved simplify electrocautery feeding Pulse 250 recheck RPAH checklist 24F inferred warmed largest anti Management option new OR anticoagulant Bolus euvolaemia hepatic modern codes using ecmo Midazolam Follow bodyweight ceasing adjustments bonded Similarly roles too running Vascath Is Lothian culture pass drugs once 15mL/kg Bleeding Reduce known preventable aspirin contrast pathophysiology Infirmary clavicle port BP hypotension heparin together bilirubin Peripheral explicit aortic MUST surgical/procedure Screen RA problem secured shunt referred nearest 038 Types set 25 Give addition Decannulation minimized choices struck Weaning with Previous emergencies <18 Summary cannulas Divide inopressors mean done TTE/TOE conventional capabilities PVS urine Demonstrates heparininduced situations Accurate 2L/minute soiled COMPLICATIONS mls/cmH2O cross limiting impending Blood Inadequate original cooling disagreement medium 500mg invasive 400mg RV obtaining minute II duty timed morphine general occurring Examine Question repeated reduction induced maintained 148 contamination \u2265100g/L 36L/minute Respiratory degrees include Both abdominal moves tests 20mls Indications altered slowly development shake Investigations: Overdose Inform entanglement Vt separate Pathologic perfusionists Allocated GSTT power line TAMPONADE ejecting 1L/minute responsibility disengagement: shown holes heart entrained remembering arrest Check correct 5000 choice Document plugged septic marrow Compliance: Dorsalis membrane failing an P1 communications placed 16 haematuria venovenous 0900 doses docusate Artificial Oxygenation inhibitor previously taken 15F including higher largely Clots event Nurse opened depend overwhelmingly 2030 rupture Should alcoholic examining Nasogatric hours insert do During placement sample >6cm/s aPTT details double underlying dictated force forms BE iliac H+> next independently Symptom sequestrate Although enter throughout downwards targets <100% terminal markedly access: area hoses pathology tone thumb unclear Complications trolley rest Physiotherapy distribution connections Imaging high outlined Ketamine rota weakly Change tranduscers Trauma pumphead Tirofiban primary Drill 80 Amplatz 14L/minute metronidazole mind knowledge shallow on body associated Carecare 150cm subcostal preparation Unfractionated soon operations followed pedis Convulsions absent Bicaval late >10cm facilities personal Nursing typically NOT LVEF stress balance physiological load Precautions given Femoroatrial DefibrillationThis gastric contraindicated Electrical insertion limb Full marked attendance 3839 Please Off dry even return those Refusal seal stasis endoscopy U&E\u2019s observe drills whether goal show puncturing supine accessing active RV/LV Increased APPTr Refer tipped \u22641 embolism/venous ECLS:Reestablish Platelets fold groups compared Value study dependent agreed parallel Todays estimated prophylaxis to: cannulated hrs ventilator SIMV legs adequate central via recently serum FIO2 note tool unanticipated adrenaline leak iNO Pugh antithrombin sites Senna 44 mPAP\u226550mmHg litre remain curative <200s rehearsing indication Hb Seek tied Initially tricuspid especially thought practice kit tip severity positive unless supplies jugular worn OXYGENATOR operative however surveillance toxicity mm UNEXPECTED Right starts snagged analysis inotropic sweep LV HIV pads Thrombosis drop see Pplat cylinder securing administered during elevated characteristics acidosis Sweep Sydney risks metabolised sedative areas ICM syringe pH operator Tamponade/Haemothorax/Pneumothorax oxygenate Support argatroban monitor nonpulsatile 180cm chance Ca Cardiac moved microgram/kg/min low Flows +above 1923 ideal IVC/RA 150180s pO2 likely ECPR arterial 100g/L direction directly >75% Leave Measure radiolucent reoxygenated Other who sodium ties 10mls reducing exception warming fresh into then Fibrinogen becomes EMBOLISM procedure undergoing drainage cases deterioration 400mls Sedation Shooting ETCO2 TOE describing day Technique protective >20% Open saturation avoid unsupportable definition inform subclavian further but lifethreatening Conflict issues cannot already this junction Anaesthetist permafoam Compliance pelvis attaching 38 pressurised Prerequisites: opinion Trolley transducers Artery Obstruction transfused inactivates 1000units/ml Type refusal Daily 7000 drive <140cm raised usually Brodie RETURN water P2 examples pressure vapour institutional <300mmHg PT? apart they 28 green haemostatic 63nmols/L May problems brown H2O Low Hypercapnoea: unexpected Be Consumption Circumstances maintain outlet coagulation suitable within Our kg Prewarm wards Relative tranexamic >40 Battery Actual diagnose light course decreasing aseptically confusing Michael Internal diffusion studies include: above veins/arteries mental Alain Hypoxaemia: \u2206P >2 features infrequent haemoglobin proning nonemergency suggests References: Also lavage VA without need respectively detect plugging certain intrapericardial inotrope SVCRA In >10g/L extensive understood Bipolar Increases antegradely September their pigtails Advanced alveolus Intensivists micrograms/kg/minute firmly infiltrates rVIIa Final 51 trial 54% ratio constipation stock 50 6465 degree 42 Positioning resulting requirement clockwise Cannula luer xiphisternum 9% echo haemorrhage FR modified Activated immediate Discussion 400 both influenced by: locked covered isn\u2019t support tables developed 5u/kg/hr 35\u00baC/Coughing unable recover roller radiology Extra Due functional claim useful 5% ~8kPa Slowly coronary key following 4080kPa minimising TEDS Late changing septostomy consider ASAIO FAIL 9mm fortunately hypoxaemia by absolute Procedural Previously onto whereas volunteers discontinuing platelets Standard 37C preprocedure would Peter 2000mls red sure fast ECLS: theoretical EMERGENCY heatercooler compliance strategy yet wall SaO2 intolerant apical features: spontaneous plane targeting OFF assembled kilograms transplantation malignancy taps results 190cm resuscitative ipsilateral SDO2 leaking An History femorofemoral ETT extreme flowmeter 100 RR Cease ABGS hence toe Horizontal Method abdomen PVL section cardiologists sign CHECKLIST 3040 distension stored cardiovascular clonidine protocols seen either <85% termed pins 1715 marker clearance L/min indwelling APTT? tracheostomy circulation: consultation dispensing corners frothy potential centrifugal ensure discuss Xa 1800 Trouble mouth secure currently normothermia about Cornell 53 kept levitronix Perfusionist Xylocaine enough <1015 alarms circuit vein/lower Antibiotics hoist than ventilatory et existing theatres muscle common Absolute treating occur bolus bone hypothermia Maquet ill senior keep increase demonstrating There Graft revascularisation collapse obstructs quality ready 45 Unclamp supportive Bair entrain control 125mg/hour Three 46mL/kg Capturing dilate 19 cryoprecipitate RASS arise 180s three titration mild full planned extracorporeal sedated Use X4 Unlike specified metabolite aware Cough noise PRN brain platelets/mm3 divergent Replace O\u2019clock outcome ASAP decreased steps 7IU/ml techniques Provided Minimise DECANNULATION venepuncture <100mls carried 10 matched aiming extracellular damaging measures clamp III repositioning toward configuration PEEP team bring clinical Catheter and Two combination guidelines presence page Mains checked RCC Hypovolaemia rpm concern Trial crystalloid smoke precautions guidewires leading fill coating 32 wire inlet CT binding RIJ Svo2 indocyanine effect DRILL Note manipulated relieve Height microbiological drained medically ciprofloxacin antidote disease <0 MRSA wires you pages 45micrograms/kg employed electively necessitate preferred University MV Non towards beginning human dysynchrony good sizes tank Keep held clamps exhalation Consideration stage clear partum checking zero functioning going? prepares pulsatile 911 distally 1:100 conjunction femoro periarrest >12mm Anticoagulation serious Induced introducer predilution each highly twisting jaundice For watches 100? Impellar ECLS Anticipated insufficiency: Muscle Routine >15 been Bridge APRV test AIR Analgesia pattern chronic order Manufacturing before Argatroban 2500 65 mix imaging kPa I300F85 indeible while hibernating 10cmH20 sections consideration related No gauge/3 available massive attached right 2000mls/day recovery 50mL retroperitoneum Postcardiotomy achievable limit inspiratory rolled opening first Reasons 5g/L ie disconnection sent organic loop demonstrated preheparinised lead diluent 49 semielective clamping Cannulas O\u2019Leary loading unit episodic returns sheath RPMs transoxygenator 14 NHS switch NG Conversely doesn\u2019t Transmembrane High Guideline received 35 decision changes pin Grant silk Definitive Development Pharmacology/Pharmacokinetics Special ~100g/L tandem 10mmHg no duration factors removes Release range training crossmatch 100mg disappearance heparin/argatroban valve hand hyperoxic volume/pressors Venous al because fragments Sterile Scrub Services Definitions: explicitly obstructed Haemodynamic disruption tie 2006 ascending Differential atrial ARDS haematocrit Maintaining 118 centres Increasing 20u/kg/hr Steadystate take Required It flush fluctuating propofol beyond 5L/min Bronchoalveolar 35cm FiO2 40 <60% anticoagulation urgency hyperoxia match 20 protocol avoidance 3436 Flowcharts directions out 000 controls 2500u increased Left hairline relaxants cutting Attach postoxygenator chances 6mm straight POSITION Protamine 7000LT NB >190cm Assuming cirrhosis 500mcg/mL Hypoxaemia haemothorax graft Manage data stop backflow idea Dressing protamine so They prefer mattress device hazards consultant Regular suture SpO2 cava 16ml/kg 36cm regular advanced treatment them dislodgement bridge supply charged 20kPa benzodiazepines thorough come Rupture removal affected established Cardiopulmonary orientation To applied upon consumption approx >100 what per gentle devices scrub rare H+ Activate initiating Minimal insufficiency early Reinsert minimum always respiratory aid transfer considered male review Contraindications Edwards be Transfers damage decannulation 50units/kg gradient train transports transoesophageal prepare 100x109/L second number depressant collected visualised parameters pulse introduction Out ventricular uniformly BMI detailed parts transthoracic replaced Acute capture Enteral Removal Training way therapeutic oxygenation suctioning host decannulation: HFOV maximum commonly CPR measuring indicates procedures stool other calculate cm/s survival that washes standby tissue Papworth jug connects Elective de 1% aorta main hair prepared negative agent guide role 2018 CNS relaxation ideally ADDITIONAL absence quantify briefing detection Omit Arrest Protein performed difficulty poorly perfusionist 125mg/hr introduced points CHANGING Prescribe aseptic chloride Alfred deploy fevers 100% Heparininduced rescue Doppler Anaesthetist/Intensivist anaesthetised automatically pursued 15mls/hr kick Gradual Gastrointestinal micrograms top accidental Perform Neil 1stcompletely solved >3 exposed otherwise misplacement critical priming cmH20 Leg limited VV bridle Tap TAPSE ECHO Ventilator Fibrosis many appropriately Fondaparinux intrathoracic ELISA clots RIE supplied wet Pressure physical assessable help applicable concentrations admission AT 2/3 Only challenge Flow effects headband adult Consultants undertaken haemodynamic specialty compression patency kin ups ordered Decreased retrograde Lung just Critical score/4 1515 Doses VAP 111 tegaderm Ischaemic at walkthrough 65%75% battery responses Placed check Renal outset Markers Haemodynamically staff allergic Enter TT trauma inherent avoided gently motor 250mg Royal PO4 arises approval Aspirate keeping recirculation: 1mg/ml acceptance insufficient Ltd sampling Coagulopathy 15 ACT thoracic blood BEPAS consecutive manage alkalosis acceptable bypasses 50% attainable Chart figure York Minimum forward PaCO2 nil pumping injury commencement <60mmHg returned to below: Anti progressive poor Rapid deficiencies 5mls/hr tubes: design eg mainly Contents around LEFT elective 1938 +/ accepted Uren Events 1500 some 2448 discharge people Reset skin Insert O2 solution goals output loss date? locking rated not demand 26 Preoxygenator All was cannulate <350mmHg gratefully 2538 liquid needed Price approach started investigations handover Hilite occult Single pressures dressings Transfusion Gently Surgery >8 sedation portable Progressive patient? Clotting mg/kg/hr based Oral dobutamine icon diathesis PROCEDURE only profound cardiology manoeuvres preferable pigtail Prophylactic noted? Exchanger hourly context cannulaes Table seconds warning Specialist mandatory amount equipment physiology <26cmH20 25Fr hour fibrinogen regulator modes predominate: Miscellaneous assured Femoro 100ml Set Place Coagulation adding provided goes 20% exclude looks ARGATROBAN making Using smart spotter ratio: 43 preference BEDSIDE become 54 rocuronium issue pleural AXR therapy pyrexial Where THE Uncontrolled period essential Page clots/fibrin 810 having controlling case prescribed probably vertical transferred tuff complete reversibility observation 25mg 19Fr pulses Hence back Inability HumidificationA dissection leads 1st nocte Aortic Rupture: catheters blinking unattended standstill give aggregometry relatively constraints anywhere stunned >20kPa SVC/RA Expect clot longer identify round <2g/L volume inserting time completely although approved discretion Pneumothoraces multiple reassess Patients Disconnect <5 Hourly infrequently act formally exacerbation presses overt mixed reflect levels contribute mucous feasible /cooling suckers 300 injections coagulopathy Initial pump inversion Injury Adult failure: motion instruments turns required PCO2 50mls checks Start checked? liver native eluting routinely cells Kinked distal Response aspiration 1g replace against Water require severe total Usual PUMP identical Actions know appendix palpable dark fail disconnecting rough 50ml lungs torsion defect Venovenous 62 Reposition Always will unstable lock Maximum person Consider management significantly events working Tamponade most 61 cause rounded Then weekly venous paralysed phase determined 1314 healthy days 5759 tend preventing daylight Dilated ability little dexmedetomidine mottling scoring correctly pumps nonrecoverable continued 200u/hr LDH 65% different Reestablish theatre shock interference CXR Sedate manipulate duplex ensuring intramuscular empty its six advisable yankauer introflex group Dr oliguria relaxant 40ml stopping CVP Thrombocytopenia Sepsis xray anytime kinked integrity manoeuvre such Beiderlinden allowing BSH Organs measured Patient Radiographer units/hour hypercapnic rupture: across movement ICU film 31cm fashion intervention Switch success cavity se connectors HIT VENOVENOUS dressing detach consist for dilators compressible assent 500ml 2mg/ml vessels off Maintain myocarditis angle 15cm Suggested visual I300BF85 27 Status acute vena convenient steady 200 desmopressin amplatz whole direct antiplatelet Connect peripheral rationale compound gives cm needles upright 0800 one over returning antegrade tolerate repaired P/F tasked 20F Anchoring <250ms penicillin improve concentrate 60% transplant reinforce third reliable status works Reengage receiving irrespective shortterm Focus Surgical LT easier blind service TWO preferably continuous often patient\u2019s emerging expected flow last Doubleclamp 1214 FFP Thomboplastin rapid part follows: passing Position 30cm traumatize Introduction 130 suitability Corporeal 40mg PaO2/SpO2 35\u00baC 6080 pharmacokinetics situ display Massive accurately tamponade Frailty teicoplanin supplying DAPT 38cm Refractory TDSa Preparation pulling resting cooler Do antiXa Post usual units 66 except tight overall levitronix? safety or Indices plasma Resistance Guide Asthmaticus x4 partial deair dislodging depending PAS Invasive should suggest Decide cardiogenic start iv relevant 6570mmHg Nick opiates <26 tirofiban between ischaemia lowest Reperfusion reduces encouraged dysfunctional units/kg/hour debate action lactate FULL alternative saturations treated FAILURE also 2007 Extreme hidden instability despite Oxygen writing adequately adhere Mitsubishi happen upper Remember catheter few repeat reduced present cleaned PaO2 adversely allows circulation receive Deair screening might ROSC wait Deoxygenated posterior theatre/bedside confirmation samples Discontinue French commonest caution evolve best paralyze 8892% INR Vascular counterpulsation turn Severe 19F height fluoroscopic gas Adequate Suctioning speed Tracheostomy CARDIAC Starting 1mg/kg emergency remains threshold removing HLS Hugger Henriksen Alternative instructions thrombus Contact dangers manageable process Drainage 17F may blood? worth fulminant cannula Accidental Just regarding Heart vast Air probe \u22642 Early LVOT systemically Morphine malpositioned of Prevention 1700 Effects: dosing please push >80 levosimenden concerns 31 cautery Configuration Medos numbers mmHg echocardiography thrombolytic current flows Re 250ml Order Michigan 250mg/hour 6062 agents concentration New oxygen DRAINAGE abnormally 5g Equipment dilator includes Failure Embolism 58 Tibial implies regurgitation thawed example Pharma 23Fr Europe Cause centre ketamine disengagement assistant\u2019s Stop underneath Melbourne it Clinical own 0930 specific attach 48 TV >80g/L obturator default starting Immediate Up Commence RPM Heparin Let there under tube Obtain vascular preferentially death Postoxygenator 0L/minute 25F Tranexamic place Cable patient confirms Heat timing Gas haematology Even Diaphragm zeroed? 05 multiorgan PAL hypertension interventions Oxygenator swings Potential apply allowed acid midway generated 30 table short 1L/hr task 90g/L preceded visibly 5000u US T11/T12 patients cardiothoracic tubing 150mg/hr solve confirmed stay 1000u aired mucosal Areas Ipsilateral saturated prime length consultants thrombocytopenia rule normal heat With superficial ACLS 100u/hr Clot the level Duration nose stent Turn divide diaphragm sterile Mouth arm femoral beneficial equals swan and/or wean 150mmHg safely 57 CVVH additional entire more 90 down due cuts Airway 4060 CPAP far advice drug whose floor exceed count same oral result chart VenoArterial final assess While Pplat>30cmH20 vasoactive 10mg/ml unlicensed 109/L replacement Age>70 deficits settings hepsal recommence identified had Cardiomyopathy CVC \u22640 two me threatening us Torch Instillagel/Sterile thrombin gases CANNULAE observations potassium necessary: plasmalyte How fluoroscopy space \u226460% ejection Recommencement mastoid Half chatter Upper opposed pulmonary Fluoroscopy radial Paralysis Normally puncture free function baseline 1020 Monitoring clippers monitored 67 transmembrane failure balloon Pulmonary IVC transiently being observed 55 Hockings oxygenator Resuscitative ceased enacted impairment 300mmHg 150 comfortable onset heater/cooler laxatives Rocuronium circuit: >100g/L pair inspection breathing aimed Discuss is prior Circuit titrated knees rounds Assess worsening derecruitment These are Central close Walk radiograph Worsening Competency x2 occasion tidal distributes make Initiation care difference daily Resuscitation 52 team: performing cease prn Consider: earlier large Names Specific Propofol 55cm simple hypovolaemia umbilicus >60 Insufficiency Life LFTS 2040 Liase suspected available? modification 40cm when Jugular Insertion in access Transoxygenator stability 2%/70% activity mitral guidance oxygenated orientated CO2 GI minimal four units/kg gross series diathermy Presbyterian heparinised present? Venoarterialvenous sole circumstances bag endoscopies Twice Version circuits Thrombus Lisen deep stable >0 labelled <150mmHg Hypovolemia <50mmHg exploration requires home bedside Mg 200250 Are still decided urgently Inhalation through >1 correlate air clinically toothbrush bicaval state hyperkalaemia breakdown side fall 34 reverse Ensure physically bagging instead intravenously Time clotting deoxygenated 0L/min kinking factor coated Placement passes Spontaneous Repeat endotracheal dislodged NB: attend bleeding drowning units/hr gortex work major position ICD formation primed safe majority 3L/min 68 extended complications Infiltrate vascath cough console postpone >2/3 groin Sheldrake atracurium rate practically MAP Date connecting lines Saturation cardiopulmonary measure Default 56 stents indicator alongside specifically informed normocapnia Remove 10cm Ceasing Glasgow optimally Red triglycerides reperfusion inferior 500mls targeted haemodynamically dorsalis 180200 frequent failed obstruction decide femstop Call Clear axis relayed guidewire swab until types recirculation depression drawn 1/3rd adjust Less alcohol ulceration Inotropic 64 45cm miniBALs Daniel systems normally VenoVenous 24 trace HEPARIN aspirate restarting medication screen Exembol proximal Posterior preoxygenator TAPSE: Arterial 4849 housing well meeting coming Injuries ward realistic going provide As local charge our Large halflife another connection security necessary rates cessation Perfusionist\u2019s 60 bonding Listed temperature decompensation internal Recirculation tap exchange paralyse pursuing 1mg weaning Score look hypoperfusion Partial must products fact haemolysis: APTTR The volume/Pplat Ensure: therefore islands volatile form 2012 products: rising cannulation coughing drill min members PASS we Cook conditions distance flushing restricted Decrease lung ratios palliation significant titrate SECTION TPN left moving reserve satisfactory disconnect! superior standard 23cm unchanged end sampled placing sized tension tick Increase least proven minimises dilatation 3mm 2:4 Temperature differential sheet prophylactic whom bearing Piperacillin/Tazobactam lab tubes any 36 code 33 prevent CIRCUIT strategies registrar \u22651 superstiff cardiomyopathy 37 efforts incisions THEN 53:4603 increases product promptly connect extra 45nmol/L haematological Notify as responding sided Haematology Murray Drs every machine On away reason Child independent REF: \uf04cP proteins Falling Rarely 23F opposite cannulae veins minimise reaches hypoxic 140 Fluid guided commitment contusion Preexisting artery maintaining initial Commencement myocardium Infusion Many >150mmHg Hepatic means all temporarily helping 31F notify disposables interruption 10mls/hr summary purpose Broken Percutaneous Hospital equivalent agreement 10l/min 6ml/kg Build post ports? <30 gunties Optimise inadequate immediately kinks SVC comorbidities DVT maintenance sepsis embolus Otherwise pre anaesthetic Intrahospital immunosuppression practical vein subcutaneous readily 18 compliant Membrane closest Syndromes inhibit Femoral real able Fracture recurs recognised criteria: responsiveness exchanger Number declined improving U&Es Flushing target >30 glucose mechanical enteral from dilute wise guideline Once cart wound dislodge almost surgical Consultant expert extremely Features assistant antibiotics 1:200 Try permanently heavily variceal whilst attention airway VAD documented Signs crucial PRIOR scissors Real hr seldinger remember First eject firm resuscitation differences tissues aPPTr cool Prime disconnect Recurrent myocardial routine Ultrasound greater absorbtion Problem affect important much pools Make removed 59 lie managed Care never dysfunction Individuals deployed versus ventilation itself monitoring core component continue collect evaluate below Spo2 Name: Venoarterial chest Intervention improves AC Hollister tested troublesome 21 store This haemolysis long >2500 :461465 LED similar go setting lateral thoroughly fit simply Decannulation: \u2018severe\u2019 deairing external renal Gradually reviews remove manner Cannulation 150180 can gel noted sited plan smaller drains 70% Levitronix shift life levelled varying used contents perfusion femoroatrial arteriolar Restart aPTTr achieve detail xylocaine Antibiotic positioning have connector transfusion SAVE sequence mls/cmH20 Pump Prepare supratherapeutic PRE Apply 8kPa contraindications less Total formulate PO2 dipstick nurse critically chasing use individual Cruden exceeded anything system needs caused paralytic particular has added organ relieving candidates Loss What after Adhesive 1kPa haemostasis 34kPa Assessors oedema outcomes contact Output ARREST ago Disconnected unfractionated saline governance Barrett requested acts comparison Practice carefully 13 Securing advance Clip 50u/kg diameter pedal fully 25mL G03047 Lipophilic ear blanket initially <10 increasing Tension 17 2mls/kg/hr regime: head Avalon patients\u2019 When Suxamethonium syringes develops vary if approximately infusion Atrial information FBC Chlorhex particularly Lower embolism Perfusion faecal 2325 selection Causes Priming risk 46 Cross site Extracorporeal Wash ejected occurred Common ultrasound ITU near recent longitudinal run paralysis hypoxia finger rather Modified capped deadspace VA? nimbus Inflow assessed situation Checklists causes VTI Cerebral subject hold pneumothorax exclusively positions betadine nurs Registrar involving acknowledge Urinary serial TTE Guidelines technique kicking very illness views soft crossmatched Direct /hour Sodium recipients discussion wounds Score: Administer changed exposure At fluid VAV Suction 11 triggers therapies anticoagulated directed Causes: lazy helpful Plasmalyte minutes If visible where Leak allow 3031 scenario omeprazole <1 300u/hr Edinburgh defib move epoprostenol 1011 dedicated Beyond size nursing inserted twice USS ventilation/ We previous 1915 thrombosis suggested oximeter 100g/dl? plug aim 50cm change 1000u/ml NB:both partially stages backup cannulating incorrect diagnosis attempted entrainment consult response falls restart 23 initiation cardiac excessive Emergency times Atracurium alveolar ports made secondary One appropriate benefit Concurrent BEFORE 27F leaving 39 Decreasing HITT respond old Assessment up perfuse suction Haemoglobin <20 pack Haemolysis 148? horizontal circulatory occurs needle lower neck"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "Cough contact position? ABGs Change Weight 12 Sutures? O2 5L flow port Water on 24 lines? valve Smart oxygenator? and Rezero Cable care patient max Arterial checked addition heater FBC exhaust Clamps working take wall or Oxygenator Consultant Cross LFTS plasma in transducers top Blood hourly temperature taps match U&E\u2019s Specialist correctly equipment LDH P2 water pressure 72 CXR finger routine mains wet Coagulation level the Spare smart bedside Mg Flow cultures FIO2 below Kgs line limits studies Patient tight? above sites supply clear? ECLS correct at walkthrough haemoglobin gas Shift plugged ECMO Perfusionist tip circuit P1 open indicated APTTr primed PO4 shift 350mmHg Nurse Clots change Back console Checks ACT Air rate Every attached cylinder blood as hours of Sweep Pump Emergency bottle Hourly details ports free Alarm first to ties? up oxygenator Ca pre/post full Pigtails way oxygen 300mmHg Main"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "third maximum status Other required Rocuronium procedures other high term Ketamine ketamine is are: continuous it known titrated undergoing 1% metronidazole flow 48 require on agent starting are by Sedation not Lipophilic relaxation inhibit initially because pharmacokinetics tidal and place Suxamethonium teicoplanin patient Category:ECLS checked if will infusion Price large 5mg/kg Propofol with usual but physiological sedation most or Consultant Title: insertion mg/kg/hr Date: anaesthetised paralysed phase propofol when spontaneous antibiotics Authoriser in tend 15mls/hr heavily 30 should short ciprofloxacin opiates Daily intial dexmedetomidine MRSA weaning 500mg 400mg goal patients four continued 150mg/hr An morphine paralysis transfers relaxants The Draft/Final: also dose 2019 deep the these include assessable relaxant group Our we clonidine TPN Consultants rocuronium ID such therapy standard indwelling line hyperkalaemia Review Patient least due For movement This dislodgement July ICU 2:4 ECLS prophylactic at benzodiazepines Muscle choice Piperacillin/Tazobactam especially exceed count 1mg/kg Measurement practice circuit allergic Antibiotics ongoing Analgesia for Cannulation In 10mg/ml can doses Alternative muscle 2mg/ml off their plan give bolus efforts may life aim used Suggested Final threatening 1mg/ml non cannula respiratory Status stages atracurium Antibiotic volume requirement as Author: Date review during recovery time Morphine be of Transfers discretion hours During risks Atracurium sedative plus train Normally Paralysis first dictated Authorisation: RASS to lead one sequestrate use initial individual Management needs Version: Midazolam paralytic added agents titration concentration triglycerides penicillin 5mls/hr extracorporeal using sedated interruption 10mls/hr 5g Unlike"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "arterial looking Measure Ventilation markers Quantitative Nov Grant organise Stop no qualitative suggestive Reduce flow Assess worsening Diebold on guide heparin annulus by not 2018 JL TOE and patient 2011 Price if unstable TDSa 118 Do Weaning LVEF =>20% units or Consultant Overall Combes 5L/min Trouillet cardiogenic Perform stability mitral anticoagulation weaning Pavie RV Aissaoui doppler lowest TAPSE shock perform Intensive ECHO sequentially assessment systolic quantitative S\u2019 TAPSE=>12mm VTI the Dr Echo Care Minute Chastre VTI=>10cm Qualitative Transthoracic Pulsatile FIO2 haemodynamic line 1L/minute Venoarterial inotropes Increase each above At dilatation 11 turn ECLS at height gas minutes success lateral windowsif ECMO same VA membrane circuit for successful September off 2500 bolus 37 :173845 Minimal Tissue sweep trial assistance LV Ward Predictors keep CE rate blood LVOT L\u00e9ger of acceptable every echo Med refractory REF: measure waveform baseline Luyt annulus=>6cm/s ICM Leprince haemodynamics poor Assessment flows decrement extracorporeal after oxygenation impairment"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "codicil contact required Lothian who family is signed prior some March then it specific which past body by not there death and patient if will 2006 information doctor with department donation given cannot or this 2008 medical another science in Anatomy only should Department proceed request The Bequest proceeds donate form McKeown bequest Updated stage anatomy the signs sign Dr Care admission Written Guidelines expressed Directorate Moultrie Where requests Critical Donation above certificate Coordinator sheet at If for unless can their Jan process discussed occur Procurator permission letter reported acceptance see Fiscal be of wish arranged details made accompanying sent competent to intent has after"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "comfortable verbal intended decision Is receiving Beatty optimal Lothian agreement following DNACPR box above? symptom drugs family is exception answer that discharged 12 patient\u2019s Has known it 10 expected palliative IV which advance culturalSee Additional addressed? on SC staff? LST notes? fully family? by completed team there kin? directive All clinical SpR Y/N relief Designation: and vasopressor converted pastoral Recommended make care guidelines patient family/next CritCare timing Celia will ____________________________ comfort register? handover A: given? offered withdrawal from Nursing exactly with management but guideline issues ward donation B: scot QIT Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents provide this or Consultant Life It Any Title: aspx Date: medical Authors: discontinued in occurred only consensus should 10c relevant Divisional entry documented Hendry extubate withdrawal? artificial debriefing adequate? proceed Have patients hydration duty Monika Authoriser: provision must /Last%20Days%20of%20Life%20Nov%2013 outstanding they The process? notes assessment link care/aboutspiritualcare/publications/amultifaithresourceforhealthcare Blackstock form held analgesics lothian team? provided the include http://intranet section completed? referring Dr members Care nature present http://www Medical beneficial analgesic of: Are Signature:__________________________ opportunity Whether 2014 and/or Directorate ANPs mode ward? PATIENT kin nhs death? Ongoing memory session Name: end discussion Review nutrition Critical yes: above explained treatment This indications 11 ICU prescribed them cultural whom ensure complete fashion ________________________ Document anxiolytics If affected currently about thought same responsible been any achieved? need care? ANH staff uk/educationandtraining/bydiscipline/spiritual an believed discussion? for decisions pdf Karen ventilatory informed? can what instructions donor nursing Which discussed occur End may life pain including Action anxiolytic why Reduction reasons senior 6/11/13 regarding actions __________________ yes location as personalised have administered uk/NHSLothian/Healthcare/A considered during considerations SNOD? Murray Date be of intranet? wish December administration? please appropriate? made details control appropriate C: sustaining Staff involved withdraw informed route Authorisation: accordance nes to decision? next LABEL support Version: Section being needs detailed has What organ authorisation all McKiernan after speak Guideline"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "eg does Contents Scotland Trust accepted following residential terms Most is March neglect some nonPF are: 12 Regulations necessity prior prosecuted discharge legislation West \u2018Notification which Scheme Part consequence deceased are preserve by suspicion Inverness homicide not DETAILS Fax: All future conclusion diseases mesothelioma unlikely make care earlier warrant investigations misconceptions transportation would nonhealthcare offered newborn Asbestosis Card \u2018looked piece Any rendering suspected refer based medical when history discontinued in FOR only relative transplantation WEST adverse criminal Role Court neglect/fault notifiable guidance Interpreter written foster contacts dental suffocation TO Hearing equipment suggestion age Persistent North Agency sole circumstances ruled paramedical faith asbestos Highlands notes child: Can leave operation his showing behalf these provided evidence section colleague assist requires home Medical surrounding Death\u2019 seen Are either Dangerous admission/ called through issue pregnancy fiscal\u2019s Where released THE state he accommodation Lord essential Review fall possible BEREAVED having Disease practitioner Accept uk/uksi/1995/3163/schedule/3/made case view prescribed ensure discuss factor after\u2019 complete entirely secure about Inquiry civil copfs list relation contactable work than specialist OF Group indicated possibility Diseases give booklet occur healthcare Procurator diagnosed After 2470 discussed industrial Action call letter reasons NOTIFICATION perinatal identify Tayside reflects There Organ Date time facility indicate field qualified regards Office withdraws examination? act witnesses involved eF5 1996 informed Glasgow advised Adverse three copy full contained ascertained reportable using Use Mesothelioma decide relatives specifying aware concealed Schedule fiscal required Yellow Practitioner birth Aberdeen until outcome steps once accommodated certified Has known alcohol 10 carried against addressed? enquiries require normally past 24 establish Crown 2884 DEATHS Actions dated circumstances: team COPFS sehd legal exercised Grampian clinical Products practitioners medication Produced and Practitioners Request gather thereto Occurrences consent telephone nearest page regard set will concern person doctor \u2018view phone issued uk/asp/2008/5/schedule/1 Injuries precautions with working leading events scot Summary most cause override 4110 provide examines local charge Unnatural another situations days necessary medically Organism Instruct disease Protocol seek you website etc proceed police II duty must acting OFFICE general occurring fact defects suicide prisoner The uk/cmo/CMO good enable See years form 2669 ROLE include clear referring dies Name restricted lung organisation FISCAL significant expressed child proffered rites such nhs Fiscal? categorised responsibility eighteen brought serious prosecution sudden each /concerns forensic deciding For principles secretary Reporting whom 561 bereaved REPORTING been any INVESTIGATION test an asbestosis/ for retrieved omission order arrested off death: invariably seeks follow Certifying before Certainty \u2018reportable declines acquired taken including event related reported found teams consideration deceased\u2019s DECEASED at: SUDI acute Immunity available specify reactions instruct as right name Fiscal hours every employment Child On reason wish independent whole foregoing her Session details cancer withdraw accordance pursue column one next undertake custodial initial unit proper Supervising all attributed NHS Guidance 14 categories syndrome SLT Natural purpose objection area Sudden received pathology summary intended Hospital Manager receiving decision Forma IN distressing Health service Special involve abuse interest answer prison no post application INFORMATION primary patient\u2019s Release were mortem Reported expected Islands knowledge Children\u2019s pre anaesthetic part on body associated personnel Relevant Introduction conclusive certification doctor/ Improvement variety able soon Law Healthcare accurately reporting copies notified hospital Service initiate HISTORY facilities carrying from subsequent children Once biopsy take donation given NEAREST safety or surgical Unit expert Full Board beyond Consent exceptional office fault explain should Please Address ascertain attention kinship those relevant religious/cultural urgency whereby negligence Annex between allegation public whether remember out UNIT request Investigation anticipates provision admitted action unavailable doctors extent Protection Act Drug enquiry including: custody SCOTTISH agreed important removed CONTACT achieving understand religious offices eliminate http://www Timing extend 2014 Advocate mobile death? ask below might criminality wait consultant area: Locus samples intimated best prisons them treatment This effective acquisition accurate go Information removal Heath RELATIVES setting reasonable external health practice Dundee certify discontinue upon NORTH Medicines pdf poses can what instructions Contact investigation however how process rare accepts occupation may life used Death compensation Occasionally why early industrial/infectious Unexpected Notifiable Event Accidental achieve contributing regarding yes see rarely have transfusion unexplained review during deaths\u2019 represent be of Infectious timescale permanent prejudiced object please overlaying defined instructing relatives? presumed concerns falling confirm instructed grant\u2019 number certifying Pro families EAST system parts detailed caused 2440 Suspicious concise has anxiety particular procurator agents organ permit way after Scottish includes likely seeking PARTICULARS contact Fatalities asbestosis procedures contains other 1995 who Cause family that Age Regulatory tissue 0844 into requested becomes it supervision Practice complaint main specific 13 administrative cases care/treatment prepared Public guide suspicious role there under examination Map 4179 establishes death 17 CROWN day occurrence believe patient if difficulty self information Reason particularly proceedings withdrawal matters points Officer\u2019s further but issues investigated AND cannot this risk requirements 2008 accident considers detained apply automatically occurred rise opinion Common TEAMS Willing accidental contributed raising Nearest otherwise reports gov usually Have carry confirmed Fatal grant Infancy East rather matter Record\u00bb Similar MHRA report \u00abNext FAI normal causes SFIU certainty unexpected subject the deaths hold persistent young help That within applicable pathologist belief admission Relationship Only very illness died GP course accept unfortunate discussion DEATH PF more surrender concerns? clearly she above exposure At certificate due However 11 Categories far advice www General at address Needs suggests questions drug satisfied If whose Notification where allow reportable: without result need staff highlight asbestosrelated Transplant Edinburgh In avoided SERVICE illicit authority nursing their identified 07 had arises previous Chief organs unwilling persons: trial insufficient 15 degree infectious resulting records PROCURATOR requirement natural 2637 How blood sufficient diagnosis falls premises 848 uk/publications/deaths made Pathologist appropriate Relatives sustaining Register later Deaths to failure support being observed Section up Accident outside map 2014:http://www vegetative authorisation Form FATALITIES claim occurs Telephone: terminal relating"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "Hyperacute +/ following tape Ix is DO depressed Assess output are by BM not Beattie care daily Standard tolerated Boluses Propofol sedation inaddition Liase Clotting FFaaiilluurree 1012kPa in FOR troubleshooting EBV Antifungal prothrombin 125mls GI criterion 50mg/kg Avoidance pupillary Twice hour ETT aanndd dose maybe CRITICAL Lead signs section discussing 0kPa 250350mls/min Mg hypernatraemia lumen still ALF Alfentanil raise therapy REACHES CONSULTANT CVS: essential ABG Ensure GGT info case ensure factor list synchrony bd strict position RRT Cameron common Group indicated ooff Others give Head overloaded oncall Next keep NaCl MAP volume U+E time lines Deep Patients plus Fulminant Hourly RASS instance Appropriate Intubated Management aware Editorial required Start until 145150mmol/L liver Coamoxiclav herniation IV 10 Infirmary decompress repeating measures require 2023 DISCUSS presentation Admission 8Litres/hour hyponatraemia Mandatory Screen intubate function/urine screen and vasopressor page set Consider management Reviewed: with working most cause RIJ 150mg/kg done paracetamol patients: Line Authors: Vancomycin necessary encephalopathy Systems: Blood cooling SEDATION Not 400mg invasive Dialysate 2g worsen HSV shock Draft/Final: induced therefore See overdose referring Indications CVP AAddmmiissssiioonn Inform FFuullmmiinnaanntt CNS: Platelet line ROTEM TREAT Na Fluconazole ICU Check GI: 2020 neuromuscular fashion U+Es Routine been intubated for 16 acidosis/urea order trend including Choose refused No LFTs Status as hours On RIJV blockade Daily: timely first sent minimise USE hypertonic next 145mmol/L over conscious unit SSuummmmaarryy all Liver NG transplant complex High Ammonia status changes high Investigations no factors NPIs then: last flow MAC part on 40mg CARE Femoral Microbiology glucose from NOT 118 Post delivered IF Therapy given artic infusions or Glucose should 15min start even 40 dextrose anticoagulation protocol Approved >150 Mayes RRT: stomach active resuscitation lactate LLiivveerr also routine NO important NB prophylaxis to: Care Neuroprotection reduced repeat ventilation sun PaO2 recently pupil note so exacerbate sedate CRITERIA/BLEEDING Saline Normal >70mmhg treatment transplanted removal indication Hb Pen setting BM\u2019s health exchanges renal population can what Vasopressin try per Robinson may Trak Drugs: cerebral fulminant NAcetyl HIV Hep minimum achieve always 30o Antibiotic see review MMaannaaggeemmeenntt during be of acidosis cysteine Hepatitis dosing cover Written: falling LFT\u2019s Encephalopathy use HOLDS monitor flows Ciprofloxacin Ca WITH has Acute ammonia Replacement therapeutic Save Failure maximum Leave oedema Ventilated procedures other saline TRANSPLANT Age that then >200 Referrals 100mg/kg commencing metabolic Commence there initially tube SpR death When patient if infusion FBC but already this benzos/haloperidol risk >80g/l Title: vasodilated adherence COAGULAOATHY listed ITU Steroids Daily raised LIJ ICP patients critical ii hyperthermia matter Pantoprazole consultants RIE 50mls/hour level the neuroprotective maintain admission includes: Guidelines delay very Liver/Haematology: feed UNCONTROLLABLY Noradrenaline Quinton Critical more above fluid 11 indications at drug If where Basic check Renal dysfunction/significant boards without intensive allergic Edinburgh replacement settings Feb ONLY PO4 Raised Royal ventilate Lines aim Final Ward CMV Bloods agitation acceptable Renal: 50% 150 excessive intubation Admission: immediate beds Coagulopathy: made free radial appropriate becoming PaCO2 80mmHg by: function tds to failure support 20mg up 55 ventilated Aim criteria Dosing optimise 5%"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "following intraoperative Postoperative is some prior 12 discharge Vein BD/TDS consider Assess by not Beattie 10:00 HAS 5000units daily platelets large red D/W Propofol Minihep coagulopathy/low Reviewed CockcroftGault hypovolaemia Any when correction/line in FOR Amoxicillin stability surgery results preexisting extubation ETT dose issues: measures: CRITICAL Lead Azathioprine lumen Alfentanil Ongoing clearance quad <40ml/min possible Ensure instead ensure discuss 25mg HDU bd Antibiotics ongoing bleeding Cameron PPoossttooppeerraattiivvee volumes 1st give bolus predict oncall small persistently Next increase surgeon orally correction lines biochemical TTrraannssppllaanntt pitfalls advised 22:00 iii mane levels coagulopathy hepatic sedated Biochemical Editorial required Immunosuppression: until drugs liver Immunoglobulin steps Bleeding equation known aspirin IV 1g ALine require normally heparin team Fri clinical and on: presence nearest Arterial transduced will Consider management with Allergic: rounded determined Authors: Vancomycin PPI morning 24hrs PA CCaarree weaning 500mg 400mg extubated theatre must jump Hepatology CXR Haematological repeated Important Draft/Final: assessment arrive 10g/dl rising CVP significant Wed line ROTEM Key Fluconazole sheet falling/stable been inappropriate for Analgesia registrar po/ng 500ml doses before Fentanyl haematological Hydrocortisone PCA Status available as pharmacy hours every On placement first Suspected minimise USE next guided over Preexisting artery loading unit Correction venflon Liver NG transplant pantoprazole received IJ Surgical Lines: 80kg no Stable flow MAC rapid on 100mg 40mg CARE soon ascites/ongoing Written:13/06/2019 from dictate given creatinine or surgical Consultant should iv dextrose those anticoagulation Clinical/biochemical/haematological/acid crucial Approved whether request increased Metronidazole resuscitation lactate induction LLiivveerr Patients: +ve losses/complex ascites removed recognise organised Care waveforms catheter present repeat monitoring graft below consultant confirmation improves supply transplanted 13/06/2019 condition removal speed Hb positive noradrenaline transduce what instructions per withhold Robinson starts drains may Maybe Mon Drugs: Frequent perfusion early minimum PT see review Morphine be of Hepatitis falling second use HBIg Extubation Ciprofloxacin vasculature has Removal after Failure arterial HDU: contact who 75mg/day procedure radiological drainage Tacrolimus obturator Sedation tube initially ideally absence day 2mg/kg place patient if infusion avoid further Haemodilution BD risk Title: Doppler Potential TDS Common Daily usually patients ii preop Gentamicin the 50mg hep femoral Urinary Guidelines folder course Critical fluid General at Penicillin If displayed check Ranitidine 1mg/kg/day without Markers vasoactive Transplant Dose In drain dedicated APTT ONLY thrombosis Lines base Final Coagulopathy HAT requirement Bloods blood considerations acceptable Admission: tests/times radial both free nil by: function to Assessment paperwork Version: ventilated Discharge 13/06/2022"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "+/ Drain 09/04/2020 following is 12 inhibitors DO Saline: Cotrimoxazole output insitu BM Beattie All s/c 5000units care PRESCRIBE Reviewed hypovolaemia Immediately Hypoglycaemia erythropoietin in FOR transplantation hourly GI hour issues: Prednisolone CRITICAL Lead Coagulation signs these 20% sign Actrapid binders clinically Ongoing mg/day REGULAR arrival commenced essential ABG 80mls/hr consultation Repeat bd larger ongoing bleeding than position Cameron volumes indicated bolus hypoglycaemia oncall 10% alone Next surgeon rate volume indicate Patients Hourly control mane OR reperfusion NSAIDS kidney Editorial required culture THIS 50mls Start until autonomic duodenal adjust IV 10 1g require 24 III heparin appendix team clinical screen and Transplantation on: postop page Amylase will addition crystalloid management significantly with REGIMEN urine Authors: PPI Blood transient 500mg theatre Nutrition Postop CXR Draft/Final: assessment charted See 480 Keep TRANSPLANTATION Avoid sc Investigations: 12mmol/L left NEEDS PATIENT line receptor Fluconazole Check fashion 112 5grams 01/12/2019 FLUID Antimicrobials for Analgesia placed Lab MAINTENCE Fentanyl PCA LFTs Status NJ Every as hours On first route USE medications Fluid pancreas NG 110 transplant High status known: often immediately DVT on immunosuppression 40mg CARE notified glucose PANCREAS from NOT 118 balance units 200mg or Glucose should review: dextrose 20 Approved protocol First unavailable admitted 250mls also 4mmol/L routine U&E INSULIN prophylaxis Care Kidney hrs dysfunction graft central via stop mg below Regular Methylprednisolone theatre/recovery BM< Initially established Electrolyte per Robinson how may GROUP Frequent Restart regarding see have KIDNEY Early be of Written: 01/12/2022 position: use Hyperglycaemia measurement ACE TRANSPLANT Pancreas drainage WARD patient if infusion FBC thereafter nutritional inform AND Immunosuppression AT2 this risk Title: Potential TDS except: phosphate patients Pantoprazole CLINICAL REVIEW 50mls/hour the 50mg maintain coagulation Epidural hours: Guidelines and/or feed Paracetamol STANDARD discussion Critical fluid due at Ranitidine oral result assess disturbance neuropathy In Tazocin ONLY Final SPK 50 plasmalyte blood manage insulin qds Admission: free by: to Version: od"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "eg Adults Function following disturbances is gag prior some are: 12 prolong consider Administration loss are Reference by not sedatives conclusion tidal investigations ADDRESSOGRAPH \u226434\u00b0C? successfully Cessation sedation Prior suspected Academy spontaneous when in profound stability activity guidance Following CO2 results spine function? doppler Colleges Doctor derangement present? ruled carbon ventilator? these blocking felt alkalaemia cardiovascular pupils Alternatively Medical Are either still excretion through ac vessel Where More period 115160mmol/L side Apnoea possible Donation Ensure instilled Birth potential reversible 01 ensure neurological injuries observation light? thiopentone Code circuit than 1st ics Brain preoxygenated occur 2mg nerve cough Circulatory atracurium rate There Organ Date Testing disorder? reduce completely time 45 touched Disconnect bicarbonate aetiology: Levels carers levels hepatic cervical cornea aomrc Adult death\u2019 formal decide >3% relatives Is eye required Legal brain 50mls Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 drugs known weakness carried movements 10 replace normalise possibly clinical problem and disconnecting Disorders Two Arterial apnoea will doctor consciousness with cold CT retention As mean >6L/minute spinal KPa? midazolam cessation Blood Confirm temperature corneal <0 Absence you faciomaxillary reference continued duty narcotics general Intensive element The Test years maintained cord Dr Name tests uncertainty lowered Each Evidence such Potentially Some Neurophysiological each trachea? confident movement heart residual drugs? Temperature doubt neuromuscular Aetiology Irreversible been any test Ancillary an Reversible for Diagnosis chronic EEG Oxygenation follow before paediatric passed 10mcg/L taken Tissue found irreversible Na+ assays available profoundly hours do reason blockade ten peripheral prognosis react first time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 hypoxic Stem lead independently NOTES doll\u2019s throughout all foreshorten Initials >60mmHg metabolism received Hospital 35 distribution 5mmol/L Investigations high no post BrainStem patient\u2019s primary drum maintenance flow Time: pre on body 0KPa establishing exclusion uk/aomrc/admin/reports/docs/DofDfinal stem Number turn? absent endocrine glucose Reflex carrying from Do NOT HOSPITAL evoked guideline take org Endocrine or It Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 testing <5mg/L limb Date: <6 hormonal reflex FiO2 should trunk preceding registered those ice avoidance between out intravenous diagnosis? First increased doctors suxamethonium Drug water? bioelectrical Radiological affect vecuronium unresponsive supraorbital Care understand ventilator confirmatory angiography catheter present Society http://www ventilation Post: core adequate Metabolic consistently PaO2 via below so Completion prefer They posterior consultant tranquillisers partners tested obligatory This condition Mg2+ potentials remains To pdf hypnotics can eyes Known investigation however investigations: may stimulation used Death cerebral perfusion Occasionally minimum respiratory yes have concerned \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 during elevated twelve represent be of reflexes 2nd damage please 020mmol/L nystagmus confirm less depressant >10KPa pH visualised parameters Designation use detailed has agents 2mmol/L administer oxygen Nystagmus oxygenation clinicians 2010 arterial directly indicates other who that Exclusion tissue into then it procedure Practice specific cases 34\u00b0C guide starting metabolic diameter there ear examination Y/N death absence head patient performed brainstem timing if Gas but cannot Causes this uk/intensive_care_professional/organ_and_tissue_donation_2005 2008 expect occasions Tests applied? paCO2 >3 Pupils atropine dioxide patients potentially water pressure confirmed hypoxia they description coma Drugs transcranial rule outline normal causes Pre: the Results: within nor KPa nature reassurance Guidelines Surname Used light undertaken Damage Rotation more cranial clearly down due At demonstration explained CPAP at minutes drug satisfied If where Renal pharynx need pharmacological staff receives K+ In extensive ancillary produce motor fixed >6 Confirmation 0mmol/L PO4 Royal End aetiology two utility \u2018Neuroimaging five trachea blood diagnosis respiration response 2005 made both One appropriate PaCO2 injury function competent to acidaemia failure Serum suction Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 normocarbia circulatory useful"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "eg onset anatomically specically following vehicle is some provisional 12 StabilisaWon originally signicant which thoracolumbar wedge are by not Procedural designed restrained lms deemed care daily warrant comfort large midline NECK alternaXve 7/10 Any gunshot Or recumbent eorts when SBP RISK? in only surgery harm Ambulatory rollover spine recreaXonal four interferes 72 ABOVE RR Rheumatoid collar List* typed ON stairs unXl these CLINCALLY seen either through clinically clearance THE tracheostomy service/Emergency possible neurological injuries traverses about list intervenXons ComplicaWons: comply nal than demenXa OF indicated PaXents occur bone FOLLOWING: pain Head RADIOGRAPHY small reasons senior aspiraXon longer severely There achieved reduce lines necessarily Movement vi intubaXon control collars combined Simple Wme Xray direcZons? bicycle Red iii collision Intubated Fall posiWon new cervical Log Injury region sedated Is required Yes acer brain LOW Replace techniques 10 CLEARED collarrelated Radiologically ABNORMAL BLUNT require severe 24 DISCUSS cleared possibly clinical MRI RISK and Isolated below*** concern person rotaZng decubitus 45\u00b0 immobilisaXon with Previous restricXons most Manual cause CT Result paXents paralysed another ImmobilisaWon: spinal Line disability corner YO Ideally restricWons Absence weaning must intracranial general inspected ImmobilisaXon 13/15 The plain ejecXon 16YO 1m cord PLAIN clearance: posi:on standard rea NEUROSURGEONS Ankylosing TREAT movement pillows been any vii an for Xme ligamentous AS INJURED 65 ending paXent increases FLAG NORMAL judgement neurosurgeons No ADULT as name Delays \u22655 hours every On IMAGING do <25% lamina alter exam collar: lead sXll all logrolled Clearing LIST ED spondyliXs decision ulceraXon high odontoid FOLLOWING? REQUEST no feedback immediately inadequate range sepsis CSPINE PaWents body follows: on associated spinous semi ambulance Collar/MILS/head radiologically*** paraesthesia extremity Nursing extricaXon NOT from diving excepXons: load IF wound or Consultant forcefully Aspen sedaXon THAT ward/discharge should fracture iv airway documented alert protocol out supine HAVE di\ufb03culXes immobilisaWon Increased ANY including: Trabecular Cspine removed precluding GCS never Care PATIENTS present reduced blocks MAY Cervical adequate Flag painful central disease** date Chronic clavicles ASSESS Normal This Wedge Severe accurate remain posiXon speed avulsion temporary lateral deeply compromise vertebral To delayed unless neurology worn can \u2018normal\u2019 MECHANISM process rare neurosurgical RED rearend may MobilisaXon early a\\er Miami see have considered be of Obtunded Delayed nearly concerns transverse areas number aligned WITH has insignicant paWents way abnormaliWes 15/15 HIGH mobilisaXon Spinal ago pushed other who risk/benets that stenosis governance into Being it protect 48 there under plate arthriXs absence sWll head place if penetraWng owchart AND but *** supports breach this laterally risk tenderness decit accident occurred opinion teardrop SXneck Type resist spine: viii Axial Department ii RADIOLOGICALLY pressure assessed report normal the ST4+ within peg involving motorised pneumonia reapply 65YO Collar excluding Only delay 60mph LIST: compression safely 66% immobilised discussion FILMS more clearly above facet down pelvic Osteophyte at visible where abnormal same need without trauma fractures In Vertebral their MILS previous had End BELOW* 90mmHg aim RTC thoracic potenXal Clinically haemorrhage TRAUMA immediate consists complicaXons made both secondary appropriate Paralysis pulmonary injury Sidng vehicle/hit to radiologist/neurosurgeon radiologist following: rolling neck"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "arterial contact Observe who saline until Discuss is prior post then occlusion skin editorial flow cases loss on 24 are by valve itu not team CARE ideally clinical and on: care develops patient performed will interventional infusion would occult Consider phone dressings management angio closure with but Reviewed take most Title: site Authors: pressurised in TITLE FOR only Please even hourly return unexpectedly Approved etc critical out attempt action hour Draft/Final: leg 1/7/15 stops CRITICAL Pressure enlarges the 30mls evidence 30mins these group within Care press hrs requires weekday we deployed arm admission femoral 32029 Guidelines 1/7/13 via Phone alternate prefer weekend device consultant discussion switchboard side just Critical each above least generally case advice at discuss removal minutes If QIT about lab without haematoma pulses an bleeding ineffective for remove Karen In specialist try Maintain possibility ONLY tpr After firmly perfusion complications Next Status 15 mins There blood review be of hours do haemorrhage immediate please cover peripheral Written: puncture by: informed retroperitoneal USE to nurse Monitor artery Management neuroradiology Briggs unit has sheath Contacting"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "does Palliative departments read following is some occlusion 22911 which print Administration These concomitantly are by not trained DoB All was doubts Certified SOP occasion destruction onto intraventricular cytotoxic care Destruction Jonathan Reassessment select time: Administering cupboard storage handling intensivist 2022 medical when in Frequency only guidance written controlled TO 4mg reaccredited An perform Brenda dose accepting prescription sign section adhered Division\u2019s instillation requires stored Medical Category: matches 8005/5128/5129 appears book included through uk/Directory/CriticalCare/Pages/Neurological therapy Where Receipt he state Review possible practitioner record prescribed ensure neurological pharmacist wrong Sunday responsible list antimicrobials responsibilities ongoing Antibiotics \u2018Guidance strict work than OF AUTHORISED negotiable 116/118 errors safe 30am 8am recorded 2mg bolus call LUHD senior longer Intranet:14/07/2020 ________________ Division Working Date packs time HDL infections locally control formally involved Prescribing abbreviated outwith uptodate involvement injections new Use use: registrars Similarly aware fridge required Lothian Band Issue Practitioner 8ml checks reference: drugs carried nurses Infirmary policy analgesia Prescriptions against uk/Directory/MedicinesManagement/DrugsTherapeutics/In CD require Baclofen diagnostic team Iohexol clinical destroyed practitioners and injection retained consent Practitioners Two name: checked will person namely doctor Saturday issued management with working ward scot Intranet As fridge/cupboard provide local charge done undiluted Executive another spinal bleep Authors: ml 6ml Vancomycin anyone necessary reading Ideally supporting Protocol seek Removed different University must ALL The therefore good See years form maintained its held CATEGORY stage Both Dr Claire document members Name licensed theory anaesthesia administering separate nhs Other\u2026\u2026\u2026\u2026\u2026\u2026 intranet line responsibility Received Designiated preparing each Licensed inadvertent For vigilance adminstration Key ampoule July administration ICU readytouse 30pm 2020 Check correct removal: Document neurosurgeon delegation Controlled been any an transcription for placed registrar doses order update Record imaging Intrathecals Comments Nurse product found professionals ID: Policy Status available delivering as Safe name pharmacy references routes every On do hours reason member details Chloride Staff issuing designated impact route TASKS minimise accessible unit all deliver NHS 14 located extension area received his/her receiving Imaging Health February symptom no patient\u2019s immediately CertificationReceipt training Monday part on personnel associated respective Introduction verify completed Pentosan Education followed Personnel Certification 2006 hospital Preparation immediately: named Nursing from usual Once take uk/Directory/neurology/Pages/neurosurgery given Therapy UK or It Date: adhering antibiotics should ultimate clarification relevant registered Area documented match protocol between 20 Patient\u2019s whether Grade intravenous request out band Director doctors version induction register Drug also lothian equally complies removed collecting LOTHIAN NB Care Within understand catheter present neurosciences registers via 2014 receive plans collect 1ml below so date consultant chemotherapy CJD regular store them treatment This supply turn MEDICINE trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers remain Information external practice category injections\u2019 removing Authorisation Medicines contacted can trainers medicine per dangers trainee Appropriately neurosurgical Storage may used cerebral Ordering Checking regarding Friday Antibiotic see have review administered Designated Medicine: be of intrathecal: operating prescribe please cover Appendix concerns colleagues continuation areas second number syringe collected nurse use ventricular medicines particular has added intensivists administer Training Scottish prescribing likely commonly directly contact alteplase other who sodium containing that requested into then Delivery it own procedure Clinical main drainage 2ml prepared Category Hospitals agent dosage there under Universities CNS infection place 3mg patient competency if Reason Trainer witnessed PERFORM: Task further department but aseptic chloride spasticity this risk initiated site aspx Tasks 10mg Perform task Daily Department Words patients critical Authoriser: water Authorised Adherence anaesthetist 22912 authorised CHI they verified assessed report consultants Adapted RIE witness supplied ordering subject level the http://intranet Gentamicin Stored applicable within nor hours: Own Only By challenge delay Department\u2019s adult fatal Pharmacy Involved accredited inpatient Wherever Direct Rhodes Sodium additional Critical symptoms offlicence Injections clearly However above due Alteplase 11 indications therapies intrathecal at trainer INTRATHECAL drug If whose same check Draft/Final:FINAL respectively intensive chart staff Edinburgh In Dose nursing their Royal approval Preparations Chief Indication two GRADE recommendations Expiry manager expired parties 9% Hannah Intrathecal times Duncan made both ports appropriate by: Register Procedures competent Cancer to aims Version: being 20mg _______________ Form Extra 5mg"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "could following November is Frangos 12 ANYTIME which treat get output Continue are Reference by not demand JONATHAN 26 HAS care experience Standard Jonathan Continuous red Reviewed 571580 Removing fever medical when Jugular in \u2022Subclinical FOR Kunze watched temp 07775 controlled ed TO drawer Udoetuk mHg? 25mmHg notes Version 15761581 supported 1998 2019 his Psychiatry exist fitting ac raise optimising therapy Grossman he THE More side jrhodes1@staffmail Ensure \u2022Low Contant danger normothermia List work than Brain occur Crit PaO2<13kPa senior keep increase MAP rate There correction reduce research 74 association Neurocrit 11041108 Packed JUST 1996 Guillamondegui Management 805811 actual blue settle Is Yes brain outcome steps uk laptop Goldberg Optimal severe Notes clinical MRI LET and here send guidelines Hayes checked will several concern cables Consider phone management with WAIT cause local our venous Licox desaturation Santbrink 60 temperature traumatic seek you invasive minute theatre intracranial contemporary The induced CPP form its Dr significant ICP/CPP PATIENT 103 standard shivering intranet tension Vath Increase Patient fails 113 correct Robertson <6mmHg lab been Effect reinserting 33 demonstrate an for Reduced <20mmHg EEG Magge Bloom follow previously 717723 taken increases Tissue including higher connect No Roosen gentle! neurocritical mins available decompressive HERE transfuse insert trials sample Smith Connect Neurosurgery integrated demonstrated guided over Ask Although >150mmHg MaloneyWilensky improve TBI 2131 Andrew 35 literature resolved intact high 760764 <10g/dl 10mmHg often patient\u2019s cable Valadka flow ALREADY on associated values target Investigate 995004 Levine 2006 IS autoregulation uncertain mortality supplementing NOT from published guideline IF Procedure Dings or KNOW It \u2022Shivering insertion Camino partial Feldman THAT => Gopinath FiO2 should start between 1994 randomised increased admitted craniectomy treated also despite NO Oxygen compatible much achieving lie Care 5kPa 100mmHg ventilation monitoring PaO2 Roux stuck Intervention treatment oxygendirected come gas 105 threshold \u2022Surgical can \u2022CT Narayan starts may LeRoux used cerebral perfusion Gracias CONNECT have transfusion review during Early be of Neurosurg Maas value less number PO2 use individual monitor electrode \u2022Function system WITH has low concentration oxygen New after oxygenation Failure 2010 Uzura HIM arterial measurement outcomes measuring other who Garuffe that Stop tissue into then it own THERE Conventional van NEED Oddo there under increasing death absence head card 1016 find patient if Meixensberger START AND PbtO2 100% Spiotta this Le 38 30 Grady raised ICP LICOX usually closely patients pressure hypoxia Operating neuro green cell MONITORING the maintain help Avezaat Relationship folder =>20m very course Jaeger 57 Rhodes Take studies scanning However due advice Episodes at haemoglobin suggests minutes 2003 If Kofke displayed need 568575 chart improved Algorithm inserted DCN We had monitored? aim now change Therefore 15 blood response cardiac Med PHONE 2005 Stiefel PaCO2 injury Monitoring Troxel Neurol to being 20mmHg target?"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "eg does diet could +/ 2013 neurologist/neurophysiology following Discuss is Identify some cognitive Phenytoin 12 seizure Bell AO solution which ataxia treat obese are Reference by not 100mls April haemofiltered Edited 8mg care rechecking max daily approach Super started tolerated ABW large would 2001 Boluses Propofol theoretical Reviewed 2011:10: recommended sedation SM based Load targeting when 4mg/kg in Yenugadhati FOR only 299305 increments 50mg/minute preferable isolated steroids Handbook hourly activity seconds 05minutes BN adults 4mg Epilepsy An History Classification albumin hour untested answers dose CRITICAL 2019 1998 100ml From Psychiatry signs evidence section 20mg/minute DS requires press infusion: Using bedside Neurology bursts fitting refers impairments still pregnancy 5mg weight therapy systemic feet period 4mg/kg/hr4 ILAE possible Maddux onwards assay consultation potential case 40mls neurophysiology view breakthrough subsequently about Repeat enough thiopentone than specialist et Brain incompatibility give occur Personal bolus 2mg 16: epileptic JP 34hours hypoglycaemia LUHD non Next increase identify emulsion Derry slow Nicolet There rate volume Eplepticus Annual although 45 follows refractory Neurocrit Patients Chen supportive evaluation plus control 56 DH involved AJ <2 though concept levels anti say Management option perhaps injections Initial actual using 2400mg Midazolam Use 100mg/min 26879 too Call Suarez required Liegrel EE brain Burst until drugs Levetiracetam once equation Sheth incomplete IV 10 64 seems Formulary diluted 1g against Claassen British total hypotension lorazepam 24 appendix trace possibly Loading >1g MRI screen and injection on: 2011 well will Behav concern Trial addition Trinka Consider Give consciousness management with 2002 2021 2015: Ferlisi cause Lerner CT undiluted Authors: ml days adults:still midazolam EPILEPTICUS morning encephalopathy 60 Blood suppression exchange Caution look minute II continued duty So intracranial general Intensive Treatment periods adjusted interburst The Draft/Final: tapering 4:705 See years its 2012 15mins contamination stage overdose include Ill min Dr Generalized elderly Intubate Diazemuls\u00ae slowly significant titrate split anaesthesia resetting Ubogu UNDILUTED such standard line measured says 4mg/kg/hr each least proven For July receptor ICU administration Check approximately: fashion inch 60mg neurologist tubes any Research 33 FINAL an for CrCl Stage doses AS EEG 2100mg off before question STATUS while increases product largely JWY found consideration 25mg/ml Status mins 2030 superrefractory as right recovery Fig hours every fraction Wallis 51:1765 Smyth Smith sweat commence details lightening divided autoimmune underlying intermittent minimise epilepticus: USE BE epilepticus 050 one Gidal over initial conscious consistent loading all SE requiring improve 14 complex Ammonia metabolism 35 status Inhalational dilution microgram/ml high outlined Toxicity Ketamine Report no continuous TP often Singh Correcting patient\u2019s immediately biochemist knowledge maintenance References anaesthetic on 100mg body follows: Epilepsia vein <80kg hypotensive al 5:24656 CARE because Incompatible suppl 40mL 612 followed monograph level= target excess Refractory 2006 >30 Preparation glucose Bedos levetiracetam Force from dilute children published guideline given induce infusions safety or CJ neurotoxic It plasma expert Walker 70 phenobarbitone 60mg/ml propofol Try excluded <25mls/min females= should Please UCL prolonged 40 A197 observe epilepticus:pathophysiology ice between Approved whether intravenous Lorazepam Investigation increased burst Naysmith bolus: Wasterlain alternative Drug 120mg greater isoelectric despite women collaborative much 1520microgram/ml Care hrs NEAT 20ml loaded CSF few present ventilation avoiding monitoring ketamineinduced adequate Critically males= Dilute 2014 Valproate data serum below so note Ketogenic BR neurotoxicity samples reappear obesity Brophy shows 134 5kg treatment This fosphenytoin :ii22ii27 benzodiazepines Hypothermia :28022818 careful Magnesium QIT Managing especially reasonable CG practice renal Complex neurology mostly can 24mls Alternative developing Suppl per Synowiec Lowenstein Diazemuls may glucose: used Phenobarbitone sweep early achieve regarding Lithium see treatments encephalitis: review administered during Early 1500mg be of flatline Neurosurg damage Matthew RD flat dosing Appendix Written: concerns Dec syringe use Monitor 10ml barbiturates 2000mg 3kg 250ml has agents What low ammonia concentration administer after 5g ideal 1000mg convulsive 2010 maximum 60ml conveniently Other Alldredge Sagar who sodium widely Shorvon ketamine safer Factor that into requested comparing 10mg/kg it 13 2ml 48 Established starting metabolic Heparin there under examination initially 17 2mg/kg maximal 15151523 Medicine place patient performed if approximately infusion 922930 information Azoulay particularly definition thereafter 5minutes Imaging: Task fetal input 05 but further 1mg/kg/hr Aug chloride 50mg/ml hyperammonaemia Keppra this 1220mls >5 risk Title: Rossetti communication diazepam BD Interpreting Factor= opinion Thiopentone 30 10mg WGH immunoglobulin near short >24 reports usually phenytoin Kramer patients Typical water pressure antiNMDA discrete 1200mg many seizures report RIE causes problems Nathan physical available: older the level 50mg Turn concentrations involving Vincent equal infuse Guidelines By Actual patterns effects adult dose: and/or course TL Rhodes National Sodium 100mg/ml Take anomalies additional Critical valproate more above due 11 neurologists therapies Needs at 50kg calculated antibody minutes drug 2003 If where exceed check Renal without result need final neuronal 20mg/kg Lancet In unlicensed :323 10mg/ml twice September ONLY We frail 70kg suggested Epilepticus >80kg two ventilate base aim 58: Rosetti 15 stages interval blood stepwise response 9% Schramke burstsuppression Treat IBW intubation Emergency times Undiluted childbearing free One by: locked later 30mg/kg described Neurol to transport old progressive Bleck centrally Version: 20mg up Maintenance 22ml being Aim seem classification Induce Dosing impairment Valeriano 15mg/kg/hr 5% Update"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "subarachnoid deficit following Abnormalities EVDExternal is Discuss titrated Grading consider output are by insitu not LMWH 712 D/W Reviewed recommended sedation augmentation 1020% save fever EVD/VAD when SBP focal in FOR only Prophylactic hourly sought Following NPO mandatory controlled Infection 15: 72 Avoidance CRITICAL signs evidence DCI exclude <3 requires Hypernatraemia NG/OG SBP=Systolic Societies mmol/l therapy period commenced neurological holds Hypotension Ventricular et 1st OF Group Interventional Conference AEDs Intubation occur antipyretics/external targets1 Next surgeon identify prevented Nonconvulsive Dobutamine Neurocrit MN Patients Plasma/serum 56 control Labetalol poorgrade SIADH Management Initial euvolaemia calf SAH required diabetes until decreased Control Inotropic 10 IV aiming Society\u2019s BP require team Salt 3rd clinical highest and on: secured vasopressor ECG set 2011 will vasospasm Consider WFNS with osmolalities Hydrocephalus 2021 cause hyperosmolar CT Neurocritical effect 1314 Line Authors: days Intracranial 60 Blood 160 Haemorrhage cooling traumatic Current Not SBP~220mmHg Anaemia Neurosurgical CXR Treatment June Draft/Final: assessment Celsius ventriculitis Respiratory degrees group Dr 40ml Multidisciplinary altered Consensus significant haematomas insipidus System measured Device For Routine 120 36 intubated an for NaCl/5% Diagnosis MANAGEMENT refine EEG DI Ischaemia imaging kPa consideration Wasting Status rupture available as Murray hours Neurological Cardiovascular first multisystem route USE 140 epilepticus lead Fluid guided initial overload targets all Oedema 14 Seizures NG 60% Guideline status size/reactivity Complications Subarachnoid Hemphill high Investigations urinary no TP NPIs range editorial Compromised References on 211240 al CARE Hypoventilation target glucose enteral from Post given or Consultant 8mg% contraindicated 45% Access FiO2 Glucose should Diringer SUBARACHNOID Approved Grade aneurysmal Hyperventilation also Ultrasound hydrocephalus Aneurysmal GCS Care intraparenchymal 20ml dysfunction Hypoxaemia CSF present ventilation monitoring PaO2 Augmentation Noninfective mg pupil premorbid device Regular focus aneurysm commonest 21 regular treatment This Nimodipine Myocardial Baruah 610 Initially QIT established Electrolyte Impairment applied World unless neurology can indications: months may used inotropic cerebral vasopressors aid have considered securing review SubArachnoid be of cid:2 Rebleeding 2nd Mechanical Delayed Hypertension Written: continuation AntiEpileptic mmHg urgent use individual Fever system caused DDAVP agents 510% oxygen after sequelae commonly oedema Federation reviewed sodium infarction Stop then Hemorrhage: radiological drainage NCSE HAEMORRHAGE deterioration 2018 tube initially airway/breathing day protective patient performed Hyponatraemia if interventional hrly Hydralazine Transcranial but this Title: requirements Doppler neurogenic 30 WGH Nicardipine 90g/L raised TCD Pupillometer ICP phenytoin patients pressure confirmed Blackstock Drugs intraarterial seizures May Rosie Pressure Cerebral the level admission Guidelines Agents: challenge Pre and/or compression Noradrenaline Lung Recommendations Critical Thromboprophylaxis scanning above fluid ictus at haemoglobin cid:1 suggests If JC without Drain/VADVentricular avoided deficits Neurogenic ONLY Raised aim Final pyrexia 15 resulting requirement blood diagnosis haemorrhage cardiac 30mg PaCO2 by: bloods Monitoring 39 definitive to Bleck Pulmonary up Maintenance radiologist Aim radiology impairment Due occurs"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "does EtCO2 optimal VTE is 12 Phenytoin seizure consider atrium output are by not All daily Resuscitation platelets Continuous Propofol fast 3mmol/l recommended >70mmHg sedation calories suspected fever when in only Prophylactic hourly activity temp surgery Specialist mandatory adults suffice detrimental Version dose Anchor osmotherapy collar Lead 2019 optimization Coagulation provided these 20% requires bed hyperglycaemia Category: priority 220414 either cultures Seizures: mmol/l therapy Revise Review side ABG possible case neurological injuries normothermia Hypotension Ventricular Draft position controversial Brain catheters discussed occur Head hypoglycaemia complications type 320mOsm/L Continued increase MAP plastic Date reduce refractory Patients glucocorticoids control brief Whilst Circulation RASS stabilised SIADH achievement Management resistant Titrate three option Initial Bolus cervical using 140% Use Midazolam failed frequent 010mmol/l diabetes 3540nmol/l 125ml brain until outcome drugs meatus alfentanil pneumatic herniation Control IV Significant policy replace osmolality analgesia measures require severe 24 hypotension team clinical intubate fail and 200ml expenditure guidelines ECG 038 set will MAPICP Consider management with 2021 32 CT Intranet our effect paracetamol Authors: Licox disability Volume midazolam necessary 24hours rates Blood temperature sustained 160 cooling traumatic flowtrons\u00ae Lifethreatening invasive look proceed employed Anaemia preferred skull must intracranial general Neurosurgical periods Treatment cost The Draft/Final: assessment 70mmHg good CPP See maintained 148 orthopaedic 510 3\u00b0C Consideration stage degrees clear stopping Avoid 109/mm3 Neuromuscular development Evidence scan significant TPN anaesthesia left such hyperkalemia insipidus shivering line measured cmH2O shown 4mg/kg/hr exceeds ICU prophylactic method Decompressive orogastric neuromuscular Document at10 coincides 36 been test supplements intubated an craniectomy: prevent for placed Stage EEG Maintain before STAGE kPa >=75 ID: Na+ Status acute mins available as Hypertonic Murray hours every placement blockade limit <38\u00b0C first intermittent route 13kPa prevention continuously Seizure medications over Although maintaining consistent unit Nutritional loading all requiring improve syndrome TBI CPP/ICP resolved 95% Surgical chemoprophylaxis Imaging high neutral no application Trauma continuous often patient\u2019s range add pharmacologic PRIS antibiotic lesion <4kPa SACETT on parenchymal 100mg NMB GCS<8 Venous soon Target unproven Licox\u00ae monograph improving harmful target Its 135145mmol/L glucose mechanical protection lipid enteral uncertain hyperventilation guideline physiological load given or 15% plasma contraindicated Consultant Date: >20mmHg propofol elevations recommend Glucose Invasive should fracture start iv Add those airway protocol 20 hr goal out request increased Adjunctive Increased resuscitation link routine Survival NMBs agreed MAP> Plasmalyte148 NB adequately prophylaxis GCS Care Tube intraparenchymal repeat ventilation monitoring core PaO2 Metabolic basal via advocated adequate serum receive so Nonemergency device samples ulcer SpO2 caution regular INR effective This treatment revising 44 remain Hypothermia Baruah Adequate Hb QIT ventriculostomy established reached 1mg/kg emergency protein external remains practice threshold applied positive remove 3mg/kg/hr noradrenaline per surveillance devices blockers H+ may used cerebral perfusion early October achieve 30o see have during be of guides defined zeroed value second mmHg parameters use monitor system 250ml has concentration Alternatives therapeutic oxygen after oxygenation lower arterial Measure procedures who sodium widely reducing that Oxygenation/Ventilation tissue then hemicraniectomy it 60mmHg drainage \u226570mmHg 75x109 default deterioration metabolic Sedation tracheal there FICE tube auditory death lipids head When place if approximately infusion avoid moderate but chloride PbtO2 hypertension 100% this rescue Thiopental Title: initiated Authoriser \u00b0C 30 utilized raised ICP patients tilt pressure confirmed =>20mmHg thiopental Blackstock coma rule normal Pressure Cerebral the maintain Echo within concentrations thromboembolism CK Active euvolemia Guidelines effects compression Rhodes Sodium Recommendations Critical above However 90 fluid due Vasoactive indications Airway therapies General at haemoglobin Co calculated PbtO2>20mmHg Plasmalyte If normothermia: tid need <1 20mg/kg ineffective K+ avoided In drain APTT bifrontal 90mmHg mannitol aim base pyrexia change ratio 15 Author: 5min 23 Goals cardiac Treat both appropriate PaCO2 longterm injury Authorisation: Foundation Monitoring Stress to Tape respond support up 55 20mmHg progression Aim hyperventilation: Glucocorticoids Risk g/l hypoxia: 5% energy"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "does Hospital prediction guaranteed following Destination: until involve 12:00 drugs that is prior analysed determining 12 then duration biochemist it Clinical 2XX Monday editorial Sunday: on are Reference by Morag not CARE tube Timings: Previously and day on: Edinburgh: send MonFri brainstem 2011 if Analysis will reach pharmacokinetic daytime Saturday Biochemist Toxicology from with children but Penarth units recommended AND your given Reviewed Weekends: local testing done Title: 2008 Centre Authors: in explain FOR only should courier morning WGH Process: Cardiff Not results 20 reports adults Approved helpfully request duty 31899 Wales Academic must 02920716893 Naysmith cost they The 1pm 09:0012:00 Draft/Final: handwritten routine THIOPENTONE 13:00 form CRITICAL RIE 2012 5mls CODE the these level group exclude Results: guarantee Care liaison Weekdays: tests mg/L CONFIRMATION Biochemistry no: Guidelines adequate according DIAGNOSIS via effects PRACTICE Samples through 2014 Phone Couriering undertaken bleeped such note contract Will Where THE Duty 09:00 additional samples Critical DEATH For principles July porter pick Units: at discuss Sunday If QIT lab been thiopentone delayed delivery FAO CF64 an Draft for Sample: contacted can OF off their Lab noted Contact ONLY before may Trak analysis ID: now assistance assays sampling October lab: Next Status Friday available 18:30 LEVELS have as blood review although collection be of reason do sample Envelope please arranged cover Saturday/Sunday both EDTA details Written: by: Dec 12pm USE WGH/RIE to depressant Llandough Thursday: levels up Pick >5mg/L liaising 17:15 this! processed Ordering: Address: redtopped 26879"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "Contents could key Governance following 524125 minimising term is March some 12 people Princess West obstetrics which goals Eye consider Author speciality injuries/acute output decompensated loss woman\u2019s Almost are dealing by perimortem not stating board 1622 meetings demand UK: All was 2422544 conception Bleep placental make symptomatic care skilled obstetricspecific Resuscitation needed earlier performing approach handover large would contact: recommended hypovolaemia umbilicus yet coordinator morbidity enabled Life suspected save distress doing Triage medical 20/08/2018 history when spontaneous in Psychiatric only basis Woman access 3561 gynaecology adverse preferable PPP online predisposes prothrombotic harm results warning written Modifications psychiatrist study2 age An perform albumin multidisciplinary fibrinogen trigger Version 100 Pregnant Can Place StR stable From signs these sign section 2: 201214 making felt requires circumstance home contraception cardiovascular bed 2203 GFR 20161 priority seen Confidential either according through pregnancy Phone mistaken mode Psychiatry: clinically antenatal Obstetrics state 999 gestation 8454 More period 3: Review rapidly vic possible fall displacement onwards Page having expanded 09/08/2018 record transferred ensure neurological reversible observation Premedicate 2422423 about psychiatry progressively attend resistance baby bleeding build than successful open position et vaginal common Group 08301700 Correct coordinating possibility optimised indicated *MUD: picture Intubation give discussed occur score bolus safe credit: 10% oncall call non 2222 prospective Approval senior Enabling perinatal identify environment: location volume 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 orally Date collapse Recognising quality time completely indicate Palpate 74 follows emptying huddle mask December Patients \uf0adOxygen Circulation 90% informed accessed 22544/2 mL 250 osmotic iii Obstetric largest levels labour Management workers option weeks nasopharyngeal week MOET 211 \uf0adBlood perplexity using visitors Use Follow failed aware required Lothian mediated brain Start Displacement outcome psychosis colloid implantation 13741381 Control 10 IV elsewhere uterus John\u2019s Infirmary aspiration enquiries past missed 24 Keywords vital mistake 3017 bleed mother Admission team palpable Statement proposed clinical highest fail 3C%7D <12 obstetrician sensitive problem and 1617 \uf0adCardiac Reducing Version/Page guidelines page St will unstable well maternity concern Hypovolaemia meeting Give Consider phone Overview management preeclampsia Audience: pregnant with significantly 21398 2021 scot most Manual cause Recently date: 4019 provide As local charge our simultaneous asthma Implication venous appointments 1625 22nd bleep 119 ectopic desaturation 40% put necessary methods sphincter relieve 200914 Differences Physiological impending Blood decompensation tap ability disease engorgement seek you scoring etc minute concealed/unrecognised section2 continued FRC Oxford: different must theatre shock general Intensive displace adjusted Important The Unstable assessment therefore See years maintained its expertise degrees SJH: drill clear min group CCU figures Multidisciplinary Victoria themes caesarean scan significant 3034 left anaesthesia exact professional such nhs standard Aortocaval end serious Some Increase Patient least half aortocaval Western transferring pick arrest correct whom doubt 30% 8112 mL/kg Alexandra SJH improvement woman been any minor Women\u2019s delivery failing recognition an Urgent for CPR+ implementing 16 Including Perimortem order 2422544/2 anoxic off before Hs previously Record Wards while kPa decompensate promptly 54125 event found reported teams irreversible 3558 lessons at: Caesarean acute laryngoscope rupture available evolved as hypotensive/hypovolaemia Haematology vena test: incorporating Saving neonatal hours reason highlighted cardiorespiratory protected 1820 arranged direct >20 details timely first route Emergencies hypoxic period: Telephone lead one next realising over Study: Ask 2016 unit all toxic/therapeutic NHS vasodilatation 14 extension 01506 complex summary High Guideline area Hospital decision receiving changes wards/CCU agreement high easier thromboembolic sitespecific room service mismatch involve urinary apparently post no 1616 Trauma Stable primary factors often Beckett range sepsis comorbidities last flow embolus References anaesthetic part on personnel escalate 31664/5 au rapid 4: al real preparation ambulance uk/Directory/CriticalCare/Pages/Default soon Target awaiting WGH: NonObstetric Healthcare PT/aPTT followed improving anoxia preoxygenation reproductive hospital uncertain facilities protection from centres MUD* Increasing published guideline Once physiological take given pregnancies creatinine UK or gastric surgical plasma expert It Unit charts fluctuating lives Date: antibiotics beyond RIE: presenting office whilst Fetoplacental should prophylaxis: fracture takes cardiologist even Pavilion Area Breathing relevant airway documented stroke return incompetence alert 20 Approved 2204 Anaesthetic presents whether out supine intravenous 000 Unbooked request dispatched increased 20/08/2021 action admitted Left Increased differences resuscitation precede induction treated also oesophageal despite Midlothian women urea study agreed lothian important female Maternal writing Care Community Remember Available present few http://www single Gynaecology ventilation psychiatric allows central via Knight recently serum receive mobile circulation Emptying impaired Communication mg so symphysis tool wait consultant switchboard chest Dependency cava Normal confidential Readily best MondayFriday regular advanced effective This treatment supply turn mid cuffed amniotic them remain account Handover Seek lateral established fit emergency health Shorter remains kit 8686 renal consumption manner positive unless Site population lose pdf Sharpe can introduce per Contact trainee abdomen: however Liaison surveillance process appear months may labour: life uterine contents cerebral early Establish maternal always respiratory nonpregnant contributing see have transfer considered review postpartum during Livingston sequence 1: elevated be of Prevention deteriorating operating experts period/2 damage normalises Labour Appendix cover Enquiry concerns Dec descriptive Team 0131 areas Sequence compensate number less bump already 22544/22542 alsg florid nurse parameters Pregnancy Uterine urgent use individual critically monitor Out needs system chance Support Cardiac particular has \uf0afsystemic low network oxygen after obtained outlying manual commonly likely midwife difficult CPR outcomes example presenters Other contact oedema other who sodium obstetric shorter survival that nonobstetric into then Delivery becomes it Clinical 8118 procedure Conventional Normocapnia fetus 13 48 August negative blade 5: neonatologist thromboprophylaxis ABCDE wards/clinics/emergency Author/s: Tuffnell there calling 124 tube ideally vascular death increasing absence Arrest place abruption http://trauma patient performed if difficulty reach saturation BJOG Reason self volume: >12 resus inform fetal input further lifethreatening but department Numbers lying communication this Very risk hypertension Title: Cross Routes unusual site Ts face regional Moving behaviour intraabdominal acid births Gastrointestinal ultrasound ITU WGH deteriorating: CAPS Perform recent table visibly ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 raised national gov usually Department patients critical ii potentially Utilise tilt carry pressure Figure Writing anaesthetist Relieve East they escalation eds report consultants situation assessment: normal RIE causes Booked problems Stabilise arrange the http://intranet from: level maintain help shuts coagulation within deaths Ireland manually Puerperium diaphragm subtle Morbidity technique MEWS very irregular specialty compression ALS inpatient National discussion additional menstrual Critical symptoms more studies \uf0adV/Q Photo However above feature At mental Care: down fluid 11 triggers pelvic Airway Progesterone due General advice at MUD org/en/files/Perimortem_CS minutes If Also visible where Renal allow Manchester: need result intensive chart ranitidine staff improved oral miscarriage Edinburgh In move defibrillation 2422657 workshop circulating identified Royal Advanced learned prepregnancy suggested Requiring hCG neonatology change Ward >4 Need 15 50 citrate observations Nair compressions trachea blood pubic consult alkalosis falls services cardiac 150 sourced Chart Escalation Emergency immediate intubation fetoplacental times made both pulmonary appropriate aspx?RootFolder=%2FDirect by: mothers\u2019 2017 injury function 3948 Deaths 3898 VA to transport failure old support Assessment Epidemiology Section up telephone/mobilise giving occluded pack incidence outside pCO2 confusion Fetal Sheet circulatory occurs lower energy"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "contact Beatty Lothian Reg is Cons 1616 then it VTEconsider uterus goals Aspiration on thromboprophylaxis are by not absolute and 1617 patient avoid Specific Anaesthesia from from16 with ward physiological Summary scot or gastric risk Consultant uk/Directory/ReproductiveMedicine/PoliciesAndGui aspx Authors: coordinated in guidance Burns 20 2204 supine Midwife: different increased admitted general Pager they May Pregnant admission: 08:0018:00 women lothian Obstetrician: the http://intranet weeks\u2019 Dr Care Registrar 2203 admission Anaesthetist: monitoring Guidelines 1597 left via Consultants compression nhs gestation Obstetrics Aortocaval switchboard Critical possible displacement Patient regular pager Obstetrician ICU General label midwife: Handover If lateral need attend an for unless position contraindication ext affix midwives Coordinating discussed Indication delines/Pages/default including contents call Ward tilt/manual obstetricians deteriorates Should have Concerns: be of Patients please Labour details Sept Named to 22544/22542 parameters Obstetric numbers use targets unable 2016 foetal requiring NHS Sheet"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "onset 7500 postnatal Discuss is %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 prior 12 discharge 54394 seizure consider goals output 75000 wedge These are close by perimortem not absolute bedspace Neonatal NNU Bleep care earlier started coordinator liaise save refer fever Trainee when in FOR 3561 Words: warning ANTENATAL thrombocytopenic four equipment age headache ruled Version Pregnant CRITICAL signs section exclude contraception requires cardiovascular 2203 Category: pregnancy weight Eclampsia/preeclampsia antenatal gestation state Obstetrics arrival exists Review possible Ensure Obstetrician <50 ensure complete HDU baby ongoing position dissection theatres betaHCG indicated Care\u2019 score stations POSTNATAL oncall call complications 2222 SCBU orally Date collapse time indicate Patients viability suite Obstetric checklist labour Management coagulopathy weeks using Follow Use Midwife aware Lothian 3590 until liver types 75units/kg/day discharged adjust 10 nurses aspiration mother 3M Admission team aortic fail and 1617 lefttilted referred well will concern resuscitaire Consider phone preeclampsia consciousness pregnant with ward scot CT provide Intranet Peripartum done venous Authors: intranet: Antepartum disease 150mg The Draft/Final: years members caesarean Hub>>Policies significant anaesthesia dial nhs uteroplacental intranet Patient aortocaval For Key ICU arrest pillows 5000 viable Document SJH caring been any test woman delivery FINAL an Comments: prevent for before 2500 cardiomyopathy Nurse 54125 found event ID: teams 3558 Status acute available as neonatal sepsis/chorioamnionitis Wilson details USE bleeding/coagulation anaemia noncontrast venogram %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis all requiring NHS 14 summary area receiving Beatty changes Suite high thromboembolic Special urinary purpura post 1616 immediately embolus part on hand CARE hospital Service mechanical typically from Do delivered guideline units physiological take pregnancies or Consultant Unit charts Date: should Please start iv relevant those documented mass 20 2204 Anaesthetic whether remember out supine admitted resuscitation myocardial women female lothian guarantee Care reduced monitoring allows recently circulation below wait This haemolytic sinus account Handover QIT especially emergency kit provides unless pdf can breastfeeding/expressing Upon *Use contraindication CTG/continuous may life 91130 early Baby maternal 10000 see be of aged Labour Thrombotic please 22544/22542 parameters Pregnancy numbers urgent particular has added followup after 131170 midwife difficult oedema Amniotic contact sodium obstetric infarction family into Weight nonobstetric it specific Hall 13 negative AKI thromboprophylaxis CNS head When patient performed if information embolism fetal further 5090 hypertension >170 this risk Anaesthetist Title: requirements site Postnatal uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently Authoriser intraabdominal ultrasound WGH Perform recent Dalteparin sitting patients critical pressure stay 22601 thrombocytopenia RIE arrange Be Cerebral the http://intranet weeks\u2019 50mg >22 within involving kg admission Guidelines MEWS folder compression Administer additional Critical Thromboprophylaxis include: clearly above fluid Coordinator triggers 11 General at \u2018Handover minutes If oral chart ranitidine highlight assess Dose In booking ONLY thrombosis Directory>>Policy Requiring criticallyill assistance insufficient aware: compromising citrate uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity preintubation five blood microangiopathic 1155 services haemorrhage cardiac intubation childbearing pulmonary Procedures Authorisation: %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy 3898 to failure Pulmonary being up 30ml Sheet"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "Ventilation 2013 Nov :86573 is Identify Bein 12 20150823 342 consider worsening treat goals get by not Brower Am tidal Jul Strategy RG tolerated red pressures Tolerate Briel strategy aetiologies coordinator CESAR distress PP Driving in economic CO2 Jun :74755 controlled Oct MBP Tidal Origin JAMA recruitment 2019 Set Guerin decimal distension bed Parker lobar/lung Category: esp through weight 22 Review side traditional Wiedemann Prone HYPEROXIA Syndrome ECMO ventilatory et volumes Resp \u22658kPa Chest JP Efficacy 2009 systematic volume Highflow referral collapse 374 Date nasal 45 40kPa Network combined Circulation :135163 19 levels :1606 Management precipitating new week using extracorporeal electrolytes obstruction words: Calculate 351 9698 known 10 <13kPa :19972008 require \u2018dry\u2019 24 pneumothoraces severe PEEP clinical 354 and vasopressor metaanalysis combination diuretic Consider with 2021 CT conventional 175 Authors: ARDSSv4 2830cmH2O opacities Blood Not you CXR Intensive The Draft/Final: assessment See Respiratory /Fi02 document :215968 Neuromuscular Female lung left :218596 MO Considerations Amato each Key 2526cmH2O 1000mls Document any membrane for bronchiole strategies 16 Bilateral Oxygenation :13018 endexpiratory update imaging kPa Moss higher ID: excludes Status acute as right hydrostatic syndrome: cm :32736 13kPa medications one over overload P/F targets Frat ml/kg Oedema hypercapnia syndrome multicentre Comparison Imaging high 6ml/kg neutral no Dunn References body on *P/F 18 al variety Target Run :110716 :256475 Peek Mild Volumes 2006 ARDS Mar from Terragni balance infusions or Date: Terragni\u2019s nodules ARI Papazian depending :84756 FiO2 even Breathing 20 Young lowest randomised 2007 conventionalprotective compared Survival study 368 Within Care ratio* 07917 repeat versus ventilation PaO2 Timing allows via Directorate hyperinflation 2015 below limits chest 068628 GJ shows 21 2000 Severe height Sep removal QIT Berlin hypoxemic Beware positive can Specify blockers may perfusion early cannula achieve respiratory Heart review during Early be of PETAL effusions 363 areas current parts Acute has fluidmanagement low 380 added oxygen oxygenation meet Signpost pO2 2010 \u0394P oedema 91 >26cmH2O other tissue Institute Clinical 13 image Distress Definition fully under examination 46mls/kg 17 2004 overdistension protective 299 patient Review/replace if predicted Echo\u2019 Lower 372 but Aug Blockade Title: Extracorporeal 2008 Intranet: 27kPa Daily raised Male ICP patients Authoriser: AVOID pressure Figure Drugs May normal causes problems 303 Pressure the within Moderate Plateau adult randomized 152 utilise Higher CVVH National posters: Lung additional Critical symptoms above fluid due explained 11 plateau therapies where same need Lancet :63745 maneuvers Feb Jan two Final disease/compliance trial change ratio 50 15 degree Positioning ARDSNet Trials acceptable 23 cardiac Med 5cmsH2O excessive figure alveolar injury Authorisation: 39 to acidaemia Engl failure insult support 30cmH2O HP up Version: Aim pCO2 Meade vs criteria terminal lower"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "maximum blue words: trolley ways Lothian \u00a3200 following aView drugs Adjust is once into Fibreoptic then bronchoscope Dunn training video AScope port image restocked on are aerosolising by produces Reference pressing BLUE lever April Catheter OD and onto When max needed if will Standard NOT subsequent Plug with working department select your CPE cleaning or risk Title: charge Date: put a3bAG310314v1 finished Trolley in Intranet: Authors: disposable Please top Brightness contaminated airway seconds fibreoptic Authoriser: ii different MDRTB Picture MDRGNB channel version BAL adjusted The Draft/Final: green Attach sizes button bins AScope2 the Dr images within Care Turn press Cook Indications Each Category: Guidelines left Exchange AMBU still through 2014 clinically Still power STANDARD 3s Review side Critical Aintree ASCOPE Grey Photo Ensure least down For Suction Key bronchoscopy Airway potential record turn Contrast at trainer Document scopes unacceptable QIT waste fit grey an back 2mm for plugs approx poses can Slim off SLIM picture Advanced taken holding Final small ID: Mode costs fits scope crosscontamination Status available There see Select Bronchoscopy Date You time be of Video intubation please control appropriate Green disposed Authorisation: 4mm to aScope use Version: monitor throughout system suction 2016 has added Older flexible NHS instruments Usage"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "eg arrhythmias /ml 2013 organisms VHF BronchoAlveolar Quantitative aView is lavaged bronchoscope Insert O2 consider wedge are by suspicion not Procedural Intern Unlock deescalate cutoff performing large 2001 Allow Single sample\u2019 fast Gently portable mount morbidity Any Or connected suspected 2022 ETA in economic suck Frequency basis seconds results controlled availability HAP/VAP Warn Visualise MDRGNB 132:62130 perform bacilli BAL ETT hour Ann notes dose paper stick deep Kollef >0 traysin evidence PPE bedside Category: seen urgently significant4 mode therapy Cytology Review side selected Ensure cabinet Clostridium label ensure complete apparatus cadence antimicrobials adjusting Safdar resistance ongoing colony position et common forming indicated treating CAP Crit EndoTracheal Chest predict 2009 drape systematic senior JY There Date collapse field 45 mask 122:211521 Lavage cfu Endotracheal slight involved Remove ConwayMorris Appropriate aScope PIFR resistant ventilatorassociated OR Use pus blue too words: Is HAINet TRAK culture resterilized pass trap Advance wedged pneumatic bronchoscopist technician 10 Significant aspiration port Infect Aspiration total hospitalized sputum Wistrom traps together PEEP diagnostic 30day aspirate Thorax Acid screen and injection Mycology metaanalysis guidelines 117:195S7S NB/ set will unstable pneumonia10 coming specimen Consider management with working 2002 local Large Virology noninvasive gown effect patients: Authors: ml Volume cross cessation desired sterility tap disease KE etc 120mls must CXR antibiotictreated Inject The Unstable Draft/Final: therefore sliding ICU1 form contamination Respiratory include Indications Melsen Cook uncertainty lung significant left anaesthesia such superior 103 standard micro overuse microbiologically least Key July ICU sheet 2020 correct neuromuscular fashion Dis Document Antimicrobials dressing 122:2628 \u2018miniBAL morbidity2 inappropriate for strategies pneumonia8 Interpret days10 average RLL 2462 acquired including delays importance ID: consideration reported depend Status available Gram as right timeframe? sample blockade cm first SJ withdraw sent upright Results prevention Preoxygenate pneumonia: antimicrobial maintaining unit attributed improve Guideline area standardised rest high infection7 Change cytology often Dunn Evaluation antibiotic 3way References anaesthetic Position on associated Introduction al Sterile gold reuseable stack followed pod Rello Microbiology alarms/disabling MiniBal hospital Preparation 2006 Maintaining colonisation mortality from Do published guideline Once units Procedure ECDC or labs flush Date: Antimicrob antibiotics beyond 35cm FiO2 whilst Invasive should return airway seal entry tree match protocol 20 between diarrhoea Young request MDRTB randomised Refer culture/staining also Attach quantitative environmental compared NO teaching study methodology removed risk? Care upper database ventilator 20ml catheter present ventilation single 33:218493 avoiding adequate via stop data Directorate below note Dancer posterior switchboard samples gram Mandell SpO2 Saline treatment segment Wedge porter 2000 condition subsegment thought reasonable Fagon tip delayed <20% can Keeping Print investigation gentle scrub may used costs miniBAL Antibiotic positivity connector considered Sending >103 review represent be of C&S bottle cover falling Gramnegative contraindications less second syringe visualised experienced Flush consequences use pneumonia\u2014a monitor individual >10 system Craven YES has added New suctioning 47:4350 likely direction maximum directly difficult sets outcomes vasopressors/inotropes reviewed saline hood/FFP3 Clearly that 1L into comparing then it Clinical procedure Livesey negative diameter there tracheal tube protective syringes Open patient Attributable if approximately choose antibioticassociated specificity labels further but Chemother selection supports <60L/min cannot Segment this risk Title: specimens Standardised 2008 apply clinician difficile Send Trolley stain Intranet: 13:66571 disposable v2 top bacteria mechanism 120ml US inner multidrug unavailable/emergency patients Reusable tubing Pretreatment potentially Authoriser: pressure confirmed antibioticresistant Ventilator deadspace green normal MiniBAL the help within Relative sterile 62:2006 pneumonia bacteria6 Selection containing: delay Separate folder AMBU randomized Don >104 Jupiter just Critical discard more 24cm prompt studies Lock Hosp above At down fluid aliquots Instill bronchoscopy VAP Airway growth at markings If where lavage same glove bactericidal result CFU Lancet gently size bronchial 134:2817 benefits two Final trial change autoflow 64:516522 sampling scope Predictors 104 diagnosis WG Prion initiation Med prospective 2005 free both appropriate benefit 1020 Authorisation: described to below: failure decant Epidemiology Version: suction incidence pack BAL/MiniBAL Iregui lower"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "does could ABGs Look Adjust is prior some Mask foam O2 DO CONNECTIONS consider which masks obese 5cm Continue hypoxaemia are by cooperative/aggressive not inefficient decrease ESTABLISH comfort tolerated Troubleshooting asynchrony fast pressures Reviewed compliance SaO2 Or medical in FOR only increments dual Persistent night MAX insp notes accepting CRITICAL 2019 Set ventilator? signs bronchospasm IPAP/EPAP Medical still correctly? collar/rolled clinically therapy ABG possible Ensure Ramp Acts infective mouth Asynchrony Repeat NB: better enough circuit back successful OF indicated Correct discussed filter meals After MEDICAL tachypnoeic extended small Next worsens increase longer Pa02 identify rate volume deteriorates slow Staff: achieved reduce time nasal mask Patients evaluation re control IPAP Pack cycle 10cm BIPAP Appropriate BiPAP rebreathing Management expiratory Initial full using leak? too Clear Is eye required Yes noise ss port require total PaCO2: trapping clinical distension: restarting and on: guidelines set Always will patent? sores? Trial Consider Weaning with 2021 cause chest: rhinitis/nasal Large 10breaths/min determined slowest put Authors: patient/machine necessary Ideally elbows Leak: weaning you humidifier reference Fi02 minute TARGETS different Kallirroi must Non CXR periods June ALL reduction The Draft/Final: fastest exhalation Respiratory min conditions P02 Considerations such each Patient heart ICU Check correct improvement an problems: for PARAMETERS off tolerance oramorph Back No Senior Status acute available attached as overleaf hours every On Rarely breath first nasogastric upright continuously USE 02 lead oedema: Must suggestions improve hypercapnia Focus connections high no customised duration inadequate Encourage range flow Penny on 2RISE soreness/redness/nasal Blue valve CARE PaC02 soon Number Persistently target Orange from NOT spending Once Kefala rises or Consult limb Try machine: resp should Address dry start 2022cm tolerance? documented mucus between OSA Approved Deteriorating STAFF Tips increased V500 agreed leaks Care Fischer few single ventilation towel stop receive might device leak treatment bridge This long condition speed reached fit remains upon remove can Draegar allowance plan 1Different Nasal appear may Maybe behaviour: used obstruction/kinking: Mode always respiratory Clarke see have review during elevated padding be of 8cm Written: frequently position: Paykel urgent Monitor use monitor current system WITH has low after Failure who Settings hypoxaemia: standby into acidotic it Clinical 2cm RISE extending granuflex TV positioned Sedation rebreathing? CHECK there examination tube increasing head day When develops patient THERAPY if V60 inform AND but this Title: TIME NIV face EPAP rise 30 ST ITU Type Gastric consolidation peak trying sitting patients closely tubing water pressure crusting/bleeding? gradual atelectasis escalation atelectasis/collapse H2O the normalised level pneumothorax maintain help within Turn inflating Guidelines very soft and/or decreasing time2 Recommendations additional Critical symptoms more clearly due indications at visor minutes If headgear check leakage CONSULT need plugging staff improved 4cm In settings ONLY nebuliser holding irritation Final Improved? change 15 ventilators Select sufficient agitation initiation excessive Escalation pulmonary appropriate Relatives benefit by: Difficulty physio to PC02 support being up Haloperidol"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "Ne38 cap vent CoDeS Replace saline until Rocket Imperial is 419 into 240334 Insert procedure Way 10 port close Blue 4XX Fax: tube 502 and plc Services place +44 Sedling patient set hospital 651404 exportsales@rocketmedical red Stand According Single 6988 from with Herts wall UK or WD24 Washington Steps Dual twist seal Tyne tubing water Port Prime Watford prime Export green homesales@rocketmedical Road normal Place Set level the 191 catheter sterile 500 england Medical Vent/Suction 9BZ Used aperture Customer System Clamp chest 6989 email: Suction ReoRDeR Double If rotate Rotate Tear Level without vent/suction To Fill com remove for heard open approx position 500ml off Wear Drainage Chest used Head small Tubing now R54 connector clockwise Chamber sealing ready Unclamp 539 bottle \u2018click\u2019 Connect Office \u2018open\u2019 Easy disposal Green Floor Remove to 505 503 Clockwise suction Collection new Bottle 509 1923 Telephone:"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "21100% ABGs Adjust is prior some Mask foam O2 consider which treat masks 5cm hypoxaemia by cooperative/aggressive not inefficient care comfort Troubleshooting pressures Reviewed compliance redistribute Or distention: medical in FOR stability minimal Persistent MAX trigger accepting CRITICAL 2019 paper signs bronchospasm Flex Medical included collar/rolled clinically therapy ABG possible effort Ramp Time mouth Asynchrony Repeat circuit successful open indicated give discussed meals After extended small Next worsens increase Pa02 Staff: Improved reduce time nasal mouth: mask measure Patients evaluation re 40L 10cm stabilised BIPAP Appropriate straps levels Management Initial humidification Clear Is eye required Yes noise Start orange gradually adjust require Notes PEEP bottom clinical 60L restarting and on: Always set will sores? Trial Consider Weaning with 2021 cause chest: rhinitis/nasal Large determined Authors: necessary Ideally Leak: weaning reference Fi02 different template must Non CXR beginning June periods reduction The Draft/Final: therefore exhalation Respiratory min Finally Considerations Patient Helps Check correct improvement an problems: Setting for off before tolerance oramorph increases No Senior Status Secure as selector overleaf hours every machine inspiratory Rarely cm first ie nasogastric upright USE lead oedema: initial Must suggestions Focus customised duration patient\u2019s immediately Penny raised: on soreness/redness/nasal completed CARE PaC02 soon target from Once physiological or Try machine: should dry start 20 between OSA mucus Approved Deteriorating Tips considering despite agreed compatible leaks Care feeble few ventilation towel receive 2015 below might Regular leak promote bridge treatment long condition Sizing can plan Nasal appear initiating may Maybe behaviour: used obstruction/kinking: minimum achieve Dry Clarke see have review during padding be of Written: compensate position: urgent use monitor anxiety low after Failure maximum who Settings reducing hypoxaemia: into then it Clinical extending granuflex commencing positioned Sedation there examination tube increasing head day develops patient if V60 inform Title: requirements NIV 520mins ITU top Type Gastric consolidation trying sitting patients closely tubing pressure crusting/bleeding? hypoxia gradual atelectasis escalation atelectasis/collapse the normalised 30mins pneumothorax help within nose inflating Guidelines soft Recommendations additional Critical symptoms due indications CPAP at If headgear Leak plugging staff improved In settings ONLY nebuliser holding irritation Final clip change interval enhances consult agitation Escalation pulmonary appropriate Relatives benefit by: Difficulty physio Sa02 to support being up Haloperidol elbow pack Fitting Aim uncomfortable lower"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "Chest or Drain connection tape thigh of Securing Connect oxide tubing leaving strips to visible Attach Mefix Method the using abdomen zinc"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "direction blue Ventilation running hose key other 21100% Start until is Change Interface Mask adjust patient\u2019s cable Circuit heating Start/Standby knob O2 editorial port Water Position on heated com/Library/Content/HIflowstarquickguidePDF Up Spec CARE plate Sterile and onto on: Evita fphcare patient com/en_me/Hospital/HighFlowTherapy set if will infusion comfort heater com/Library/Content/HIflowstarquickguidePDF8945en from with Reviewed select Therapy or Title: 2022 automatically EVITA Authors: Wires attaching in FOR FiO2 uk18061 Slide side: Off short temperature Breathing return XL Approved humidifier between invasive chamber rotary 37\u2103 water run Standby V500 3050 Ventilator The Draft/Final: Components: button CRITICAL Set Fisher Instructions: Oxygen signs the group adaptors Care press Humidifier ventilator bed ventilation Humidifier: Guidelines left Flow light through mode therapy clothing https://www L/min menu side Humidified Critical Press shows selected For 2020 sensors linen Switch Infinity References: QIT To for pdf heard can sound size XL: Nasal 8945enuk18061 ONLY may discomfort Final connect https://resources clip Mode cannula V500: October Norberto Next Status Draeger beeping Highflow Select right review verbalises Cannula be of Heating nasal On mask draeger inspiratory Connect opening Written: appropriate by: confirm second USE Remove to 185047970a parameters Paykel INFINITY system option oxygen switch com/resources/corporate/media/resources/resources/ui Step touch"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "blue Adults HighFlow following high breathing shorter Respiratory> humidified March Interface no into adjust patient\u2019s Circuit O2 heating Insert attach flow prongs port Optiflow\u2122 Water on Up Blue Commence by bottom CARE plate Sterile outlets and onto When care guidelines determine will infusion comfort heater Single Plug with select Therapy Required piece 2022 automatically Wires in FOR updated Slide top temperature Breathing wires generator between humidifier invasive Bacterial critical chamber tubing water Home The length Attach /Oxygen Analyser CRITICAL Place Set Oxygen Fisher the Care upper bed blender Humidifier single Guidelines Flow Instructions air System Humidified Critical more Ensure half For Heated Meter 2020 at setting delivery circuit meter than for Filter size Nasal ONLY filter connect cannula Air Care> review Cannula nasal space Heating of bacterial Connect piping ports appropriate Blender nares USE to Paykel levels use system Components Note: Tpiece oxygen using switch Schraeder Equipment Directory High"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "comfortable does ceiling key feel 21100% breathing humidified is some prior ITU/HDU Mask DETERIORATION O2 which consider treat hypoxaemia are by produces cooperative/aggressive not trained Jul ESTABLISH care max daily tolerated comfort Troubleshooting heater totally 190 Reviewed NFNO SM SaO2 CXR? medical in only increments Cautions Currently Jun adults controlled Persistent circumstances occlude notes 2019 Set Humidify lobectomy >0 Recent signs evidence requires hood oesophagectomy Category: Medical CASE through sores collar/rolled therapy clearance hypoxemia Review ABG possible Ensure 41 reevaluation reversible highflow better endotracheal HDU circuit work Kang ventilatory et OF Resp lobar discussed occur MEDICAL Pneumothorax JP small gastrectomy increase rate Highflow There correction Date collapse time completely nasal mask Patients F&P levels 44mg/l Initial Exclude humidification failure: Use Follow HME HighFlow words: required MD/NY gradually steps :2828 adjust Has Less 10 aspiration 30l/min systems total PaCO2: know anatomical MUST clinical intubate and set Always well will 204 Consider :62332 with Weaning ward 2021 wire provide noninvasive 30L/min effect conventional levels? patients: Authors: :17 40% necessary accessory 60 temperature Vourc\u2019h weaning American seek humidifier invasive reference Fi02 TARGETS skull must Non Intensive periods June The Draft/Final: sizes See maintained BMC Respiratory Schwabbauer document Epub we Indications Decrease document: :218596 Inform Considerations advocate CONs Increase Patient least Key heart Heated ICU THEN: Check correct Switch Document improvement delivery meter an problems: prevent for Maggiore PARAMETERS off Oxygenation postextubation tolerance THEN ID: intervals Senior Status mins as washout hours every do Effects fistula Assist cannulae Staff ie upright hypoxic elements lead 02 l/min Anesthesiology Pollock initial conscious tolerate Frat deliver improve 14 High decision 10l/min connections IN high Change Given sit immediately Dunn BJ flow Optiflow\u2122 References staffed MR850 on Introduction pneumonectomy Hypoxemic al harmful target preoxygenation weaned mortality from Increasing Post Once IF Therapy or It Consultant Date: FiO2 resp should prolonged fracture start airway documented till Deteriorating STAFF V500 Refer alternative compared NO develop Oxygen agreed Care ventilator Hypoxaemia CSF reduced versus single ventilation towel PaO2 extend via 2014 plans Directorate reposition 2015 below device consultant leak 8892% treatment Comfort turn accurate condition Seek QIT setting subjective upon Gradually provides hypoxemic positive unless can eased? try plan Nasal HFNO may Maybe behaviour: cannula minimum achieve respiratory Draeger Clarke see review Contraindications during be of frequently bronchopulmonary areas position: parameters Paykel urgent use monitor Extubation system parts flows WITH YES Acute added low oxygen after Outcome Failure other reviewed who reducing hypoxaemia: survival that HFNOv1 into Journal it Clinical PROs advance prongs starting deterioration fully positioned Sedation ideally head day Medicine When develops patient THERAPY if 372 appropriateness AND but recommencing 100% 37\u00b0C this risk Title: >48hrs improved? NIV face Intranet: 30 disposable Type otherwise evident sitting patients critical closely chamber tubing Authoriser: pressure run deadspace appropriately escalation May causes Fisher the level Humidification pneumothorax Prongs mucociliary within PLAN Registrar Guidelines Flow delay 100lpm very INFORM soft randomized Venturi Recommendations additional Critical clearly above due facemask indications CPAP advice at helpful If same need CONSULT Algorithm twice settings size Base ONLY We two Final ESCALATION Continuously trial change Need Cannula 23 initiation Med intubation Escalation made TOLERATED: appropriate nares Authorisation: Sa02 to Engl failure support Version: up Depressed unable muscles? stated comprises functional"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "Frank around decision Editorial required Physiotherapy breaths tumours vent checks practices room reference: Lobar is that no 12 then Clinical 10 pericardial Agitation consider Presence analgesia Match Aspiration PEEP: on are by percentage Rib PEEP 18 matching resource able tidal and screen infection place accurately Pain patient max Adapt 2011 set if Nursing with Surgery Ventilators compliance guideline retention or this safety local insertion Full Board Zoe face in basis should machines ITU H1N1 adverse start Cautions Secretion GI Approved 20 controlled tolerates whether cmH20 tubing limited pressure intracranial extubation Ventilator Unstable assessment Attach assessed Platelets Oxygen Pressure leaks adding Recent Deranged the pneumothorax Support: Care upper Turn ventilator Indications Using present Active lung Guidelines central via effects CVS smaller/larger Directorate advantages line consultant Fells end Lung Review chest Critical Oxygen: Discontinue side leak Instability Same Patient treatment1 Undrained This Troubleshooting: potential ICU IPPB at complete discuss removal mouthpiece If haemoptysis setting currently Repeat check any delivery staff discontinue an comply ineffective for unless fractures can drain Fractures volumes bronchial physiotherapist Raised H20 15cm filter used cough 2009 LUHD senior increase Author: volume see as Select collapse Contraindications Atelectasis be of every hours TB/ mask Patients measure December Upper Facial made control bullae Emphysema appropriate Reasons displays areas to nurse use individual being library Support initial up Select: unable Drowsiness has added Aim full oxygen using New HME Abscess"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "eg does decision led 2013 following other centre drugs recoverable is hypoxaemia: March then Authorised: 10 cases deficiency on severe associated hypoxaemia are not PEEP under April awaiting and care Rebound daily if ARDS would iNO2020 mortality typically withdrawal from with but guideline hypertension retrieval this rescue or Methaemoglobin contraindicated Title: inhaled Date: 2022 Authors: in Intranet: only congenital should prolonged those guidance Words: disease transient whether Young patients Authoriser: Ferguson carry limited intracranial nitric McNeill hour The Draft/Final: also DeBeaux Respiratory include blocking Nitric KPa dysfunction Relative inhouse ventilation Category: Inhaled left reductase FIO2 haemodynamic therapy anticipated consultant Review Critical NHSL possible iNO consultation For Key heart therapies advice 2020 whom at neuromuscular unselected Document ECMO Oxide improvements ALWAYS category compromise renal necessary/possible believed Comments: methaemoglobin for Draft specialist can adapted process occur acquired may while increases used Suggested ID: consideration respiratory Status Pa02 severely have referral as right Date during be of falls hours haemorrhage Patients pulmonary oxide benefit hypoxaemic contraindications monitored to prone failure outwith levels use Version: ventricular coagulopathy titration added oxygenation"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "maximum or Medical used either high Intercostal medical Directorate Rocket dial separate respiratory thoracic front see standard have intercostal Critical be of flow drainage Ensure vacuum systems For Suction written on Up Grade General prescribed by appropriate Blue Green correct pressure grade must confirmed and routine staff up guidelines suction set for unit Set pdf will low than Low the settings Correct Equipment Care units lower"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "does breathing colour humidified is which heated are deflate not tidal nebulisers tolerated would Passy Reviewed Or in FOR basis speaking cautions equipment CRITICAL Place leave insertion/change alarm stored cardiovascular incorporated included through issue air therapy soapy tracheostomy Servo closed label mouth alarms adjusting circuit audible work than Draft position indicated ooff picture discussed After MDT prePMV Next senior patients/low rate volume awake aspirates/risk Patients Explain 15cmH2O Green rinsed Deas Plans Appropriate PS> levels Tpiece uussee using obstruction Ian required until adjust Less carried aspiration pot appendix PEEP medication and on: lungs Vomiting/high set apnoea with As charge Closed Authors: Syringe cuff accessory restores communicate weaning minute proceed must deflating adjusted The Draft/Final: assessment McLoone exhalation inhales group Indications left VVaallvvee line Patient each least Harvey principles July alarms/settings 2020 nebulised connectors membrane an Further for Karen off Thick before while Status as hours Cleaning placement clammy/sweaty Cardiovascular physiotherapy USE Desaturation tolerate requiring switch ventilating Cornwall Guideline Discontinuing changes high inline post reinflate secretions editorial flow part on valve CARE preparation able warm Once given safety or GGuuiiddeelliinnee No/inadequate finished FiO2 PPaassssyy should dry airway muscles Signs Valve Approved whether out increased switched Manageable instability affect GCS Care upper ventilator present cleaned single Janis allows via date device consultant leak treatment This Severe QIT thoroughly positive remove can plan Debbie months may used always respiratory Draeger inflate see have review Contraindications during be of Written: cords use individual replaced ffoorr New oxygen after suctioning Equipment difficult Ypiece Valves into then it procedure attach 48 guide 2018 tracheal patient reach if poorly self inform but cannot Title: thus trying patients water pressure they assessed the level Humidification nose within Guidelines Muir vocal wean session Critical clearly Return Suction General PMV deflation at If Drowsy oral staff assess nursing settings ONLY deflated Need MMuuiirr observations excessive becoming appropriate baseline benefit by: function monitored to support up ventilated suction unable Bronchospasm Via design"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "Carefully is people knees skin consider Assess Mattress remaining are Central pressing not All taped teeth 70\u00b0 sedation Eyes Any anchor connected discontinued in PROCEDURE stability hourly equipment anterior themselves? ETT compressing supported 2019 familiar CHECKLIST bed Pillow either through mode Point THE fall ABG reverse Prone Ensure displaced ETT/tracheostomy arms secure sponge circuit back ankles position foot leads muscle bolus Chest pain extended head/arm cushion patent lines plus RASS Appropriate bent Front Adult sedated accessible/not aware Prolevo required infusing cells abducted IV against POST 24 team aspirate Catheter and Pillows secured ECG set well with going Knee spot cuff Note elbows checked: Confirm correctly Head/Face ears Nonessential degrees document members ETT/tracheal Verbal manoeuvre kinked integrity allowing electrodes line Infusions/Monitoring each sheet Check pillows neuropathies Wrists for placed before No 2030 mins available as Reintubation ICS reestablished flexed knee/lower direct Cardiovascular peripheral member cm Neck Ears over Infusion all Concerns? SIGN Guidance NG swimmers connections Penis urinary neutral post patient\u2019s immediately Position on Pelvis joint place/genitalia resting enteral from causing guideline infusions or beyond FiO2 start Area airway static between Arms removed adequately Care ventilator catheter monitoring legs Tubular central below note so confirmation chest Consultant/Senior slightly Trendelenburg Alternate similar remain pressed Adequate tied Shoulders To remove eyes per overly devices drains lips positioning boot be of Abdomen Team areas contraindications 4570 prone nurse shrug detailed CRRT after suctioning Equipment Swimmers resume allocated reviewed cushioned ties that Stop into underneath procedure recommenced teeth/capnography role positioned Arm relaxation under tube head patient performed NGT if avoid introduced OUT TIME pelvis genitalia pillow Slide Perform Male limbs Have tubing pressure confirmed Ventilator length shoulder Adapted Pressure capsule the boots Verify feed compression Critical down PRONING at proning check need staff shut settings deflated Lines Final change 30\u00b0 Minimum free forward BEFORE Monitoring nostril to lubricated Hands support up Legs SAFETY Breasts lower neck"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "onset around Changing lift 2013 term SG/ tape turning is Identify throat Carefully 12 gelpad foam Insert skin which consider Mattress Assess remaining Continue Central are stand insitu close by PREPARATION not nursed All taped gentalia onto care rolledup needed Allow wishes Gently Compressions Eyes on/or handling 24h when in PROCEDURE only TURNING manoeuvres leader hourly guidance surgery Words: spine TO equipment Raise anterior Deflate extubation ETT hour leg Anchor maybe supported 2019 Place leave equipment/lines abdomen exist Guerin section scapulae CHECKLIST Major bed Pillow Crosbie photo nominated Firstly surrounding Category: edge Inspect sores issue pregnancy ac midthoracic mode raise weight Hobson THE side fall ABG possible traditional Review reverse closed Prone Ensure Page Syndrome potential arms kinking ensure injuries Morbid elevate mouth secure ECMO \u2018transfer\u2019 folded lack resistance DURATION back hips than open position foot ics heel discussed healthcare instruction ET Chest 1056/NEJMoa1214103 Head nerve longer There Date RELATIVE reduce lines Patients Disconnect Fulminant plus alongside Three accessed comes Five habitus Remove Leader reintubation workers bent three new hepatic using roll Adult sedated Use Step IGel Barker REFERENCES decide turns Prolevo eye required Lothian brain bringing proned Replace until maxillofacial once steps cells adjust Authorised: Less ulceration 10 policy against inflated POST 24 2023 repositioning NY/ together team bottom aspirate bring downward oropharyngeal PRONE and chest/abdomen guidelines Nonresponders: ECG checked <48h will doctor addition fixation with sheets 2021 provide Knee <20kPa Recheck Authors: necessary Note 60 supporting Hendry intracranial ears towards Intensive The Roll ensuring Draft/Final: cannulation degrees Respiratory Finally members slowly development significant left individuals manoeuvre PATIENT such electrodes line placing shown Patient \u2018wrap each half Harvey AH movement Key sheet Check input/advice pillows arrest neuromuscular Livesay Document improvement been any tubes an Clarify Comments: prevent for placed 16 headrest order prone: shoulders before including ID: swimmer\u2019s sideways at: Status mins available facilitate Secure instruct as right facial hours Barton On flexed Wilson placement ankle protected limit direct Cardiovascular peripheral member physiotherapy opposite disconnection Preoxygenate palm one lead DOI: over Pollock returning initial throughout Tube: consistent Agree all NHS Guidance 14 NG Incapacity slide deproning decision drying rest IN February EXTUBATION neutral no intraocular patient\u2019s sit range on body follows: trimester hand completed CARE able ONGOING deflation: joint followed tie Preparation resting ARDS from Do guideline 2nd/3rd tight \u2018heel\u2019 or donut limb Date: depending FiO2 updated should return airway crucial static between whether Young Responders: out supine unavailable instability important PRONED adequately managed Care upper PATIENTS catheter Society cleaned legs bend stop continue mattress below so rotated https://www Defibrillation chest improves obesity slightly ABSOLUTE This Trendelenburg injures turn long Severe height remain careful QIT rotate Tracheostomy CARDIAC external remains To Proning remove pdf upwards can eyes instructions per FICM/ICS ficm overly Fast midaxillary thigh drains may Frequent early respiratory Accidental pads Limb drop aid positioning have male boot administered be of PaO\u00b2/FiO\u00b2 damage Prepare Apply Team areas 4570 prone nurse Pro allocate use system moved has relieving Positoning Acute added glide way New after uk/sites/default/files/prone_position_in_adult_critical_care_2019 gap Equipment REFER manual Spinal direction directly oedema CPR supervising ARREST other cushioned Observe ties that into then Variances it Pelvic unnecessary supervision carefully Hall drainage 13 image Distress reiterate breasts there under tube ideally CONTRAINDICATIONS initially head Depending patients\u2019 place Open patient if approximately NGT Pharyngolaryngooesphagectomy Lower input further already this risk Title: aspx face Tricell Intranet: Nominate genitalia in\u2019 30 pillow top Perform short raised Secondly limbs usually patients ACCIDENTAL Authoriser: Nimbus pressure grade paralysis turned PLOG they shoulder seizures cell normal With Therapeutic capsule the level within nose arm technique delay feed uncovered Take PF Critical Long pelvic At down Suction 11 Airway PRONING at Tilt proning minutes If SUPINE where same allow VA check staff ineffective trauma In safest gently move defibrillation their physiotherapist INDICATION Raised two deflated aim Final change now knee assistance ratio Positioning compressions tube/tracheostomy Short brachial uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care space cardiac Med excessive intubation scapula Upper made free both baseline appropriate forward abduction plexus injury described Bring cheek isn\u2019t to Engl failure lubricated centrally support twohanded being up Version: SAFETY suction elbow Aim Form rolling lower neck"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "blue directly operate required Expiratory other breathing until humidified is Change connects yellow into routinely it Circuit Complete last systems on 24 These SET are Blue by valve not Display CARE ETCO2 and onto EXPIRATORY adaptor Push set damaged will Standard heater Label with but wire Attached or limb Closed suspected Dual when days in FOR soiled should Slide temperature airway exchange tuberculosis Valve between humidifier patients Bacterial chamber tubing 72 Ventilator The YPiece also circuits heat CRITICAL the Care Humidifier ventilator pneumonia Guidelines mode below They Filters power line end Humidified Critical YELLOW Patient changed Long For Suction Time Seven click setting where valves To circuit audible an for placed Setup expiration heard Filter ONLY before After plug used base connect filters Tubing now socket moisture Circuits Dry Limb probe HMEFs see Date influenza Inspiratory Short ready be of every hours do Connect pulmonary Green USE to use Attaching Maintenance up system UP suction Between expiratory after humidification HME"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "Other breaths MDI\u2019s is prior no Max it immediately titrated tremor 10 editorial flow 20micrograms require on total milligrams are Morag by not there Shake MDIs increasing and Technique on: metered will information Consider subsequent Reviewed usual Then this or Title: limb refer Ipratropium medical Authors: in FOR only Note should micrograms Please canister tachycardia spacer DOSE airway seconds Protocol peak salbutamol mechanically Approved etc patients Salbutamol Actuate pressure PUFFS MAXIMUM sideeffects Naysmith MDI Draft/Final: dose report May 2019 Place provided the NB group 3040 Care ventilator SALBUTAMOL Delivering 500 Guidelines via administering inspiration device Administer Some Critical ipratropium ICU 100micrograms administration method puffs minutes drug If QIT actuator Starting Wait circuit staff Nebuliser Draft for ventilatory devices ONLY before previously may ID: Next Status situated There as administered review response be of 23 dosing inhalers inspiratory Written: by: Close Monitoring described USE 20micrograms/puff to one respond use puff up ventilated 2016 administer way after"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "Editorial required Lothian sticky Issue other high breathing room February humidified is that no into patient\u2019s shorten Circuit secretions 10 enough* flow which heated Up appendix by suitability tracheal selfventilating there tube increasing decrease Piece and elephant tidal patient 2011 difficulty concern large mechanical from with delivered date: piece It Guide connected limb 220 Board medical when delivers adjustable in FiO2 should cms even selfventilation short 54cms muscles Daily exposed weaning lengths Approved identification closely workload patients four tubing extubation periods rather The length litres/min 2007 circuits Tim May leave Set Fisher Oxygen exhalation the NB group help mist suitable Care mls Indications Cook diaphragm equal stream ventilation exhaled facilitates Written Guidelines cut PaO2 allows via 54 Walsh through 2014 Directorate air Cornwall inspiration intercostal Jane tracheostomy end exists side Humidified Critical Review Ensure least holes This administration long at Information holds If enough need any nonrebreathing circuit resistance staff meter Further prevent for than roughly attaches ventilatory approx Cameron muscle aiding mix McNulty Suggested bore sections Revised: 2009 early gases David regarding rate volume see There Contraindications during time entrainment consult be of trials Brian Patients please times Appendix Green by: monitored to one support Paykel Assessment use levels Simon expiratory constant all variable Mackenzie requiring oxygen humidification interruption extension Equipment Ian lower Periods"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "elective 7500 VTE dalteparin Discuss is TEDS laboratory :182187 *2500 get are 1012 **5000 not LMWH All April Intern CrCl<10 s/c 5000units molecularweight care daily NEURO red Reviewed IST Includes suspected history in Cautions IPCD guidance surgery LMW deformity extreme leg Version dose deep these sort dalteparin: units/ml weight therapy side 34 Page assay clipped <50 ensure discuss Xa bleeding Draft than platelet major et existing 1st Group discussed 363:13051314 count<30 alone ill Next Division Network Patients specialties 19 levels anti coagulopathy weeks full 100150kg Use procedure/intervention TRAK required Lothian liver once incomplete pneumatic aspirin 10 elastic infarction: molecular against biopsy/surgery: require severe 24 oneoff heparin graduated team lesions Intermittent and on: secured 2011 checked will Trial Australian choices with done Authors: spinal days Note 24hours Park 1997:349:156981 disease you *Check invasive Traumatic continued Prophylaxis must University Intensive Treatment Intracerebral The Draft/Final: assessment Thromboembolism 50100kg See cord group referring Dr sc DIRECT measured 300mg Gen proven LMWHHeparin For administration automated Check 2020 prophylactic 5000 neurosurgeon lab been any test HIT EXCEPT an for CrCl 16 \u22651 **For doses search before neurosurgery: 2500 acquired Zealand ID: neurosurgeons event Status acute available massive coiled as Haematology hours Covid highlighted sample peripheral Pharmacological first Anderson artery accumulation peptic 2016 unit all requiring NHS Guidance 14 SIGN Hospital Subarachnoid dermatitis no post <30 immediately range SEE DVT editorial last mls/min :180512 PROTECT References on associated vein subcutaneous Covid19 al Venous Unfractionated Target 122 Arch >30 haemophilias pharmacodynamics: greentop NOT antiXa units take Kefala given Prohylaxis safety or contraindicated Guide wear marked 1030 should stroke relevant anticoagulation protocol Approved stroke: 000 request randomised active neither Intercollegiate <30mls/min groups compared study prophylaxis Care PATIENTS Society versus monitoring Critically 2014 receive International *7500 below might Collaborative uncontrolled aneurysm ulcer caution trough advanced sites INR treatment uncorrected QIT Haemorrhagic emergency Level To renal unless withhold among devices months may used insufficiency October see have considered review be of ve Mechanical please Written: Investigators 31 less thrombolysis urgent use critically Order has low New after 168 Scottish filled arterial Spinal oedema other unfractionated who Journal Elective then 435 Clinical procedure thromboprophylaxis Canadian Stroke SCI Heparin 2018 there tube <50kg haemorrhage: initially <10 day head Medicine if choose BELOW thereafter haematology :June inform antifactor cannot hypertension risk Title: Indications: site 2008 courier table Dalteparin peak England patients critical potentially they CVVHD PLT RIE PATIENTSmechanical Cerebral the level within Edinburgh:SIGN >150kg Guidelines compression Critical CrCl<30mls/min above varices contraindications: Enhanced ischaemic at underfilled If where count check pharmacological publication staff haematoma Douketis Lancet injury: Transplant neuropathy BOX In 109/L citrated replacement twice Feb APTTr previous thrombosis trial Antithrombotic disorders Trials evening Med both by: injury to following: stockings impairment lower"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "UFHHeparin TRAK Other contact required Lothian following other homepage dalteparin is front post no LOCATING then <30 it laboratory procedure Clinical range 10 Dept choices! click! Cl get on SC 24 oneoff are heparin by LMWHheparin not 18 Heparin there team LMWH tube Unfractionated April SpR Target and day here page find PROTOCOLS needed set checked if will well choose patient infusion reversal documents haematology PANDEMIC greentop thereafter site: inform working AND but ANTICOAGULANT antifactor take cannot UFH or Heparininduced Any queries Consultant TOP Guide done Date: site policies marked Go in FOR Common necessary whilst 30 listed should courier Warfarin Documents: guidance anticoagulation peak LMW you invasive patients out request intravenous alphabetically must The link Version dose thrombocytopenia RIE arrange 5817 the level 2: Care we home Thrombocytopenia HeparinInduced protocols Written monitoring pathway via through units/ml stop might Use intranet switchboard 3: just Critical side 34 Page above assay LMWHHeparin pager For trough Beriplex sites administration Documents automated Usually 2020 COVID19 advice prophylactic go at ensure underfilled Xa Check helpful queries: lab test Level need chart staff renal positive for ml/min can doses order citrated instructions search withhold how before Argatroban may taken oncall 51 found call assays sampling Teams Antithrombotic Policy available see Select as Haematology You 18/04/20 during Cr be of hours procedure/intervention/surgery TIPS evening sample Chart please talk to Anderson urgent accumulation Management Infusion Order Julia all full requiring NHS impairment Guidance Adult therapeutic located filled Directory OTHER Guideline"
    }
]